##GENOME_BUILD=GRCh38
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 2021_12-139-gf78f8476
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous counts of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype counts of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140549_01	GS140550_01	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	1022518	1022518	G	T	hom	hom	het	off-target	QUAL=3744;DP=63,45,56;AF=0.98,1.00,0.64;MQM=60;SAP=305;ABP=13	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+56G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron2/38:c.463+56G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron2/36:c.463+56G>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron2/36:c.463+56G>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/37:n.534+56G>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677944 [benign DISEASE=not provided];			rs2799064	0.3451		9381,.	33649	99475	-0.4950			2.94			COSV65071508	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041950	1041950	T	C	hom	hom	hom		QUAL=1742;DP=13,20,26;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron6/38:c.764-6T>C::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron6/38:c.1178-6T>C::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron5/35:c.863-6T>C::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:XM_005244749.3:splice_region_variant&intron_variant:LOW:intron6/36:c.1178-6T>C::,AGRN:XM_011541429.2:splice_region_variant&intron_variant:LOW:intron6/36:c.1178-6T>C::,AGRN:XR_946650.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron6/37:n.1249-6T>C::	regulatory_region_variant:promoter_flanking_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128292 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2799066	0.9233	0.7112,0.9515,0.9998,0.9180,0.9530	58337,.	15313	19177	-0.8440			0.67		6.81>6.95		0.12	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1042190	1042190	G	A	hom	hom	hom	off-target	QUAL=1524;DP=18,15,21;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.970+28G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1384+28G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1069+28G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron7/36:c.1384+28G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron7/36:c.1384+28G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/37:n.1455+28G>A::	regulatory_region_variant:promoter_flanking_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263159 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs2710876	0.8973	0.4355,0.9316,0.9726,0.9149,0.9451	50662,.	18508	32242	-1.7260			0.18				0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1043224	1043225	CT	-	wt	wt	het	off-target	QUAL=1477;DP=58,167,186;AF=0.00,0.00,0.46;MQM=60;SAP=132;ABP=6	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.971-15_971-14del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron7/38:c.1385-15_1385-14del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron6/35:c.1070-15_1070-14del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron7/36:c.1385-15_1385-14del::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron7/36:c.1385-15_1385-14del::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/37:n.1456-15_1456-14del::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263160 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs35881187	0.5514	0.0943,0.6972,0.7858,0.5385,0.5463	18381,.	30472	84478	-0.1120			4.43				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045707	1045707	A	G	hom	hom	hom	off-target	QUAL=5739;DP=67,51,64;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron14/38:c.2123-26A>G::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron14/38:c.2537-26A>G::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron13/35:c.2222-26A>G::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron14/36:c.2537-26A>G::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron14/36:c.2537-26A>G::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/37:n.2608-26A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263172 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified,not provided];			rs3128098	0.9206	0.6365,0.9462,0.9999,0.9247,0.9552	56727,.	16419	22233	-0.8630			1.44				0.11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1046551	1046551	A	G	hom	hom	hom		QUAL=6187;DP=51,70,93;AF=1.00,1.00,1.00;MQM=60;SAP=5;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon18/39:c.2652A>G:p.Ser884=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon18/39:c.3066A>G:p.Ser1022=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon17/36:c.2751A>G:p.Ser917=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon18/37:c.3066A>G:p.Ser1022=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon18/37:c.3066A>G:p.Ser1022=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon18/38:n.3137A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128297 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2465128	0.8865	0.4974,0.9296,0.9677,0.9059,0.8885	51078,.	19390	30092	-1.0320			0.11			COSV65068047	0.01	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047561	1047561	T	C	hom	hom	hom	off-target	QUAL=9183;DP=47,105,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron20/38:c.3103-12T>C::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron20/38:c.3517-12T>C::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron19/35:c.3202-12T>C::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron20/36:c.3517-12T>C::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron20/36:c.3517-12T>C::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/37:n.3588-12T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263181 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs3128102	0.8963	0.4469,0.9319,0.9726,0.9133,0.9443	51078,.	18612	31360	-0.1470			2.44		6.84>6.29		0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047614	1047614	T	C	hom	hom	hom		QUAL=15498;DP=140,142,208;AF=0.99,1.00,1.00;MQM=60;SAP=11;ABP=0	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon21/39:c.3144T>C:p.Phe1048=:PF01390 [SEA domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon21/39:c.3558T>C:p.Phe1186=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon20/36:c.3243T>C:p.Phe1081=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon21/37:c.3558T>C:p.Phe1186=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon21/37:c.3558T>C:p.Phe1186=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon21/38:n.3629T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128302 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs10267	0.9083	0.5251,0.9388,0.9995,0.9167,0.9527	53403,.	17888	27446	2.1470			7.24			COSV65071416	0.01	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1048922	1048922	T	C	het	wt	hom		QUAL=588;DP=9,17,19;AF=0.67,0.00,1.00;MQM=60;SAP=7;ABP=5	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon24/39:c.3747T>C:p.Thr1249=:	AGRN:NM_001305275.2:synonymous_variant:LOW:exon24/39:c.4161T>C:p.Thr1387=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon23/36:c.3846T>C:p.Thr1282=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon24/37:c.4161T>C:p.Thr1387=:,AGRN:XM_011541429.2:synonymous_variant:LOW:exon24/37:c.4161T>C:p.Thr1387=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon24/38:n.4232T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128307 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs9442391	0.5883	0.2729,0.7050,0.8196,0.5652,0.5594	20786,.	34643	74961	-1.2460			0.61				0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1049886	1049886	C	T	het	wt	hom	off-target	QUAL=584;DP=8,11,20;AF=0.50,0.00,1.00;MQM=60;SAP=3;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron26/38:c.4331-17C>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron26/38:c.4745-17C>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron25/35:c.4430-17C>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron26/36:c.4745-17C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron26/36:c.4745-17C>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron26/37:n.4816-17C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263188 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs2275813	0.5575	0.1480,0.7111,0.8103,0.5353,0.5454	18221,.	31986	82908	-1.7470			1.60		11.49>11.28		0.14	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050064	1050064	G	-	hom	hom	wt	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+41del::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+41del::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+41del::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+41del::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+41del::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+41del::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+41del::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292619 [benign DISEASE=not provided];			rs71576592	0.5472	0.7422,0.5306,0.6485,0.4549,0.4871	19472,.	34173	60513	0.0280			0.38				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050066	1050066	G	T	wt	wt	het	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=10;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+29G>T::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+29G>T::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+29G>T::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+29G>T::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+29G>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+29G>T::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+29G>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263191 [benign DISEASE=not specified,not provided];			rs2275812	0.4151	0.1015,0.4381,0.1553,0.4588,0.4611	9412,.	30480	90870	-1.2390			0.55			COSV65067816	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050069	1050069	G	A	wt	wt	hom	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=4;ABP=3	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+32G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+32G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+32G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+32G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+32G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+32G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263192 [benign DISEASE=not specified,not provided];			rs2799067	0.5832	0.2618,0.5481,0.5050,0.6172,0.6162	13928,.	32696	47336	0.1660			1.25			COSV65067820	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050070	1050070	G	A	hom	hom	wt	off-target;low_conf_region	QUAL=303;DP=4,8,6;AF=0.75,1.00,0.00;MQM=60;SAP=13;ABP=0	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+33G>A::	AGRN:NM_001305275.2:intron_variant:MODIFIER:intron27/38:c.4879+33G>A::,AGRN:NM_001364727.2:intron_variant:MODIFIER:intron26/35:c.4564+33G>A::,AGRN:NM_198576.4:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:XM_005244749.3:intron_variant:MODIFIER:intron27/36:c.4879+33G>A::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron27/36:c.4879+33G>A::,AGRN:XR_946650.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4950+33G>A::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1232566 [benign DISEASE=not provided];			rs397834473	0.5028	0.6971,0.4836,0.6056,0.4288,0.4499	19437,.	34644	72688	-0.3950			0.59			COSV65068887	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051820	1051820	C	T	hom	hom	hom		QUAL=10531;DP=63,134,150;AF=0.97,1.00,0.99;MQM=60;SAP=113;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron34/38:c.5249+5C>T::	AGRN:NM_001305275.2:splice_region_variant&intron_variant:LOW:intron34/38:c.5663+5C>T::,AGRN:NM_001364727.2:splice_region_variant&intron_variant:LOW:intron33/35:c.5348+5C>T::,AGRN:NM_198576.4:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:XM_005244749.3:splice_region_variant&intron_variant:LOW:intron34/36:c.5663+5C>T::,AGRN:XM_011541429.2:splice_region_variant&intron_variant:LOW:intron34/36:c.5663+5C>T::,AGRN:XR_946650.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron34/37:n.5734+5C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128317 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs9803031	0.8871	0.4387,0.9320,0.9957,0.9082,0.8828	50443,.	18847	32349	-1.1710			0.73		9.65>8.73		0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1054900	1054900	C	T	wt	het	het		QUAL=4766;DP=100,174,207;AF=0.00,0.51,0.59;MQM=60;SAP=309;ABP=12	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon39/39:c.5712C>T:p.Asp1904=:PF00054 [Laminin G domain]	AGRN:NM_001305275.2:synonymous_variant:LOW:exon39/39:c.6126C>T:p.Asp2042=:,AGRN:NM_001364727.2:synonymous_variant:LOW:exon36/36:c.5754C>T:p.Asp1918=:,AGRN:NM_198576.4:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:,AGRN:XM_005244749.3:synonymous_variant:LOW:exon37/37:c.6069C>T:p.Asp2023=:,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5992+349C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6140C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128319 [benign DISEASE=Myasthenic syndrome, congenital, 8,not specified];			rs4275402	0.6764	0.3114,0.7722,0.8138,0.6980,0.6133	28830,.	32220	62120	-0.7120			0.31			COSV65070964	0	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055000	1055000	C	T	hom	het	het		QUAL=12295;DP=158,330,428;AF=0.97,0.44,0.49;MQM=60;SAP=121;ABP=10	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*19C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-377C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6240C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263157 [benign DISEASE=not specified];			rs3121561	0.3513	0.5233,0.2137,0.1794,0.2920,0.3087	10237,.	32927	98619	-0.4130			0.50			COSV65069616	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055037	1055037	T	C	hom	het	het		QUAL=16508;DP=186,389,502;AF=0.99,0.46,0.49;MQM=60;SAP=15;ABP=8	AGRN	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*56T>C::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-340T>C::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6277T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292868 [benign DISEASE=not provided];			rs2465136	0.3856		12824,.	32989	93421	0.2810			13.13			COSV65069776	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055137	1055137	C	T	hom	het	hom		QUAL=18346;DP=119,285,371;AF=0.99,0.48,1.00;MQM=60;SAP=198;ABP=4	AGRN	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,:ENST00000418300.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*156C>T::,AGRN:XM_011541429.2:intron_variant:MODIFIER:intron36/36:c.5993-240C>T::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon37/38:n.6377C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1185529 [benign DISEASE=Myasthenic syndrome, congenital, 8,not provided];			rs2710872	0.8800		59057,.	15807	18271	0.1560			6.08				0.05	32314116	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055393	1055393	C	T	hom	het	hom		QUAL=22413;DP=180,296,404;AF=1.00,0.54,1.00;MQM=60;SAP=86;ABP=7	AGRN	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+178C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*412C>T::,AGRN:XM_011541429.2:synonymous_variant:LOW:exon37/37:c.6009C>T:p.Pro2003=:,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6472C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799072	0.8172		51702,.	20907	27811	-1.0550			5.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055426	1055426	G	A	hom	het	hom		QUAL=24597;DP=214,311,448;AF=0.99,0.54,1.00;MQM=60;SAP=60;ABP=7	AGRN	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+211G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*445G>A::,AGRN:XM_011541429.2:3_prime_UTR_variant:MODIFIER:exon37/37:c.*27G>A::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6505G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799073	0.8173		51712,.	20902	27798	-0.1780			2.88				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055604	1055604	G	A	hom	het	hom		QUAL=15857;DP=145,190,272;AF=1.00,0.59,1.00;MQM=60;SAP=270;ABP=16	AGRN	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,:ENST00000418300.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.184-294G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::	AGRN:NM_001305275.2:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::,AGRN:NM_001364727.2:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:NM_198576.4:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:XM_005244749.3:3_prime_UTR_variant:MODIFIER:exon37/37:c.*623G>A::,AGRN:XM_011541429.2:3_prime_UTR_variant:MODIFIER:exon37/37:c.*205G>A::,AGRN:XR_946650.2:non_coding_transcript_exon_variant:MODIFIER:exon38/38:n.6683G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs8014	0.8838		59543,.	15418	17680	-1.8980			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	2024923	2024923	G	A	hom	het	het	off-target	QUAL=6547;DP=80,172,170;AF=1.00,0.49,0.48;MQM=60;SAP=84;ABP=4	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron1/7:c.69-19G>A::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron1/8:c.69-19G>A::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron1/8:c.69-19G>A::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron1/8:c.108-19G>A::,GABRD:XM_017000936.1:missense_variant:MODERATE:exon1/8:c.755G>A:p.Arg252Gln:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256824 [benign DISEASE=not specified];			rs2376805	0.8127	0.7935,0.7394,0.7174,0.8311,0.7722	50293,.	23074	28492	-0.2210			4.09		7.68>6.22	COSV66080160	0.02	25741868,20561060	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025598	2025598	T	C	het	wt	het		QUAL=6779;DP=156,340,399;AF=0.53,0.00,0.49;MQM=60;SAP=77;ABP=3	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon4/8:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]	GABRD:NM_000815.5:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:,GABRD:XM_011541194.3:synonymous_variant:LOW:exon4/9:c.369T>C:p.Gly123=:,GABRD:XM_017000936.1:synonymous_variant:LOW:exon3/8:c.1035T>C:p.Gly345=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256823 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs2229110	0.6546	0.7305,0.4736,0.3137,0.6572,0.4740	33171,.	33152	52502	-1.2170			12.60			COSV66080001	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025781	2025781	G	-	het	wt	het	off-target	QUAL=1292;DP=52,54,75;AF=0.44,0.00,0.52;MQM=60;SAP=138;ABP=3	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron4/7:c.470+45del::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron4/8:c.470+45del::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron4/8:c.509+45del::,GABRD:XM_017000936.1:intron_variant:MODIFIER:intron3/7:c.1175+45del::	regulatory_region_variant:promoter	137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs3831907	0.1288	0.2114,0.0549,0.0248,0.1141,0.0777	1489,.	16610	132514	-3.0860			0.76				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029235	2029235	C	T	het	het	wt		QUAL=4927;DP=119,265,386;AF=0.49,0.56,0.01;MQM=60;SAP=18;ABP=7	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon7/8:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon7/9:c.900C>T:p.Ser300=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:	GABRD:NM_000815.5:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:,GABRD:XM_011541194.3:synonymous_variant:LOW:exon7/9:c.855C>T:p.Ser285=:,GABRD:XM_017000936.1:synonymous_variant:LOW:exon6/8:c.1521C>T:p.Ser507=:		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256825 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided];			rs28408173	0.1918	0.0319,0.2378,0.4717,0.1428,0.2543	1790,.	15636	132968	-0.4760			3.35			COSV66080067	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029969	2029969	C	T	het	het	wt	off-target	QUAL=1614;DP=67,64,73;AF=0.57,0.50,0.01;MQM=60;SAP=45;ABP=4	GABRD	intron,synonymous	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::,GABRD:ENST00000638771.1:synonymous_variant:LOW:exon8/8:c.1266C>T:p.Thr422=:,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron8/8:c.1144-14C>T::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron8/8:c.991-14C>T::	GABRD:NM_000815.5:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::,GABRD:XM_011541194.3:intron_variant:MODIFIER:intron8/8:c.1099-14C>T::,GABRD:XM_017000936.1:intron_variant:MODIFIER:intron7/7:c.1765-14C>T::		137163_[GENE=GABRD_PHENOS={Epilepsy, idiopathic generalized, 10}, 613060 (3), Autosomal dominant; {Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3), Autosomal dominant; {Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256822 [benign DISEASE=not specified];			rs28431879	0.1856	0.0295,0.2369,0.4852,0.1366,0.2428	1826,.	15558	132994	-0.9510			0.64		7.61>6.94	COSV66079834	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2405838	2405838	C	T	het	n/a	n/a		QUAL=108;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=5	PEX10	splice_region&intron,intron	PEX10:ENST00000288774.8:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513.7:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron5/5:c.913-10G>A::	PEX10:NM_001374425.1:splice_region_variant&intron_variant:LOW:intron5/5:c.970-4G>A::,PEX10:NM_001374426.1:splice_region_variant&intron_variant:LOW:intron5/5:c.538-4G>A::,PEX10:NM_001374427.1:splice_region_variant&intron_variant:LOW:intron5/5:c.481-4G>A::,PEX10:NM_002617.4:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:NM_153818.2:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:NR_164636.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron5/5:n.1028-4G>A::,PEX10:XR_946666.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron5/5:n.978-4G>A::		602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	262791 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs11586985	0.1050	0.0217,0.0584,0.1222,0.1219,0.1099	808,.	11752	138850	-1.5970			0.04		13.68>13.46,-18.79>-18.77	COSV56580725	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2406687	2406687	C	A	wt	het	het	off-target	QUAL=1037;DP=46,44,55;AF=0.00,0.48,0.49;MQM=60;SAP=34;ABP=3	PEX10	intron	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron4/5:c.776+33G>T::	PEX10:NM_001374425.1:intron_variant:MODIFIER:intron4/5:c.833+33G>T::,PEX10:NM_001374426.1:intron_variant:MODIFIER:intron4/5:c.401+33G>T::,PEX10:NM_001374427.1:intron_variant:MODIFIER:intron4/5:c.344+33G>T::,PEX10:NM_002617.4:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:NM_153818.2:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:NR_164636.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.891+33G>T::,PEX10:XR_946666.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.841+33G>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1180486 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,not provided];			rs3795269	0.4016	0.2892,0.4078,0.2649,0.4329,0.3642	12033,.	34868	93054	0.5960			3.45			COSV56579855	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2408761	2408761	T	C	wt	het	het		QUAL=985;DP=41,39,48;AF=0.02,0.44,0.54;MQM=60;SAP=47;ABP=3	PEX10	synonymous	PEX10:ENST00000288774.8:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.7:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.5:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]	PEX10:NM_001374425.1:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NM_001374426.1:5_prime_UTR_variant:MODIFIER:exon3/6:c.-142A>G::,PEX10:NM_001374427.1:5_prime_UTR_variant:MODIFIER:exon3/6:c.-142A>G::,PEX10:NM_002617.4:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NM_153818.2:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:,PEX10:NR_164636.1:non_coding_transcript_exon_variant:MODIFIER:exon3/6:n.410A>G::,PEX10:XM_011541576.2:synonymous_variant:LOW:exon3/4:c.291A>G:p.Thr97=:,PEX10:XR_946666.2:non_coding_transcript_exon_variant:MODIFIER:exon3/6:n.360A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	129884 [benign DISEASE=Peroxisome biogenesis disorder 6A,Peroxisome biogenesis disorder 6B,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,not specified,not provided];			rs2494598	0.7735	0.5917,0.7710,0.7184,0.8112,0.7245	42746,.	27445	39037	-6.5220			0.15			COSV56581176	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5862774	5862774	C	A	het	wt	hom	off-target	QUAL=1524;DP=54,26,42;AF=0.35,0.00,1.00;MQM=60;SAP=127;ABP=13	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156.9:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::			607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]				rs12133533	0.1268	0.0152,0.0833,0.0529,0.1640,0.1101	1586,.	16125	132849	-0.3670			0.69						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866447	5866447	T	C	het	wt	hom		QUAL=8932;DP=271,153,183;AF=0.50,0.00,0.99;MQM=60;SAP=31;ABP=3	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon23/27:c.2031A>G:p.Glu677=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon22/26:c.2034A>G:p.Glu678=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon29/33:n.4337A>G::,NPHP4:XM_006710563.3:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541213.1:synonymous_variant:LOW:exon25/29:c.3567A>G:p.Glu1189=:,NPHP4:XM_011541214.1:synonymous_variant:LOW:exon25/29:c.3528A>G:p.Glu1176=:,NPHP4:XM_011541215.1:synonymous_variant:LOW:exon24/28:c.3459A>G:p.Glu1153=:,NPHP4:XM_011541216.2:synonymous_variant:LOW:exon27/31:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541217.2:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_011541218.2:synonymous_variant:LOW:exon27/31:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000996.1:synonymous_variant:LOW:exon25/29:c.3525A>G:p.Glu1175=:,NPHP4:XM_017000997.1:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000998.1:synonymous_variant:LOW:exon25/26:c.3570A>G:p.Glu1190=:,NPHP4:XM_017000999.1:synonymous_variant:LOW:exon26/30:c.3042A>G:p.Glu1014=:,NPHP4:XM_017001000.2:synonymous_variant:LOW:exon25/29:c.3042A>G:p.Glu1014=:,NPHP4:XM_017001001.1:synonymous_variant:LOW:exon20/24:c.2772A>G:p.Glu924=:,NPHP4:XM_017001003.1:synonymous_variant:LOW:exon18/22:c.2031A>G:p.Glu677=:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon25/28:n.3608A>G::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon24/28:n.3421A>G::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95683 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs555164	0.3926	0.2002,0.3706,0.2558,0.4222,0.4302	10237,.	33267	98163	0.3050			2.05			COSV65394708	0.01	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866971	5866971	A	G	het	wt	hom	off-target	QUAL=3779;DP=81,65,97;AF=0.48,0.00,1.00;MQM=60;SAP=150;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron22/26:c.2019+59T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron21/25:c.2022+59T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron28/32:n.4325+59T>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron24/28:c.3555+59T>C::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron24/28:c.3516+59T>C::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron23/27:c.3447+59T>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron26/30:c.3558+59T>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron26/30:c.3558+59T>C::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron24/28:c.3513+59T>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron24/25:c.3558+59T>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron25/29:c.3030+59T>C::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron24/28:c.3030+59T>C::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron19/23:c.2760+59T>C::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron17/21:c.2019+59T>C::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron24/27:n.3596+59T>C::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/27:n.3409+59T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233249 [benign DISEASE=not provided];			rs12122135	0.1287		1581,.	16413	132519	-0.2330			1.83			COSV65397177	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867883	5867883	G	A	wt	wt	het		QUAL=3638;DP=132,269,358;AF=0.00,0.00,0.48;MQM=60;SAP=44;ABP=5	NPHP4	missense	NPHP4:ENST00000378156.9:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:	NPHP4:NM_001291593.2:missense_variant:MODERATE:exon21/27:c.1790C>T:p.Ala597Val:,NPHP4:NM_001291594.2:missense_variant:MODERATE:exon20/26:c.1793C>T:p.Ala598Val:,NPHP4:NM_015102.5:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon27/33:n.4096C>T::,NPHP4:XM_006710563.3:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541213.1:missense_variant:MODERATE:exon23/29:c.3326C>T:p.Ala1109Val:,NPHP4:XM_011541214.1:missense_variant:MODERATE:exon23/29:c.3287C>T:p.Ala1096Val:,NPHP4:XM_011541215.1:missense_variant:MODERATE:exon22/28:c.3218C>T:p.Ala1073Val:,NPHP4:XM_011541216.2:missense_variant:MODERATE:exon25/31:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541217.2:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_011541218.2:missense_variant:MODERATE:exon25/31:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000996.1:missense_variant:MODERATE:exon23/29:c.3284C>T:p.Ala1095Val:,NPHP4:XM_017000997.1:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000998.1:missense_variant:MODERATE:exon23/26:c.3329C>T:p.Ala1110Val:,NPHP4:XM_017000999.1:missense_variant:MODERATE:exon24/30:c.2801C>T:p.Ala934Val:,NPHP4:XM_017001000.2:missense_variant:MODERATE:exon23/29:c.2801C>T:p.Ala934Val:,NPHP4:XM_017001001.1:missense_variant:MODERATE:exon18/24:c.2531C>T:p.Ala844Val:,NPHP4:XM_017001003.1:missense_variant:MODERATE:exon16/22:c.1790C>T:p.Ala597Val:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon23/28:n.3367C>T::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon22/28:n.3180C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95682 [benign/likely benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0037	0.0012,0.0030,0.0000,0.0060,0.0008	2,.	547	151633	0.0440	T(0.55)	B(0.01)	0.12	0.32		COSV65394401	0.01	23757202	2	180	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874430	5874430	A	G	hom	het	hom	off-target	QUAL=5942;DP=73,68,112;AF=0.99,0.49,1.00;MQM=60;SAP=474;ABP=3	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron19/26:c.1692+41T>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron18/25:c.1695+41T>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/32:n.3998+41T>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron21/28:c.3228+41T>C::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron21/28:c.3189+41T>C::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron20/27:c.3120+41T>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron23/30:c.3231+41T>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron23/30:c.3231+41T>C::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron21/28:c.3186+41T>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron21/25:c.3231+41T>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron22/29:c.2703+41T>C::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron21/28:c.2703+41T>C::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron16/23:c.2433+41T>C::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron14/21:c.1692+41T>C::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron21/27:n.3269+41T>C::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/27:n.3082+444T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260554 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs868163	0.6401	0.7125,0.4989,0.2688,0.6436,0.6148	31634,.	33692	54506	-4.9310			0.03			COSV65397189	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875102	5875102	T	A	het	wt	het		QUAL=2668;DP=88,87,127;AF=0.61,0.00,0.47;MQM=60;SAP=225;ABP=5	NPHP4	splice_acceptor	NPHP4:ENST00000378156.9:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::	NPHP4:NM_001291593.2:splice_acceptor_variant:HIGH:intron17/26:c.1279-2A>T::,NPHP4:NM_001291594.2:splice_acceptor_variant:HIGH:intron16/25:c.1282-2A>T::,NPHP4:NM_015102.5:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:NR_111987.2:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron23/32:n.3585-2A>T::,NPHP4:XM_006710563.3:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_011541213.1:splice_acceptor_variant:HIGH:intron19/28:c.2815-2A>T::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron19/28:c.2818-44A>T::,NPHP4:XM_011541215.1:splice_acceptor_variant:HIGH:intron18/27:c.2707-2A>T::,NPHP4:XM_011541216.2:splice_acceptor_variant:HIGH:intron21/30:c.2818-2A>T::,NPHP4:XM_011541217.2:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_011541218.2:splice_acceptor_variant:HIGH:intron21/30:c.2818-2A>T::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron19/28:c.2815-44A>T::,NPHP4:XM_017000997.1:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T::,NPHP4:XM_017000998.1:splice_acceptor_variant:HIGH:intron19/25:c.2818-2A>T::,NPHP4:XM_017000999.1:splice_acceptor_variant:HIGH:intron20/29:c.2290-2A>T::,NPHP4:XM_017001000.2:splice_acceptor_variant:HIGH:intron19/28:c.2290-2A>T::,NPHP4:XM_017001001.1:splice_acceptor_variant:HIGH:intron14/23:c.2020-2A>T::,NPHP4:XM_017001003.1:splice_acceptor_variant:HIGH:intron12/21:c.1279-2A>T::,NPHP4:XR_001737114.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron19/27:n.2856-2A>T::,NPHP4:XR_001737115.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron19/27:n.2856-2A>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]		CS057899 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=NPHP4];		rs1287637	0.1543		1975,.	19525	128629	5.3340			24.40		9.27>0.90			20844548,26578562,23402433	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5877331	5877331	C	T	n/a	n/a	hom	off-target	QUAL=158;DP=1,0,4;AF=1.00,,1.00;MQM=60;SAP=7;ABP=0	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron16/26:c.1073-33G>A::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron15/25:c.1076-33G>A::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/32:n.3116-33G>A::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron18/28:c.2609-33G>A::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron18/28:c.2612-33G>A::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron17/27:c.2501-33G>A::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron20/30:c.2612-33G>A::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron20/30:c.2612-33G>A::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron18/28:c.2609-33G>A::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron18/25:c.2612-33G>A::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron19/29:c.2084-33G>A::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron18/28:c.2084-33G>A::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron13/23:c.1814-33G>A::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron18/19:c.2612-33G>A::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron11/21:c.1073-33G>A::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/27:n.2650-33G>A::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/27:n.2650-33G>A::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/17:n.2489-33G>A::	regulatory_region_variant:CTCF_binding_site	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260547 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs3747989	0.8314	0.9382,0.7305,0.8517,0.8010,0.7363	52841,.	20832	25648	-2.4900			0.18				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5887248	5887248	G	A	wt	wt	het	off-target	QUAL=1781;DP=129,147,187;AF=0.00,0.01,0.42;MQM=60;SAP=88;ABP=13	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron18/19:c.2482+38C>T::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron15/26:c.946+38C>T::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron14/25:c.949+38C>T::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/32:n.2702+38C>T::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron17/28:c.2482+38C>T::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron17/28:c.2485+38C>T::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron16/27:c.2374+38C>T::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron19/30:c.2485+38C>T::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron19/30:c.2485+38C>T::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron17/28:c.2482+38C>T::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron17/25:c.2485+38C>T::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron18/29:c.1957+38C>T::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron17/28:c.1957+38C>T::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron12/23:c.1687+38C>T::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron17/19:c.2485+38C>T::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron10/21:c.946+38C>T::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/27:n.2523+38C>T::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/27:n.2523+38C>T::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/17:n.2362+38C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260546 [benign DISEASE=Nephronophthisis 4,not specified,not provided];			rs41280814	0.1342	0.0275,0.0789,0.0795,0.1716,0.1155	1363,.	15262	134166	-2.0980			0.01			COSV65397198	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905321	5905321	C	T	wt	wt	het		QUAL=2693;DP=207,206,262;AF=0.00,0.00,0.43;MQM=60;SAP=34;ABP=15	NPHP4	synonymous	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:ENST00000622020.4:synonymous_variant:LOW:exon15/20:c.1923G>A:p.Glu641=:	NPHP4:NM_001291593.2:synonymous_variant:LOW:exon12/27:c.387G>A:p.Glu129=:,NPHP4:NM_001291594.2:synonymous_variant:LOW:exon11/26:c.390G>A:p.Glu130=:,NPHP4:NM_015102.5:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:NR_111987.2:non_coding_transcript_exon_variant:MODIFIER:exon15/33:n.2143G>A::,NPHP4:XM_006710563.3:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_011541213.1:synonymous_variant:LOW:exon14/29:c.1923G>A:p.Glu641=:,NPHP4:XM_011541214.1:synonymous_variant:LOW:exon14/29:c.1926G>A:p.Glu642=:,NPHP4:XM_011541215.1:synonymous_variant:LOW:exon13/28:c.1815G>A:p.Glu605=:,NPHP4:XM_011541216.2:synonymous_variant:LOW:exon16/31:c.1926G>A:p.Glu642=:,NPHP4:XM_011541217.2:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_011541218.2:synonymous_variant:LOW:exon16/31:c.1926G>A:p.Glu642=:,NPHP4:XM_017000996.1:synonymous_variant:LOW:exon14/29:c.1923G>A:p.Glu641=:,NPHP4:XM_017000997.1:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:,NPHP4:XM_017000998.1:synonymous_variant:LOW:exon14/26:c.1926G>A:p.Glu642=:,NPHP4:XM_017000999.1:synonymous_variant:LOW:exon15/30:c.1398G>A:p.Glu466=:,NPHP4:XM_017001000.2:synonymous_variant:LOW:exon14/29:c.1398G>A:p.Glu466=:,NPHP4:XM_017001001.1:synonymous_variant:LOW:exon9/24:c.1128G>A:p.Glu376=:,NPHP4:XM_017001002.1:synonymous_variant:LOW:exon14/20:c.1926G>A:p.Glu642=:,NPHP4:XM_017001003.1:synonymous_variant:LOW:exon7/22:c.387G>A:p.Glu129=:,NPHP4:XR_001737114.1:non_coding_transcript_exon_variant:MODIFIER:exon14/28:n.1964G>A::,NPHP4:XR_001737115.1:non_coding_transcript_exon_variant:MODIFIER:exon14/28:n.1964G>A::,NPHP4:XR_946605.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1964G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95673 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs12120967	0.1317	0.0271,0.0767,0.0768,0.1672,0.1125	1357,.	15233	134185	-0.7400			1.57			COSV65395162	0	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927636	5927636	T	C	wt	wt	het	off-target	QUAL=2465;DP=132,152,186;AF=0.00,0.02,0.54;MQM=60;SAP=33;ABP=6	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron11/19:c.1441+13A>G::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron10/26:c.75+13A>G::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron9/25:c.75+13A>G::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/32:n.1661+13A>G::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_011541213.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_011541214.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_011541215.1:intron_variant:MODIFIER:intron10/27:c.1441+13A>G::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron12/30:c.1441+13A>G::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron12/30:c.1441+13A>G::,NPHP4:XM_017000996.1:intron_variant:MODIFIER:intron10/28:c.1441+13A>G::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::,NPHP4:XM_017000998.1:intron_variant:MODIFIER:intron10/25:c.1441+13A>G::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron11/29:c.913+13A>G::,NPHP4:XM_017001000.2:intron_variant:MODIFIER:intron10/28:c.913+13A>G::,NPHP4:XM_017001001.1:intron_variant:MODIFIER:intron5/23:c.643+13A>G::,NPHP4:XM_017001002.1:intron_variant:MODIFIER:intron10/19:c.1441+13A>G::,NPHP4:XM_017001003.1:intron_variant:MODIFIER:intron5/21:c.75+13A>G::,NPHP4:XR_001737114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/27:n.1479+13A>G::,NPHP4:XR_001737115.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/27:n.1479+13A>G::,NPHP4:XR_946605.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/17:n.1479+13A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95671 [benign DISEASE=Nephronophthisis,Nephronophthisis 4,Senior-Loken syndrome 4,not specified,not provided];			rs7520105	0.1709	0.2101,0.0876,0.0770,0.1681,0.1150	2301,.	21383	126057	0.5400			12.77			COSV65395165	0	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5986372	5986372	C	G	wt	wt	het	off-target	QUAL=795;DP=53,46,52;AF=0.00,0.02,0.63;MQM=60;SAP=40;ABP=11	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron1/19:c.-38-45G>C::	NPHP4:NM_001291593.2:intron_variant:MODIFIER:intron1/26:c.-1267-45G>C::,NPHP4:NM_001291594.2:intron_variant:MODIFIER:intron1/25:c.-1088+5872G>C::,NPHP4:NM_015102.5:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:NR_111987.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/32:n.183-45G>C::,NPHP4:XM_006710563.3:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_011541216.2:intron_variant:MODIFIER:intron2/30:c.-38-45G>C::,NPHP4:XM_011541217.2:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_011541218.2:intron_variant:MODIFIER:intron2/30:c.-38-45G>C::,NPHP4:XM_017000997.1:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::,NPHP4:XM_017000999.1:intron_variant:MODIFIER:intron1/29:c.-471-140G>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1263812 [benign DISEASE=not provided];			rs1295111	0.4116		13024,.	36420	89300	-0.1890			2.27				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5992511	5992511	G	A	wt	wt	het	off-target	QUAL=398;DP=3,29,39;AF=0.00,0.00,0.51;MQM=60;SAP=46;ABP=3	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::		regulatory_region_variant:promoter	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1258554 [benign DISEASE=not provided];			rs61760765	0.0406		183,.	5811	145999	-0.1670			10.42				0		1	18	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	5992521	5992521	G	A	n/a	het	hom	off-target	QUAL=1335;DP=1,28,33;AF=1.00,0.68,1.00;MQM=60;SAP=118;ABP=11	KCNAB2	5'UTR	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::		regulatory_region_variant:promoter,TF_binding_site_variant	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252161 [benign DISEASE=not provided];			rs806109	0.8360		53596,.	19943	24943	-0.3260			7.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6466123	6466123	G	A	het	wt	het		QUAL=380;DP=12,5,20;AF=0.50,0.00,0.70;MQM=60;SAP=7;ABP=7	TNFRSF25	5'UTR	TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::	TNFRSF25:NM_001039664.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1468C>T::,TNFRSF25:NM_003790.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148965.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:NM_148966.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148967.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:NM_148970.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-16C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297904 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs3007417	0.1886	0.5020,0.0510,0.0004,0.0703,0.0791	5413,.	17773	123059	-0.6470			9.16			COSV61068166	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466143	6466150	CGTGCTCT	-	het	wt	het		QUAL=349;DP=11,6,20;AF=0.55,0.00,0.65;MQM=60;SAP=6;ABP=6	TNFRSF25	5'UTR	TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::	TNFRSF25:NM_001039664.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1441_*1448del::,TNFRSF25:NM_003790.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:NM_148965.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:NM_148966.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148967.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:NM_148970.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-43_-36del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.1889	0.4251,0.0464,0.0006,0.0579,0.0691	5410,.	17842	123038	0.5380			8.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466181	6466184	CGCC	-	hom	wt	het		QUAL=317;DP=4,3,15;AF=1.00,0.00,0.73;MQM=60;SAP=4;ABP=10	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1407_*1410del::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.1884		5413,.	17771	123179	1.5390			11.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466259	6466259	C	T	het	wt	het		QUAL=296;DP=30,30,32;AF=0.37,0.00,0.38;MQM=60;SAP=53;ABP=12	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1332G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297910 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];			rs45604837	0.0883		827,.	11777	138663	-1.4900			3.58				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466405	6466405	C	G	het	wt	het		QUAL=3444;DP=82,150,199;AF=0.49,0.00,0.54;MQM=60;SAP=110;ABP=4	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1186G>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297912 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4];		MIR3 (SINE/MIR)	rs2986754	0.1881		5643,.	17316	123472	-0.5600			3.06				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466798	6466798	A	-	het	het	het		QUAL=265;DP=44,6,7;AF=0.25,0.50,0.14;MQM=60;SAP=7;ABP=31	PLEKHG5,TNFRSF25	downstream_gene,upstream_gene	PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::	PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*765del::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*793del::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297922 [uncertain significance DISEASE=Distal spinal muscular atrophy];		AluSz (SINE/Alu)	rs372197062	0.0703		880,.	7980	128752	-2.9370			0.44				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467273	6467273	A	G	het	wt	het		QUAL=1562;DP=75,53,59;AF=0.49,0.00,0.47;MQM=60;SAP=3;ABP=3	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850.10:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728.8:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377740.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748.6:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.8:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000673471.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000675123.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*290T>C::,PLEKHG5:ENST00000675694.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::	PLEKHG5:NM_001042663.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001042664.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001042665.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265592.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:NM_001265593.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_001265594.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:NM_020631.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:NM_198681.4:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297928 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,not provided];			rs14708	0.2613		8164,.	23413	112333	2.4130			12.38				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469123	6469125	TCC	-	het	wt	het		QUAL=1322;DP=47,63,106;AF=0.38,0.05,0.45;MQM=60;SAP=37;ABP=9	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850.10:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.5:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.8:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732.5:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377740.5:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377748.6:inframe_deletion:MODERATE:exon20/22:c.2340_2342del:p.Glu781del:,PLEKHG5:ENST00000400913.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915.8:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000535355.6:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245.6:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000673471.2:inframe_deletion:MODERATE:exon20/22:c.2463_2465del:p.Glu822del:,PLEKHG5:ENST00000675123.1:inframe_deletion:MODERATE:exon18/20:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675694.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:	PLEKHG5:NM_001042663.3:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:NM_001042664.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001042665.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_001265592.2:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:NM_001265593.1:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:NM_001265594.2:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_020631.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:NM_198681.4:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,Distal spinal muscular atrophy,not specified,not provided];		(TCC)n (Simple_repeat)	rs113541584	0.0876	0.1890,0.0573,0.0085,0.0753,0.0956	707,.	11301	132517	0.9800			10.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469383	6469383	A	G	het	wt	het		QUAL=9691;DP=312,391,487;AF=0.48,0.00,0.48;MQM=60;SAP=16;ABP=6	PLEKHG5	synonymous	PLEKHG5:ENST00000340850.10:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.5:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.8:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732.5:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377740.5:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377748.6:synonymous_variant:LOW:exon19/22:c.2175T>C:p.Ser725=:,PLEKHG5:ENST00000400913.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915.8:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000535355.6:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245.6:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000673471.2:synonymous_variant:LOW:exon19/22:c.2298T>C:p.Ser766=:,PLEKHG5:ENST00000675123.1:synonymous_variant:LOW:exon17/20:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675694.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:	PLEKHG5:NM_001042663.3:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:NM_001042664.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001042665.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_001265592.2:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:NM_001265593.1:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:NM_001265594.2:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:NM_020631.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:NM_198681.4:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194881 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified,not provided];			rs730600	0.2624	0.5922,0.0937,0.0041,0.1423,0.1761	8213,.	23479	112199	-0.1930			5.83				0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470375	6470375	A	G	het	wt	het	off-target	QUAL=1086;DP=40,49,55;AF=0.45,0.00,0.53;MQM=60;SAP=3;ABP=3	PLEKHG5	intron	PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron16/21:c.1855-20T>C::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron16/21:c.1978-20T>C::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron14/19:c.1681-20T>C::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::	PLEKHG5:NM_001042663.3:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_001265592.2:intron_variant:MODIFIER:intron16/21:c.1792-20T>C::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:NM_020631.6:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:NM_198681.4:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1260549 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs2986753	0.1818	0.3429,0.0779,0.0039,0.1301,0.1509	3225,.	21169	124335	-0.3690			0.44		7.80>7.76		0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470905	6470905	-	G	hom	hom	hom	off-target	QUAL=6021;DP=42,84,117;AF=0.98,0.99,1.00;MQM=60;SAP=18;ABP=0	PLEKHG5	intron	PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron14/21:c.1567-22dup::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron14/21:c.1690-22dup::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron12/19:c.1393-22dup::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::	PLEKHG5:NM_001042663.3:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:NM_001042664.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001042665.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_001265592.2:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:NM_001265593.1:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:NM_001265594.2:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:NM_020631.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:NM_198681.4:intron_variant:MODIFIER:intron14/21:c.1393-22dup::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670557 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs111312565	1.0000	1.0000,1.0000,0.9999,1.0000,1.0000	75882,.	4	4				2.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471529	6471529	C	T	het	wt	het		QUAL=1642;DP=35,115,114;AF=0.66,0.00,0.45;MQM=60;SAP=50;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon13/22:c.1414G>A:p.Ala472Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon13/22:c.1537G>A:p.Ala513Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon11/20:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain]	PLEKHG5:NM_001042663.3:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_001265592.2:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_020631.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:,PLEKHG5:NM_198681.4:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297959 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not provided];			rs74809741	0.0610	0.0889,0.0369,0.0002,0.0593,0.0518	308,.	8674	142914	0.9380	T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.42),T(0.45),T(0.43),T(0.41),T(0.43),T(0.44),T(0.47),T(0.45)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00),B(0.00),B(0.01)	18.48	0.04		COSV61699881	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6473333	6473333	G	C	het	wt	het		QUAL=479;DP=25,19,25;AF=0.44,0.00,0.56;MQM=60;SAP=57;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon9/22:c.887C>G:p.Thr296Ser:,PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon9/22:c.1010C>G:p.Thr337Ser:,PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon7/20:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:	PLEKHG5:NM_001042663.3:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:NM_001042664.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001042665.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_001265592.2:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:NM_001265593.1:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:NM_001265594.2:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_020631.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:NM_198681.4:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:		611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	198895 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified,not provided];			rs61741379	0.2765	0.6445,0.0990,0.0072,0.1406,0.1621	9529,.	23016	110106	0.8540	T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.76),T(0.68),T(0.70),T(0.78),T(0.70),T(0.66),T(0.66),T(0.68)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	4.56	0.07		COSV61700195	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6519461	6519461	G	C	het	het	het		QUAL=3428;DP=121,76,91;AF=0.53,0.46,0.52;MQM=60;SAP=320;ABP=3	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670484 [likely benign DISEASE=not provided];			rs17438786	0.0242	0.0050,0.0165,0.0000,0.0326,0.0176	48,.	3253	148755	0.1090			6.88						22	864	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519547	6519547	C	T	hom	hom	hom		QUAL=20041;DP=176,204,269;AF=1.00,1.00,1.00;MQM=60;SAP=739;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	380860 [benign DISEASE=Distal spinal muscular atrophy, autosomal recessive 4,Charcot-Marie-Tooth disease, recessive intermediate c,not specified];			rs1556035	0.8595	0.5189,0.9267,0.7933,0.8816,0.8645	48522,.	22035	32943	0.6350			7.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519783	6519783	C	T	hom	hom	hom		QUAL=41973;DP=291,456,585;AF=0.99,1.00,1.00;MQM=60;SAP=143;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	PLEKHG5:NM_198681.4:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::	regulatory_region_variant:promoter_flanking_region	611101_[GENE=PLEKHG5_PHENOS=Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667919 [benign DISEASE=not provided];			rs1010584	0.7731		47329,.	22983	34527	-0.5550			1.89						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10258594	10258594	C	G	wt	het	wt		QUAL=2875;DP=316,229,251;AF=0.00,0.50,0.00;MQM=60;SAP=5;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083.5:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377093.9:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon3/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]	KIF1B:NM_001365951.3:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:,KIF1B:NM_001365953.1:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:,KIF1B:NM_183416.4:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs12402052	0.2766	0.0864,0.3446,0.2917,0.2914,0.2293	4955,.	26135	115909	0.0670			10.86			COSV55805367	0.04	25741868,24033266,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10261996	10261996	G	A	wt	het	wt	off-target	QUAL=2023;DP=317,179,272;AF=0.00,0.46,0.00;MQM=60;SAP=10;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.429+26G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.429+26G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1266483 [benign DISEASE=not provided];			rs4846209	0.3477	0.3418,0.3938,0.3671,0.3431,0.2578	9287,.	34204	99036	0.2760			1.71			COSV55815439	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10267349	10267349	A	T	wt	het	wt	off-target	QUAL=1116;DP=256,100,130;AF=0.00,0.50,0.00;MQM=60;SAP=55;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron4/46:c.430-31A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron5/20:c.430-31A>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1181451 [benign DISEASE=not provided];			rs12141246	0.3717	0.4133,0.3974,0.4087,0.3425,0.2575	10656,.	35078	95316	-1.5780			0.98			COSV55808764	0	17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10268280	10268280	C	T	wt	het	wt	off-target	QUAL=2383;DP=239,186,187;AF=0.00,0.52,0.00;MQM=60;SAP=46;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron6/46:c.720+17C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron7/20:c.720+17C>T::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	260542 [benign DISEASE=Pheochromocytoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,not specified,not provided];			rs1339458	0.2817	0.1535,0.3485,0.2906,0.2919,0.2301	5356,.	28278	112918	-1.5610			2.36			COSV55802811	0	25741868,17418584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282571	10282571	G	A	wt	het	het	off-target	QUAL=5608;DP=180,218,224;AF=0.01,0.50,0.50;MQM=60;SAP=99;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron13/46:c.1392+38G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron14/47:c.1356+38G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292705 [benign DISEASE=not provided];		L3 (LINE/CR1)	rs3748576	0.7041	0.9335,0.7352,0.5293,0.5971,0.6222	39359,.	28328	44992	-0.5210			0.35			COSV55814192	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10295776	10295776	C	T	wt	het	wt		QUAL=1539;DP=135,128,157;AF=0.01,0.48,0.00;MQM=60;SAP=11;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron18/47:c.1777+10C>T::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron17/46:c.1735+10C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron18/47:c.1699+10C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs3753037	0.2844	0.1871,0.3503,0.2912,0.2920,0.2295	5574,.	29250	111510	0.2620			6.71			COSV55805392	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10297149	10297149	T	-	het	het	het	off-target;low_conf_region	QUAL=3797;DP=178,164,233;AF=0.34,0.29,0.32;MQM=60;SAP=3;ABP=168	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron20/47:c.2043-9del::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron19/46:c.2001-9del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron20/47:c.1965-9del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:NM_001365953.1:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:NM_183416.4:intron_variant:MODIFIER:intron19/20:c.1905-9del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	917114 [benign DISEASE=Charcot-Marie-Tooth disease];		(T)n (Simple_repeat)	rs58344165	0.4250	0.4308,0.4320,0.4215,0.4277,0.4367	1,.	982	142408	0.1110			0.09				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306429	10306429	T	G	wt	het	wt		QUAL=2589;DP=248,230,227;AF=0.00,0.45,0.00;MQM=60;SAP=4;ABP=8	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9183T>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9183T>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs8019	0.3932		11978,.	35760	92170	0.5490			7.79				0	22363396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10306634	10306634	C	G	wt	het	wt		QUAL=2901;DP=289,253,279;AF=0.00,0.47,0.00;MQM=60;SAP=84;ABP=4	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000377083.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+9388C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+9388C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			7SLRNA (srpRNA)	rs4623	0.3398		8848,.	33550	99552	-0.5050			2.10				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307366	10307366	G	A	wt	het	wt		QUAL=344;DP=114,43,45;AF=0.01,0.42,0.00;MQM=60;SAP=29;ABP=5	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10120G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10120G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs2004034	0.2379		5002,.	26178	115880	0.6790			3.12				0	23032637	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10307533	10307533	T	C	wt	het	wt		QUAL=1161;DP=190,87,99;AF=0.00,0.59,0.01;MQM=60;SAP=116;ABP=9	KIF1B	intron,3'UTR	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377093.9:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron20/46:c.2073+10287T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron21/47:c.2037+10287T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:NM_001365953.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:NM_183416.4:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs1065828	0.3397		8901,.	33744	100212	-0.5710			2.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10324118	10324118	-	TTGAAA	het	het	het	off-target;low_conf_region	QUAL=4473;DP=227,136,185;AF=0.42,0.42,0.38;MQM=60;SAP=437;ABP=44	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2495+57_2495+58insTGAAAT::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2459+57_2459+58insTGAAAT::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241982 [benign DISEASE=not provided];			rs3831405	0.2394		4994,.	26340	115448				3.98				0.1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10334478	10334478	C	G	het	het	het	off-target	QUAL=8213;DP=247,151,219;AF=0.53,0.48,0.53;MQM=60;SAP=434;ABP=5	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron25/46:c.2883-42C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron26/47:c.2847-42C>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1179832 [benign DISEASE=not provided];			rs2276100	0.3280	0.3230,0.3842,0.3667,0.3197,0.2621	8308,.	33236	102156	-0.1170			3.79			COSV55805280	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10337022	10337022	A	G	wt	wt	het	off-target	QUAL=1132;DP=202,79,101;AF=0.00,0.00,0.47;MQM=60;SAP=47;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron27/46:c.3088-52A>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron28/47:c.3052-52A>G::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]				rs71643087	0.0210		51,.	3087	148999	0.3500			0.68				0		8	805	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10348780	10348780	T	-	het	het	het	off-target;low_conf_region	QUAL=304;DP=135,134,144;AF=0.19,0.17,0.10;MQM=60;SAP=61;ABP=436	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron35/46:c.3811+60del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron36/47:c.3949+60del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron35/46:c.3907+60del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron36/47:c.3871+60del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron37/48:c.3949+60del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron35/46:c.3811+60del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]			FRAM (SINE/Alu)	rs35253111	0.2842	0.2232,0.3608,0.4320,0.2693,0.2557	11,.	1491	143965	0.2760			0.70				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360879	10360879	C	T	het	het	het	off-target	QUAL=11881;DP=257,298,372;AF=0.52,0.51,0.49;MQM=60;SAP=367;ABP=3	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-50C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-50C>T::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,LOC105376725:XR_946953.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.276+542G>A::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248757 [benign DISEASE=not provided];			rs3748579	0.3279	0.3225,0.3839,0.3664,0.3196,0.2625	8292,.	33211	102063	-0.6290			1.47			COSV55805298	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365060	10365060	T	-	het	het	het	off-target	QUAL=3187;DP=97,87,111;AF=0.45,0.46,0.52;MQM=60;SAP=150;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-33del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-33del::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron39/46:c.4229-33del::,LOC105376725:XR_946953.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.230+1321del::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1260773 [benign DISEASE=not provided];			rs34161257	0.5276	0.6622,0.4695,0.3722,0.4743,0.4639	21584,.	36162	71034	1.3520			2.77				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10371100	10371100	T	C	het	het	het	off-target	QUAL=7053;DP=218,156,224;AF=0.45,0.47,0.53;MQM=60;SAP=385;ABP=4	KIF1B	intron	KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron42/46:c.4783-41T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron43/47:c.4747-41T>C::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::	KIF1B:NM_001365951.3:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_001365952.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:NM_015074.3:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1228335 [benign DISEASE=not provided];			rs17411502	0.2841	0.1495,0.3490,0.2841,0.2958,0.2375	5473,.	28257	112885	-0.5520			5.68			COSV55805429	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375266	10375266	C	A	het	het	het		QUAL=7267;DP=295,115,148;AF=0.45,0.57,0.52;MQM=60;SAP=4;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon46/47:c.5259C>A:p.Thr1753=:PF00169 [PH domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon47/48:c.5223C>A:p.Thr1741=:PF00169 [PH domain],KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain]	KIF1B:NM_001365951.3:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_001365952.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:,KIF1B:NM_015074.3:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:		605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2A1,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,not specified,not provided];			rs11121552	0.2795	0.0874,0.3464,0.2848,0.2956,0.2374	5097,.	26330	115552	-0.5900			5.52			COSV55805449	0.01	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376834	10376834	-	AC	het	het	wt		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=28;ABP=222	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473_5367-1472dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473_5331-1472dup::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs111663673	0.0543		195,.	7430	136094				2.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376866	10376866	C	T	het	wt	het		QUAL=4734;DP=120,108,127;AF=0.40,0.31,0.01;MQM=60;SAP=15;ABP=6	KIF1B	3'UTR,intron	KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473C>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291594 [benign DISEASE=Neuroblastoma];		(AC)n (Simple_repeat)	rs78490707	0.0079		49,.	1006	138404	-1.7410			0.41				0		0	4	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10377948	10377948	A	T	het	het	wt		QUAL=1163;DP=76,54,72;AF=0.41,0.48,0.00;MQM=60;SAP=80;ABP=7	KIF1B	intron,3'UTR	KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-391A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-391A>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*1361A>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291610 [benign DISEASE=Neuroblastoma];		AluSg (SINE/Alu)	rs2847347	0.0380		153,.	5477	146357	0.2090			2.28						1	19	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378629	10378629	C	T	het	het	het		QUAL=12151;DP=253,281,354;AF=0.56,0.51,0.51;MQM=60;SAP=4;ABP=7	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*227C>T::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2042C>T::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291618 [benign DISEASE=Neuroblastoma];			rs1536262	0.5518		24286,.	35278	68098	-1.2380			0.55					27980619	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378834	10378834	G	A	het	het	het		QUAL=8764;DP=281,160,191;AF=0.52,0.57,0.52;MQM=60;SAP=71;ABP=9	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*432G>A::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2247G>A::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291619 [benign DISEASE=Neuroblastoma];			rs1002076	0.3278		8298,.	33216	102130	0.4980			2.91						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10380498	10380498	A	G	het	het	het		QUAL=9089;DP=324,182,224;AF=0.51,0.49,0.48;MQM=51;SAP=11;ABP=3	KIF1B	3'UTR	KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2096A>G::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::	KIF1B:NM_001365951.3:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_001365952.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:NM_015074.3:3_prime_UTR_variant:MODIFIER:exon47/47:c.*3911A>G::	regulatory_region_variant:promoter_flanking_region	605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291652 [benign DISEASE=Neuroblastoma];		AluSx (SINE/Alu)	rs1138791	0.3571		9821,.	34607	97663	-1.5530			2.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10381606	10381606	T	C	het	het	het		QUAL=13658;DP=453,272,349;AF=0.53,0.44,0.50;MQM=60;SAP=304;ABP=3	KIF1B	downstream_gene	KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000620295.2:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000622724.3:downstream_gene_variant:MODIFIER::::,:ENST00000641117.1:downstream_gene_variant:MODIFIER::::,:ENST00000641619.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000676179.1:downstream_gene_variant:MODIFIER::::			605995_[GENE=KIF1B_PHENOS=Pheochromocytoma, 171300 (3), Autosomal dominant; {Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581	0.5321		22184,.	36444	71054	0.4330			9.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11024947	11024947	-	TGTTT	het	het	hom		QUAL=16206;DP=371,256,267;AF=0.49,0.50,1.00;MQM=60;SAP=32;ABP=3	TARDBP	3'UTR	TARDBP:ENST00000240185.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::	TARDBP:NM_007375.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::,TARDBP:XM_017000863.2:3_prime_UTR_variant:MODIFIER:exon6/7:c.*2294_*2295insGTTTT::,TARDBP:XM_017000864.2:intron_variant:MODIFIER:intron6/8:c.*1682-162_*1682-161insGTTTT::,TARDBP:XM_017000865.2:intron_variant:MODIFIER:intron6/7:c.*1682-162_*1682-161insGTTTT::,TARDBP:XM_017000866.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1560_*1561insGTTTT::,TARDBP:XM_017000867.2:intron_variant:MODIFIER:intron7/8:c.*948-162_*948-161insGTTTT::,TARDBP:XM_017000868.2:intron_variant:MODIFIER:intron6/6:c.*676-162_*676-161insGTTTT::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs3059695	0.8802		59078,.	15398	18178				4.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11786035	11786035	-	T	het	hom	het		QUAL=4368;DP=116,37,50;AF=0.75,0.89,0.90;MQM=60;SAP=250;ABP=129	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4644dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3639+757dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3702+757dup::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3702+757dup::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3702+757dup::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3702+757dup::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3648+757dup::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3567+757dup::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1983+757dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775	0.9840		72488,.	2333	2393				1.54				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786195	11786195	G	A	hom	het	het		QUAL=15057;DP=330,159,181;AF=1.00,0.50,0.54;MQM=60;SAP=44;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4485C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3639+906G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3702+906G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3702+906G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3702+906G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3702+906G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3648+906G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3567+906G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1983+906G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.6780		35684,.	31653	48935	0.4760			3.52				0	31637880,21273288,19493349,19593234,20056627,22747749,26046315,28963520,20692813,24853127,25566964,32117640,18221821,24687778,28969008,29299150,29340069,31694048,32073761,18180959,31601265,31750632,31737664,25165408,26770518,23430981,23166529,23848401	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786390	11786390	G	A	hom	hom	hom		QUAL=25307;DP=382,181,214;AF=1.00,1.00,1.00;MQM=60;SAP=30;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4290C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-998G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-998G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-998G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-998G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-998G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-998G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-998G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-998G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs4845884	0.9395		67802,.	7342	9214	-0.8090			0.77				0.01	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786606	TTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.64,0.48,0.61;MQM=58;SAP=29;ABP=14	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4074_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-770_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-770_3703-767del::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-770_3703-767del::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-770_3703-767del::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-770_3703-767del::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-770_3649-767del::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-770_3568-767del::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-770_1984-767del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.5416		21344,.	34207	65093	0.3080			0.58				0.02	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786607	TTTTT	-	het	het	het		QUAL=2020;DP=69,21,28;AF=0.23,0.38,0.11;MQM=59;SAP=3;ABP=78	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4073_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-771_3640-767del::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-771_3568-767del::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4073_*4077del::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-771_3703-767del::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-771_3703-767del::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-771_3703-767del::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-771_3703-767del::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-771_3649-767del::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-771_3568-767del::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-771_1984-767del::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs55780505	0.0017		0,.	241	141893	0.3080			0.57				0.02	26046315	0	53	0 / 0					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787277	11787277	-	GAA	hom	het	het		QUAL=9454;DP=223,132,220;AF=0.96,0.58,0.40;MQM=60;SAP=71;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*3400_*3402dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron16/20:c.3640-108_3640-106dup::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron17/21:c.3703-108_3703-106dup::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron17/21:c.3703-108_3703-106dup::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron18/21:c.3703-108_3703-106dup::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron17/20:c.3703-108_3703-106dup::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron17/20:c.3649-108_3649-106dup::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron16/19:c.3568-108_3568-106dup::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron12/15:c.1984-108_1984-106dup::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs35134728	0.5655		25339,.	35163	65945				0.59				0.02	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787702	11787702	C	T	hom	het	het		QUAL=11991;DP=189,243,289;AF=0.99,0.51,0.52;MQM=60;SAP=40;ABP=4	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2978G>A::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron17/20:c.3746-171C>T::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron18/21:c.3809-171C>T::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron18/21:c.3809-171C>T::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron19/21:c.3809-171C>T::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron18/20:c.3809-171C>T::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron18/20:c.3755-171C>T::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron17/19:c.3674-171C>T::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron13/15:c.2090-171C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs3737966	0.5525		24365,.	35269	68041	0.6820			4.70			COSV57172225	0.01	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788082	11788082	G	A	wt	het	het		QUAL=2663;DP=122,84,122;AF=0.01,0.55,0.48;MQM=60;SAP=4;ABP=3	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2598C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron18/20:c.3920+35G>A::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron19/21:c.3983+35G>A::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron19/21:c.3983+35G>A::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446506.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446507.1:intron_variant:MODIFIER:intron20/21:c.3983+35G>A::,C1orf167:XM_024446508.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446509.1:intron_variant:MODIFIER:intron19/20:c.3983+35G>A::,C1orf167:XM_024446512.1:intron_variant:MODIFIER:intron19/20:c.3929+35G>A::,C1orf167:XM_024446514.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446515.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446517.1:intron_variant:MODIFIER:intron18/19:c.3848+35G>A::,C1orf167:XM_024446518.1:intron_variant:MODIFIER:intron14/15:c.2264+35G>A::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs11559040	0.1685	0.0352,0.0850,0.1026,0.1856,0.2669	1758,.	17084	131552	-1.3250			2.70			COSV57171817	0.01	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788822	11788822	A	G	hom	hom	hom		QUAL=19132;DP=244,151,217;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,C1orf167:ENST00000433342.5:intron_variant:MODIFIER:intron20/20:c.4230+76A>G::	C1orf167:NM_001010881.2:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,C1orf167:XM_011541272.3:intron_variant:MODIFIER:intron21/21:c.4308+76A>G::,C1orf167:XM_011541276.3:intron_variant:MODIFIER:intron21/21:c.4214+76A>G::,C1orf167:XM_011541277.3:intron_variant:MODIFIER:intron20/20:c.4119+444A>G::,C1orf167:XM_011541278.2:intron_variant:MODIFIER:intron20/20:c.4213+444A>G::,C1orf167:XM_024446506.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446507.1:missense_variant:MODERATE:exon22/22:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446508.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446509.1:missense_variant:MODERATE:exon21/21:c.4384A>G:p.Thr1462Ala:,C1orf167:XM_024446512.1:missense_variant:MODERATE:exon21/21:c.4330A>G:p.Thr1444Ala:,C1orf167:XM_024446514.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446515.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446517.1:missense_variant:MODERATE:exon20/20:c.4249A>G:p.Thr1417Ala:,C1orf167:XM_024446518.1:missense_variant:MODERATE:exon16/16:c.2665A>G:p.Thr889Ala:	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs2077360	0.9371		67508,.	7562	9574	-0.5450			0.76				0	26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11789390	11789390	A	G	hom	hom	hom		QUAL=17765;DP=149,188,226;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,C1orf167:ENST00000433342.5:missense_variant:MODERATE:exon21/21:c.4351A>G:p.Arg1451Gly:	C1orf167:NM_001010881.2:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,C1orf167:XM_011541272.3:missense_variant:MODERATE:exon22/22:c.4429A>G:p.Arg1477Gly:,C1orf167:XM_011541276.3:synonymous_variant:LOW:exon22/22:c.4335A>G:p.Pro1445=:,C1orf167:XM_011541277.3:missense_variant:MODERATE:exon21/21:c.4240A>G:p.Arg1414Gly:,C1orf167:XM_024446506.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*347A>G::,C1orf167:XM_024446508.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446509.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446512.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*347A>G::,C1orf167:XM_024446514.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446515.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446517.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*347A>G::,C1orf167:XM_024446518.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*347A>G::	regulatory_region_variant:promoter	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs868014	0.9874	0.7812,0.9875,1.0000,0.9990,0.9997	67781,.	7318	9188	-5.2110	 , , , ,T(0.22)	 , , , ,B(0.00)	0.01	0.03		COSV57171235	0	28171870,26046315,23292069,30182779	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790308	11790308	T	G	hom	het	het		QUAL=19144;DP=316,347,383;AF=1.00,0.49,0.49;MQM=60;SAP=228;ABP=4	MTHFR	3'UTR	MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000423400.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::	MTHFR:NM_001330358.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:NM_005957.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263460.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263462.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_005263463.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_011541495.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:XM_011541496.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*232A>C::,MTHFR:XM_024447198.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292223 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency];			rs4846049	0.6320		31075,.	33888	55934	-0.8740			1.52				0	22100073,31637880,20556870,24991086,31469255,19683694,21448238,19593234,20056627,20962791,26046315,28657672,28722783,28963520,24391914,23227261,25723397,32117640,24315498,31601265,21515602,22647417,25882505,26690224,27454313,29379315,31737664,27106592,28855605,29657307,29434917,24006081,29534533,23303660,27980618	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790946	11790946	G	C	wt	het	het	off-target	QUAL=3881;DP=208,168,179;AF=0.00,0.48,0.43;MQM=60;SAP=43;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1753-230C>G::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1018-48C>G::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron11/11:c.1507-48C>G::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron11/11:c.1876-230C>G::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron11/11:c.1876-198C>G::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron11/11:c.1507-48C>G::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.2854-230C>G::	TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1224887 [benign DISEASE=Homocystinuria due to MTHFR deficiency,not provided];			rs3818762	0.2600	0.1340,0.1420,0.2153,0.2748,0.4137	4602,.	26511	116241	-2.2640			0.05			COSV100453746	0.04	22100073,21273288,22241680,23874907	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11792243	11792243	C	T	wt	het	het	off-target	QUAL=4655;DP=170,197,207;AF=0.01,0.47,0.48;MQM=60;SAP=13;ABP=5	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron6/7:c.897+35G>A::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron10/11:c.1386+35G>A::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron10/11:c.1386+35G>A::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/10:n.2733+35G>A::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1170841 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided];			rs1476413	0.2614	0.1509,0.1389,0.2267,0.2731,0.4203	4505,.	26634	116410	-1.1200			1.21			COSV57171175	0	21273288,27437086,19493349,19048631,21254358,21254359,19593234,20056627,20962791,22039442,22155867,22241680,22747749,22903727,23893618,26646537,20692813,22495907,28266606,30339177,29732742,19064567,23430981,23166529,19075497,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794400	11794400	G	A	hom	hom	hom		QUAL=18568;DP=120,204,264;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	MTHFR	synonymous	MTHFR:ENST00000376583.7:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.6:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590.9:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592.6:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000423400.7:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:ENST00000641407.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:,MTHFR:ENST00000641820.1:synonymous_variant:LOW:exon4/8:c.570C>T:p.Phe190=:	MTHFR:NM_001330358.2:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:NM_005957.5:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263460.5:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263462.4:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:XM_005263463.4:synonymous_variant:LOW:exon8/12:c.1059C>T:p.Phe353=:,MTHFR:XM_011541495.3:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:XM_011541496.3:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:XM_017001328.2:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:XM_024447198.1:synonymous_variant:LOW:exon8/12:c.1059C>T:p.Phe353=:,MTHFR:XR_002956640.1:non_coding_transcript_exon_variant:MODIFIER:exon7/11:n.2406C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	167306 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Homocystinuria due to MTHFR deficiency,not specified];			rs4846051	0.9748	0.6780,0.9819,0.9991,0.9983,0.9993	64232,.	9718	13764	0.6480			4.72				0.01	28871186,19591822,19493349,25110414,29193749,22241680,31208817,16439441,18483346,23300409,25982422,19144510	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794419	11794419	T	G	wt	het	het		QUAL=7183;DP=166,228,287;AF=0.01,0.54,0.54;MQM=60;SAP=7;ABP=11	MTHFR	missense	MTHFR:ENST00000376583.7:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.6:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590.9:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592.6:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000423400.7:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:ENST00000641407.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000641820.1:missense_variant:MODERATE:exon4/8:c.551A>C:p.Glu184Ala:	MTHFR:NM_001330358.2:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:NM_005957.5:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263460.5:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263462.4:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:XM_005263463.4:missense_variant:MODERATE:exon8/12:c.1040A>C:p.Glu347Ala:,MTHFR:XM_011541495.3:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:XM_011541496.3:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:XM_017001328.2:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:XM_024447198.1:missense_variant:MODERATE:exon8/12:c.1040A>C:p.Glu347Ala:,MTHFR:XR_002956640.1:non_coding_transcript_exon_variant:MODIFIER:exon7/11:n.2387A>C::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	3521 [conflicting interpretations of pathogenicity, other DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stromal tumor,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Neural tube defects, folate-sensitive,MTHFR deficiency, thermolabile type,Homocystinuria due to MTHFR deficiency,not specified,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2890	0.1582,0.1594,0.2198,0.3186,0.4116	5754,.	28495	111877	3.7560	T(0.15),T(0.15),T(0.14),T(0.14),T(0.16),T(0.19),T(0.12)	B(0.07),B(0.07),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01)	20.90	0.20		COSV57171183	0	21467728,18603647,21146954,21533139,21919968,22100073,23205182,27348238,29972410,30409984,30571812,20078877,26446360,26451011,22281051,18992148,16642433,21273288,24944790,21514219,23946381,25928231,25294155,18936436,19538716,19591822,20417488,20556870,21857382,21935354,22540831,22707612,22992668,23776350,25266489,26091847,27018927,27233804,28086795,31646966,25214541,28827732,30337837,30793520,19493349,25110414,25691056,29193749,21658613,22486600,12970910,28253266,19048631,26884752,30877365,21254358,21254359,22927710,26843965,22496743,30235667,28927418,27369588,22022476,18191955,21204206,19442614,29694444,19064578,22655231,23175176,27583843,26870349,30203425,19683694,21274745,27808252,24340057,27217270,20718043,28822116,19593234,20056627,20962791,22155867,22241680,22747749,22903727,22792358,24130171,21748308,19062539,24048206,18182569,30139066,19700502,25980667,23049672,9545395,10677336,10958762,11590551,11742092,11752418,11781870,11938441,12560871,14724163,15103709,15951337,16244782,16372906,17035141,17119116	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794698	11794698	G	A	hom	het	het	off-target	QUAL=3045;DP=70,57,54;AF=1.00,0.46,0.39;MQM=60;SAP=192;ABP=9	MTHFR	intron	MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.431+31C>T::	MTHFR:NM_001330358.2:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:NM_005957.5:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263460.5:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263462.4:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:XM_005263463.4:intron_variant:MODIFIER:intron7/11:c.920+31C>T::,MTHFR:XM_011541495.3:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:XM_011541496.3:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:XM_017001328.2:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:XM_024447198.1:intron_variant:MODIFIER:intron7/11:c.920+31C>T::,MTHFR:XR_002956640.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/10:n.2267+31C>T::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177042 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not specified,not provided];			rs1994798	0.6074	0.4333,0.7727,0.7596,0.5879,0.4685	24771,.	35822	66524	-4.4220			0.05			COSV64877997	0.04	20718043,20056627,22241680,11781870,18538037,32073761,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11949898	11949898	C	T	het	het	het		QUAL=6852;DP=125,190,248;AF=0.46,0.53,0.49;MQM=60;SAP=59;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs7529452	0.3295	0.0589,0.3522,0.3748,0.3160,0.4236	6298,.	25999	113363	1.0800			13.23			COSV52144592	0.05	25741868,20357209,20072119,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11949899	11949899	G	A	wt	het	wt		QUAL=1997;DP=151,186,243;AF=0.00,0.47,0.00;MQM=60;SAP=4;ABP=5	PLOD1	missense	PLOD1:ENST00000196061.5:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:	PLOD1:NM_000302.4:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:NM_001316320.2:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2590	0.5503,0.0894,0.2527,0.1526,0.2126	7475,.	24404	112578	1.2640	T(1.00)	B(0.00)	15.53	0.15		COSV52140857	0.05	25741868,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11956900	11956900	T	G	wt	het	wt	off-target	QUAL=3761;DP=108,311,391;AF=0.00,0.50,0.00;MQM=60;SAP=70;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.644-17T>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron6/18:c.644-17T>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron7/19:c.785-17T>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	384719 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified];			rs41307745	0.0679	0.0104,0.0250,0.1423,0.0613,0.1356	271,.	6630	144896	1.9980			17.56		10.55>8.84	COSV52140829	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11964178	11964178	C	T	het	het	het		QUAL=1167;DP=17,35,53;AF=0.59,0.40,0.53;MQM=60;SAP=3;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:	PLOD1:NM_000302.4:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:NM_001316320.2:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype];			rs1130529	0.3609	0.2929,0.3668,0.3896,0.3275,0.4443	8715,.	32864	101562	-0.7380			6.42			COSV52140468	0.01	25741868,20357209,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967147	11967147	C	T	het	hom	het	off-target	QUAL=9535;DP=39,205,211;AF=0.46,1.00,0.52;MQM=60;SAP=125;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron17/19:c.1896+56C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1297286 [benign DISEASE=not provided];			rs2273293	0.5040		19900,.	36738	75326	-3.2240			0.01			COSV52142788	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973056	11973056	A	G	het	hom	het	off-target	QUAL=11278;DP=134,209,263;AF=0.51,1.00,0.48;MQM=60;SAP=389;ABP=3	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::	PLOD1:NM_000302.4:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::,PLOD1:NM_001316320.2:intron_variant:MODIFIER:intron19/19:c.2169+59A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1278494 [benign DISEASE=not provided];			rs3737961	0.5670		26077,.	33653	65519	-0.1100			3.69			COSV52144992	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11980146	11980146	A	G	het	hom	het	off-target	QUAL=880;DP=23,20,24;AF=0.43,1.00,0.46;MQM=60;SAP=84;ABP=4	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.5:upstream_gene_variant:MODIFIER::::,:ENST00000660216.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674548.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675053.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675298.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1290963 [benign DISEASE=not provided];			rs2236053	0.5015		19724,.	36612	75598	-0.8990			3.38						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980267	11980267	A	G	het	hom	het		QUAL=4117;DP=30,101,123;AF=0.47,1.00,0.36;MQM=60;SAP=111;ABP=22	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-312A>G::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-270A>G::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-367A>G::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-367A>G::	MFN2:XM_005263543.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-435A>G::,MFN2:XM_005263548.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-431A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2236054	0.5066		20255,.	36400	74898	-0.9010			3.28				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980422	11980422	T	C	het	hom	het		QUAL=5098;DP=54,113,128;AF=0.43,1.00,0.43;MQM=60;SAP=138;ABP=11	MFN2	5'UTR	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-157T>C::,MFN2:ENST00000674658.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-310T>C::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674910.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-189T>C::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-115T>C::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-212T>C::	MFN2:XM_005263543.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-280T>C::,MFN2:XM_005263545.3:5_prime_UTR_variant:MODIFIER:exon1/19:c.-208T>C::,MFN2:XM_005263548.3:5_prime_UTR_variant:MODIFIER:exon1/20:c.-276T>C::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not provided];			rs2180183	0.5325		22800,.	35289	71003	-0.2290			9.63				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTT	het	het	wt	off-target	QUAL=274;DP=86,34,137;AF=0.06,0.26,0.11;MQM=59;SAP=49;ABP=365	MFN2	intron,5'UTR	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1443_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-43_-247-38dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1443_-127+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-140_-52-135dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-43_-211-38dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-43_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-43_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-43_-271-38dup::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron1/17:c.-5+1443_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-43_-149-38dup::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron1/19:c.-217-43_-217-38dup::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron1/18:c.-145-47_-145-42dup::,MFN2:XM_005263547.3:5_prime_UTR_variant:MODIFIER:exon2/19:c.-192_-187dup::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron1/19:c.-213-47_-213-42dup::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-260_-255dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1251375 [benign DISEASE=not provided];			rs34602102	0.0259		202,.	3166	134388				3.98				0.01		1	26	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11981920	11981920	-	TTTTTTT	wt	het	het	off-target	QUAL=274;DP=86,34,137;AF=0.08,0.21,0.08;MQM=58;SAP=58;ABP=338	MFN2	intron,5'UTR	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1442_-95+1448dup::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron1/17:c.-247-44_-247-38dup::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1442_-127+1448dup::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron1/18:c.-52-141_-52-135dup::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron1/19:c.-211-44_-211-38dup::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron1/19:c.-149-44_-149-38dup::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron1/19:c.-239-44_-239-38dup::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron1/19:c.-271-44_-271-38dup::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron1/17:c.-5+1442_-5+1448dup::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron1/18:c.-149-44_-149-38dup::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron1/19:c.-217-44_-217-38dup::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron1/18:c.-145-48_-145-42dup::,MFN2:XM_005263547.3:5_prime_UTR_variant:MODIFIER:exon2/19:c.-193_-187dup::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron1/19:c.-213-48_-213-42dup::,MFN2:XM_024451299.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-261_-255dup::	regulatory_region_variant:promoter	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1238604 [benign DISEASE=not provided];			rs34602102	0.3259		8015,.	28707	92547				3.93				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002148	12002148	A	G	hom	hom	hom	off-target	QUAL=14610;DP=179,138,190;AF=0.98,0.99,0.99;MQM=60;SAP=1067;ABP=0	MFN2	intron	MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+45A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+45A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	MFN2:NM_001127660.2:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263543.3:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:XM_005263545.3:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263547.3:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:XM_005263548.3:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:XM_024451299.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]				rs2236057	0.6522	0.6479,0.5317,0.6765,0.6679,0.7034	32381,.	33932	53404	-2.3750			0.13			COSV52420984	0.01	26816493,26916081,30940795	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011623	12011623	A	G	hom	hom	hom		QUAL=29424;DP=256,323,417;AF=0.99,0.99,1.00;MQM=60;SAP=135;ABP=0	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1897A>G::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::		608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292381 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not specified,not provided];			rs1042842	0.7082		39029,.	29587	44347	-0.7360			1.04			COSV52422477	0	29352517,17940179,21686698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012461	12012461	G	C	hom	hom	hom		QUAL=12738;DP=105,142,172;AF=0.99,1.00,1.00;MQM=60;SAP=78;ABP=0	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1796G>C::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292393 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs3088064	0.5546		23926,.	36315	67589	0.1930			4.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012477	12012477	C	T	wt	het	wt		QUAL=1661;DP=101,143,189;AF=0.00,0.50,0.00;MQM=60;SAP=4;ABP=3	MFN2	3'UTR,intron	MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1780C>T::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	MFN2:NM_001127660.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263543.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:XM_005263545.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263547.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:XM_005263548.3:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::,MFN2:XM_024451299.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*912C>T::	regulatory_region_variant:promoter_flanking_region	608507_[GENE=MFN2_PHENOS=Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292394 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy];			rs14305	0.0535		318,.	7500	143932	0.1590			6.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16043933	16043937	GGGGG	-	n/a	n/a	hom	off-target	QUAL=51;DP=0,0,3;AF=,,1.00;MQM=60;SAP=10;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron1/13:c.-8+61_-8+65del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron3/21:c.-8+61_-8+65del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron2/20:c.-7-545_-7-541del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron4/22:c.-8+61_-8+65del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron1/19:c.-7-545_-7-541del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs140434107	0.4818		10009,.	28607	52301	0.2600			0.91				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16044572	16044572	G	T	het	n/a	hom		QUAL=235;DP=4,1,5;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5	CLCNKB	missense	CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000619181.4:missense_variant:MODERATE:exon2/14:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon4/22:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon3/21:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon5/23:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:	regulatory_region_variant:promoter_flanking_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447107 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2015352	0.6267	0.2881,0.7293,0.6328,0.6333,0.6878	24634,.	33907	68537	0.0080	D(0.01),D(0.03),D(0.01),D(0.01),D(0.02),D(0.01),D(0.01)	B(0.16),B(0.02),B(0.16),B(0.16),B(0.01),B(0.16),B(0.16)	18.63	0.30		COSV65159885	0	16109321,32327693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045508	16045508	G	C	het	het	hom	off-target	QUAL=6436;DP=55,128,148;AF=0.42,0.48,1.00;MQM=60;SAP=355;ABP=6	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron2/13:c.101-50G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-50G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-50G>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-50G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron2/19:c.101-50G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209775 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs6604910	0.6357	0.2698,0.7354,0.6801,0.6380,0.7118	24662,.	33514	69114	-0.4740			4.26			COSV65160072	0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046476	16046476	G	A	hom	hom	hom	off-target	QUAL=12404;DP=78,142,182;AF=1.00,1.00,1.00;MQM=60;SAP=439;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron3/13:c.230-59G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-59G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-59G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-59G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron3/19:c.230-59G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209776 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs2014841	0.7025		40551,.	25638	45198	0.0580			1.12				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046629	16046629	A	G	hom	hom	hom		QUAL=23205;DP=180,247,314;AF=0.99,1.00,1.00;MQM=60;SAP=5;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon4/14:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon6/22:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon5/21:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon7/23:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447104 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs5257	0.8121	0.3791,0.8994,0.9891,0.8093,0.8739	40534,.	25628	45140	-3.8900			0.63				0.88	26045835	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046705	16046707	CTT	-	hom	het	hom	off-target;low_conf_region	QUAL=9620;DP=108,146,205;AF=1.00,0.49,1.00;MQM=60;SAP=347;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron4/13:c.358+44_358+46del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+44_358+46del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+44_358+46del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+44_358+46del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1280604 [benign DISEASE=not provided];			rs35820664	0.7861	0.3540,0.8883,0.9891,0.7803,0.8442	37662,.	27213	49121	1.7440			8.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048038	16048038	G	C	hom	hom	hom		QUAL=383;DP=5,5,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon5/14:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon7/22:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon6/21:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon8/23:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447105 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2014562	0.9317	0.7589,0.9575,0.9997,0.9439,0.9278	60802,.	13717	16629	-0.5020			7.47				0.12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048499	16048499	C	T	hom	hom	hom		QUAL=17965;DP=155,203,244;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000619181.4:splice_region_variant&intron_variant:LOW:intron6/13:c.577-5C>T::,CLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron8/21:c.577-5C>T::,CLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron7/20:c.577-5C>T::,CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron9/22:c.577-5C>T::,CLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	CLCNKB:NM_000085.5:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	381050 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889788	0.8104	0.3760,0.8986,0.9890,0.8075,0.8732	40322,.	25719	45457	-0.3220			5.31		4.28>4.16	COSV65161773	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048568	16048568	C	G	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+54C>G::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon9/22:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon8/21:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon10/23:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:	regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504916 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889789	0.9069	0.5589,0.9388,0.9997,0.9259,0.9256	53660,.	17877	26439	-0.2280	T(0.79), ,T(0.79),T(0.79),T(1.00),T(0.79),T(0.79)	B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	5.97	0.22		COSV65159497	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048569	16048569	A	C	hom	hom	hom		QUAL=16977;DP=185,174,215;AF=0.98,1.00,1.00;MQM=52;SAP=213;ABP=0	CLCNKB	synonymous,intron	CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+55A>C::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon9/22:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon8/21:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon10/23:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504915 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs1889790	0.9069	0.5589,0.9388,0.9997,0.9258,0.9256	53659,.	17878	26434	-2.9260			2.40			COSV65161020	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048715	16048715	G	A	het	wt	hom	off-target	QUAL=4177;DP=96,103,100;AF=0.48,0.00,0.99;MQM=60;SAP=11;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+201G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.655+133G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.655+133G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.655+133G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.655+133G>A::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1290690 [benign DISEASE=not provided];			rs9633514	0.2987		8204,.	28923	106427	0.0370			7.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048859	16048859	C	T	hom	hom	hom		QUAL=18683;DP=167,201,235;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667.7:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.587+345C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.656-261C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.656-261C>T::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.656-261C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:NM_001165945.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1259614 [benign DISEASE=not provided];		MIR (SINE/MIR)	rs9442227	0.6911		39478,.	26091	46943	0.4180			8.65				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049696	16049696	C	T	hom	hom	hom		QUAL=25484;DP=176,312,402;AF=1.00,1.00,1.00;MQM=45;SAP=275;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-820C>T::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon11/22:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon10/21:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon12/23:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447108 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs7367494	0.9249	0.5573,0.9597,0.9988,0.9484,0.9335	54670,.	16546	24918	-0.1040	T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.01), ,B(0.01),B(0.01),B(0.00),B(0.01),B(0.01)	0.08	0.22		COSV65159503	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049735	16049735	-	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-781_588-780insT::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+33_866+34insT::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+33_866+34insT::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+33_866+34insT::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277184 [benign DISEASE=not provided];			rs59006537	0.9242	0.4294,0.9451,0.9983,0.9544,0.9487	54700,.	16575	24959				1.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049737	16049737	A	T	hom	hom	hom	off-target	QUAL=26382;DP=84,345,451;AF=0.99,1.00,1.00;MQM=51;SAP=34;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+35A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-779A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+35A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+35A>T::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+35A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+35A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209692 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs59924562	0.9253	0.4491,0.9459,0.9984,0.9547,0.9477	54726,.	16582	24972	-2.4980			0.10			COSV65161540	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049744	16049744	C	-	hom	hom	hom	off-target	QUAL=24247;DP=81,335,440;AF=0.96,0.99,0.99;MQM=52;SAP=12;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+47del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-767del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+47del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+47del::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+47del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+47del::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.359+47del::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209750 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs34589727	0.9148	0.4231,0.9419,0.9988,0.9470,0.9354	54759,.	16533	24903	-0.1770			1.35				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049783	16049783	G	A	hom	hom	hom	off-target	QUAL=30508;DP=136,364,499;AF=1.00,1.00,1.00;MQM=57;SAP=40;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.360-32G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-733G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.867-32G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.867-32G>A::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.867-32G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron2/12:c.360-32G>A::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209751 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7365182	0.9209	0.5528,0.9546,0.9999,0.9463,0.9313	54745,.	16712	25312	0.7450			5.09				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049824	16049824	T	C	hom	hom	hom		QUAL=32735;DP=180,361,483;AF=1.00,1.00,1.00;MQM=60;SAP=174;ABP=0	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-692T>C::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon12/22:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon11/21:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon13/23:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	377683 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs7368151	0.9168	0.5579,0.9485,0.9998,0.9431,0.9271	54977,.	16636	25062	-4.6600			0.08			COSV65161411	0.07		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049963	16049963	T	C	hom	hom	hom	off-target	QUAL=17634;DP=127,192,273;AF=0.99,1.00,1.00;MQM=59;SAP=231;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+47T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron7/13:c.588-553T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+47T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+47T>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+47T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron3/12:c.461+47T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209752 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7368166	0.9131	0.5505,0.9457,0.9985,0.9398,0.9198	54369,.	16889	25259	-3.1490			1.04			COSV65161797	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052154	16052154	C	G	het	het	wt	off-target	QUAL=482;DP=19,19,10;AF=0.58,0.68,0.00;MQM=60;SAP=39;ABP=9	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron7/12:c.902-44C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron11/13:c.1028-44C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron16/21:c.1409-44C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron15/20:c.1409-44C>G::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron17/22:c.1409-44C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1232843 [benign DISEASE=not provided];			rs2297726	0.1727	0.0715,0.1591,0.2995,0.1706,0.1631	1846,.	18427	130027	0.0340			8.76			COSV65160804	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052244	16052244	G	A	wt	het	wt		QUAL=108;DP=27,22,16;AF=0.00,0.36,0.00;MQM=60;SAP=4;ABP=7	CLCNKB	synonymous	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000619181.4:synonymous_variant:LOW:exon12/14:c.1074G>A:p.Ala358=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon17/22:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon16/21:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon18/23:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	585703 [benign DISEASE=not specified,not provided];			rs34652156	0.0366	0.0580,0.0117,0.0000,0.0274,0.0299	145,.	5274	146618	-4.4550			0.08			COSV65160149	0.01		25	1075	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16053701	16053701	T	C	hom	hom	hom		QUAL=28466;DP=297,251,371;AF=1.00,1.00,1.00;MQM=51;SAP=166;ABP=0	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+11T>C::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447094 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs5253	0.9347	0.6863,0.9480,0.8076,0.9843,0.9317	61122,.	12747	17037	-1.3380	T(0.49),T(0.46), ,T(0.46),T(0.46),T(0.63),T(0.46),T(0.46)	B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.03	0.28			0.04	25919862	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053748	16053748	A	G	hom	het	hom		QUAL=15672;DP=139,232,313;AF=1.00,0.42,0.99;MQM=49;SAP=9;ABP=15	CLCNKB	missense,intron	CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+58A>G::,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain]	CLCNKB:NM_000085.5:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:,CLCNKB:NM_001165945.2:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447096 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.6948	0.7975,0.5184,0.7947,0.6591,0.5830	37116,.	31137	46283	1.0120	T(1.00),T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	7.04	0.16			0.16	25919862	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053757	16053757	C	T	hom	het	hom		QUAL=14504;DP=119,217,303;AF=1.00,0.43,1.00;MQM=49;SAP=18;ABP=13	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1293+67C>T::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon18/22:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon17/21:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon19/23:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain]	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447097 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not specified,not provided];			rs2275167	0.6207	0.5768,0.4929,0.7894,0.6443,0.5281	29518,.	35073	57501	0.5150			8.01			COSV65152867	0.31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056382	16056382	A	G	hom	hom	hom	off-target	QUAL=11604;DP=50,147,203;AF=1.00,0.99,1.00;MQM=60;SAP=31;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-805A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-40A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-40A>G::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-40A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209753 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs7517792	0.7963	0.7061,0.8840,0.8077,0.7871,0.8423	45030,.	26537	35107	-2.2960			0.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056834	16056834	-	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-29dup::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-347dup::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-29dup::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-29dup::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-29dup::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-29dup::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1246688 [benign DISEASE=not provided];			rs138507185	0.6602		29214,.	27005	43981				0.54				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056841	16056841	G	C	hom	het	hom	off-target;low_conf_region	QUAL=45;DP=3,22,6;AF=0.00,0.18,0.67;MQM=45;SAP=7;ABP=22	CLCNKB	intron	CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-346G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-28G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-28G>C::,CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-28G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::	CLCNKB:NM_000085.5:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:NM_001165945.2:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209827 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs12746138	0.7212	0.4283,0.8343,0.7670,0.6997,0.7947	32995,.	27312	36064	-2.2870			0.07				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056907	16056907	C	T	het	wt	wt		QUAL=698;DP=257,140,144;AF=0.26,0.00,0.07;MQM=35;SAP=168;ABP=135	CLCNKB	synonymous,intron	CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-280C>T::,CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon22/22:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon21/21:c.2052C>T:p.Ala684=:,CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon23/23:c.2055C>T:p.Ala685=:,CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:	CLCNKB:NM_000085.5:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:,CLCNKB:NM_001165945.2:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	785932 [likely benign DISEASE=not provided];			rs6698427	0.0714	0.0128,0.0033,0.0132,0.0013,0.0025	1,.	6814	88636	-0.0040			4.92			COSV65152730	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056953	16056953	A	C	het	hom	hom	low_conf_region	QUAL=15870;DP=218,241,287;AF=0.70,1.00,0.90;MQM=40;SAP=906;ABP=77	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-234A>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*37A>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*37A>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*37A>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209828 [benign DISEASE=Bartter syndrome, type 4b,Bartter syndrome type 3,not provided];			rs10803415	0.9041	0.8429,0.9248,0.6951,0.9399,0.8839	29942,.	34903	35599	-1.8020			0.48				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057052	16057052	T	C	wt	wt	het		QUAL=542;DP=234,394,594;AF=0.05,0.00,0.19;MQM=31;SAP=272;ABP=509	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-135T>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*136T>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*136T>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*136T>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057839	0.2225		8,.	22599	79035	0.2550			5.43			COSV65152725	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057079	16057079	A	T	het	wt	het		QUAL=888;DP=245,379,614;AF=0.13,0.00,0.20;MQM=33;SAP=342;ABP=759	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-108A>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*163A>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*163A>T::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*163A>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057841	0.2559		0,.	26706	77672	0.6160			6.28				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057086	16057086	G	T	het	het	het		QUAL=19906;DP=249,378,613;AF=0.85,0.51,0.79;MQM=37;SAP=74;ABP=517	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-101G>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*170G>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*170G>T::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*170G>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057844	0.5151		10449,.	55380	71806	-1.4160			0.21				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057110	16057110	A	G	het	het	het		QUAL=19800;DP=196,403,645;AF=0.74,0.53,0.77;MQM=38;SAP=4;ABP=376	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-77A>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*194A>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*194A>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*194A>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057845	0.5067		9210,.	56591	73041	-0.6030			1.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057173	16057173	T	G	hom	hom	hom		QUAL=32874;DP=174,360,659;AF=0.99,1.00,1.00;MQM=41;SAP=399;ABP=0	CLCNKB	3'UTR,intron	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000619181.4:intron_variant:MODIFIER:intron13/13:c.1294-14T>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*257T>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*257T>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*257T>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6660218	1.0000	1.0000,1.0000,0.9998,0.9999,1.0000	76104,.	2	2	0.3150			3.77		-10.56>-11.38		0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057187	16057187	G	C	het	wt	het		QUAL=4440;DP=222,321,648;AF=0.19,0.00,0.36;MQM=41;SAP=38;ABP=262	CLCNKB	3'UTR,missense&splice_region	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000619181.4:missense_variant&splice_region_variant:MODERATE:exon14/14:c.1294G>C:p.Ala432Pro:,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*271G>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*271G>C::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*271G>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	402540 [benign DISEASE=not specified];			rs1057854	0.3286	0.4019,0.2177,0.4238,0.3039,0.2888	223,.	46374	95650	-3.2250	 , ,D(0.00), , , , , 	 , ,D(0.98), , , , , 	0.15	0.01	-10.56>-11.54	COSV65152876	0	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057247	16057247	C	G	het	hom	het		QUAL=18401;DP=339,224,515;AF=0.55,1.00,0.53;MQM=58;SAP=737;ABP=13	CLCNKB	3'UTR,missense	CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000619181.4:missense_variant:MODERATE:exon14/14:c.1354C>G:p.Pro452Ala:,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*331C>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*331C>G::,CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*331C>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::	CLCNKB:NM_000085.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:NM_001165945.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057857	0.6415	0.5897,0.6972,0.4932,0.6536,0.6177	19811,.	55386	55948	-0.3610	 , ,D(0.00), , , , , 	 , ,P(0.74), , , , , 	3.09	0.02		COSV65153970	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057359	16057359	A	G	het	wt	het	off-target	QUAL=706;DP=105,56,110;AF=0.38,0.00,0.17;MQM=38;SAP=131;ABP=98	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000619181.4:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::			602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs749928769	0.0271		9,.	4101	147625	-0.5220			2.21						0	11	0 / 0					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16986248	16986248	C	T	het	hom	het		QUAL=707;DP=17,19,25;AF=0.41,0.95,0.44;MQM=60;SAP=12;ABP=5	ATP13A2	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676.9:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7136C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:NM_001141974.3:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:XM_005245810.1:missense_variant:MODERATE:exon28/28:c.3343G>A:p.Ala1115Thr:,ATP13A2:XM_005245811.1:missense_variant:MODERATE:exon28/28:c.3331G>A:p.Ala1111Thr:,ATP13A2:XM_005245812.1:missense_variant:MODERATE:exon28/28:c.3319G>A:p.Ala1107Thr:,ATP13A2:XM_005245815.1:missense_variant:MODERATE:exon27/27:c.3229G>A:p.Ala1077Thr:,ATP13A2:XM_006710512.1:missense_variant:MODERATE:exon28/28:c.3328G>A:p.Ala1110Thr:,ATP13A2:XM_006710513.1:missense_variant:MODERATE:exon28/28:c.3304G>A:p.Ala1102Thr:,ATP13A2:XM_011541128.1:missense_variant:MODERATE:exon28/28:c.3331G>A:p.Ala1111Thr:,ATP13A2:XM_011541129.1:missense_variant:MODERATE:exon27/27:c.3139G>A:p.Ala1047Thr:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon29/29:c.3498G>A:p.Pro1166=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon29/29:c.3474G>A:p.Pro1158=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon29/29:c.3471G>A:p.Pro1157=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon28/28:c.3399G>A:p.Pro1133=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon28/28:c.3384G>A:p.Pro1128=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon28/28:c.3309G>A:p.Pro1103=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128475 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.4703	0.2020,0.4851,0.2946,0.5286,0.4630	14373,.	33576	89314	-2.7740	 ,T(0.32), , 	 ,B(0.00), , 	0.29	0.24		COSV58697923	0	25741868,18414213,19085912,22743658,31562340,30232368,32327693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986662	16986662	G	A	het	hom	het	off-target	QUAL=9679;DP=84,216,293;AF=0.39,1.00,0.50;MQM=60;SAP=38;ABP=5	ATP13A2	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7550G>A::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:XM_005245810.1:intron_variant:MODIFIER:intron27/27:c.3232+143C>T::,ATP13A2:XM_005245811.1:intron_variant:MODIFIER:intron27/27:c.3220+143C>T::,ATP13A2:XM_005245812.1:intron_variant:MODIFIER:intron27/27:c.3208+143C>T::,ATP13A2:XM_005245815.1:intron_variant:MODIFIER:intron26/26:c.3118+143C>T::,ATP13A2:XM_006710512.1:intron_variant:MODIFIER:intron27/27:c.3217+143C>T::,ATP13A2:XM_006710513.1:intron_variant:MODIFIER:intron27/27:c.3193+143C>T::,ATP13A2:XM_011541128.1:intron_variant:MODIFIER:intron27/27:c.3220+143C>T::,ATP13A2:XM_011541129.1:intron_variant:MODIFIER:intron26/26:c.3028+143C>T::,ATP13A2:XM_017000844.1:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::,ATP13A2:XM_017000845.1:intron_variant:MODIFIER:intron27/28:c.3218-30C>T::,ATP13A2:XM_017000846.1:intron_variant:MODIFIER:intron27/28:c.3194-30C>T::,ATP13A2:XM_017000847.1:intron_variant:MODIFIER:intron27/28:c.3191-30C>T::,ATP13A2:XM_017000848.1:intron_variant:MODIFIER:intron26/27:c.3119-30C>T::,ATP13A2:XM_017000849.1:intron_variant:MODIFIER:intron26/27:c.3104-30C>T::,ATP13A2:XM_017000850.1:intron_variant:MODIFIER:intron26/27:c.3029-30C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	559000 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,not provided];			rs2076605	0.4706	0.2188,0.4839,0.2956,0.5242,0.4771	14617,.	34089	88347	2.1340			9.24			COSV58702203	0.01	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986750	16986761	CCCAGGGCTCCT	-	het	wt	het	off-target	QUAL=2063;DP=45,167,208;AF=0.27,0.00,0.50;MQM=60;SAP=12;ABP=7	ATP13A2	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	ATP13A2:NM_001141973.3:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::,ATP13A2:NM_001141974.3:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:NM_022089.4:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:XM_005245810.1:intron_variant:MODIFIER:intron27/27:c.3232+44_3232+55del::,ATP13A2:XM_005245811.1:intron_variant:MODIFIER:intron27/27:c.3220+44_3220+55del::,ATP13A2:XM_005245812.1:intron_variant:MODIFIER:intron27/27:c.3208+44_3208+55del::,ATP13A2:XM_005245815.1:intron_variant:MODIFIER:intron26/26:c.3118+44_3118+55del::,ATP13A2:XM_006710512.1:intron_variant:MODIFIER:intron27/27:c.3217+44_3217+55del::,ATP13A2:XM_006710513.1:intron_variant:MODIFIER:intron27/27:c.3193+44_3193+55del::,ATP13A2:XM_011541128.1:intron_variant:MODIFIER:intron27/27:c.3220+44_3220+55del::,ATP13A2:XM_011541129.1:intron_variant:MODIFIER:intron26/26:c.3028+44_3028+55del::,ATP13A2:XM_017000844.1:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::,ATP13A2:XM_017000845.1:intron_variant:MODIFIER:intron27/28:c.3217+44_3217+55del::,ATP13A2:XM_017000846.1:intron_variant:MODIFIER:intron27/28:c.3193+44_3193+55del::,ATP13A2:XM_017000847.1:intron_variant:MODIFIER:intron27/28:c.3190+44_3190+55del::,ATP13A2:XM_017000848.1:intron_variant:MODIFIER:intron26/27:c.3118+44_3118+55del::,ATP13A2:XM_017000849.1:intron_variant:MODIFIER:intron26/27:c.3103+44_3103+55del::,ATP13A2:XM_017000850.1:intron_variant:MODIFIER:intron26/27:c.3028+44_3028+55del::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1174788 [benign DISEASE=not specified,not provided];			rs143483351	0.2409		4929,.	26724	115258	1.8490			4.15				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986848	16986848	G	A	het	hom	het		QUAL=10657;DP=90,199,282;AF=0.47,1.00,0.50;MQM=60;SAP=18;ABP=3	ATP13A2	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7736G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon27/28:c.3189C>T:p.Ala1063=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon27/28:c.3177C>T:p.Ala1059=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon27/28:c.3165C>T:p.Ala1055=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon26/27:c.3075C>T:p.Ala1025=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon27/28:c.3174C>T:p.Ala1058=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon27/28:c.3150C>T:p.Ala1050=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon27/28:c.3177C>T:p.Ala1059=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon26/27:c.2985C>T:p.Ala995=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon27/29:c.3174C>T:p.Ala1058=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon27/29:c.3150C>T:p.Ala1050=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon27/29:c.3147C>T:p.Ala1049=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon26/28:c.3075C>T:p.Ala1025=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon26/28:c.3060C>T:p.Ala1020=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon26/28:c.2985C>T:p.Ala995=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128473 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.4652	0.1875,0.4783,0.2891,0.5225,0.4729	14510,.	33570	89334	-0.3600			0.47			COSV58700662	0.02	25741868,18414213,19085912,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986959	16986959	G	A	het	wt	het		QUAL=2312;DP=59,138,178;AF=0.47,0.00,0.44;MQM=60;SAP=33;ABP=9	ATP13A2	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000341676.9:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7847G>A::,ATP13A2:ENST00000452699.5:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	ATP13A2:NM_001141973.3:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::,ATP13A2:NM_001141974.3:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:NM_022089.4:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:XM_005245810.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3081-3C>T::,ATP13A2:XM_005245811.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3069-3C>T::,ATP13A2:XM_005245812.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3057-3C>T::,ATP13A2:XM_005245815.1:splice_region_variant&intron_variant:LOW:intron25/26:c.2967-3C>T::,ATP13A2:XM_006710512.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3066-3C>T::,ATP13A2:XM_006710513.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3042-3C>T::,ATP13A2:XM_011541128.1:splice_region_variant&intron_variant:LOW:intron26/27:c.3069-3C>T::,ATP13A2:XM_011541129.1:splice_region_variant&intron_variant:LOW:intron25/26:c.2877-3C>T::,ATP13A2:XM_017000844.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::,ATP13A2:XM_017000845.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3066-3C>T::,ATP13A2:XM_017000846.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3042-3C>T::,ATP13A2:XM_017000847.1:splice_region_variant&intron_variant:LOW:intron26/28:c.3039-3C>T::,ATP13A2:XM_017000848.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2967-3C>T::,ATP13A2:XM_017000849.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2952-3C>T::,ATP13A2:XM_017000850.1:splice_region_variant&intron_variant:LOW:intron25/27:c.2877-3C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128471 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.2819	0.1706,0.3596,0.5506,0.2392,0.2307	4944,.	26893	114749	0.7470			8.06		9.29>9.90	COSV104399909	0	25741868,18414213,19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16987159	16987159	C	T	het	hom	het		QUAL=10638;DP=65,245,281;AF=0.51,1.00,0.47;MQM=60;SAP=149;ABP=5	ATP13A2	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+8047C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon26/28:c.2967G>A:p.Val989=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon26/28:c.2955G>A:p.Val985=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon26/28:c.2943G>A:p.Val981=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon25/27:c.2853G>A:p.Val951=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon26/28:c.2952G>A:p.Val984=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon26/28:c.2928G>A:p.Val976=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon26/28:c.2955G>A:p.Val985=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon25/27:c.2763G>A:p.Val921=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon26/29:c.2952G>A:p.Val984=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon26/29:c.2928G>A:p.Val976=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon26/29:c.2925G>A:p.Val975=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon25/28:c.2853G>A:p.Val951=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon25/28:c.2838G>A:p.Val946=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon25/28:c.2763G>A:p.Val921=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128470 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.4654	0.2158,0.4792,0.2830,0.5203,0.4730	14645,.	34185	88451	-0.8540			0.19			COSV58699127	0.03	25741868,18414213,19085912,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988207	16988207	C	T	het	wt	het		QUAL=11072;DP=278,493,583;AF=0.48,0.01,0.51;MQM=60;SAP=31;ABP=3	ATP13A2	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9095C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon25/28:c.2787G>A:p.Ser929=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon25/28:c.2775G>A:p.Ser925=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon25/28:c.2763G>A:p.Ser921=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon24/27:c.2673G>A:p.Ser891=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon25/28:c.2772G>A:p.Ser924=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon25/28:c.2748G>A:p.Ser916=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon25/28:c.2775G>A:p.Ser925=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon24/27:c.2583G>A:p.Ser861=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon25/29:c.2772G>A:p.Ser924=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon25/29:c.2748G>A:p.Ser916=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon25/29:c.2745G>A:p.Ser915=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon24/28:c.2673G>A:p.Ser891=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon24/28:c.2658G>A:p.Ser886=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon24/28:c.2583G>A:p.Ser861=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128468 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2494	0.1518,0.3342,0.5507,0.1933,0.2217	3993,.	24198	119838	-2.3080			0.37			COSV58700021	0.05	25741868,18414213,19085912,22285144,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988447	16988447	G	A	het	hom	het		QUAL=14033;DP=294,260,322;AF=0.50,0.99,0.45;MQM=60;SAP=394;ABP=6	ATP13A2	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF00702 [haloacid dehalogenase-like hydrolase],:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9335G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon24/28:c.2634C>T:p.Gly878=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon24/28:c.2622C>T:p.Gly874=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon24/28:c.2610C>T:p.Gly870=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon23/27:c.2520C>T:p.Gly840=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon24/28:c.2619C>T:p.Gly873=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon24/28:c.2595C>T:p.Gly865=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon24/28:c.2622C>T:p.Gly874=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon23/27:c.2430C>T:p.Gly810=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon24/29:c.2619C>T:p.Gly873=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon24/29:c.2595C>T:p.Gly865=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon24/29:c.2592C>T:p.Gly864=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon23/28:c.2520C>T:p.Gly840=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon23/28:c.2505C>T:p.Gly835=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon23/28:c.2430C>T:p.Gly810=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128466 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.4633	0.1867,0.4771,0.2888,0.5193,0.4726	14422,.	33573	89507	-5.0290			3.79			COSV58700683	0	25741868,18414213,19085912,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16992516	16992516	G	A	het	hom	het		QUAL=6562;DP=78,128,151;AF=0.47,1.00,0.48;MQM=60;SAP=55;ABP=4	ATP13A2	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase],:ENST00000446261.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-12127G>A::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon17/28:c.1812C>T:p.Pro604=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon17/28:c.1788C>T:p.Pro596=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon17/27:c.1815C>T:p.Pro605=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon17/28:c.1797C>T:p.Pro599=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon17/28:c.1773C>T:p.Pro591=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon16/27:c.1608C>T:p.Pro536=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon17/29:c.1797C>T:p.Pro599=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon17/29:c.1773C>T:p.Pro591=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon17/29:c.1770C>T:p.Pro590=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon17/28:c.1815C>T:p.Pro605=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon17/28:c.1800C>T:p.Pro600=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon16/28:c.1608C>T:p.Pro536=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128465 [benign DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.5563	0.4404,0.5455,0.2863,0.6263,0.5184	23512,.	36216	68750	-0.0780			7.24			COSV58700878	0.01	25741868,18414213,19085912,22743658,30232368,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17004773	17004773	C	T	wt	het	wt		QUAL=643;DP=133,74,121;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=9	ATP13A2	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],:ENST00000446261.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]	ATP13A2:NM_001141973.3:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:NM_001141974.3:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:NM_022089.4:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_005245810.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245811.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245812.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_005245815.1:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:XM_006710512.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_006710513.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_011541128.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_011541129.1:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:,ATP13A2:XM_017000844.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000845.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000846.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000847.1:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:,ATP13A2:XM_017000848.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_017000849.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:,ATP13A2:XM_017000850.1:synonymous_variant:LOW:exon5/28:c.396G>A:p.Ala132=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	293803 [uncertain significance(replaced by megSAP based on classifications:1x2,1x3) DISEASE=Kufor-Rakeb syndrome,Spastic paraplegia 78, autosomal recessive];			rs140631323	0.0001	0.0000,0.0001,0.0000,0.0001,0.0002	0,.	14	152166	-4.7190			0.12			COSV58702839	0		1	11	0 / 0					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	18871570	18871570	T	G	het	wt	het		QUAL=3442;DP=95,148,185;AF=0.53,0.00,0.47;MQM=60;SAP=9;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2683A>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2836A>C::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294333 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138333	0.2420		4696,.	27365	115129	0.9220			12.39				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871606	18871606	C	G	het	wt	het		QUAL=3398;DP=96,144,166;AF=0.54,0.00,0.49;MQM=60;SAP=7;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2647G>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2800G>C::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294334 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138328	0.2349		4485,.	26750	116340	0.1220			4.21			COSV51895732	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871647	18871647	T	C	het	wt	het		QUAL=3477;DP=123,139,146;AF=0.54,0.00,0.48;MQM=60;SAP=5;ABP=3	ALDH4A1	3'UTR	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:NM_170726.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2606A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2759A>G::	regulatory_region_variant:promoter_flanking_region	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294336 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7366541	0.2420		4701,.	27374	115184	-1.1350			1.41			COSV51895747	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871920	18871920	G	A	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2333C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2486C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294341 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1140477	0.2516		4959,.	28316	113706	0.5890			4.94				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871924	18871924	C	T	het	wt	het		QUAL=4287;DP=167,168,196;AF=0.47,0.00,0.49;MQM=60;SAP=26;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2329G>A::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2482G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294342 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138269	0.2516		4960,.	28309	113707	0.1370			5.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872082	18872082	A	G	hom	hom	hom		QUAL=29643;DP=366,238,311;AF=1.00,1.00,0.99;MQM=60;SAP=10;ABP=0	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2171T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2324T>C::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294344 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs1138267	0.6588		33624,.	32916	51874	-4.5340			0.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872133	18872133	G	A	het	wt	het		QUAL=6408;DP=291,203,262;AF=0.48,0.00,0.45;MQM=60;SAP=20;ABP=7	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2120C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2273C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294346 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs14311	0.2509		4985,.	28185	113947	-0.0090			1.70				0	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872143	18872143	G	A	het	hom	het		QUAL=12547;DP=239,205,258;AF=0.49,1.00,0.53;MQM=60;SAP=6;ABP=4	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2110C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2263C>T::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294347 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs3202002	0.3984		13009,.	34573	91479	-0.2920			3.42				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872188	18872188	C	-	het	hom	het		QUAL=7778;DP=103,165,182;AF=0.49,0.99,0.53;MQM=60;SAP=6;ABP=3	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2065del::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2218del::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294349 [likely benign DISEASE=Hyperprolinemia];			rs11311839	0.4073		13583,.	34763	90125	-3.2790			0.02				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872401	18872401	A	G	het	wt	het		QUAL=5039;DP=190,194,247;AF=0.48,0.00,0.45;MQM=60;SAP=10;ABP=8	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1852T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.2005T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294353 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs9117	0.1839		3075,.	21832	124152	0.2290			4.35				0	12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872727	18872727	C	T	het	hom	het		QUAL=20784;DP=213,404,487;AF=0.43,1.00,0.47;MQM=60;SAP=57;ABP=16	ALDH4A1	intron,3'UTR	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::	ALDH4A1:NM_001161504.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_001319218.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::,ALDH4A1:NM_003748.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1526G>A::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon14/14:n.1679G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294359 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs11740	0.3994		13035,.	34563	91179	-0.7970			0.48			COSV51892981	0	18843385,12970910,24686056	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872979	18872979	T	A	het	hom	het	off-target	QUAL=12560;DP=148,227,285;AF=0.47,0.99,0.52;MQM=60;SAP=126;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1296-22A>T::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1449-22A>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188868 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28700162	0.4724	0.2427,0.5821,0.6726,0.4245,0.5857	13110,.	34605	91183	0.0000			7.70			COSV51895558	0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872993	18872993	A	G	het	wt	het	off-target	QUAL=4653;DP=104,201,254;AF=0.62,0.00,0.48;MQM=60;SAP=108;ABP=4	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1296-36T>C::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1449-36T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35255325	0.1962	0.0962,0.1974,0.0007,0.2520,0.1205	3134,.	22350	123496	0.0900			5.74				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874414	18874414	G	C	het	hom	het	off-target	QUAL=6916;DP=104,121,166;AF=0.55,1.00,0.46;MQM=60;SAP=368;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1295+49C>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1448+49C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188869 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs28529092	0.5001	0.4323,0.5988,0.6738,0.4409,0.6074	16498,.	37225	81665	3.1040			11.59			COSV51895606	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18875462	18875462	A	G	hom	hom	hom		QUAL=18220;DP=311,131,136;AF=1.00,1.00,1.00;MQM=60;SAP=207;ABP=0	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:,ALDH4A1:NM_001319218.2:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon11/13:n.1096T>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon12/14:n.1249T>C::	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294369 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified];			rs2230708	0.7321	0.6880,0.8178,0.7106,0.7190,0.7577	38866,.	30784	43356	-1.3090			0.29				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876276	18876276	T	C	hom	hom	hom	off-target	QUAL=4035;DP=48,30,54;AF=1.00,1.00,1.00;MQM=60;SAP=148;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1055-773A>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/13:n.1207+39A>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188872 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs7550822	0.9653	0.7709,0.9760,0.9999,0.9775,0.9836	65159,.	9867	11909	-0.0870			5.29				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876402	18876402	G	A	hom	het	hom		QUAL=7422;DP=132,72,96;AF=0.99,0.33,0.99;MQM=60;SAP=26;ABP=20	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+806C>T::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1120C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294374 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not provided];			rs2230707	0.5117	0.4402,0.6932,0.6078,0.4697,0.4989	17651,.	37218	79394	-9.1790			1.01			COSV51891838	0.01	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876423	18876423	T	C	hom	hom	hom		QUAL=7586;DP=96,74,87;AF=1.00,0.97,0.99;MQM=60;SAP=4;ABP=0	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+785A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1099A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294375 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs7550938	0.6986	0.4836,0.7945,0.7121,0.6946,0.7419	31974,.	33395	54093	-6.0680			1.04			COSV51894187	0.03	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876432	18876432	T	C	hom	hom	hom		QUAL=6356;DP=65,73,87;AF=1.00,0.96,0.99;MQM=60;SAP=5;ABP=0	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1054+776A>G::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon11/14:n.1090A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294376 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase,not specified,not provided];			rs2230706	0.6978	0.4828,0.7939,0.7102,0.6929,0.7422	31934,.	33409	54203	0.1280			2.89			COSV51893163	0.02	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877503	18877503	C	G	hom	hom	hom		QUAL=7567;DP=84,56,107;AF=0.98,1.00,1.00;MQM=60;SAP=133;ABP=0	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family]	ALDH4A1:NM_001161504.2:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:,ALDH4A1:NM_001319218.2:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:,ALDH4A1:NM_003748.4:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:,ALDH4A1:NM_170726.3:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:,ALDH4A1:XR_001737510.1:non_coding_transcript_exon_variant:MODIFIER:exon9/13:n.919G>C::,ALDH4A1:XR_946786.1:non_coding_transcript_exon_variant:MODIFIER:exon9/14:n.919G>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294382 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs2230705	0.7099	0.7234,0.7459,0.4494,0.7190,0.5900	38609,.	30705	44113	1.5970			8.71			COSV51892136	0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877660	18877660	G	A	het	hom	wt	off-target	QUAL=269;DP=14,8,20;AF=0.43,1.00,0.00;MQM=60;SAP=33;ABP=4	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-48C>T::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron9/14:c.761-48C>T::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/12:n.810-48C>T::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/13:n.810-48C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188873 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs6426813	0.7698	0.6963,0.8857,0.9544,0.7067,0.8413	40352,.	29360	41898	-0.8390			0.54				0	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18881651	18881651	-	GGTTGCCT	hom	hom	hom	off-target	QUAL=672;DP=7,7,14;AF=1.00,1.00,1.00;MQM=60;SAP=64;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.735+1472_735+1473insAGGCAACC::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/13:n.735+1472_735+1473insAGGCAACC::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs112548638	0.9957	0.9437,0.9967,0.9999,0.9998,0.9995	73707,.	2254	2370				1.51				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885436	18885436	A	C	wt	hom	wt	off-target;low_conf_region	QUAL=55;DP=4,7,5;AF=0.00,0.86,0.00;MQM=60;SAP=9;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+37T>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron5/14:c.273+37T>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron5/13:c.453+37T>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+37T>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+37T>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.510+37T>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.510+37T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs752213358	0.2907	0.3541,0.4488,0.4416,0.2331,0.2196	0,.	12845	41481	-3.5210			0.04			COSV51892118	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18885441	18885441	G	C	n/a	het	wt	off-target;low_conf_region	QUAL=27;DP=2,9,6;AF=0.00,0.56,0.00;MQM=60;SAP=14;ABP=3	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.453+32C>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron5/14:c.273+32C>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron5/13:c.453+32C>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron5/14:c.453+32C>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron5/15:c.453+32C>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.510+32C>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.510+32C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			(CACCC)n (Simple_repeat)	rs188233802	0.3275	0.4060,0.4609,0.4566,0.2761,0.2668	0,.	9992	32668	-0.6210			0.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18889340	18889340	T	C	hom	hom	hom	off-target	QUAL=11008;DP=118,95,143;AF=1.00,1.00,1.00;MQM=60;SAP=175;ABP=0	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron3/13:c.249+22A>G::	ALDH4A1:NM_001161504.2:intron_variant:MODIFIER:intron3/14:c.69+22A>G::,ALDH4A1:NM_001319218.2:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:NM_003748.4:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:NM_170726.3:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:XR_001737510.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/12:n.306+22A>G::,ALDH4A1:XR_946786.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/13:n.306+22A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188912 [benign DISEASE=Deficiency of pyrroline-5-carboxylate reductase];			rs941495	0.9689	0.9926,0.9727,0.9999,0.9571,0.9863	71460,.	4553	4729	-0.5210			2.91				0.03	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21563142	21563142	T	C	hom	hom	het		QUAL=4777;DP=29,90,125;AF=0.97,1.00,0.52;MQM=60;SAP=32;ABP=3	ALPL	synonymous	ALPL:ENST00000374832.5:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374840.8:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.5:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.5:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase]	ALPL:NM_000478.6:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001127501.4:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:,ALPL:NM_001177520.3:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:,ALPL:NM_001369803.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369804.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:NM_001369805.2:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:,ALPL:XM_017000903.1:synonymous_variant:LOW:exon3/10:c.174T>C:p.Ser58=:		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	197678 [benign DISEASE=Infantile hypophosphatasia,Hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not specified,not provided];			rs1780316	0.9472	0.8650,0.9679,0.9864,0.9435,0.9535	65340,.	10226	11268	-0.8670			4.19			COSV66379629	0	25972531,27507156,30283886,23823483,25147783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21570432	21570432	C	T	het	wt	het	off-target	QUAL=6286;DP=187,243,304;AF=0.49,0.00,0.55;MQM=60;SAP=189;ABP=6	ALPL	intron	ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron7/10:c.697+58C>T::	ALPL:NM_000478.6:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001127501.4:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:NM_001177520.3:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:NM_001369803.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369804.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:NM_001369805.2:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:XM_017000903.1:intron_variant:MODIFIER:intron6/9:c.706+58C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	1177590 [benign DISEASE=Infantile hypophosphatasia,Childhood hypophosphatasia,Adult hypophosphatasia,not provided];			rs2275375	0.2608		5477,.	28651	112235	-1.1040			0.36			COSV66376176	0	19500388	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577713	21577713	C	T	wt	het	wt		QUAL=1739;DP=60,173,234;AF=0.00,0.46,0.00;MQM=60;SAP=12;ABP=6	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*65C>T::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*65C>T::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*65C>T::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295558 [benign DISEASE=Hypophosphatasia,not provided];			rs1697405	0.3554		10025,.	33949	97951	1.5200			10.69			COSV66376405	0	27468225,31666285	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577770	21577770	C	-	het	het	wt		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295560 [benign/likely benign DISEASE=Hypophosphatasia,not provided];			rs140511985	0.0458		213,.	6536	145012	0.9820			11.71				0		1	19	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577774	21577774	A	G	hom	hom	hom		QUAL=20497;DP=180,240,280;AF=0.53,0.45,1.00;MQM=60;SAP=14;ABP=3	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295561 [benign DISEASE=Hypophosphatasia,not provided];			rs1697406	0.8719		57845,.	16890	19484	0.1730			14.65				0	27468225,28899360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577881	21577881	A	C	wt	wt	het		QUAL=2232;DP=125,190,197;AF=0.00,0.00,0.46;MQM=60;SAP=18;ABP=5	ALPL	3'UTR	ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::	ALPL:NM_000478.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001127501.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*233A>C::,ALPL:NM_001177520.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::,ALPL:NM_001369803.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369804.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:NM_001369805.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*233A>C::,ALPL:XM_017000903.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*233A>C::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal dominant, Autosomal recessive; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal dominant, Autosomal recessive]	295563 [benign DISEASE=Hypophosphatasia,not provided];			rs1772719	0.1869		2714,.	23018	123728	0.5140			15.42				0	25972531,19931660,31959995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21822690	21822690	G	C	het	wt	hom		QUAL=1349;DP=23,27,42;AF=0.43,0.00,1.00;MQM=60;SAP=91;ABP=4	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:ENST00000374695.8:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,HSPG2:NM_001291860.2:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:NM_005529.7:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:XM_011541318.2:3_prime_UTR_variant:MODIFIER:exon102/102:c.*626C>G::,HSPG2:XM_017001120.1:3_prime_UTR_variant:MODIFIER:exon98/98:c.*626C>G::,HSPG2:XM_017001121.1:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::,HSPG2:XM_017001122.1:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295685 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome];			rs1049644	0.2994		7246,.	30857	106115	1.9690			10.28			COSV60827857	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823442	21823442	T	C	hom	hom	hom		QUAL=15077;DP=110,143,232;AF=1.00,1.00,1.00;MQM=60;SAP=244;ABP=0	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon97/97:c.13053A>G:p.Ser4351=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon102/102:c.13599A>G:p.Ser4533=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon98/98:c.13245A>G:p.Ser4415=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon97/97:c.13194A>G:p.Ser4398=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon97/97:c.13191A>G:p.Ser4397=:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295695 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs897467	0.8075	0.7083,0.7501,0.8158,0.8242,0.8256	47809,.	24698	31672	-3.7920			0.96			COSV60827391	0.23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823625	21823625	C	T	wt	wt	het		QUAL=3357;DP=145,206,313;AF=0.00,0.00,0.44;MQM=60;SAP=11;ABP=12	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-285C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1410C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12997G>A:p.Val4333Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12994G>A:p.Val4332Ile:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon101/102:c.13543G>A:p.Val4515Ile:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon97/98:c.13189G>A:p.Val4397Ile:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon96/97:c.13138G>A:p.Val4380Ile:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon96/97:c.13135G>A:p.Val4379Ile:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295699 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1138469	0.0571	0.0286,0.0272,0.0002,0.0622,0.1027	257,.	7136	144500	-2.5780	 ,T(1.00), 	 ,B(0.00), 	0.00	0.21		COSV60828274	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823627	21823627	C	T	het	wt	het		QUAL=5826;DP=151,208,317;AF=0.46,0.01,0.55;MQM=60;SAP=8;ABP=5	LDLRAD2,HSPG2	3'UTR,missense,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,HSPG2:NM_001291860.2:missense_variant:MODERATE:exon96/97:c.12995G>A:p.Ser4332Asn:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon101/102:c.13541G>A:p.Ser4514Asn:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon97/98:c.13187G>A:p.Ser4396Asn:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon96/97:c.13136G>A:p.Ser4379Asn:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon96/97:c.13133G>A:p.Ser4378Asn:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295700 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3736360	0.1814	0.0825,0.1274,0.1596,0.1792,0.2850	1950,.	19359	128821	0.0090	 ,T(0.39), 	 ,B(0.00), 	9.47	0.12		COSV60827612	0	20072119,18559102	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823667	21823667	G	T	het	wt	het		QUAL=8041;DP=290,205,324;AF=0.48,0.01,0.55;MQM=60;SAP=4;ABP=5	LDLRAD2,HSPG2	3'UTR,synonymous,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain],LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,HSPG2:NM_001291860.2:synonymous_variant:LOW:exon96/97:c.12955C>A:p.Arg4319=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon101/102:c.13501C>A:p.Arg4501=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon97/98:c.13147C>A:p.Arg4383=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon96/97:c.13096C>A:p.Arg4366=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon96/97:c.13093C>A:p.Arg4365=:	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295701 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3736358	0.1781	0.0345,0.1263,0.1596,0.1793,0.2850	1837,.	17638	130754	3.7350			10.61			COSV60828118,COSV60829904	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823764	21823764	C	T	het	hom	wt	off-target	QUAL=3653;DP=74,108,202;AF=0.51,0.99,0.00;MQM=60;SAP=116;ABP=3	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::	LDLRAD2:NM_001013693.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron95/96:c.12903-45G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron100/101:c.13449-45G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron96/97:c.13095-45G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron95/96:c.13044-45G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron95/96:c.13041-45G>A::	regulatory_region_variant:promoter	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1225015 [benign DISEASE=not provided];			rs3736357	0.4680	0.1381,0.5328,0.6492,0.4898,0.3376	13591,.	32255	92483	1.1280			8.82				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828352	21828352	A	G	het	wt	hom		QUAL=1307;DP=43,37,32;AF=0.37,0.00,0.97;MQM=60;SAP=7;ABP=9	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon89/97:c.12315T>C:p.Asp4105=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon94/102:c.12861T>C:p.Asp4287=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon90/98:c.12507T>C:p.Asp4169=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon89/97:c.12456T>C:p.Asp4152=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon89/97:c.12453T>C:p.Asp4151=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295707 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228347	0.2911	0.1341,0.1842,0.1585,0.3076,0.4730	5420,.	27565	113591	1.3570			5.83			COSV60827859	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829348	21829348	T	C	het	wt	het	off-target	QUAL=1232;DP=37,65,75;AF=0.54,0.00,0.52;MQM=60;SAP=106;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+35A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron92/101:c.12541+35A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron88/97:c.12187+35A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron87/96:c.12136+35A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron87/96:c.12133+35A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618168 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12042189	0.1787	0.0343,0.1268,0.1582,0.1789,0.2840	1839,.	17699	130727	-0.9940			0.12			COSV60828432	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829360	21829360	C	T	het	wt	het	off-target	QUAL=1401;DP=58,71,83;AF=0.36,0.00,0.54;MQM=60;SAP=129;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron87/96:c.11995+23G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron92/101:c.12541+23G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron88/97:c.12187+23G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron87/96:c.12136+23G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron87/96:c.12133+23G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618169 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12023794	0.1804	0.0844,0.1273,0.1652,0.1786,0.2752	1944,.	19395	128829	-1.2010			0.53			COSV60829275	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831196	21831196	G	A	hom	hom	hom	off-target	QUAL=16192;DP=94,201,254;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron84/96:c.11565+19C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron84/96:c.11562+19C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron89/101:c.12111+19C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron85/97:c.11757+19C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron84/96:c.11706+19C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron84/96:c.11703+19C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1174648 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs3736355	0.7910	0.6961,0.7415,0.8055,0.8006,0.8091	45249,.	26569	34919	-2.8120			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831627	21831627	G	T	het	wt	het	off-target	QUAL=2878;DP=81,101,142;AF=0.52,0.00,0.54;MQM=60;SAP=100;ABP=5	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron82/96:c.11355+25C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron87/101:c.11901+25C>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron83/97:c.11547+25C>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron82/96:c.11496+25C>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron82/96:c.11493+25C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1261831 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2270701	0.1812	0.0590,0.1278,0.1579,0.1796,0.2864	1894,.	18499	129759	-3.4990			0.00				0.1	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833281	21833281	G	A	het	wt	het		QUAL=4176;DP=136,207,237;AF=0.43,0.00,0.50;MQM=60;SAP=105;ABP=5	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF00054 [Laminin G domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon80/97:c.11085C>T:p.Pro3695=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon85/102:c.11631C>T:p.Pro3877=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon81/98:c.11277C>T:p.Pro3759=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon80/97:c.11226C>T:p.Pro3742=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon80/97:c.11223C>T:p.Pro3741=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295724 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229486	0.1006	0.1725,0.0410,0.0003,0.0796,0.1105	927,.	13452	136778	-3.3340			0.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833550	21833550	C	T	het	wt	het		QUAL=5290;DP=183,221,284;AF=0.43,0.00,0.49;MQM=60;SAP=170;ABP=8	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon79/97:c.10898G>A:p.Arg3633Gln:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon84/102:c.11444G>A:p.Arg3815Gln:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon80/98:c.11090G>A:p.Arg3697Gln:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon79/97:c.11039G>A:p.Arg3680Gln:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon79/97:c.11036G>A:p.Arg3679Gln:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295727 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229493	0.1008	0.1735,0.0410,0.0002,0.0796,0.1106	924,.	13460	136626	0.0570	T(0.54)	B(0.03)	11.56	0.05			0.05	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833655	21833655	C	T	het	hom	wt	off-target	QUAL=5299;DP=102,131,183;AF=0.60,1.00,0.00;MQM=60;SAP=285;ABP=12	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron78/96:c.10834-41G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron83/101:c.11380-41G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron79/97:c.11026-41G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron78/96:c.10975-41G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron78/96:c.10972-41G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223305 [benign DISEASE=not provided];			rs7547731	0.4643	0.1375,0.5314,0.6473,0.4863,0.3319	13557,.	32324	92632	-2.8300			0.11				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836897	21836897	G	A	het	wt	het		QUAL=5569;DP=180,226,353;AF=0.51,0.00,0.40;MQM=60;SAP=4;ABP=22	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10263C>T:p.His3421=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon80/102:c.10809C>T:p.His3603=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon76/98:c.10455C>T:p.His3485=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon75/97:c.10404C>T:p.His3468=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon75/97:c.10401C>T:p.His3467=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295741 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35444472	0.1002	0.1701,0.0426,0.0004,0.0797,0.1119	920,.	13410	136914	2.2680			8.58			COSV65932770	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836909	21836909	G	A	wt	wt	het		QUAL=5289;DP=180,223,347;AF=0.01,0.00,0.60;MQM=60;SAP=3;ABP=35	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon75/97:c.10251C>T:p.Ser3417=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon75/97:c.10248C>T:p.Ser3416=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon80/102:c.10797C>T:p.Ser3599=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon76/98:c.10443C>T:p.Ser3481=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon75/97:c.10392C>T:p.Ser3464=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon75/97:c.10389C>T:p.Ser3463=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295743 [benign/likely benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];	CS011537 [CLASS=DM? MUT=ALT PHEN="Dyssegmental dysplasia Silverman-Handmaker type" GENE=HSPG2];		rs41310390	0.0586	0.0290,0.0287,0.0001,0.0642,0.0964	257,.	7130	144516	-2.2060			3.36			COSV65933172	0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839408	21839408	A	G	het	wt	het		QUAL=2715;DP=82,39,87;AF=0.65,0.00,0.67;MQM=60;SAP=46;ABP=39	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon73/97:c.9855T>C:p.Ala3285=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon78/102:c.10401T>C:p.Ala3467=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon74/98:c.10047T>C:p.Ala3349=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon73/97:c.9996T>C:p.Ala3332=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon73/97:c.9993T>C:p.Ala3331=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295750 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2291826	0.3351	0.5383,0.1851,0.1598,0.2599,0.3809	9706,.	31500	101022	-3.3420			1.09			COSV65933346	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841112	21841112	C	T	het	wt	het		QUAL=2082;DP=48,164,183;AF=0.46,0.00,0.42;MQM=60;SAP=94;ABP=15	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon71/97:c.9505G>A:p.Ala3169Thr:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon76/102:c.10051G>A:p.Ala3351Thr:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon72/98:c.9697G>A:p.Ala3233Thr:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon71/97:c.9646G>A:p.Ala3216Thr:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon71/97:c.9643G>A:p.Ala3215Thr:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295758 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2228349	0.0980	0.1609,0.0403,0.0002,0.0788,0.1103	859,.	13201	137253	0.9590	T(0.71)	B(0.01)	9.06	0.12			0.01	20072119,23049933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841723	21841723	C	T	het	hom	wt	off-target	QUAL=6336;DP=79,181,231;AF=0.47,1.00,0.00;MQM=60;SAP=61;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron69/96:c.9197-50G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron74/101:c.9743-50G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron70/97:c.9389-50G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron69/96:c.9338-50G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron69/96:c.9335-50G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231634 [benign DISEASE=not provided];			rs7556412	0.6519	0.5013,0.6175,0.8146,0.6580,0.6022	29274,.	34977	58347	-0.1040			1.72				0	21146954,23593148,31970092,30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842308	21842308	T	C	het	wt	het		QUAL=1449;DP=62,76,87;AF=0.47,0.00,0.43;MQM=60;SAP=37;ABP=7	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8986A>G:p.Ser2996Gly:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon73/102:c.9532A>G:p.Ser3178Gly:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon69/98:c.9178A>G:p.Ser3060Gly:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon68/97:c.9127A>G:p.Ser3043Gly:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon68/97:c.9124A>G:p.Ser3042Gly:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295764 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229491	0.1025	0.1818,0.0411,0.0002,0.0794,0.1100	968,.	13664	136558	-0.1830	T(1.00)	B(0.00)	3.31	0.04			0.04	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842352	21842352	A	T	het	wt	het		QUAL=927;DP=42,44,56;AF=0.52,0.00,0.38;MQM=60;SAP=58;ABP=6	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895 [Immunoglobulin domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon68/97:c.8942T>A:p.Leu2981His:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon73/102:c.9488T>A:p.Leu3163His:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon69/98:c.9134T>A:p.Leu3045His:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon68/97:c.9083T>A:p.Leu3028His:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon68/97:c.9080T>A:p.Leu3027His:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295765 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229489	0.0490	0.0084,0.0237,0.0002,0.0568,0.1047	177,.	5813	145935	3.3680	T(1.00)	B(0.00)	18.20	0.07			0.03	20452482,20072119	59	2088	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21846651	21846651	C	T	het	wt	het	off-target	QUAL=8159;DP=103,376,509;AF=0.52,0.00,0.54;MQM=60;SAP=220;ABP=12	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron62/96:c.8168-52G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron67/101:c.8714-52G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron63/97:c.8360-52G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron62/96:c.8309-52G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron62/96:c.8306-52G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1182109 [benign DISEASE=not provided];			rs34792235	0.0493	0.0081,0.0237,0.0002,0.0568,0.1058	180,.	5815	146015	-0.3120			1.46				0		46	1638	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847497	21847497	A	G	het	wt	het		QUAL=7221;DP=159,324,425;AF=0.54,0.00,0.49;MQM=60;SAP=37;ABP=3	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::	HSPG2:NM_001291860.2:splice_region_variant&intron_variant:LOW:intron61/96:c.8029-5T>C::,HSPG2:NM_005529.7:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::,HSPG2:XM_011541318.2:splice_region_variant&intron_variant:LOW:intron66/101:c.8575-5T>C::,HSPG2:XM_017001120.1:splice_region_variant&intron_variant:LOW:intron62/97:c.8221-5T>C::,HSPG2:XM_017001121.1:splice_region_variant&intron_variant:LOW:intron61/96:c.8170-5T>C::,HSPG2:XM_017001122.1:splice_region_variant&intron_variant:LOW:intron61/96:c.8167-5T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295781 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35917892	0.0492	0.0083,0.0237,0.0002,0.0569,0.1058	179,.	5811	145957	-2.0680			0.39		4.39>3.72		0		60	2079	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847933	21847933	T	G	het	wt	hom	off-target	QUAL=11585;DP=181,310,323;AF=0.46,0.01,0.99;MQM=60;SAP=3;ABP=6	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron60/96:c.7876+25A>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron65/101:c.8422+25A>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron61/97:c.8068+25A>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron60/96:c.8017+25A>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron60/96:c.8014+25A>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256801 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2290501	0.3695	0.5255,0.2081,0.1694,0.3145,0.4753	11153,.	33836	95784	-0.6650			5.02			COSV65971017	0	23593148,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848025	21848025	G	T	het	wt	het		QUAL=7471;DP=271,358,363;AF=0.43,0.00,0.51;MQM=60;SAP=4;ABP=7	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon60/97:c.7809C>A:p.Val2603=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon65/102:c.8355C>A:p.Val2785=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon61/98:c.8001C>A:p.Val2667=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon60/97:c.7950C>A:p.Val2650=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon60/97:c.7947C>A:p.Val2649=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295785 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12737091	0.0491	0.0083,0.0237,0.0002,0.0567,0.1058	177,.	5812	146004	2.1420			13.41				0.98		59	2080	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848107	21848107	A	G	hom	hom	hom	off-target	QUAL=17523;DP=86,234,247;AF=1.00,1.00,1.00;MQM=60;SAP=163;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7741-14T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7738-14T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron64/101:c.8287-14T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron60/97:c.7933-14T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron59/96:c.7882-14T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron59/96:c.7879-14T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295787 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs3767138	0.7946	0.7018,0.6937,0.8172,0.8169,0.8136	46175,.	25821	33859	0.2490			13.76		10.37>10.27	COSV65970146	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848603	21848603	T	C	het	wt	het	off-target	QUAL=1825;DP=58,56,86;AF=0.50,0.00,0.58;MQM=60;SAP=142;ABP=6	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron59/96:c.7740+40A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron64/101:c.8286+40A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron60/97:c.7932+40A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron59/96:c.7881+40A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron59/96:c.7878+40A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1236320 [benign DISEASE=not provided];			rs34726153	0.0494	0.0085,0.0240,0.0002,0.0573,0.1059	179,.	5848	145780	-1.0900			0.26				0		46	1653	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851976	21851976	A	G	het	wt	het	off-target	QUAL=2489;DP=66,84,121;AF=0.61,0.02,0.53;MQM=60;SAP=7;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron53/96:c.6874-50T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron58/101:c.7420-50T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron54/97:c.7066-50T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron53/96:c.7015-50T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron53/96:c.7012-50T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223987 [benign DISEASE=not provided];			rs34346159	0.0491	0.0080,0.0238,0.0002,0.0567,0.1058	180,.	5807	145959	0.4620			6.02				0.05		46	1644	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852751	21852751	C	T	het	wt	het		QUAL=3486;DP=86,152,203;AF=0.43,0.00,0.51;MQM=60;SAP=20;ABP=3	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon52/97:c.6676G>A:p.Gly2226Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon57/102:c.7222G>A:p.Gly2408Ser:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon53/98:c.6868G>A:p.Gly2290Ser:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon52/97:c.6817G>A:p.Gly2273Ser:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon52/97:c.6814G>A:p.Gly2272Ser:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295807 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs35669711	0.0492	0.0084,0.0238,0.0002,0.0569,0.1059	176,.	5810	145722	0.0570	T(0.09)	B(0.07)	11.19	0.23			0.02		58	2075	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852958	21852958	C	T	het	wt	het		QUAL=5793;DP=76,272,434;AF=0.49,0.00,0.46;MQM=60;SAP=69;ABP=9	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF13927 [Immunoglobulin domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon51/97:c.6555G>A:p.Thr2185=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon56/102:c.7101G>A:p.Thr2367=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon52/98:c.6747G>A:p.Thr2249=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon51/97:c.6696G>A:p.Thr2232=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon51/97:c.6693G>A:p.Thr2231=:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295810 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs34443576	0.0493	0.0085,0.0240,0.0004,0.0568,0.1060	179,.	5815	145957	-8.1810			1.04			COSV65974636	0.02		57	2073	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854230	21854230	C	T	het	wt	het		QUAL=3095;DP=83,143,196;AF=0.47,0.00,0.51;MQM=60;SAP=35;ABP=3	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon50/97:c.6405G>A:p.Val2135=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon55/102:c.6951G>A:p.Val2317=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon51/98:c.6597G>A:p.Val2199=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon50/97:c.6546G>A:p.Val2182=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon50/97:c.6543G>A:p.Val2181=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285614 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs12742444	0.0472	0.0076,0.0233,0.0002,0.0540,0.1044	177,.	5788	146030	0.0570			2.62				0		58	2068	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854829	21854829	A	G	het	wt	het	off-target	QUAL=1210;DP=44,63,74;AF=0.55,0.00,0.43;MQM=60;SAP=108;ABP=4	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron48/96:c.6136+19T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron48/96:c.6133+19T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron53/101:c.6682+19T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron49/97:c.6328+19T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron48/96:c.6277+19T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron48/96:c.6274+19T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1242960 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs36080251	0.0491	0.0083,0.0239,0.0002,0.0567,0.1061	180,.	5821	145881	-1.1260			0.01				0		45	1643	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21855402	21855402	C	T	het	wt	het		QUAL=5591;DP=149,257,311;AF=0.48,0.00,0.53;MQM=60;SAP=116;ABP=4	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF07679 [Immunoglobulin I-set domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon47/97:c.5902G>A:p.Val1968Ile:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon52/102:c.6448G>A:p.Val2150Ile:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon48/98:c.6094G>A:p.Val2032Ile:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon47/97:c.6043G>A:p.Val2015Ile:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon47/97:c.6040G>A:p.Val2014Ile:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295823 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229475	0.0487	0.0082,0.0236,0.0002,0.0562,0.1053	178,.	5794	146024	1.9340	T(0.17)	D(1.00)	22.50	0.24			0.01	20072119	58	2071	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856978	21856978	A	C	hom	hom	hom	off-target	QUAL=1037;DP=18,7,13;AF=1.00,1.00,1.00;MQM=60;SAP=77;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+37T>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+37T>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+37T>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+37T>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+37T>G::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293461 [benign DISEASE=not provided];			rs12024579	0.7884	0.6607,0.7038,0.8137,0.8107,0.7977	44462,.	26810	36176	-0.9590			1.67				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856983	21856983	A	G	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+32T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+32T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+32T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+32T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+32T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+32T>C::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285244 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs200354565	0.0525	0.0409,0.0256,0.0003,0.0585,0.1067	206,.	7228	144458	-3.0650			0.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856984	21856984	G	T	het	wt	het	off-target	QUAL=103;DP=19,8,13;AF=0.16,0.00,0.54;MQM=60;SAP=25;ABP=13	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron44/96:c.5578+31C>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron44/96:c.5575+31C>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron49/101:c.6124+31C>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron45/97:c.5770+31C>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron44/96:c.5719+31C>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron44/96:c.5716+31C>A::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1285245 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs12757277	0.0525	0.0409,0.0256,0.0003,0.0584,0.1067	206,.	7229	144499	-2.1160			0.03				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21857246	21857246	A	G	hom	hom	het	off-target	QUAL=7807;DP=95,119,114;AF=1.00,1.00,0.48;MQM=60;SAP=67;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron43/96:c.5397+39T>C::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron48/101:c.5943+39T>C::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron44/97:c.5589+39T>C::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron43/96:c.5538+39T>C::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron43/96:c.5535+39T>C::	regulatory_region_variant:promoter_flanking_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1220862 [benign DISEASE=not provided];			rs2305562	0.5040	0.4198,0.4836,0.4471,0.5460,0.3863	19217,.	37482	75896	1.6720			9.86			COSV65970004	0.01	21146954,20072119,27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864961	21864961	G	A	het	hom	wt		QUAL=7140;DP=119,208,347;AF=0.39,1.00,0.00;MQM=60;SAP=4;ABP=14	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon36/97:c.4511C>T:p.Ala1504Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon41/102:c.5057C>T:p.Ala1686Val:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon37/98:c.4703C>T:p.Ala1568Val:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon36/97:c.4652C>T:p.Ala1551Val:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon36/97:c.4649C>T:p.Ala1550Val:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	291236 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs897471	0.7321	0.6122,0.8067,0.8922,0.7350,0.5771	38063,.	30958	44974	4.3150	T(0.06)	D(1.00)	22.80	0.15		COSV65969427	0.01	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872588	21872588	A	T	hom	hom	hom	off-target	QUAL=5905;DP=52,80,80;AF=0.98,1.00,1.00;MQM=60;SAP=3;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron32/96:c.4032+32T>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron33/101:c.4083+32T>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron33/97:c.4224+32T>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron32/96:c.4173+32T>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron32/96:c.4170+32T>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1233017 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501266	0.9958	0.9402,0.9969,1.0000,0.9997,0.9999	73569,.	2443	2593	-2.1080			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872752	21872752	C	T	het	hom	wt		QUAL=3063;DP=44,79,76;AF=0.64,1.00,0.01;MQM=60;SAP=21;ABP=10	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon32/97:c.3900G>A:p.Val1300=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon33/102:c.3951G>A:p.Val1317=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon33/98:c.4092G>A:p.Val1364=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon32/97:c.4041G>A:p.Val1347=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon32/97:c.4038G>A:p.Val1346=:	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285755 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs2229482	0.5558	0.2867,0.4025,0.4363,0.6384,0.5035	21449,.	34134	74768	0.2560			7.98			COSV65968754	0.04	28552196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873328	21873328	G	A	het	hom	wt	off-target	QUAL=1489;DP=44,32,39;AF=0.48,1.00,0.00;MQM=60;SAP=6;ABP=3	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron30/96:c.3796+47C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron31/101:c.3847+47C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron31/97:c.3988+47C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron30/96:c.3937+47C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron30/96:c.3934+47C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1235752 [benign DISEASE=not provided];			rs2454290	0.8308	0.4849,0.9126,0.9771,0.8489,0.7345	45165,.	24004	37690	0.0950			1.96				0	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21875616	21875616	C	T	hom	hom	hom	off-target	QUAL=26105;DP=196,282,399;AF=0.98,1.00,1.00;MQM=60;SAP=461;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron25/96:c.3305+13G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron25/96:c.3302+13G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron26/101:c.3356+13G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron26/97:c.3497+13G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron25/96:c.3446+13G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron25/96:c.3443+13G>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295864 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];		MIRb (SINE/MIR)	rs2501265	0.9858	0.8166,0.9903,1.0000,0.9993,0.9996	69043,.	6415	7713	-6.5350			0.00				0.14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878973	21878973	T	C	hom	hom	hom	off-target;low_conf_region	QUAL=3619;DP=35,49,36;AF=0.97,1.00,1.00;MQM=60;SAP=28;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron18/96:c.2474+21A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron19/101:c.2525+21A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron19/97:c.2666+21A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron18/96:c.2615+21A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron18/96:c.2612+21A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1263480 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2454293	0.9890	0.8732,0.9919,0.9977,0.9977,0.9976	71099,.	4693	5279	-0.5580			2.13			COSV65975893	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880156	21880156	T	C	hom	hom	hom		QUAL=22020;DP=193,236,255;AF=1.00,1.00,1.00;MQM=60;SAP=41;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon17/97:c.2297A>G:p.Asn766Ser:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon18/102:c.2348A>G:p.Asn783Ser:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon18/98:c.2489A>G:p.Asn830Ser:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon17/97:c.2438A>G:p.Asn813Ser:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon17/97:c.2435A>G:p.Asn812Ser:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295881 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs989994	0.9845	0.7872,0.9901,1.0000,0.9996,0.9996	67938,.	7274	9102	0.8000	T(0.19)	B(0.02)	15.51	0.14			0.01	26648445,20072119,22257501	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880449	21880449	G	A	hom	hom	hom		QUAL=7816;DP=118,61,73;AF=1.00,1.00,1.00;MQM=60;SAP=115;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon16/97:c.2112C>T:p.Ala704=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon17/102:c.2163C>T:p.Ala721=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon17/98:c.2304C>T:p.Ala768=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon16/97:c.2253C>T:p.Ala751=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon16/97:c.2250C>T:p.Ala750=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295882 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874793	0.9845	0.7876,0.9901,1.0000,0.9996,0.9997	67904,.	7258	9086	1.5060			10.77			COSV65974984	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880572	21880572	G	A	het	wt	het	off-target	QUAL=807;DP=36,41,52;AF=0.33,0.00,0.48;MQM=60;SAP=8;ABP=8	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron15/96:c.2002-13C>T::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron15/96:c.1999-13C>T::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron16/101:c.2053-13C>T::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron16/97:c.2194-13C>T::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron15/96:c.2143-13C>T::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron15/96:c.2140-13C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295886 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs77828146	0.0126	0.0028,0.0051,0.0000,0.0151,0.0198	20,.	1675	150525	-1.8390			0.42		5.42>5.43		0.01		7	527	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880742	21880742	T	C	hom	hom	hom		QUAL=10972;DP=156,73,131;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]	HSPG2:NM_001291860.2:missense_variant:MODERATE:exon15/97:c.1915A>G:p.Met639Val:,HSPG2:NM_005529.7:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:,HSPG2:XM_011541318.2:missense_variant:MODERATE:exon16/102:c.1966A>G:p.Met656Val:,HSPG2:XM_017001120.1:missense_variant:MODERATE:exon16/98:c.2107A>G:p.Met703Val:,HSPG2:XM_017001121.1:missense_variant:MODERATE:exon15/97:c.2056A>G:p.Met686Val:,HSPG2:XM_017001122.1:missense_variant:MODERATE:exon15/97:c.2053A>G:p.Met685Val:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295887 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs1874792	0.9944	0.9191,0.9964,1.0000,0.9996,1.0000	72826,.	3131	3395	1.1480	T(1.00)	B(0.00)	7.39	0.07			0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881312	21881324	CCCAGGGTGGCAG	-	hom	hom	hom	off-target	QUAL=6197;DP=46,70,113;AF=1.00,1.00,1.00;MQM=60;SAP=151;ABP=0	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron14/96:c.1821+15_1821+27del::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron14/96:c.1818+15_1818+27del::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron15/101:c.1872+15_1872+27del::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron15/97:c.2013+15_2013+27del::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron14/96:c.1962+15_1962+27del::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron14/96:c.1959+15_1959+27del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267614 [benign DISEASE=not provided];			rs60267433	0.9908	0.8763,0.9931,0.9998,0.9996,0.9998	71087,.	4667	5259	1.2990			4.37				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881537	21881537	C	T	het	hom	het	off-target	QUAL=4582;DP=69,93,122;AF=0.45,1.00,0.43;MQM=60;SAP=225;ABP=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron13/96:c.1658-35G>A::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron14/101:c.1709-35G>A::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron14/97:c.1850-35G>A::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron13/96:c.1799-35G>A::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron13/96:c.1796-35G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439797 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided];			rs921847	0.9723	0.7947,0.9850,1.0000,0.9843,0.9800	66533,.	8674	10408	-0.3390			1.18				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21884729	21884729	T	C	het	het	het	off-target	QUAL=6842;DP=81,244,301;AF=0.54,0.43,0.48;MQM=60;SAP=65;ABP=10	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	HSPG2:NM_001291860.2:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::,HSPG2:NM_005529.7:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::,HSPG2:XM_011541318.2:intron_variant:MODIFIER:intron13/101:c.1558+38A>G::,HSPG2:XM_017001120.1:intron_variant:MODIFIER:intron13/97:c.1699+38A>G::,HSPG2:XM_017001121.1:intron_variant:MODIFIER:intron12/96:c.1648+38A>G::,HSPG2:XM_017001122.1:intron_variant:MODIFIER:intron12/96:c.1648+38A>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248089 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs4654994	0.9135	0.8502,0.8797,0.9665,0.9312,0.8939	62475,.	12818	14358	-1.0400			1.28				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21887634	21887634	A	G	hom	het	hom		QUAL=12537;DP=116,181,213;AF=1.00,0.50,1.00;MQM=60;SAP=229;ABP=3	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon9/102:c.795T>C:p.Leu265=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon9/98:c.936T>C:p.Leu312=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon8/97:c.885T>C:p.Leu295=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon8/97:c.885T>C:p.Leu295=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295909 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2229478	0.4490	0.6401,0.5793,0.6276,0.3342,0.4043	16869,.	34419	83635	-1.8380			0.99			COSV65929973	0.12	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21890615	21890615	G	A	hom	hom	hom		QUAL=26146;DP=229,276,333;AF=1.00,1.00,1.00;MQM=60;SAP=262;ABP=0	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:	HSPG2:NM_001291860.2:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:,HSPG2:NM_005529.7:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:,HSPG2:XM_011541318.2:synonymous_variant:LOW:exon4/102:c.324C>T:p.Phe108=:,HSPG2:XM_017001120.1:synonymous_variant:LOW:exon4/98:c.465C>T:p.Phe155=:,HSPG2:XM_017001121.1:synonymous_variant:LOW:exon4/97:c.465C>T:p.Phe155=:,HSPG2:XM_017001122.1:synonymous_variant:LOW:exon4/97:c.465C>T:p.Phe155=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295913 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided];			rs2501260	0.9887	0.8450,0.9934,1.0000,0.9996,0.9998	69966,.	5594	6608	2.0910			13.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22452666	22452666	T	C	hom	hom	hom		QUAL=28795;DP=266,256,395;AF=1.00,1.00,1.00;MQM=60;SAP=596;ABP=0	ZBTB40	intron,5'UTR	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000404138.5:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	ZBTB40:NM_001083621.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron1/17:c.-70+23652T>C::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron1/15:c.-70+23652T>C::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/18:n.154+662T>C::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/18:n.154+662T>C::	regulatory_region_variant:promoter				MER58B (DNA/hAT-Charlie)	rs10737466	0.9776		72832,.	3131	3405	-1.5700			1.63				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22506250	22506250	A	T	hom	het	hom		QUAL=15643;DP=214,167,209;AF=1.00,0.56,0.99;MQM=60;SAP=486;ABP=8	ZBTB40	intron	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::	ZBTB40:NM_001083621.2:intron_variant:MODIFIER:intron7/18:c.1360+9A>T::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron6/17:c.1360+9A>T::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron4/15:c.1024+9A>T::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/18:n.1583+9A>T::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/18:n.1583+9A>T::						rs209732	0.7216	0.8973,0.8436,0.8953,0.6147,0.7058	40836,.	27996	42308	0.9000			10.34			COSV65144922	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22509184	22509184	A	G	hom	het	hom		QUAL=24905;DP=339,273,308;AF=1.00,0.53,1.00;MQM=60;SAP=4;ABP=5	ZBTB40	missense	ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:	ZBTB40:NM_001083621.2:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:,ZBTB40:NM_001330398.2:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:XM_011542499.2:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:XM_011542500.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-941A>G::,ZBTB40:XM_024451297.1:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon9/19:n.2007A>G::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon9/19:n.2007A>G::			1260804 [benign DISEASE=not provided];			rs209729	0.7878	0.9128,0.8838,0.8964,0.7168,0.7161	47731,.	24208	32240	0.2260	T(0.10),D(0.03),D(0.03)	B(0.00),B(0.00),B(0.00)	10.71	0.02		COSV65144925	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22520216	22520216	G	A	hom	hom	hom		QUAL=12185;DP=169,93,135;AF=1.00,1.00,1.00;MQM=60;SAP=109;ABP=0	ZBTB40	missense	ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type]	ZBTB40:NM_001083621.2:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:,ZBTB40:NM_001330398.2:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:,ZBTB40:NM_014870.4:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:,ZBTB40:XM_011542499.2:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:,ZBTB40:XM_011542500.2:missense_variant:MODERATE:exon7/11:c.1258G>A:p.Val420Met:,ZBTB40:XM_024451297.1:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon14/19:n.3212G>A::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon14/19:n.3212G>A::						rs209720	0.9969	0.9991,0.9974,1.0000,0.9948,0.9993	75621,.	478	480	1.8680	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	16.30	0.17			0	18840274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22522510	22522510	A	C	hom	het	hom	off-target	QUAL=15091;DP=171,196,254;AF=0.99,0.48,0.99;MQM=60;SAP=341;ABP=4	ZBTB40	intron	ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::	ZBTB40:NM_001083621.2:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::,ZBTB40:NM_001330398.2:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:NM_014870.4:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:XM_011542499.2:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:XM_011542500.2:intron_variant:MODIFIER:intron9/10:c.1567+47A>C::,ZBTB40:XM_024451297.1:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:XR_946804.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3521+47A>C::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3521+47A>C::					MIR (SINE/MIR)	rs998978	0.3392	0.1520,0.1757,0.4593,0.3725,0.4202	8092,.	30420	105318	-6.2610			0.01			COSV65144854	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22526222	22526222	G	C	hom	het	hom		QUAL=10743;DP=165,108,140;AF=0.99,0.46,0.99;MQM=60;SAP=169;ABP=4	ZBTB40	synonymous	ZBTB40:ENST00000374651.8:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000375647.5:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000404138.5:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:	ZBTB40:NM_001083621.2:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:,ZBTB40:NM_001330398.2:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:NM_014870.4:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:XM_011542499.2:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:XM_011542500.2:synonymous_variant:LOW:exon11/11:c.1815G>C:p.Pro605=:,ZBTB40:XM_024451297.1:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.3769G>C::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.3769G>C::						rs881646	0.3388	0.1520,0.1749,0.4593,0.3724,0.4203	8078,.	30406	105412	-1.1450			0.27			COSV65144952	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22526648	22526648	G	A	hom	het	hom		QUAL=17240;DP=138,234,316;AF=1.00,0.50,1.00;MQM=60;SAP=18;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*252G>A::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon18/19:n.4195G>A::,ZBTB40:XR_946805.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/18:n.4037+158G>A::						rs2281354	0.2564		6335,.	26300	113046	0.1690			1.44			COSV65144954	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	T	het	het	het		QUAL=985;DP=34,32,39;AF=0.44,0.25,0.56;MQM=60;SAP=84;ABP=8	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2320dup::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2320dup::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2320dup::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2320dup::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6086dup::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.5168dup::					AluJo (SINE/Alu)	rs35637563	0.3478		8815,.	31844	92758				0.68				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22528701	22528701	-	TT	wt	wt	het		QUAL=985;DP=34,32,39;AF=0.06,0.00,0.18;MQM=59;SAP=23;ABP=93	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2319_*2320dup::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*2319_*2320dup::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2319_*2320dup::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2319_*2320dup::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6085_6086dup::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.5167_5168dup::					AluJo (SINE/Alu)	rs35637563	0.0016		1,.	231	142133				0.65				0.01		0	12	0 / 0					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22530108	22530108	T	C	hom	het	hom		QUAL=18911;DP=222,216,281;AF=0.99,0.49,1.00;MQM=60;SAP=81;ABP=3	ZBTB40	3'UTR	ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	ZBTB40:NM_001083621.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::,ZBTB40:NM_001330398.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:NM_014870.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:XM_011542499.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:XM_011542500.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3712T>C::,ZBTB40:XM_024451297.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:XR_946804.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.7478T>C::,ZBTB40:XR_946805.1:non_coding_transcript_exon_variant:MODIFIER:exon19/19:n.6560T>C::	regulatory_region_variant:promoter_flanking_region					rs1062663	0.3161		8345,.	31180	103572	-2.4240			0.05			COSV65144958	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22638945	22638945	A	G	het	n/a	het		QUAL=333;DP=14,2,5;AF=0.64,1.00,0.60;MQM=60;SAP=13;ABP=6	C1QA	synonymous	C1QA:ENST00000374642.8:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.1:synonymous_variant:LOW:exon2/2:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)]	C1QA:NM_001347465.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_001347466.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:,C1QA:NM_015991.4:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:		120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1167796 [benign DISEASE=C1q deficiency,not specified,not provided];			rs172378	0.5118	0.7372,0.6240,0.5917,0.3861,0.5848	21690,.	34402	74194	-0.7330			4.63			COSV65889459	0	25294155,19440201,19493541,20528885,25817358,20003265,20332777,21060334,25326229,26085599,26798662,29795138,31019999,26683148,22897949,25637052	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22639734	22639734	T	G	het	het	het	off-target	QUAL=7779;DP=141,222,257;AF=0.52,0.54,0.47;MQM=60;SAP=188;ABP=4	C1QC,C1QA	upstream_gene,downstream_gene	C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.8:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:CTCF_binding_site	120550_[GENE=C1QA_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs10917274	0.3576		10137,.	34034	97564	-2.9250			1.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647804	22647804	C	A	wt	het	wt		QUAL=578;DP=125,66,94;AF=0.02,0.50,0.00;MQM=60;SAP=79;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*21C>A::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*21C>A::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1221376 [benign DISEASE=not provided];			rs9434	0.5046	0.8162,0.5080,0.5875,0.3688,0.4165	22004,.	32351	74967	0.4160			3.88			COSV65889466	0.01	19440201,19493541,19503741,19753309,31019999	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22647887	22647903	CCACCAGATGGACTTCT	-	wt	het	wt		QUAL=68;DP=24,18,16;AF=0.00,0.50,0.00;MQM=60;SAP=23;ABP=3	C1QC	3'UTR	C1QC:ENST00000374637.1:3_prime_UTR_variant:MODIFIER:exon3/3:::,C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*106_*122del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*106_*122del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs60255495	0.3447		9073,.	32936	97108	2.1680			6.21				0	20147302	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648041	T	-	het	wt	het		QUAL=1407;DP=48,39,71;AF=0.40,0.21,0.46;MQM=60;SAP=93;ABP=23	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]			L2d2 (LINE/L2)	rs10601144	0.0928		591,.	11698	125920	0.1970			0.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648041	22648042	TT	-	wt	het	wt		QUAL=1407;DP=48,39,71;AF=0.13,0.26,0.10;MQM=60;SAP=45;ABP=175	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*272_*273del::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*272_*273del::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1257095 [benign DISEASE=not provided];		L2d2 (LINE/L2)	rs10601144	0.5121		20079,.	30895	67693	0.1970			0.35				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22648073	22648073	T	G	het	wt	wt		QUAL=58;DP=46,46,61;AF=0.35,0.04,0.07;MQM=58;SAP=51;ABP=12	C1QC	3'UTR	C1QC:ENST00000374639.7:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:ENST00000374640.9:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::	C1QC:NM_001114101.3:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347619.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::,C1QC:NM_001347620.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*290T>G::,C1QC:NM_172369.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*290T>G::		120575_[GENE=C1QC_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs1003478565	0.0029		0,.	383	131945	-0.6130			5.99				0		0	14	0 / 0					C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22653162	22653162	T	G	het	het	het	off-target	QUAL=528;DP=26,22,16;AF=0.62,0.41,0.31;MQM=60;SAP=68;ABP=4	C1QB	upstream_gene	C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::			120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]				rs291990	0.5835		27958,.	32717	63271	-1.0180			4.53			COSV59246057			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22661465	22661465	A	G	hom	hom	hom		QUAL=38239;DP=411,347,456;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	C1QB	3'UTR	C1QB:ENST00000509305.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::	C1QB:NM_000491.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:NM_001371184.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::,C1QB:NM_001378156.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::		120570_[GENE=C1QB_PHENOS=C1q deficiency, 613652 (3), Autosomal recessive]	1258616 [benign DISEASE=not provided];			rs10580	0.9841		73653,.	2388	2424	-1.0460			4.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	23796496	23796496	C	T	het	het	wt	off-target;low_conf_region	QUAL=928;DP=80,48,54;AF=0.56,0.44,0.02;MQM=60;SAP=140;ABP=3	GALE	intron	GALE:ENST00000374497.7:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:ENST00000617979.5:intron_variant:MODIFIER:intron10/11:c.873+13G>A::	GALE:NM_000403.4:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001008216.2:intron_variant:MODIFIER:intron10/11:c.873+13G>A::,GALE:NM_001127621.2:intron_variant:MODIFIER:intron9/10:c.873+13G>A::		606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]	92889 [benign DISEASE=UDPglucose-4-epimerase deficiency,not specified,not provided];		G-rich (Low_complexity)	rs760941	0.6705	0.5444,0.7020,0.6319,0.6194,0.7364	19762,.	33021	35649	-0.7980			0.86			COSV100994767,COSV65720422,COSV65720626	0	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	23801977	23801977	C	T	hom	het	hom		QUAL=30065;DP=362,347,431;AF=1.00,0.50,1.00;MQM=60;SAP=42;ABP=3	HMGCL	3'UTR	HMGCL:ENST00000374490.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	HMGCL:NM_000191.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:NM_001166059.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::	regulatory_region_variant:promoter	606953_[GENE=GALE_PHENOS=Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	296841 [benign DISEASE=UDPglucose-4-epimerase deficiency,Deficiency of hydroxymethylglutaryl-CoA lyase];			rs11714	0.9131		63472,.	12028	13234	-0.9180			7.69				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23808231	23808231	T	C	hom	het	hom		QUAL=21774;DP=292,224,287;AF=1.00,0.53,1.00;MQM=60;SAP=18;ABP=4	HMGCL	synonymous	HMGCL:ENST00000374490.8:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.6:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	HMGCL:NM_000191.3:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:,HMGCL:NM_001166059.2:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	92602 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified];			rs719400	0.9230	0.9678,0.8940,0.7880,0.9126,0.8738	64879,.	10582	11712	1.2340			10.02				0.01	25741868,17847002,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23817442	23817442	A	G	hom	het	hom	off-target	QUAL=12961;DP=186,116,181;AF=0.99,0.50,1.00;MQM=60;SAP=388;ABP=3	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	HMGCL:NM_000191.3:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:NM_001166059.2:intron_variant:MODIFIER:intron3/6:c.252+34T>C::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	255488 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified,not provided];			rs2076344	0.9232	0.9678,0.8946,0.7893,0.9132,0.8739	64954,.	10565	11691	-1.1720			1.30				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23825506	23825506	C	A	het	het	hom	off-target	QUAL=1442;DP=24,34,34;AF=0.29,0.47,1.00;MQM=60;SAP=102;ABP=8	HMGCL	upstream_gene	HMGCL:ENST00000374490.8:upstream_gene_variant:MODIFIER::::,HMGCL:ENST00000436439.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177626 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not provided];			rs6697805	0.4050		12241,.	36415	89485	-2.8170			0.15						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23845053	23845053	C	G	het	het	hom	off-target	QUAL=2963;DP=103,47,45;AF=0.50,0.60,0.98;MQM=60;SAP=272;ABP=4	FUCA1	downstream_gene	FUCA1:ENST00000374479.4:downstream_gene_variant:MODIFIER::::			612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]				rs4649119	0.3654		10647,.	34137	96281	-0.2530			2.56					19442614	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854317	23854317	A	-	het	het	het	off-target	QUAL=589;DP=105,33,48;AF=0.12,0.61,0.15;MQM=59;SAP=66;ABP=134	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron5/7:c.969+43del::	FUCA1:NM_000147.5:intron_variant:MODIFIER:intron5/7:c.969+43del::,FUCA1:XM_005245821.3:intron_variant:MODIFIER:intron5/7:c.594+43del::,FUCA1:XM_011541167.3:intron_variant:MODIFIER:intron5/7:c.336+43del::,FUCA1:XM_017000905.2:intron_variant:MODIFIER:intron5/7:c.666+43del::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	1252223 [benign DISEASE=not provided];		(A)n (Simple_repeat)	rs55699941	0.3054	0.2476,0.3209,0.3769,0.3017,0.3165	644,.	11841	127421	2.7730			8.02			COSV65699151	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854472	23854472	T	C	het	wt	hom		QUAL=9719;DP=256,209,202;AF=0.50,0.00,1.00;MQM=60;SAP=12;ABP=3	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	FUCA1:NM_000147.5:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:,FUCA1:XM_005245821.3:missense_variant:MODERATE:exon5/8:c.482A>G:p.Gln161Arg:,FUCA1:XM_011541167.3:missense_variant:MODERATE:exon5/8:c.224A>G:p.Gln75Arg:,FUCA1:XM_017000905.2:missense_variant:MODERATE:exon5/8:c.554A>G:p.Gln185Arg:	regulatory_region_variant:CTCF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided];			rs13551	0.2792	0.1406,0.2037,0.2647,0.3358,0.1516	6032,.	28741	111233	0.6870	D(0.02)	B(0.00)	17.84	0.06		COSV65698861	0	7815431	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23868258	23868258	G	C	wt	het	wt		QUAL=1393;DP=157,112,122;AF=0.00,0.54,0.01;MQM=60;SAP=48;ABP=5	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.29C>G:p.Pro10Arg:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-521C>G::	regulatory_region_variant:promoter	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193053 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070956	0.1078	0.1111,0.1145,0.1998,0.0910,0.1267	954,.	14353	135845	0.7020	T(0.16)	B(0.02)	11.56	0.09		COSV65692258	0	24033266,9039984,27346075	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868280	23868280	C	G	het	het	wt		QUAL=2473;DP=143,107,112;AF=0.45,0.45,0.00;MQM=60;SAP=155;ABP=8	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	296895 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs61996282	0.0153	0.0025,0.0506,0.0000,0.0080,0.0166	21,.	1392	150718	-2.1530	D(0.02)	B(0.00)	6.24	0.07			0	25741868	3	214	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868283	23868283	G	A	wt	het	wt		QUAL=1196;DP=121,103,113;AF=0.00,0.52,0.01;MQM=60;SAP=63;ABP=4	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:	FUCA1:NM_000147.5:missense_variant:MODERATE:exon1/8:c.4C>T:p.Arg2Trp:,FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-546C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193052 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070955	0.1119	0.1141,0.1164,0.2051,0.0948,0.1271	952,.	14345	135795	-0.7810	D(0.00)	B(0.00)	16.29	0.08		COSV65692243	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868298	23868298	A	G	wt	het	wt		QUAL=1137;DP=74,96,100;AF=0.00,0.52,0.01;MQM=60;SAP=55;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::	FUCA1:XM_005245821.3:5_prime_UTR_variant:MODIFIER:exon1/8:c.-561T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	193051 [benign DISEASE=Fucosidosis,not specified,not provided];			rs2070954	0.1140	0.1164,0.1167,0.2068,0.0965,0.1275	953,.	14338	135722	0.1300			10.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868372	23868372	A	C	wt	het	wt		QUAL=417;DP=26,49,33;AF=0.00,0.43,0.03;MQM=60;SAP=51;ABP=5	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	368872 [benign/likely benign DISEASE=Fucosidosis,not provided];			rs2070953	0.1070		962,.	14351	135845	-0.5800			6.98						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868408	23868408	C	A	wt	het	wt	off-target	QUAL=322;DP=19,36,20;AF=0.00,0.47,0.00;MQM=60;SAP=40;ABP=3	CNR2,FUCA1	downstream_gene,upstream_gene	CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::,FUCA1:ENST00000374479.4:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683915 [benign DISEASE=not provided];			rs2070952	0.1067		961,.	14298	135846	-0.5740			5.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	25805163	25805163	G	A	hom	hom	het		QUAL=15894;DP=160,220,332;AF=1.00,1.00,0.52;MQM=60;SAP=261;ABP=4	SELENON	missense	SELENON:ENST00000354177.9:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000361547.7:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:	SELENON:NM_020451.3:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:NM_206926.2:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95963 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs7349185	0.8183	0.7779,0.9062,0.9425,0.7826,0.8772	48208,.	24310	31106	0.8690	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.21	0.04		COSV62525203	0	25741868,24033266,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811645	25811645	C	A	hom	hom	het	off-target	QUAL=18745;DP=148,278,383;AF=1.00,1.00,0.53;MQM=60;SAP=42;ABP=6	SELENON	intron	SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron7/11:c.922-46C>A::,SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron7/11:c.991-46C>A::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261271 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,not provided];			rs760598	0.7903	0.4605,0.8803,0.9652,0.7681,0.8741	38885,.	28477	45737	0.9110			4.70				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811771	25811771	T	C	hom	hom	het		QUAL=24631;DP=211,353,488;AF=1.00,1.00,0.51;MQM=60;SAP=3;ABP=4	SELENON	synonymous	SELENON:ENST00000354177.9:synonymous_variant:LOW:exon8/12:c.1002T>C:p.Pro334=:,SELENON:ENST00000361547.7:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	SELENON:NM_020451.3:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:NM_206926.2:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs760597	0.8099	0.6070,0.8907,0.9651,0.7838,0.8768	43465,.	27044	38112	0.3020			9.57			COSV62525913	0	25741868,24033266,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812646	25812646	C	T	hom	hom	het	off-target	QUAL=2973;DP=18,54,70;AF=1.00,1.00,0.54;MQM=60;SAP=79;ABP=4	SELENON	intron	SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-41C>T::,SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::	SELENON:NM_020451.3:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:NM_206926.2:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	261274 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,not provided];			rs10902685	0.7930	0.2898,0.8793,0.9662,0.7870,0.8780	36507,.	25883	51299	-0.0280			3.13				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25814082	25814082	C	A	hom	hom	het		QUAL=22046;DP=216,321,438;AF=1.00,1.00,0.50;MQM=60;SAP=124;ABP=3	SELENON	missense,missense&NMD_transcript	SELENON:ENST00000354177.9:missense_variant:MODERATE:exon11/12:c.1335C>A:p.Asn445Lys:,SELENON:ENST00000361547.7:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,:ENST00000527604.1:missense_variant&NMD_transcript_variant:MODERATE:exon2/4:c.27C>A:p.Asn9Lys:	SELENON:NM_020451.3:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:NM_206926.2:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	95959 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-Related Disorders,not provided];			rs2294228	0.7864	0.2906,0.8791,0.9655,0.7822,0.8768	36889,.	26305	51897	0.1400	T(0.10),T(0.12),T(0.14),T(0.17)	B(0.02),B(0.00),B(0.00),B(0.00)	13.69	0.09		COSV62525671	0.33	25741868,24033266,18414213,23757202,22615972	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25817213	25817213	-	TTTTG	hom	hom	het		QUAL=11752;DP=148,191,232;AF=0.97,1.00,0.43;MQM=59;SAP=211;ABP=13	SELENON	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.304-338_304-334dup::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.387-338_387-334dup::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3051_123+3055dup::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]				rs3033477	0.7226		40659,.	27525	41775				1.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817330	25817330	T	C	hom	hom	het		QUAL=16585;DP=247,179,269;AF=1.00,0.98,0.45;MQM=55;SAP=20;ABP=8	SELENON	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+232A>G::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.386+232A>G::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3152T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297050 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs3203750	0.7208		40881,.	27687	42399	0.3080			2.99				0	27586304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817440	25817440	T	C	hom	hom	het		QUAL=22311;DP=341,228,349;AF=1.00,1.00,0.45;MQM=54;SAP=99;ABP=11	SELENON	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.303+122A>G::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.386+122A>G::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3262T>C::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::		606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297053 [benign DISEASE=SEPN1-Related Disorders];		AluSx (SINE/Alu)	rs4659383	0.8102		50114,.	22945	28863	-1.2160			0.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817947	25817947	C	-	hom	hom	het		QUAL=4521;DP=77,77,105;AF=0.99,1.00,0.61;MQM=60;SAP=269;ABP=14	SELENON	3'UTR,intron&non_coding_transcript,intron&NMD_transcript	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::,:ENST00000442055.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.152-234del::,:ENST00000453649.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.235-234del::,:ENST00000527604.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/3:c.123+3776del::	SELENON:NM_020451.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:NM_206926.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessive]	297061 [uncertain significance DISEASE=SEPN1-Related Disorders];			rs371383269	0.7254		41194,.	27583	41639	-0.8170			0.76				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26181802	26181802	G	A	het	het	wt	off-target	QUAL=5043;DP=208,206,281;AF=0.50,0.51,0.00;MQM=60;SAP=293;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron3/20:c.-377-55G>A::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron3/20:c.393-55G>A::	regulatory_region_variant:open_chromatin_region				MIRb (SINE/MIR)	rs3819033	0.1250		2675,.	13651	133021	0.6040			7.55			COSV64163468	0	32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181989	26181989	T	C	het	het	wt	off-target	QUAL=5554;DP=211,243,318;AF=0.46,0.52,0.00;MQM=60;SAP=245;ABP=3	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron4/20:c.-293+48T>C::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron4/20:c.477+48T>C::	regulatory_region_variant:open_chromatin_region					rs2275945	0.2282	0.1604,0.4817,0.6399,0.0981,0.3757	3415,.	18164	127090	0.3060			11.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185209	26185209	A	G	hom	hom	hom	off-target	QUAL=20266;DP=160,212,265;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+23A>G::	CNKSR1:NM_001297647.2:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:NM_001297648.2:intron_variant:MODIFIER:intron14/20:c.534+23A>G::,CNKSR1:NM_006314.3:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::						rs2783680	0.6818	0.4561,0.8001,0.9695,0.5905,0.7834	27499,.	34630	62158	-0.7820			0.29				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26780484	26780484	C	T	wt	wt	het		QUAL=3133;DP=158,190,236;AF=0.00,0.00,0.52;MQM=60;SAP=11;ABP=4	ARID1A	synonymous	ARID1A:ENST00000324856.13:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000374152.7:synonymous_variant:LOW:exon19/19:c.5437C>T:p.Leu1813=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000430799.7:synonymous_variant:LOW:exon20/20:c.5434C>T:p.Leu1812=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa],ARID1A:ENST00000457599.6:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:PF12031 [SWI/SNF-like complex subunit BAF250/Osa]	ARID1A:NM_006015.6:synonymous_variant:LOW:exon20/20:c.6586C>T:p.Leu2196=:,ARID1A:NM_139135.4:synonymous_variant:LOW:exon20/20:c.5935C>T:p.Leu1979=:		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]	210262 [benign/likely benign DISEASE=not specified,not provided];			rs149633292	0.0051	0.0005,0.0008,0.0000,0.0050,0.0007	10,.	653	151541	0.6540			7.24			COSV61385556	0	25741868	1	157	0 / 0	2	"Prima Vista kein Anhalt für Splice-Defekt; 160727 [2] ahwalds1 28.07.2016"			ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	26781160	26781160	A	-	het	het	het	low_conf_region	QUAL=626;DP=86,16,24;AF=0.24,0.25,0.29;MQM=60;SAP=4;ABP=69	ARID1A	3'UTR	ARID1A:ENST00000324856.13:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:ENST00000430799.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::	ARID1A:NM_006015.6:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::,ARID1A:NM_139135.4:3_prime_UTR_variant:MODIFIER:exon20/20:c.*421del::		603024_[GENE=ARID1A_PHENOS=Coffin-Siris syndrome 2, 614607 (3), Autosomal dominant]			(A)n (Simple_repeat)	rs71007893	0.0184		10,.	2086	112576	0.0460			6.28				0		0	196	0 / 0					ARID1A (inh=AD oe_syn=1.08 oe_mis=0.70 oe_lof=0.02)
chr1	27369520	27369520	C	T	hom	hom	hom	off-target	QUAL=26178;DP=313,256,312;AF=1.00,1.00,1.00;MQM=60;SAP=1916;ABP=0	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	FCN3:NM_003665.4:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:NM_173452.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::	regulatory_region_variant:CTCF_binding_site	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs10218730	0.9981	0.9740,0.9990,1.0000,0.9999,0.9999	75011,.	1104	1134	-0.5380			1.56				0.06		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	32780201	32780201	C	G	het	het	het		QUAL=9592;DP=260,186,254;AF=0.54,0.61,0.46;MQM=60;SAP=65;ABP=8	YARS1	synonymous	YARS1:ENST00000373477.9:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain],YARS1:ENST00000675785.1:synonymous_variant:LOW:exon10/12:c.1071G>C:p.Leu357=:PF01588 [Putative tRNA binding domain]	YARS1:NM_003680.4:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:,YARS1:XM_011542347.2:synonymous_variant:LOW:exon9/11:c.588G>C:p.Leu196=:,YARS1:XM_011542348.1:synonymous_variant:LOW:exon10/12:c.588G>C:p.Leu196=:,YARS1:XM_017002651.2:synonymous_variant:LOW:exon12/14:c.588G>C:p.Leu196=:		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297151 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs699005	0.1036	0.1027,0.2180,0.0003,0.0970,0.0607	905,.	13934	136328	3.9130			9.05				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32786499	32786521	CACATGCATGACTATTCCTAGCC	-	het	het	wt	off-target	QUAL=3595;DP=114,226,316;AF=0.48,0.50,0.00;MQM=60;SAP=148;ABP=3	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron6/11:c.674-74_674-52del::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron5/10:c.191-74_191-52del::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron6/11:c.191-74_191-52del::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron8/13:c.191-74_191-52del::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1175561 [benign DISEASE=not provided];		L2d (LINE/L2)	rs149745059	0.1434	0.0236,0.0903,0.1858,0.1445,0.2117	1779,.	17256	131172	1.7760			4.89				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791283	32791283	C	A	hom	hom	het	off-target	QUAL=16364;DP=243,164,263;AF=0.99,0.99,0.52;MQM=60;SAP=278;ABP=4	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron4/11:c.445-29G>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron3/10:c.-39-29G>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron4/11:c.-39-29G>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron6/13:c.-39-29G>T::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670888 [benign DISEASE=not provided];			rs1765223	0.3118	0.3001,0.3504,0.2128,0.3120,0.3043	7496,.	32348	104510	1.2110			7.15			COSV65113032	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32810823	32810823	G	A	hom	hom	hom	off-target	QUAL=21306;DP=291,158,212;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron1/11:c.58-57C>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron1/10:c.-250-4212C>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron1/11:c.-297-4212C>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron2/13:c.-473-57C>T::	regulatory_region_variant:promoter_flanking_region	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670335 [benign DISEASE=not provided];			rs4951787	0.9874		74171,.	1836	1920	-0.4320			0.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32817174	32817174	C	A	het	het	het	off-target	QUAL=3099;DP=120,71,103;AF=0.48,0.51,0.44;MQM=60;SAP=49;ABP=5	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron1/12:c.57+14G>T::,YARS1:ENST00000675785.1:intron_variant:MODIFIER:intron1/11:c.57+14G>T::	YARS1:NM_003680.4:intron_variant:MODIFIER:intron1/12:c.57+14G>T::,S100PBP:XM_011541962.2:intron_variant:MODIFIER:intron1/6:c.-120+192C>A::,YARS1:XM_011542347.2:intron_variant:MODIFIER:intron1/10:c.-251+14G>T::,YARS1:XM_011542348.1:intron_variant:MODIFIER:intron1/11:c.-298+14G>T::,YARS1:XM_017002651.2:intron_variant:MODIFIER:intron1/13:c.-621+14G>T::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297163 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not specified];			rs72654020	0.1031	0.0965,0.2176,0.0003,0.0969,0.0607	890,.	13727	136639	-0.2670			5.06				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	32817927	32817927	G	A	het	n/a	n/a		QUAL=27;DP=7,0,1;AF=0.57,,0.00;MQM=60;SAP=12;ABP=3	S100PBP	intron	S100PBP:ENST00000373475.10:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:ENST00000373476.5:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::	S100PBP:NM_001256121.2:intron_variant:MODIFIER:intron1/6:c.-120+328G>A::,S100PBP:NM_022753.4:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:XM_011541961.2:intron_variant:MODIFIER:intron1/6:c.-120+81G>A::,S100PBP:XM_011541962.2:intron_variant:MODIFIER:intron1/6:c.-120+945G>A::,S100PBP:XM_011541963.2:intron_variant:MODIFIER:intron1/7:c.-120+238G>A::,S100PBP:XM_017002098.2:intron_variant:MODIFIER:intron1/6:c.-120+238G>A::,S100PBP:XR_001737363.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::,S100PBP:XR_001737364.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::,S100PBP:XR_001737365.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.135+238G>A::,S100PBP:XR_946740.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.135+238G>A::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297175 [benign DISEASE=Charcot-Marie-Tooth disease, dominant intermediate C,not provided];			rs72654022	0.0793		676,.	10724	140128	1.5060			14.83				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	33010464	33010464	G	A	het	het	wt		QUAL=864;DP=321,105,140;AF=0.22,0.13,0.07;MQM=34;SAP=4;ABP=337	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2717C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20571G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*567C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*365C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2717C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*414C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*365C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2940C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2717C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*365C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1024C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2142C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2237C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs143947377	0.4970	0.1568,0.4139,0.3199,0.3716,0.3520	0,.	64367	65137	2.3890			18.09			COSV61470449			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010473	33010473	A	T	het	het	wt		QUAL=971;DP=341,110,148;AF=0.23,0.13,0.07;MQM=34;SAP=6;ABP=351	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2708T>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20562A>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*558T>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*356T>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2708T>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*405T>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*356T>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2931T>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2708T>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*356T>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1015T>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2133T>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2228T>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs199780633	0.4969	0.1455,0.4073,0.2964,0.3645,0.3485	0,.	64398	65206	0.7280			15.20			COSV61467968			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010489	33010489	T	C	het	het	wt		QUAL=1331;DP=390,112,146;AF=0.24,0.11,0.08;MQM=35;SAP=8;ABP=372	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2692A>G::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20546T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*542A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*340A>G::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2692A>G::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*389A>G::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340A>G::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2915A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2692A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*340A>G::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.999A>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2117A>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2212A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs140167370	0.4968	0.1035,0.3746,0.2373,0.3256,0.3048	0,.	64433	65269	-2.4150			0.37			COSV61470454			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010542	33010542	G	A	het	het	het		QUAL=70;DP=256,84,107;AF=0.14,0.12,0.11;MQM=38;SAP=5;ABP=535	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2639C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20493G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*489C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*287C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2639C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*336C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*287C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2862C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2639C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*287C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.946C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2064C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2159C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201412582	0.4968	0.0026,0.0257,0.0074,0.0132,0.0111	0,.	63975	64805	0.4830			8.62			COSV61467875			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010623	33010624	AC	-	het	het	het		QUAL=1717;DP=219,71,72;AF=0.28,0.27,0.33;MQM=46;SAP=3;ABP=142	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2557_*2558del::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20410_246-20409del::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*407_*408del::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*205_*206del::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2557_*2558del::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*254_*255del::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*205_*206del::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2780_*2781del::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2557_*2558del::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*205_*206del::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.864_865del::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1982_1983del::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2077_2078del::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs67829320	0.4992	0.2745,0.4509,0.3832,0.4501,0.4693	0,.	74401	74629	-0.1030			4.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010638	33010638	T	C	het	het	het		QUAL=2686;DP=268,72,78;AF=0.31,0.32,0.36;MQM=47;SAP=8;ABP=117	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2543A>G::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20397T>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*393A>G::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*191A>G::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2543A>G::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*240A>G::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*191A>G::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2766A>G::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2543A>G::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*191A>G::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.850A>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1968A>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2063A>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066438	0.4994	0.3834,0.4825,0.4540,0.4748,0.4879	0,.	75176	75358	0.0200			4.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010691	33010691	A	G	het	het	het		QUAL=4593;DP=269,136,117;AF=0.30,0.49,0.45;MQM=50;SAP=130;ABP=65	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2490T>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20344A>G::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*340T>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*138T>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2490T>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*187T>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*138T>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2713T>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2490T>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*138T>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.797T>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1915T>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2010T>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs74066439	0.4995	0.4701,0.4886,0.4898,0.4828,0.4891	0,.	75861	76011	0.1500			6.12			COSV61466645			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010752	33010752	C	T	het	het	het		QUAL=2531;DP=231,155,143;AF=0.17,0.41,0.33;MQM=47;SAP=30;ABP=215	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2429G>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20283C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*279G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*77G>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2429G>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*126G>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*77G>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2652G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2429G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*77G>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.736G>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1854G>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1949G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs66599471	0.4992	0.2505,0.1430,0.1915,0.2371,0.1579	4,.	74888	75138	-0.2060			9.65			COSV61466298			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010784	33010784	C	G	het	het	het	low_conf_region	QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2397G>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20251C>G::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*247G>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*45G>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2397G>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*94G>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*45G>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2620G>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2397G>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*45G>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.704G>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1822G>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1917G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76881767	0.4971	0.0649,0.0106,0.0261,0.0577,0.0143	0,.	67589	68379	0.0650			19.37			COSV61466684			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010786	33010786	C	T	het	het	het	low_conf_region	QUAL=1872;DP=232,141,136;AF=0.21,0.37,0.26;MQM=48;SAP=7;ABP=243	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2395G>A::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20249C>T::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*245G>A::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*43G>A::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2395G>A::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*92G>A::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*43G>A::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2618G>A::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2395G>A::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*43G>A::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.702G>A::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1820G>A::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1915G>A::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs201842558	0.4968	0.0529,0.0087,0.0213,0.0484,0.0123	0,.	65619	66475	0.0390			16.02						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010795	33010795	G	A	het	het	het	low_conf_region	QUAL=1786;DP=230,132,136;AF=0.20,0.35,0.23;MQM=48;SAP=5;ABP=276	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2386C>T::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20240G>A::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*236C>T::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*34C>T::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2386C>T::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*83C>T::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*34C>T::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2609C>T::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2386C>T::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*34C>T::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.693C>T::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1811C>T::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1906C>T::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs79824855	0.4951	0.0220,0.0029,0.0075,0.0218,0.0043	0,.	58215	59365	1.6360			22.60			COSV61466650			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33010803	33010803	T	G	het	het	het	low_conf_region	QUAL=1366;DP=219,128,132;AF=0.20,0.32,0.23;MQM=48;SAP=5;ABP=284	AK2	3'UTR,intron&non_coding_transcript	AK2:ENST00000354858.11:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2378A>C::,AK2:ENST00000373449.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-20232T>G::,AK2:ENST00000467905.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:ENST00000548033.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*228A>C::,AK2:ENST00000672715.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::	AK2:NM_001199199.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NM_001319139.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*26A>C::,AK2:NM_001319140.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2378A>C::,AK2:NM_001319141.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*75A>C::,AK2:NM_001319142.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*26A>C::,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*2601A>C::,AK2:NM_001625.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2378A>C::,AK2:NM_013411.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*26A>C::,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.685A>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.1803A>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1898A>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs76230073	0.4896	0.0150,0.0019,0.0038,0.0149,0.0025	0,.	48571	50645	1.7520			20.60			COSV61467923			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013330	33013330	G	C	het	wt	wt	low_conf_region	QUAL=530;DP=662,475,594;AF=0.18,0.04,0.02;MQM=36;SAP=23;ABP=610	AK2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17705G>C::,AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:PF00406 [Adenylate kinase],AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon5/6:c.*74C>G::,AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:PF00406 [Adenylate kinase]	AK2:NM_001199199.3:missense_variant:MODERATE:exon6/7:c.547C>G:p.His183Asp:,AK2:NM_001319139.3:missense_variant:MODERATE:exon7/8:c.427C>G:p.His143Asp:,AK2:NM_001319140.2:missense_variant:MODERATE:exon7/7:c.427C>G:p.His143Asp:,AK2:NM_001319141.3:missense_variant:MODERATE:exon6/8:c.571C>G:p.His191Asp:,AK2:NM_001319142.3:missense_variant:MODERATE:exon5/6:c.445C>G:p.His149Asp:,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*74C>G::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.571C>G:p.His191Asp:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.571C>G:p.His191Asp:,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.531C>G::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.516C>G::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.611C>G::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]	529737 [benign DISEASE=Reticular dysgenesis];			rs80324279	0.0346	0.0514,0.0241,0.0262,0.0454,0.0179	0,.	450	144648	9.9640	D(0.01),D(0.01), ,D(0.01), ,D(0.01), ,D(0.01)	B(0.17),B(0.31), ,B(0.44), ,P(0.88), ,B(0.44)	25.30	0.78		COSV61466144	0		0	606	0 / 0					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	33013358	33013358	C	G	het	wt	wt	low_conf_region	QUAL=667;DP=634,421,555;AF=0.17,0.03,0.02;MQM=36;SAP=18;ABP=596	AK2	missense,intron&non_coding_transcript,3'UTR	AK2:ENST00000354858.11:missense_variant:MODERATE:exon5/5:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000373449.7:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],:ENST00000427524.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.246-17677C>G::,AK2:ENST00000467905.5:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase],AK2:ENST00000480134.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:ENST00000548033.5:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:PF00406 [Adenylate kinase],AK2:ENST00000629371.2:3_prime_UTR_variant:MODIFIER:exon5/6:c.*46G>C::,AK2:ENST00000672715.1:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:PF00406 [Adenylate kinase]	AK2:NM_001199199.3:missense_variant:MODERATE:exon6/7:c.519G>C:p.Lys173Asn:,AK2:NM_001319139.3:missense_variant:MODERATE:exon7/8:c.399G>C:p.Lys133Asn:,AK2:NM_001319140.2:missense_variant:MODERATE:exon7/7:c.399G>C:p.Lys133Asn:,AK2:NM_001319141.3:missense_variant:MODERATE:exon6/8:c.543G>C:p.Lys181Asn:,AK2:NM_001319142.3:missense_variant:MODERATE:exon5/6:c.417G>C:p.Lys139Asn:,AK2:NM_001319143.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*46G>C::,AK2:NM_001625.4:missense_variant:MODERATE:exon6/6:c.543G>C:p.Lys181Asn:,AK2:NM_013411.5:missense_variant:MODERATE:exon6/7:c.543G>C:p.Lys181Asn:,AK2:NR_134976.3:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.503G>C::,AK2:XR_001737036.1:non_coding_transcript_exon_variant:MODIFIER:exon5/6:n.488G>C::,AK2:XR_246248.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.583G>C::		103020_[GENE=AK2_PHENOS=Reticular dysgenesis, 267500 (3), Autosomal recessive]				rs72884305	0.1114	0.1538,0.0784,0.0983,0.1469,0.0605	0,.	280	143274	-0.3850	D(0.03),D(0.03), ,D(0.03), ,D(0.03), ,D(0.03)	B(0.00),B(0.03), ,B(0.09), ,B(0.05), ,B(0.09)	21.60	0.19		COSV61466156	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AK2 (inh=AR oe_syn=1.39 oe_mis=0.98 oe_lof=0.68)
chr1	34781247	34781247	-	C	wt	wt	het		QUAL=151;DP=8,10,14;AF=0.00,0.00,0.57;MQM=60;SAP=20;ABP=4	GJB3	5'UTR,intron&non_coding_transcript	GJB3:ENST00000373366.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+6740dup::	GJB3:NM_024009.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-551dup::,LOC105378642:XR_001737967.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.1023+17123dup::	regulatory_region_variant:promoter,TF_binding_site_variant	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive; Deafness, autosomal dominant, with peripheral neuropathy (3)]				rs3831969	0.2563		5890,.	27030	112632				8.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34785628	34785628	G	A	wt	het	het		QUAL=9695;DP=261,357,376;AF=0.00,0.54,0.50;MQM=60;SAP=7;ABP=5	GJB3	3'UTR,intron&non_coding_transcript	GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373366.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,:ENST00000542839.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.110+2360C>T::	GJB3:NM_001005752.2:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:NM_024009.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,LOC105378642:XR_001737967.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.1023+12743C>T::	regulatory_region_variant:CTCF_binding_site	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Digenic dominant, Autosomal recessive; Deafness, autosomal recessive (3); Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal dominant, Autosomal recessive; Deafness, autosomal dominant, with peripheral neuropathy (3)]	297196 [benign DISEASE=Erythrokeratodermia variabilis et progressiva 1,not provided];			rs476220	0.4781		18250,.	36058	79204	-0.1210			2.32			COSV64904373	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39026255	39026255	G	C	het	hom	het	off-target	QUAL=4562;DP=72,84,102;AF=0.46,1.00,0.50;MQM=60;SAP=165;ABP=3	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.8:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600	0.7036		39640,.	27435	44963	-0.2760			6.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39026408	39026408	G	T	het	hom	het		QUAL=4652;DP=91,91,111;AF=0.52,1.00,0.47;MQM=60;SAP=53;ABP=3	NDUFS5	intron,splice_region&intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.8:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron1/2:c.-3+10G>T::,NDUFS5:NM_004552.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1122472	0.7015		39510,.	27441	45299	-1.2850			5.35		6.53>7.92		0.74		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	-	T	het	wt	wt	off-target;low_conf_region	QUAL=360;DP=113,47,68;AF=0.09,0.38,0.22;MQM=59;SAP=92;ABP=206	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+69dup::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::	regulatory_region_variant:CTCF_binding_site					rs35464164	0.6957		35867,.	25994	42740				0.37				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	C	T	wt	het	het	off-target;low_conf_region	QUAL=360;DP=113,47,68;AF=0.19,0.21,0.15;MQM=55;SAP=96;ABP=195	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	NDUFS5:NM_001184979.2:intron_variant:MODIFIER:intron2/2:c.216+54C>T::,NDUFS5:NM_004552.3:intron_variant:MODIFIER:intron2/2:c.216+54C>T::	regulatory_region_variant:CTCF_binding_site					rs372159643	0.0001		0,.	9	140641	-1.1560			0.28				0		13	128	0 / 0					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40073404	40073404	C	T	hom	het	het		QUAL=18469;DP=389,207,252;AF=1.00,0.39,0.50;MQM=60;SAP=59;ABP=13	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*657G>A::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*788G>A::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657G>A::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297230 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126973	0.7017		37586,.	31457	45321	0.4510			7.40				0	17145094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073531	40073531	-	TGAT	hom	het	het		QUAL=19323;DP=341,360,457;AF=0.99,0.44,0.47;MQM=60;SAP=62;ABP=16	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*526_*529dup::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657_*660dup::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*526_*529dup::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297233 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,Neuronal Ceroid-Lipofuscinosis, Recessive,not provided];			rs397730033	0.6608		33891,.	32395	51415				4.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073556	40073556	G	C	hom	het	het		QUAL=29708;DP=534,423,540;AF=1.00,0.46,0.48;MQM=60;SAP=157;ABP=10	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*505C>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*636C>G::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*505C>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297234 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126972	0.6974		37183,.	31575	45969	-0.6230			3.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073776	40073776	A	C	hom	het	het		QUAL=39398;DP=859,416,464;AF=0.99,0.53,0.45;MQM=60;SAP=63;ABP=4	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*285T>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*416T>G::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*285T>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297240 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs1126970	0.6976		37211,.	31579	45957	1.3970			10.22				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073900	40073900	A	G	het	wt	het		QUAL=7482;DP=342,237,267;AF=0.46,0.00,0.48;MQM=60;SAP=88;ABP=10	PPT1	3'UTR	PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*161T>C::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*292T>C::,PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*161T>C::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::	PPT1:NM_000310.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:NM_001142604.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,PPT1:NM_001363695.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297242 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs11552578	0.1156		1193,.	15194	134524	2.4760			15.49			COSV61222731	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080537	40080537	C	T	het	wt	het	off-target	QUAL=6263;DP=236,222,288;AF=0.49,0.00,0.49;MQM=60;SAP=192;ABP=4	PPT1	intron	PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron5/8:c.534-50G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron5/7:c.537-50G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron5/9:c.537-50G>A::,PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron6/9:c.624-50G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron5/8:c.537-50G>A::	PPT1:NM_000310.4:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron2/5:c.228-50G>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron5/7:c.537-50G>A::	regulatory_region_variant:promoter_flanking_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180457 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs77623018	0.0862	0.0162,0.1045,0.1396,0.0569,0.1362	442,.	8128	142904	-2.3850			0.07			COSV65655090	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091270	40091270	A	T	wt	het	wt	off-target	QUAL=2670;DP=152,207,216;AF=0.00,0.51,0.00;MQM=60;SAP=39;ABP=3	PPT1	intron	PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+59T>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+59T>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+59T>A::,PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+59T>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+59T>A::	PPT1:NM_000310.4:intron_variant:MODIFIER:intron4/8:c.433+59T>A::,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1758T>A::,PPT1:NM_001363695.2:intron_variant:MODIFIER:intron4/7:c.433+59T>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670785 [benign DISEASE=not provided];			rs56654546	0.0958		767,.	13007	137323	1.0410			4.78			COSV65655895	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091361	40091361	A	G	het	wt	het		QUAL=9444;DP=434,344,349;AF=0.44,0.00,0.48;MQM=60;SAP=3;ABP=13	PPT1	missense,intron	PPT1:ENST00000433473.8:missense_variant:MODERATE:exon4/9:c.398T>C:p.Ile133Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000439754.6:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::,PPT1:ENST00000641319.1:missense_variant:MODERATE:exon4/10:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000641471.1:missense_variant:MODERATE:exon5/10:c.488T>C:p.Ile163Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000642050.2:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase]	PPT1:NM_000310.4:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:,PPT1:NM_001142604.2:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::,PPT1:NM_001363695.2:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	130022 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,History of neurodevelopmental disorder,not specified,not provided];			rs1800205	0.0659	0.0097,0.0357,0.1235,0.0483,0.1213	303,.	6509	144973	0.6890	T(0.37),T(0.36), ,T(0.38),T(0.38),T(0.37)	B(0.00),B(0.00), ,B(0.00),B(0.16),B(0.04)	16.02	0.20		COSV65655693	0.01	25741868,19054571	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097321	40097321	T	C	hom	hom	hom		QUAL=5693;DP=36,56,97;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	PPT1	upstream_gene	PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297250 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs6600313	0.8441		54447,.	19476	23718	-0.6120			8.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097347	40097347	G	T	het	wt	het		QUAL=1551;DP=30,46,82;AF=0.60,0.02,0.54;MQM=60;SAP=7;ABP=6	PPT1	upstream_gene	PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297251 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided];			rs41301070	0.0865		820,.	11518	139030	-0.5190			6.03				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40270145	40270145	T	G	wt	het	wt	off-target	QUAL=327;DP=100,43,62;AF=0.00,0.40,0.00;MQM=60;SAP=4;ABP=7	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.627+18T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.627+18T>G::,ZMPSTE24:XR_001736906.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.821+18T>G::	regulatory_region_variant:open_chromatin_region	606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140531 [benign DISEASE=not specified,not provided];			rs16827109	0.1068	0.0627,0.1451,0.1617,0.0893,0.1472	714,.	12290	138452	0.2410			7.05			COSV65638901	0	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	40271844	40271844	T	G	hom	hom	hom	off-target	QUAL=11360;DP=124,105,126;AF=1.00,1.00,1.00;MQM=60;SAP=395;ABP=0	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.628-50T>G::	ZMPSTE24:NM_005857.5:intron_variant:MODIFIER:intron5/9:c.628-50T>G::,ZMPSTE24:XR_001736906.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/10:n.822-50T>G::		606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140535 [benign DISEASE=not specified,not provided];			rs6677717	0.9875	0.9983,0.9974,0.9999,0.9870,0.9859	74221,.	1845	1905	-0.2280			0.98				0	25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	42733051	42733051	C	T	het	n/a	n/a	off-target	QUAL=171;DP=14,0,1;AF=0.64,,1.00;MQM=58;SAP=25;ABP=5	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::			610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSg (SINE/Alu)	rs11210707	0.6347		30220,.	34286	54510	-0.5640			1.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733077	42733077	-	TC	het	n/a	het	off-target	QUAL=231;DP=25,1,3;AF=0.60,0.00,0.33;MQM=53;SAP=38;ABP=4	CLDN19	downstream_gene	CLDN19:ENST00000296387.6:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::,CLDN19:ENST00000539749.5:downstream_gene_variant:MODIFIER::::			610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs200763067	0.0823		400,.	10590	127084				0.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733353	42733353	C	T	het	wt	het		QUAL=6657;DP=213,253,333;AF=0.51,0.00,0.51;MQM=59;SAP=153;ABP=4	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2515G>A::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297316 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];		AluSx1 (SINE/Alu)	rs112310775	0.1218		1173,.	16174	133518	-0.2000			0.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733444	42733444	A	G	het	wt	het		QUAL=10843;DP=405,354,441;AF=0.48,0.00,0.50;MQM=60;SAP=15;ABP=3	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2424T>C::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297318 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement];			rs56345167	0.1894		3000,.	22777	123205	1.0130			6.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42734855	42734855	T	C	het	het	het		QUAL=5019;DP=134,127,142;AF=0.49,0.43,0.51;MQM=60;SAP=4;ABP=5	CLDN19	3'UTR	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1013A>G::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::,CLDN19:NM_148960.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297335 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement,not provided];			rs912075	0.5839		26092,.	36486	63186	-1.7400			0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735184	42735184	G	A	het	het	het		QUAL=7187;DP=118,210,253;AF=0.52,0.55,0.47;MQM=60;SAP=148;ABP=3	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.627-50C>T::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1276324 [benign DISEASE=not provided];			rs74885359	0.0980	0.0235,0.0526,0.0003,0.1380,0.0400	941,.	12423	137781	-1.0660			0.27				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735545	42735545	A	C	het	het	het		QUAL=10357;DP=184,284,353;AF=0.45,0.49,0.49;MQM=60;SAP=4;ABP=5	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::,CLDN19:NM_001185117.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+333T>G::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1287286 [benign DISEASE=not provided];		L2b (LINE/L2)	rs12141833	0.5392		22921,.	36055	69995	-1.3840			0.82				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735863	42735863	G	A	het	wt	het		QUAL=4084;DP=87,176,242;AF=0.45,0.01,0.56;MQM=60;SAP=257;ABP=5	CLDN19	intron,3'UTR,missense	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+15C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:ENST00000539749.5:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:	CLDN19:NM_001123395.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::,CLDN19:NM_001185117.2:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:NM_148960.3:intron_variant:MODIFIER:intron4/4:c.626+15C>T::	regulatory_region_variant:CTCF_binding_site	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297339 [benign DISEASE=Hypomagnesemia 5, renal, with ocular involvement,not provided];			rs4660658	0.1861	0.2412,0.2467,0.2450,0.1585,0.1289	2767,.	22749	123703	0.4830	 , ,T(0.07)	 , ,B(0.00)	0.26	0.12		COSV56418053	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42746440	42746440	C	T	het	het	het		QUAL=9051;DP=296,180,206;AF=0.49,0.54,0.48;MQM=60;SAP=25;ABP=3	P3H1	3'UTR	P3H1:ENST00000236040.8:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:ENST00000296388.10:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000397054.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::	P3H1:NM_001146289.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:NM_001243246.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::,P3H1:NM_022356.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:XM_005271110.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*257G>A::,P3H1:XM_011541948.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:XM_017002051.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*257G>A::,P3H1:XM_017002052.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*257G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	873598 [benign DISEASE=Osteogenesis imperfecta type 8,Osteogenesis Imperfecta, Recessive,not provided];			rs6882	0.6422		31658,.	34354	54414	0.2250			4.65				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747198	42747198	A	T	het	wt	het		QUAL=2939;DP=109,74,126;AF=0.48,0.00,0.50;MQM=60;SAP=3;ABP=3	P3H1	missense,intron	P3H1:ENST00000236040.8:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:NM_001243246.2:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:,P3H1:NM_022356.4:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:XM_005271110.2:intron_variant:MODIFIER:intron13/13:c.1047+74T>A::,P3H1:XM_011541948.1:intron_variant:MODIFIER:intron14/14:c.1080+74T>A::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron15/15:c.1080+74T>A::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron15/15:c.1077+74T>A::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674902 [benign DISEASE=not provided];			rs3738496	0.1309	0.0737,0.2078,0.2524,0.1144,0.0733	1062,.	14774	135232	0.2420	T(0.73), , 	B(0.03), , 	1.93	0.02		COSV52536380	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747828	42747828	C	T	het	het	het	off-target	QUAL=5978;DP=176,135,219;AF=0.47,0.49,0.47;MQM=60;SAP=137;ABP=5	P3H1	intron	P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:NM_001243246.2:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:XM_005271110.2:intron_variant:MODIFIER:intron11/13:c.831-30G>A::,P3H1:XM_011541948.1:intron_variant:MODIFIER:intron12/14:c.864-30G>A::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron13/15:c.864-30G>A::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron13/15:c.861-30G>A::,P3H1:XR_946739.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1964-30G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674901 [benign DISEASE=Osteogenesis imperfecta type 8,not provided];			rs3738499	0.6021	0.3579,0.6219,0.6767,0.5938,0.6960	22679,.	35774	70732	-1.4520			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762518	42762518	T	A	hom	hom	hom	off-target	QUAL=19167;DP=189,212,255;AF=1.00,1.00,1.00;MQM=60;SAP=533;ABP=0	P3H1	intron	P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron1/14:c.466-43A>T::	P3H1:NM_001146289.2:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:NM_001243246.2:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,P3H1:NM_022356.4:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:XM_017002051.2:intron_variant:MODIFIER:intron1/15:c.-565-43A>T::,P3H1:XM_017002052.2:intron_variant:MODIFIER:intron1/15:c.-565-43A>T::,P3H1:XR_946739.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.523-43A>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674899 [benign DISEASE=not provided];			rs2816593	0.9882	0.9973,0.9974,1.0000,0.9816,0.9927	74272,.	1754	1798	-0.1310			2.13				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767127	42767127	G	T	wt	het	wt	off-target	QUAL=350;DP=8,27,19;AF=0.00,0.67,0.00;MQM=60;SAP=42;ABP=10	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,:ENST00000603943.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	1290909 [benign DISEASE=not provided];			rs11210712	0.1990		3590,.	23057	121687	0.0180			6.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767136	42767136	C	G	het	het	het	off-target	QUAL=604;DP=11,22,18;AF=0.73,0.64,0.56;MQM=60;SAP=72;ABP=10	P3H1,C1orf50	upstream_gene	P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,:ENST00000603943.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674898 [benign DISEASE=not provided];			rs3738504	0.5999		27569,.	36083	60841	0.7320			10.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42926579	42926579	C	G	wt	het	wt		QUAL=2154;DP=293,227,266;AF=0.00,0.41,0.00;MQM=60;SAP=3;ABP=19	SLC2A1	3'UTR	SLC2A1:ENST00000426263.10:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::,SLC2A1:ENST00000674765.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*228G>C::	SLC2A1:NM_006516.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*462G>C::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	297374 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1];			rs4658	0.3411		10880,.	30080	100144	-0.3080			1.42				0	26358256,28698656,30062472,29307798,30564000,30531820,26980812	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42927574	42927574	-	GGTGAGAAAT	wt	het	het	off-target	QUAL=727;DP=177,99,77;AF=0.00,0.35,0.32;MQM=60;SAP=61;ABP=42	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron8/8:c.1030-718_1030-717insATTTCTCACC::	SLC2A1:NM_006516.4:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	1222935 [benign DISEASE=not provided];			rs3831326	0.5698		25919,.	34482	65176				1.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42929964	42929964	C	T	wt	het	wt		QUAL=1557;DP=118,160,234;AF=0.00,0.43,0.00;MQM=60;SAP=71;ABP=11	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon5/9:c.588G>A:p.Pro196=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon5/10:c.588G>A:p.Pro196=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95414 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs2229682	0.1845	0.0418,0.1995,0.0761,0.2078,0.1880	2275,.	19277	128123	-5.4280			1.82			COSV65286860	0.13	25741868,18414213,23757202,23427181,18212354,21135204,20419766	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42930743	42930743	G	A	wt	het	wt		QUAL=2460;DP=253,154,166;AF=0.00,0.62,0.01;MQM=60;SAP=5;ABP=21	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter],SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon4/9:c.399C>T:p.Cys133=:PF00083 [Sugar (and other) transporter]	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon4/10:c.399C>T:p.Cys133=:	regulatory_region_variant:CTCF_binding_site	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95411 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs11537641	0.1897	0.0925,0.2031,0.0999,0.2048,0.1983	2436,.	21033	126147	-1.4980			4.27			COSV65287469	0.05	25741868,18414213,23757202,30353771,21135204	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943295	42943295	G	A	het	het	wt		QUAL=7385;DP=293,350,487;AF=0.43,0.52,0.00;MQM=60;SAP=70;ABP=5	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:,SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon2/9:c.45C>T:p.Ala15=:	SLC2A1:NM_006516.4:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal dominant, Autosomal recessive; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95413 [benign DISEASE=Dystonia 9,GLUT1 deficiency syndrome 1,Stomatin-deficient cryohydrocytosis with neurologic defects,GLUT1 deficiency syndrome 2,History of neurodevelopmental disorder,GLUT1 deficiency syndrome 1, autosomal recessive,not specified,not provided];			rs1385129	0.2416	0.1769,0.3054,0.2876,0.2187,0.2675	3829,.	25667	118655	-1.8290			7.23			COSV65287476	0	25741868,25512783,18414213,23757202,22707195,29867928,25701507,30353771,18212354,21135204,31222984,25381171	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43346404	43346404	G	A	het	wt	het	off-target	QUAL=3908;DP=136,111,148;AF=0.59,0.01,0.53;MQM=60;SAP=225;ABP=12	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron6/11:c.960-41G>A::	MPL:NM_005373.3:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:XM_017001320.1:intron_variant:MODIFIER:intron5/10:c.1152-41G>A::	regulatory_region_variant:promoter_flanking_region	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Autosomal dominant, Somatic mutation; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	259760 [benign DISEASE=not specified,not provided];			rs1760670	0.3123	0.2200,0.3028,0.0676,0.3792,0.1450	7921,.	31582	104452	0.5750			8.30			COSV65245058	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43354522	43354522	G	A	wt	het	wt	off-target	QUAL=1541;DP=182,121,119;AF=0.00,0.51,0.01;MQM=60;SAP=55;ABP=3	CDC20,MPL	upstream_gene,downstream_gene	CDC20:ENST00000310955.11:upstream_gene_variant:MODIFIER::::,CDC20:ENST00000372462.1:upstream_gene_variant:MODIFIER::::,MPL:ENST00000372470.9:downstream_gene_variant:MODIFIER::::,MPL:ENST00000413998.7:downstream_gene_variant:MODIFIER::::,:ENST00000424948.1:downstream_gene_variant:MODIFIER::::			159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Thrombocythemia 2, 601977 (3), Autosomal dominant, Somatic mutation; Thrombocytopenia, congenital amegakaryocytic, 604498 (3), Autosomal recessive]	1287360 [benign DISEASE=not provided];			rs79064184	0.0372		152,.	5349	146519	0.0160			0.45						0	18	0 / 0					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53), CDC20 (inh=n/a oe_syn=0.86 oe_mis=0.70 oe_lof=0.54)
chr1	43824858	43824858	A	G	het	het	hom		QUAL=7889;DP=267,116,112;AF=0.46,0.41,0.98;MQM=60;SAP=25;ABP=13	ST3GAL3	missense,intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000351035.8:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372368.7:missense_variant:MODERATE:exon4/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000372372.7:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron18/25:c.*1531+9925A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron2/10:c.161+9925A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron5/12:c.209+9925A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000647237.1:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron3/7:c.161+9925A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron4/13:c.-245+9925A>G::,ST3GAL3:NM_001363573.2:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:NM_174963.5:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron4/6:c.209+9925A>G::,ST3GAL3:NM_174968.5:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron3/5:c.161+9925A>G::,ST3GAL3:NM_174971.5:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/11:n.397+9925A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/9:n.307-13361A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/10:n.397+9925A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.307-69525A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.349+9925A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/9:n.397+9925A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.397+9925A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/12:n.397+9925A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron3/11:c.161+9925A>G::,ST3GAL3:XM_011541973.2:missense_variant:MODERATE:exon5/14:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541974.2:missense_variant:MODERATE:exon5/14:c.337A>G:p.Thr113Ala:,ST3GAL3:XM_011541976.2:missense_variant:MODERATE:exon4/13:c.289A>G:p.Thr97Ala:,ST3GAL3:XM_011541981.2:missense_variant:MODERATE:exon5/11:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron5/13:c.-74+9925A>G::,ST3GAL3:XM_011541984.2:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541985.2:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541986.3:missense_variant:MODERATE:exon5/12:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron4/13:c.-286+9925A>G::,ST3GAL3:XM_017002109.2:missense_variant:MODERATE:exon5/14:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_017002110.1:missense_variant:MODERATE:exon5/11:c.382A>G:p.Thr128Ala:,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron4/13:c.-245+9925A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron3/12:c.-245+9925A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron4/12:c.-74+9925A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron4/12:c.-286+9925A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron2/10:c.-286+9925A>G::,ST3GAL3:XR_001737368.1:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946742.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946743.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::,ST3GAL3:XR_946744.2:non_coding_transcript_exon_variant:MODIFIER:exon5/14:n.575A>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.575A>G::	regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	130378 [benign DISEASE=not specified,not provided];		MER5B (DNA/hAT-Charlie)	rs37458	0.3178	0.3232,0.2169,0.1363,0.3575,0.1441	7879,.	32554	103692	-0.1460	T(0.74), , , ,T(0.70), , , , , , , , , ,T(0.71), ,T(0.74), , , , , , , , , , , , , , , ,T(0.72)	B(0.00), , , ,B(0.00), , , , , , , , , ,B(0.00), ,B(0.00), , , , , , , , , , , , , , , ,B(0.00)	0.65	0.01		COSV53510755	0.13	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899785	43899785	A	G	het	wt	het	off-target	QUAL=3725;DP=140,106,157;AF=0.49,0.00,0.56;MQM=60;SAP=219;ABP=5	ST3GAL3	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+58A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+58A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+58A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron23/25:c.*2066+58A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+58A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+58A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+58A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.603+58A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.554+522A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.509+522A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron10/13:c.465+58A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.397+5308A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.349+5308A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/11:n.964+58A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.841+58A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1105+58A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.780+58A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.697+522A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.919+522A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.585+5308A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/12:n.964+58A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron8/11:c.696+58A>G::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron10/13:c.951+58A>G::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron10/13:c.906+58A>G::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron9/12:c.858+58A>G::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron6/9:c.579+58A>G::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.951+58A>G::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron10/13:c.462+58A>G::,ST3GAL3:XM_011541984.2:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541985.2:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541986.3:intron_variant:MODIFIER:intron10/11:c.951+58A>G::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron10/13:c.423+58A>G::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron5/8:c.423+58A>G::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron10/13:c.951+58A>G::,ST3GAL3:XM_017002110.1:intron_variant:MODIFIER:intron10/10:c.951+58A>G::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron10/13:c.465+58A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron9/12:c.465+58A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron9/12:c.462+58A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron10/12:c.423+58A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron8/10:c.423+58A>G::,ST3GAL3:XR_001737368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946742.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946743.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1144+58A>G::,ST3GAL3:XR_946744.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/13:n.1144+58A>G::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/12:n.1176+58A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1233138 [benign DISEASE=not provided];			rs783304	0.2372		5422,.	25214	115932	-0.0920			1.77			COSV53512272	0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920943	43920943	A	G	hom	hom	hom	off-target	QUAL=11971;DP=76,127,210;AF=0.99,0.98,1.00;MQM=60;SAP=228;ABP=0	ST3GAL3	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+15A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+393A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9189A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+15A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2360+15A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+15A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+15A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+15A>G::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+15A>G::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9189A>G::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9189A>G::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9189A>G::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+15A>G::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+15A>G::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+15A>G::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+15A>G::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+15A>G::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9189A>G::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+15A>G::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+15A>G::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9189A>G::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+15A>G::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+15A>G::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+15A>G::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9189A>G::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+15A>G::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+15A>G::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9189A>G::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+15A>G::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+15A>G::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron10/11:c.990+15A>G::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron12/13:c.1245+15A>G::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron12/13:c.1200+15A>G::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron11/12:c.1152+15A>G::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron8/9:c.873+15A>G::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-9189A>G::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron12/13:c.756+15A>G::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron12/13:c.717+15A>G::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron7/8:c.717+15A>G::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron12/13:c.1245+15A>G::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1038+15A>G::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron12/13:c.759+15A>G::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron11/12:c.759+15A>G::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron11/12:c.756+15A>G::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.717+15A>G::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.717+15A>G::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1470+15A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262909 [benign DISEASE=Mental retardation, autosomal recessive 12,Early infantile epileptic encephalopathy 15,Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs3120803	0.8813	0.6951,0.8484,0.8544,0.9213,0.8667	55812,.	17670	22580	-1.2040			2.10				0.29	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920970	43920970	G	C	het	wt	het	off-target	QUAL=3416;DP=85,95,157;AF=0.49,0.00,0.64;MQM=60;SAP=121;ABP=19	ST3GAL3	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+42G>C::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+420G>C::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9162G>C::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2360+42G>C::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+42G>C::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+42G>C::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.948+42G>C::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-9162G>C::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-9162G>C::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-9162G>C::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron12/13:c.759+42G>C::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-9162G>C::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-9162G>C::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1258+42G>C::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1135+42G>C::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-9162G>C::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1074+42G>C::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.991+42G>C::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-9162G>C::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.879+42G>C::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1258+42G>C::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron10/11:c.990+42G>C::,ST3GAL3:XM_011541973.2:intron_variant:MODIFIER:intron12/13:c.1245+42G>C::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron12/13:c.1200+42G>C::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron11/12:c.1152+42G>C::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron8/9:c.873+42G>C::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-9162G>C::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron12/13:c.756+42G>C::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron12/13:c.717+42G>C::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron7/8:c.717+42G>C::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron12/13:c.1245+42G>C::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron12/13:c.759+42G>C::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron11/12:c.759+42G>C::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron11/12:c.756+42G>C::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.717+42G>C::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.717+42G>C::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1470+42G>C::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261387 [benign DISEASE=not provided];			rs3764833	0.0553	0.0891,0.0490,0.1303,0.0398,0.0432	288,.	7838	143684	1.2920			9.06			COSV53519387	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43930114	43930114	C	T	het	hom	het	off-target	QUAL=10324;DP=170,184,258;AF=0.43,1.00,0.47;MQM=60;SAP=99;ABP=12	ST3GAL3	intron,intron&NMD_transcript	ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-18C>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1132-18C>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-18C>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1054-18C>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-18C>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-18C>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron12/12:c.1280-18C>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-18C>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron12/12:c.1235-18C>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,:ENST00000645057.1:intron_variant&NMD_transcript_variant:MODIFIER:intron25/25:c.*2361-18C>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron10/10:c.1187-18C>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1039-18C>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron12/12:c.1166-18C>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-18C>T::	ST3GAL3:NM_001270459.2:intron_variant:MODIFIER:intron11/11:c.949-18C>T::,ST3GAL3:NM_001270460.2:intron_variant:MODIFIER:intron10/10:c.946-18C>T::,ST3GAL3:NM_001270461.3:intron_variant:MODIFIER:intron8/8:c.697-18C>T::,ST3GAL3:NM_001270462.3:intron_variant:MODIFIER:intron7/7:c.604-18C>T::,ST3GAL3:NM_001270463.3:intron_variant:MODIFIER:intron7/7:c.555-18C>T::,ST3GAL3:NM_001270464.3:intron_variant:MODIFIER:intron7/7:c.510-18C>T::,ST3GAL3:NM_001270465.3:intron_variant:MODIFIER:intron7/7:c.*23-18C>T::,ST3GAL3:NM_001270466.3:intron_variant:MODIFIER:intron4/4:c.255-18C>T::,ST3GAL3:NM_001350619.2:intron_variant:MODIFIER:intron12/12:c.1280-18C>T::,ST3GAL3:NM_001350620.2:intron_variant:MODIFIER:intron12/12:c.1235-18C>T::,ST3GAL3:NM_001350621.2:intron_variant:MODIFIER:intron13/13:c.956-18C>T::,ST3GAL3:NM_001363573.2:intron_variant:MODIFIER:intron10/10:c.907-18C>T::,ST3GAL3:NM_006279.5:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:NM_174963.5:intron_variant:MODIFIER:intron12/12:c.1246-18C>T::,ST3GAL3:NM_174964.4:intron_variant:MODIFIER:intron11/11:c.1084-18C>T::,ST3GAL3:NM_174965.4:intron_variant:MODIFIER:intron6/6:c.443-18C>T::,ST3GAL3:NM_174966.4:intron_variant:MODIFIER:intron9/9:c.745-18C>T::,ST3GAL3:NM_174967.4:intron_variant:MODIFIER:intron6/6:c.398-18C>T::,ST3GAL3:NM_174968.5:intron_variant:MODIFIER:intron12/12:c.1201-18C>T::,ST3GAL3:NM_174969.4:intron_variant:MODIFIER:intron10/10:c.991-18C>T::,ST3GAL3:NM_174970.4:intron_variant:MODIFIER:intron5/5:c.350-18C>T::,ST3GAL3:NM_174971.5:intron_variant:MODIFIER:intron11/11:c.1153-18C>T::,ST3GAL3:NR_073016.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/11:n.1259-18C>T::,ST3GAL3:NR_073017.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1136-18C>T::,ST3GAL3:NR_073018.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1106-18C>T::,ST3GAL3:NR_073019.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.1075-18C>T::,ST3GAL3:NR_073020.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.992-18C>T::,ST3GAL3:NR_073021.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.920-18C>T::,ST3GAL3:NR_073023.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/8:n.880-18C>T::,ST3GAL3:NR_146867.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1455-18C>T::,ST3GAL3:XM_006710827.4:intron_variant:MODIFIER:intron11/11:c.1187-18C>T::,ST3GAL3:XM_011541973.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*28C>T::,ST3GAL3:XM_011541974.2:intron_variant:MODIFIER:intron13/13:c.1397-18C>T::,ST3GAL3:XM_011541976.2:intron_variant:MODIFIER:intron12/12:c.1349-18C>T::,ST3GAL3:XM_011541980.3:intron_variant:MODIFIER:intron9/9:c.1070-18C>T::,ST3GAL3:XM_011541981.2:intron_variant:MODIFIER:intron10/10:c.952-18C>T::,ST3GAL3:XM_011541983.2:intron_variant:MODIFIER:intron13/13:c.953-18C>T::,ST3GAL3:XM_011541987.2:intron_variant:MODIFIER:intron13/13:c.914-18C>T::,ST3GAL3:XM_011541988.2:intron_variant:MODIFIER:intron8/8:c.914-18C>T::,ST3GAL3:XM_017002109.2:intron_variant:MODIFIER:intron13/13:c.1442-18C>T::,ST3GAL3:XM_017002113.1:intron_variant:MODIFIER:intron11/11:c.1039-18C>T::,ST3GAL3:XM_017002114.1:intron_variant:MODIFIER:intron13/13:c.956-18C>T::,ST3GAL3:XM_017002115.1:intron_variant:MODIFIER:intron12/12:c.956-18C>T::,ST3GAL3:XM_017002116.1:intron_variant:MODIFIER:intron12/12:c.953-18C>T::,ST3GAL3:XM_017002120.1:intron_variant:MODIFIER:intron12/12:c.718-18C>T::,ST3GAL3:XM_017002121.1:intron_variant:MODIFIER:intron10/10:c.718-18C>T::,ST3GAL3:XR_946745.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/12:n.1471-18C>T::	regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262910 [benign DISEASE=Mental retardation, autosomal recessive 12,Early infantile epileptic encephalopathy 15,Early infantile epileptic encephalopathy with suppression bursts,not specified];			rs2108202	0.6753	0.2202,0.5744,0.6408,0.7772,0.6130	31729,.	27752	60796	0.2390			12.44		9.65>10.17	COSV53521961	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930524	43930524	A	G	het	wt	het		QUAL=3226;DP=153,75,118;AF=0.44,0.00,0.49;MQM=60;SAP=3;ABP=6	ST3GAL3	3'UTR,3'UTR&NMD_transcript	ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000361812.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:ENST00000372366.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*415A>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000372372.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,:ENST00000645057.1:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon26/26:c.*2753A>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*322A>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*303A>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*341A>G::,ST3GAL3:NM_001270465.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:NM_001270466.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NM_174965.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1651A>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1528A>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1498A>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1467A>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1384A>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1312A>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1272A>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1847A>G::,ST3GAL3:XM_006710827.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*322A>G::,ST3GAL3:XM_011541974.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541976.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_011541980.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*322A>G::,ST3GAL3:XM_011541981.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:XM_011541983.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541987.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_011541988.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*322A>G::,ST3GAL3:XM_017002109.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_017002113.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:XM_017002114.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*322A>G::,ST3GAL3:XM_017002115.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_017002116.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:XM_017002120.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:XM_017002121.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1863A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs12561948	0.0381		135,.	5519	146343	1.8380			17.29				0.01		0	0	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930974	43930974	C	G	het	hom	het		QUAL=13487;DP=226,221,263;AF=0.49,1.00,0.54;MQM=60;SAP=10;ABP=4	ST3GAL3	3'UTR,3'UTR&NMD_transcript	ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,:ENST00000645057.1:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon26/26:c.*3203C>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*772C>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::	ST3GAL3:NM_001270459.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_001270460.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_001270461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:NM_001270462.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*753C>G::,ST3GAL3:NM_001270463.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270464.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*791C>G::,ST3GAL3:NM_001270465.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:NM_001270466.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:NM_001350619.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350620.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:NM_001350621.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:NM_001363573.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_006279.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174963.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174964.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NM_174965.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174966.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:NM_174967.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:NM_174968.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:NM_174969.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:NM_174970.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*772C>G::,ST3GAL3:NM_174971.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:NR_073016.3:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2101C>G::,ST3GAL3:NR_073017.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1978C>G::,ST3GAL3:NR_073018.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1948C>G::,ST3GAL3:NR_073019.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1917C>G::,ST3GAL3:NR_073020.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1834C>G::,ST3GAL3:NR_073021.3:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.1762C>G::,ST3GAL3:NR_073023.3:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.1722C>G::,ST3GAL3:NR_146867.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2297C>G::,ST3GAL3:XM_006710827.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*772C>G::,ST3GAL3:XM_011541974.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541976.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_011541980.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*772C>G::,ST3GAL3:XM_011541981.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:XM_011541983.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541987.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_011541988.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*772C>G::,ST3GAL3:XM_017002109.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_017002113.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:XM_017002114.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*772C>G::,ST3GAL3:XM_017002115.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_017002116.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:XM_017002120.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:XM_017002121.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:XR_946745.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2313C>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs6801	0.6003		31765,.	27751	60785	0.1650			2.26			COSV53521971	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44819862	44819862	A	C	wt	het	wt		QUAL=164;DP=127,26,28;AF=0.00,0.42,0.00;MQM=60;SAP=19;ABP=4	PTCH2	3'UTR	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::	PTCH2:NM_001166292.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*827T>G::,LOC107984952:XR_001738036.2:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.741A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]				rs181782534	0.0116		25,.	1714	150446	-0.4220			0.75						3	139	0 / 0					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819976	44819976	C	T	hom	het	het		QUAL=20079;DP=512,168,176;AF=0.99,0.55,0.49;MQM=60;SAP=681;ABP=4	RNU5E-6P,PTCH2	non_coding_transcript_exon,3'UTR	RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::,PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::	PTCH2:NM_001166292.2:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::,LOC107984952:XR_001738036.2:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.855C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]			U5 (snRNA)	rs41269085	0.2278		4638,.	25366	117448	-0.3300			0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44827194	44827194	G	A	hom	het	het		QUAL=9033;DP=164,147,208;AF=0.99,0.51,0.50;MQM=60;SAP=53;ABP=3	PTCH2	synonymous	PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:,PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:	PTCH2:NM_001166292.2:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166504 [benign DISEASE=Gorlin syndrome,not provided];			rs2295996	0.1624	0.0810,0.1773,0.2106,0.1669,0.1589	1775,.	18316	130248	0.4630			2.03			COSV64709782	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44827846	44827846	A	G	hom	het	het		QUAL=12971;DP=192,271,323;AF=0.99,0.48,0.48;MQM=60;SAP=466;ABP=5	PTCH2	synonymous	PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:,PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:	PTCH2:NM_001166292.2:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:NM_003738.5:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1166505 [benign DISEASE=Gorlin syndrome,not provided];			rs7525308	0.4236	0.5872,0.4169,0.4801,0.3461,0.3545	14614,.	35202	87666	1.9440			11.23			COSV64709500	0	30591961,20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44828484	44828484	T	C	hom	het	het	off-target	QUAL=21878;DP=234,517,682;AF=1.00,0.53,0.48;MQM=60;SAP=99;ABP=3	PTCH2	intron	PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::,PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::	PTCH2:NM_001166292.2:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327456 [benign DISEASE=Gorlin syndrome];			rs2273940	0.4221	0.5776,0.4168,0.4807,0.3456,0.3543	14452,.	35255	87847	-2.2410			0.07			COSV64709511	0.01	20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44841834	44841834	G	A	hom	het	het	off-target	QUAL=7505;DP=80,183,212;AF=0.99,0.51,0.55;MQM=60;SAP=196;ABP=6	PTCH2	intron	PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron2/21:c.265+13C>T::,PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron2/22:c.265+13C>T::	PTCH2:NM_001166292.2:intron_variant:MODIFIER:intron2/22:c.265+13C>T::,PTCH2:NM_003738.5:intron_variant:MODIFIER:intron2/21:c.265+13C>T::	regulatory_region_variant:promoter	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3)]	1327457 [benign DISEASE=Gorlin syndrome];			rs3795720	0.3744	0.3300,0.5242,0.4336,0.3463,0.3434	9477,.	34201	98769	1.5370			12.41			COSV64709520	0	20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44874610	44874610	C	T	hom	het	het		QUAL=20737;DP=402,252,314;AF=1.00,0.48,0.48;MQM=60;SAP=323;ABP=5	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000372183.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::	EIF2B3:NM_001166588.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron11/11:c.815+68G>A::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron11/12:c.815+68G>A::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	1288223 [benign DISEASE=not provided];		HAL1 (LINE/L1)	rs9988451	0.4308	0.5880,0.5364,0.4362,0.3537,0.3517	14980,.	35457	86427	0.3200			4.60				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44879774	44879774	T	A	hom	het	het	off-target	QUAL=4407;DP=102,44,64;AF=1.00,0.57,0.48;MQM=60;SAP=296;ABP=3	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron8/9:c.975+44A>T::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron8/10:c.975+44A>T::	EIF2B3:NM_001166588.3:intron_variant:MODIFIER:intron8/9:c.975+44A>T::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron9/11:c.588+44A>T::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron9/12:c.588+44A>T::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261223 [benign DISEASE=not specified,not provided];			rs3738248	0.1619	0.1145,0.1545,0.1655,0.1739,0.1604	1830,.	19180	129218	0.2800			8.31			COSV64517062	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897320	44897320	T	C	hom	het	het	off-target	QUAL=6694;DP=143,71,91;AF=1.00,0.52,0.57;MQM=60;SAP=243;ABP=6	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron6/9:c.656+35A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron6/10:c.656+35A>G::	EIF2B3:NM_001166588.3:intron_variant:MODIFIER:intron6/9:c.656+35A>G::,EIF2B3:NM_001261418.2:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:NM_020365.5:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:XM_017002745.2:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:XM_017002746.1:intron_variant:MODIFIER:intron7/11:c.269+35A>G::,EIF2B3:XM_017002747.1:intron_variant:MODIFIER:intron7/12:c.269+35A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	261222 [benign DISEASE=not specified,not provided];			rs263978	0.6783	0.9083,0.7886,0.9742,0.5467,0.6533	37076,.	28990	48908	-1.3970			1.06				0	25741868,15986317,18854859	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44986555	44986555	G	C	hom	het	het		QUAL=6870;DP=126,107,187;AF=1.00,0.43,0.43;MQM=60;SAP=3;ABP=16	EIF2B3	5'UTR	EIF2B3:ENST00000360403.7:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000372183.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,EIF2B3:ENST00000620860.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::	EIF2B3:NM_001166588.3:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,EIF2B3:NM_001261418.2:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:NM_020365.5:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:XM_017002745.2:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:XM_017002746.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-526C>G::,EIF2B3:XM_017002747.1:5_prime_UTR_variant:MODIFIER:exon1/13:c.-526C>G::	regulatory_region_variant:promoter	606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessive]	297453 [benign DISEASE=Leukoencephalopathy with vanishing white matter];			rs489676	0.4788		18278,.	36169	79181	-3.4960			1.33				0	15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), PPIAP35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45509417	45509417	T	-	het	het	het		QUAL=662;DP=86,111,119;AF=0.23,0.26,0.09;MQM=60;SAP=15;ABP=267	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+85del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*217del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	1208561 [likely benign DISEASE=not provided];		AluSg7 (SINE/Alu)	rs56934185	0.0366		161,.	4351	122889	-2.0820			0.14				0		2	17	0 / 0					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509494	45509494	A	G	wt	wt	het		QUAL=1064;DP=197,122,142;AF=0.01,0.00,0.38;MQM=60;SAP=46;ABP=21	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+147A>G::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*279A>G::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*279A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297502 [benign DISEASE=Cobalamin C disease,Disorders of Intracellular Cobalamin Metabolism,not provided];		AluSg7 (SINE/Alu)	rs9729395	0.2298		3982,.	26021	113887	0.6060			3.67				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45509628	45509628	G	A	wt	het	wt		QUAL=2026;DP=182,134,192;AF=0.01,0.59,0.01;MQM=60;SAP=40;ABP=12	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*132+281G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*413G>A::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*413G>A::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297505 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSg7 (SINE/Alu)	rs12021717	0.1786		2711,.	21536	124024	0.5480			2.18			COSV53113272	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510068	45510069	CT	-	wt	wt	het	low_conf_region	QUAL=1771;DP=238,174,185;AF=0.00,0.01,0.49;MQM=58;SAP=22;ABP=3	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-459_*133-458del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*855_*856del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*855_*856del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297512 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluSx4 (SINE/Alu)	rs398052965	0.6744		33011,.	31711	47179	0.2820			0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510077	45510077	A	-	het	het	het	low_conf_region	QUAL=968;DP=156,103,101;AF=0.19,0.24,0.17;MQM=59;SAP=3;ABP=284	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-437del::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*877del::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*877del::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]			AluSx4 (SINE/Alu)	rs986671995	0.0722		574,.	6328	96032	0.2270			0.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510475	45510475	G	A	wt	wt	het		QUAL=4633;DP=344,281,402;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=3	MMACHC	3'UTR,intron	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:ENST00000616135.1:intron_variant:MODIFIER:intron4/4:c.*133-54G>A::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1260G>A::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1260G>A::	regulatory_region_variant:promoter_flanking_region	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297522 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluJr (SINE/Alu)	rs882803	0.6691		34371,.	32837	50247	-3.1030			0.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510591	45510591	-	T	wt	wt	het		QUAL=3847;DP=316,259,317;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=5	MMACHC	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*195_*196insT::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1376_*1377insT::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1376_*1377insT::	regulatory_region_variant:promoter_flanking_region	609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297525 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs5773883	0.6689		34342,.	32888	50276				0.75			COSV53112744	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45510915	45510915	A	G	wt	wt	het		QUAL=2435;DP=264,153,170;AF=0.00,0.00,0.56;MQM=60;SAP=5;ABP=8	MMACHC,PRDX1	3'UTR	MMACHC:ENST00000401061.9:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,PRDX1:ENST00000424390.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,PRDX1:ENST00000447184.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::,MMACHC:ENST00000616135.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*519A>G::,PRDX1:ENST00000676549.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*414T>C::	MMACHC:NM_001330540.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:NM_015506.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1700A>G::,MMACHC:XM_005270724.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1700A>G::		609831_[GENE=MMACHC_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessive]&176763_[GENE=PRDX1_PHENOS=Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessive]	297529 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1044717	0.7376		41804,.	28546	39892	-0.7710			1.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MMACHC (inh=AR oe_syn=1.26 oe_mis=1.23 oe_lof=1.21), PRDX1 (inh=AR oe_syn=1.03 oe_mis=0.95 oe_lof=1.40)
chr1	45698718	45698727	TTTTTTTTTT	-	hom	n/a	hom		QUAL=737;DP=21,1,5;AF=1.00,1.00,1.00;MQM=60;SAP=62;ABP=0	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron9/9:c.1651+1343_1651+1352del::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::,IPP:XM_005270839.5:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1484_*1493del::,IPP:XM_006710623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1450_*1459del::,IPP:XM_024446763.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1798+1343_1798+1352del::					AluJb (SINE/Alu)	rs78627575	0.3196		6150,.	29519	89047	0.7410			0.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45699174	45699174	A	T	hom	het	hom		QUAL=21052;DP=306,179,299;AF=0.99,0.47,1.00;MQM=60;SAP=747;ABP=4	IPP	3'UTR	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron9/9:c.1651+896T>A::,IPP:NM_005897.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::,IPP:XM_005270839.5:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1037T>A::,IPP:XM_006710623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1003T>A::,IPP:XM_024446763.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/9:n.1798+896T>A::						rs10749856	0.2862		6344,.	30799	108463	1.3890			7.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45700203	45700203	-	A	hom	het	hom	off-target;low_conf_region	QUAL=9574;DP=142,190,202;AF=0.86,0.41,0.88;MQM=60;SAP=190;ABP=18	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron8/8:c.1531-14dup::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron8/9:c.1531-14dup::,IPP:NM_005897.3:intron_variant:MODIFIER:intron8/8:c.1531-14dup::,IPP:XM_005270839.5:intron_variant:MODIFIER:intron8/8:c.*21-14dup::,IPP:XM_006710623.4:intron_variant:MODIFIER:intron7/7:c.1310-14dup::,IPP:XM_024446763.1:intron_variant:MODIFIER:intron8/8:c.1531-14dup::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/9:n.1678-14dup::						rs550999501	0.3258	0.2497,0.3549,0.3603,0.3157,0.3748	6009,.	30262	106158				15.65				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729703	45729703	T	C	hom	het	hom		QUAL=10569;DP=230,60,65;AF=1.00,0.57,0.97;MQM=60;SAP=139;ABP=5	IPP	missense	IPP:ENST00000396478.4:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	IPP:NM_001145349.2:missense_variant:MODERATE:exon4/10:c.791A>G:p.Lys264Arg:,IPP:NM_005897.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_005270839.5:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_006710623.4:missense_variant:MODERATE:exon4/8:c.791A>G:p.Lys264Arg:,IPP:XM_011541394.3:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_017001210.2:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XM_024446763.1:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:,IPP:XR_001737155.2:non_coding_transcript_exon_variant:MODIFIER:exon4/10:n.1050A>G::	regulatory_region_variant:promoter_flanking_region					rs28375469	0.3037	0.2374,0.3238,0.3392,0.2946,0.3608	6168,.	30492	109198	7.6030	T(0.22)	B(0.00)	22.40	0.19		COSV63431879	0	32327693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740868	45740868	A	G	hom	het	hom	off-target	QUAL=9799;DP=270,25,37;AF=1.00,0.68,1.00;MQM=60;SAP=704;ABP=10	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+33T>C::	IPP:NM_001145349.2:intron_variant:MODIFIER:intron3/9:c.724+33T>C::,IPP:NM_005897.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_005270839.5:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_006710623.4:intron_variant:MODIFIER:intron3/7:c.724+33T>C::,IPP:XM_011541394.3:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_017001210.2:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XM_024446763.1:intron_variant:MODIFIER:intron3/8:c.724+33T>C::,IPP:XR_001737155.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.983+33T>C::						rs28507722	0.2999	0.2384,0.3223,0.3345,0.2944,0.3666	6160,.	30508	109258	1.3640			8.30			COSV63433613	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46189486	46189486	T	C	hom	hom	hom		QUAL=12797;DP=140,141,131;AF=0.99,1.00,1.00;MQM=60;SAP=158;ABP=0	POMGNT1	missense,missense&splice_region,3'UTR	POMGNT1:ENST00000371984.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon18/19:c.*1536A>G::	POMGNT1:NM_001243766.2:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:NM_001290129.2:missense_variant:MODERATE:exon20/22:c.1801A>G:p.Met601Val:,POMGNT1:NM_001290130.2:missense_variant:MODERATE:exon20/22:c.1438A>G:p.Met480Val:,POMGNT1:NM_017739.4:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_005271010.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_006710755.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:XM_006710756.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.678+4178T>C::,POMGNT1:XM_011541760.3:missense_variant:MODERATE:exon20/21:c.1801A>G:p.Met601Val:,POMGNT1:XM_017001690.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:	regulatory_region_variant:promoter_flanking_region	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	167524 [benign DISEASE=Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,Muscle eye brain disease,not specified];			rs6659553	0.9868	0.8186,0.9914,1.0000,0.9996,0.9997	68933,.	6431	7889	5.8290		B(0.00),B(0.00), 	22.50	0.33	2.63>0.43		0.19	24033266,25373335,28765568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=AR oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193432	46193432	T	C	hom	hom	het	off-target	QUAL=40792;DP=348,624,797;AF=1.00,1.00,0.49;MQM=60;SAP=16;ABP=4	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon9/19:c.*652A>G::	POMGNT1:NM_001243766.2:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:NM_001290129.2:intron_variant:MODIFIER:intron10/21:c.961-44A>G::,POMGNT1:NM_001290130.2:intron_variant:MODIFIER:intron10/21:c.598-44A>G::,POMGNT1:NM_017739.4:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_005271010.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_006710755.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:XM_006710756.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-2770T>C::,POMGNT1:XM_011541760.3:intron_variant:MODIFIER:intron10/20:c.961-44A>G::,POMGNT1:XM_017001690.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	260869 [benign DISEASE=Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,not specified,not provided];			rs7527668	0.3772	0.4473,0.3957,0.1454,0.3563,0.4455	11081,.	35149	94623	-0.3030			4.53			COSV64339664	0.12	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193691	46193691	T	C	hom	hom	het	off-target	QUAL=23740;DP=296,318,329;AF=0.99,1.00,0.55;MQM=60;SAP=166;ABP=9	POMGNT1	intron,3'UTR	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.7:3_prime_UTR_variant:MODIFIER:exon9/19:c.*393A>G::	POMGNT1:NM_001243766.2:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:NM_001290129.2:intron_variant:MODIFIER:intron9/21:c.885-52A>G::,POMGNT1:NM_001290130.2:intron_variant:MODIFIER:intron9/21:c.522-52A>G::,POMGNT1:NM_017739.4:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_005271010.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_006710755.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:XM_006710756.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-2511T>C::,POMGNT1:XM_011541760.3:intron_variant:MODIFIER:intron9/20:c.885-52A>G::,POMGNT1:XM_017001690.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671035 [benign DISEASE=Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3,Retinitis pigmentosa 76,not provided];			rs7527935	0.3552	0.3463,0.3885,0.1456,0.3530,0.4452	9408,.	34163	98953	-0.0180			1.62			COSV64339668	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46194623	46194623	T	C	hom	hom	het		QUAL=17580;DP=258,198,303;AF=1.00,0.99,0.45;MQM=60;SAP=111;ABP=11	POMGNT1	synonymous,missense	POMGNT1:ENST00000371984.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.7:missense_variant:MODERATE:exon7/19:c.563A>G:p.Asn188Ser:	POMGNT1:NM_001243766.2:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:NM_001290129.2:synonymous_variant:LOW:exon7/22:c.615A>G:p.Lys205=:,POMGNT1:NM_001290130.2:synonymous_variant:LOW:exon7/22:c.252A>G:p.Lys84=:,POMGNT1:NM_017739.4:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_005271010.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_006710755.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:XM_006710756.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,TSPAN1:XM_011540460.3:intron_variant:MODIFIER:intron8/8:c.679-1579T>C::,POMGNT1:XM_011541760.3:synonymous_variant:LOW:exon7/21:c.615A>G:p.Lys205=:,POMGNT1:XM_017001690.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:	regulatory_region_variant:promoter_flanking_region	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	95761 [benign DISEASE=Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3,Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B3,Limb-girdle muscular dystrophy-dystroglycanopathy, type C3,Retinitis pigmentosa 76,Muscle eye brain disease,not specified,Congenital Muscular Dystrophy, alpha-dystroglycan related,not provided];			rs2292487	0.3552	0.3470,0.3886,0.1448,0.3532,0.4458	9428,.	34204	98904	0.3970		 , ,B(0.06)	10.11	0.05		COSV64339346	0.04	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47250369	47250370	AA	-	het	het	wt		QUAL=5540;DP=253,174,174;AF=0.51,0.52,0.00;MQM=56;SAP=3;ABP=4	STIL	3'UTR	STIL:ENST00000337817.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:ENST00000360380.7:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.8:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::	STIL:NM_001048166.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:NM_001282936.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282937.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:NM_001282938.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_001282939.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_001377417.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:NM_003035.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:XM_011542001.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*1490_*1491del::,STIL:XM_017002123.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:XM_017002124.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*766_*767del::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon18/18:n.4907_4908del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	297544 [benign DISEASE=Primary Microcephaly, Recessive];			rs75930208	0.4249		15808,.	32905	87333	1.6070			3.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47251517	47251517	A	G	het	het	wt		QUAL=8543;DP=442,231,305;AF=0.51,0.40,0.01;MQM=60;SAP=38;ABP=7	STIL	synonymous	STIL:ENST00000337817.10:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:ENST00000360380.7:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.8:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000396221.6:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:ENST00000447475.7:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:,STIL:ENST00000682977.1:synonymous_variant:LOW:exon18/18:c.3345T>C:p.Pro1115=:	STIL:NM_001048166.1:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:NM_001282936.1:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:NM_001282937.1:synonymous_variant:LOW:exon18/18:c.3432T>C:p.Pro1144=:,STIL:NM_001282938.1:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:NM_001282939.1:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:,STIL:NM_001377417.1:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:NM_003035.2:synonymous_variant:LOW:exon17/17:c.3483T>C:p.Pro1161=:,STIL:XM_006710834.3:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541991.2:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541992.2:synonymous_variant:LOW:exon18/18:c.3486T>C:p.Pro1162=:,STIL:XM_011541994.2:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:XM_011541998.2:synonymous_variant:LOW:exon18/18:c.3291T>C:p.Pro1097=:,STIL:XM_011542001.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XM_017002123.1:synonymous_variant:LOW:exon18/18:c.3342T>C:p.Pro1114=:,STIL:XM_017002124.1:synonymous_variant:LOW:exon13/13:c.2775T>C:p.Pro925=:,STIL:XM_017002125.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XM_017002126.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*343T>C::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon18/18:n.3760T>C::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94095 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs2758735	0.5020	0.1611,0.4426,0.4497,0.5248,0.5374	15893,.	32953	87277	-0.8210			0.85				0	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47260415	47260415	T	C	het	het	het		QUAL=6427;DP=211,117,176;AF=0.51,0.47,0.47;MQM=60;SAP=76;ABP=4	STIL	missense	STIL:ENST00000337817.10:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:ENST00000360380.7:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.8:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000396221.6:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:ENST00000447475.7:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:,STIL:ENST00000682977.1:missense_variant:MODERATE:exon17/18:c.2813A>G:p.His938Arg:	STIL:NM_001048166.1:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:NM_001282936.1:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:NM_001282937.1:missense_variant:MODERATE:exon17/18:c.2900A>G:p.His967Arg:,STIL:NM_001282938.1:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:NM_001282939.1:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:,STIL:NM_001377417.1:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:NM_003035.2:missense_variant:MODERATE:exon16/17:c.2951A>G:p.His984Arg:,STIL:XM_006710834.3:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541991.2:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541992.2:missense_variant:MODERATE:exon17/18:c.2954A>G:p.His985Arg:,STIL:XM_011541994.2:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:XM_011541998.2:missense_variant:MODERATE:exon17/18:c.2759A>G:p.His920Arg:,STIL:XM_011542001.2:intron_variant:MODIFIER:intron15/15:c.2829+2488A>G::,STIL:XM_017002123.1:missense_variant:MODERATE:exon17/18:c.2810A>G:p.His937Arg:,STIL:XM_017002124.1:missense_variant:MODERATE:exon12/13:c.2243A>G:p.His748Arg:,STIL:XM_017002125.1:intron_variant:MODIFIER:intron15/15:c.2826+2488A>G::,STIL:XM_017002126.1:intron_variant:MODIFIER:intron15/15:c.2775+2488A>G::,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon17/18:n.3228A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94094 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs13376679	0.2528	0.2040,0.1450,0.0230,0.3086,0.2306	5203,.	28020	113584	0.0110	T(0.52),T(0.53),T(0.53),T(0.58),T(0.58),T(0.52)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	1.81	0.03		COSV54551803	0	25741868,23757202,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47269608	47269608	T	C	het	n/a	n/a	off-target	QUAL=66;DP=5,0,0;AF=0.60,,;MQM=60;SAP=10;ABP=3	STIL	intron	STIL:ENST00000337817.10:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000360380.7:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::	STIL:NM_001048166.1:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:NM_001282936.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282937.1:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:NM_001282938.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_001282939.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_001377417.1:intron_variant:MODIFIER:intron16/18:c.2474+27A>G::,STIL:NM_003035.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:XM_006710834.3:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541991.2:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541992.2:intron_variant:MODIFIER:intron15/17:c.2615+27A>G::,STIL:XM_011541994.2:intron_variant:MODIFIER:intron14/16:c.2615+27A>G::,STIL:XM_011541998.2:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:XM_011542001.2:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002123.1:intron_variant:MODIFIER:intron15/17:c.2474+27A>G::,STIL:XM_017002124.1:intron_variant:MODIFIER:intron10/12:c.1904+27A>G::,STIL:XM_017002125.1:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002126.1:intron_variant:MODIFIER:intron14/15:c.2615+27A>G::,STIL:XM_017002127.1:intron_variant:MODIFIER:intron14/14:c.2615+27A>G::,STIL:XR_001737370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/17:n.2770+27A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	160057 [benign DISEASE=not specified,not provided];			rs2742104	0.5026	0.1611,0.4436,0.4519,0.5254,0.5374	15882,.	32941	87211	-0.1460			1.27			COSV54550059	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47302242	47302242	G	A	het	het	hom		QUAL=13720;DP=245,185,258;AF=0.51,0.54,0.99;MQM=60;SAP=33;ABP=5	STIL	missense	STIL:ENST00000337817.10:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000360380.7:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.8:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000447475.7:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000682977.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]	STIL:NM_001048166.1:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:NM_001282936.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282937.1:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:NM_001282938.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_001282939.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_001377417.1:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:,STIL:NM_003035.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:XM_006710834.3:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541991.2:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541992.2:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:,STIL:XM_011541994.2:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:,STIL:XM_011541998.2:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:,STIL:XM_011542001.2:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002123.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:,STIL:XM_017002125.1:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002126.1:missense_variant:MODERATE:exon4/16:c.257C>T:p.Ala86Val:,STIL:XM_017002127.1:missense_variant:MODERATE:exon4/15:c.257C>T:p.Ala86Val:,STIL:XR_001737370.1:non_coding_transcript_exon_variant:MODIFIER:exon4/18:n.412C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	21354 [benign DISEASE=Primary autosomal recessive microcephaly 7,not specified,not provided];			rs3125630	0.5751	0.8412,0.5552,0.5487,0.4763,0.4630	27255,.	32820	64532	5.3540	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	18.91	0.17		COSV54548838	0	25741868,20301772,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	50600416	50600416	T	C	het	het	wt		QUAL=3511;DP=166,136,172;AF=0.43,0.48,0.00;MQM=60;SAP=78;ABP=9	FAF1	intron	FAF1:ENST00000371778.5:intron_variant:MODIFIER:intron7/15:c.539-16752A>G::,FAF1:ENST00000396153.7:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::	FAF1:NM_007051.3:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::,FAF1:XM_017000136.1:intron_variant:MODIFIER:intron9/19:c.418-4200A>G::,FAF1:XM_024452734.1:intron_variant:MODIFIER:intron8/18:c.721-4200A>G::,FAF1:XM_024452736.1:intron_variant:MODIFIER:intron9/19:c.418-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.2326		4536,.	26275	116641	0.3190			4.52			COSV65639546	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	53197151	53197151	C	A	het	wt	het	off-target	QUAL=1504;DP=11,61,106;AF=0.36,0.00,0.60;MQM=60;SAP=3;ABP=10	CPT2	intron	CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron1/3:c.152+56C>A::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::	CPT2:NM_000098.3:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:NM_001330589.2:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:promoter	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	1177631 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,not provided];			rs72673121	0.1450		2092,.	17868	130030	-0.0020			7.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53210776	53210776	G	A	het	wt	hom		QUAL=11219;DP=287,215,230;AF=0.53,0.00,1.00;MQM=60;SAP=57;ABP=6	CPT2	missense,intron&non_coding_transcript,intron	CPT2:ENST00000371486.4:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],:ENST00000452466.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.436-232C>T::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636867.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-2488G>A::,CPT2:ENST00000637252.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase]	CPT2:NM_000098.3:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	92429 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,Carnitine palmitoyltransferase II deficiency,not specified,not provided]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, 4, susceptibility to];	CM139511 [CLASS=DP MUT=ALT PHEN="Infuenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.4877	0.2816,0.4382,0.7280,0.5441,0.2629	17289,.	35129	82165	-0.0480	T(1.00), ,T(1.00),T(1.00),T(0.99), ,T(1.00)	B(0.00), ,B(0.01),B(0.03),B(0.01), ,B(0.01)	0.01	0.23		COSV53758728	0	15986317,23757202,15811315,18306170,20934285,21697855,22809552,26874509,26010953,26460316	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53213557	53213557	A	G	het	wt	het		QUAL=6125;DP=267,177,238;AF=0.48,0.00,0.46;MQM=60;SAP=8;ABP=7	CPT2	missense,non_coding_transcript_exon,3'UTR	CPT2:ENST00000371486.4:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:PF00755 [Choline/Carnitine o-acyltransferase],:ENST00000452466.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.219T>C::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon6/6:c.1906A>G:p.Met636Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636867.1:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*192A>G::,CPT2:ENST00000636935.1:missense_variant:MODERATE:exon4/4:c.634A>G:p.Met212Val:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000637252.1:missense_variant:MODERATE:exon6/6:c.1975A>G:p.Met659Val:PF00755 [Choline/Carnitine o-acyltransferase]	CPT2:NM_000098.3:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:,CPT2:NM_001330589.2:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	92433 [benign DISEASE=Carnitine palmitoyltransferase II deficiency, infantile,Carnitine palmitoyltransferase II deficiency, lethal neonatal,Carnitine palmitoyltransferase II deficiency,not specified,not provided];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase 2 deficiency" GENE=CPT2];		rs1799822	0.1644	0.0460,0.1283,0.0839,0.2198,0.1010	2187,.	18683	129113	7.4310	D(0.01), ,D(0.01),D(0.01), ,D(0.02),D(0.01)	B(0.01), ,B(0.00),B(0.01), ,B(0.07),B(0.00)	22.80	0.29		COSV53759353	0.02	23757202,31201655,15647998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53214206	53214206	T	C	wt	wt	het		QUAL=694;DP=104,48,47;AF=0.00,0.00,0.60;MQM=60;SAP=14;ABP=7	CZIB	3'UTR	CZIB:ENST00000294360.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::	CZIB:NM_001304759.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*453A>G::,CZIB:NM_001304760.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*453A>G::,CZIB:NM_017887.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*453A>G::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal dominant, Autosomal recessive; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal dominant, Autosomal recessive]	368876 [benign DISEASE=Carnitine palmitoyltransferase II deficiency];			rs1056438	0.2551		6029,.	26732	113280	-0.2760			5.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	54849678	54849678	T	C	hom	hom	hom		QUAL=17140;DP=246,129,156;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2555A>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297612 [benign DISEASE=Desmosterolosis];			rs657688	0.9994		76006,.	85	85	-0.6870			2.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850268	54850268	G	T	het	wt	het		QUAL=10592;DP=445,318,385;AF=0.47,0.00,0.50;MQM=60;SAP=22;ABP=5	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1965C>A::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297621 [benign DISEASE=Desmosterolosis];			rs11555500	0.0239		75,.	3486	148562	0.8670			6.54				0		0	9	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850409	54850409	A	C	hom	hom	hom		QUAL=25126;DP=318,190,256;AF=1.00,1.00,1.00;MQM=60;SAP=8;ABP=0	DHCR24	3'UTR	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1824T>G::	DHCR24:NM_014762.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::	regulatory_region_variant:promoter_flanking_region	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297623 [benign DISEASE=Desmosterolosis];			rs654561	0.9895		74529,.	1556	1604	-0.2930			3.19				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54854229	54854229	A	G	hom	hom	hom		QUAL=601;DP=7,3,9;AF=1.00,1.00,1.00;MQM=60;SAP=29;ABP=0	DHCR24	synonymous	DHCR24:ENST00000371269.9:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000436604.2:synonymous_variant:LOW:exon7/10:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.6:synonymous_variant:LOW:exon8/10:c.1062T>C:p.Ile354=:	DHCR24:NM_014762.4:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297654 [benign DISEASE=Desmosterolosis,not provided];			rs718265	0.6648	0.6163,0.5374,0.3983,0.6914,0.8057	33896,.	33113	50887	1.6670			9.77			COSV64875204	0	17510943,21901424,17579359,24489783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54999070	54999070	T	C	hom	hom	het		QUAL=35366;DP=338,531,650;AF=0.99,1.00,0.48;MQM=60;SAP=532;ABP=5	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297673 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500340	0.6697		35224,.	31321	50203	-0.3600			1.25			COSV64870665	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999117	54999117	C	G	hom	hom	het		QUAL=37486;DP=330,570,758;AF=0.99,1.00,0.48;MQM=60;SAP=206;ABP=5	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::	BSND:NM_057176.3:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297674 [benign DISEASE=Bartter disease type 4a,not provided];			rs2500341	0.6699		35240,.	31320	50172	-1.0610			2.96			COSV64871304	0	19646679,31879347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008652	55008652	A	C	het	wt	hom		QUAL=18393;DP=295,321,451;AF=0.56,0.01,1.00;MQM=60;SAP=164;ABP=11	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297681 [benign DISEASE=Bartter disease type 4a,not provided];			rs6682884	0.4178	0.4963,0.2002,0.3039,0.4267,0.2805	13661,.	36103	88397	0.5590			3.81			COSV64871593	0	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008803	55008803	C	G	het	wt	hom	off-target	QUAL=5156;DP=167,81,124;AF=0.43,0.00,1.00;MQM=60;SAP=426;ABP=11	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::	BSND:NM_057176.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	368877 [benign DISEASE=Bartter syndrome,not provided];			rs4339899	0.4543		16440,.	36094	82854	-1.1140			0.18			COSV64871308	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	56875054	56875054	C	A	het	hom	wt		QUAL=5788;DP=135,141,210;AF=0.43,0.99,0.00;MQM=60;SAP=7;ABP=9	C8A	missense	C8A:ENST00000361249.4:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:	C8A:NM_000562.3:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:XM_011542079.2:missense_variant:MODERATE:exon3/8:c.277C>A:p.Gln93Lys:,C8A:XM_017002234.1:missense_variant:MODERATE:exon3/8:c.277C>A:p.Gln93Lys:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	17039 [benign DISEASE=COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM,not specified,not provided];			rs652785	0.3653	0.2062,0.2106,0.4662,0.3818,0.4981	8678,.	32107	102473	0.0330	T(0.67)	B(0.01)	6.82	0.10		COSV63484431	0.04	24033266,15986317,7649542,20029952	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56917685	56917685	C	T	wt	wt	het		QUAL=6231;DP=370,376,465;AF=0.00,0.00,0.53;MQM=60;SAP=4;ABP=6	C8A	missense	C8A:ENST00000361249.4:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:PF00090 [Thrombospondin type 1 domain]	C8A:NM_000562.3:missense_variant:MODERATE:exon11/11:c.1724C>T:p.Pro575Leu:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	1166647 [benign DISEASE=not provided];			rs17300936	0.0932	0.0305,0.0374,0.0763,0.1263,0.0758	729,.	11748	138882	0.5720	T(0.48)	B(0.00)	14.20	0.02		COSV63486347	0	25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56929347	56929347	A	G	het	het	wt	low_conf_region	QUAL=14161;DP=536,529,781;AF=0.52,0.49,0.00;MQM=60;SAP=137;ABP=3	C8B	3'UTR	C8B:ENST00000371237.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000535057.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:ENST00000543257.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::	C8B:NM_000066.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:NM_001278543.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:NM_001278544.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:XM_017002235.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::,C8B:XR_001737397.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1692T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs2795	0.3185		8247,.	31928	103590	0.0380			4.66				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929578	56929578	T	C	hom	hom	hom	off-target	QUAL=25439;DP=273,249,294;AF=1.00,1.00,1.00;MQM=60;SAP=1172;ABP=0	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:ENST00000535057.5:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::,C8B:ENST00000543257.5:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::	C8B:NM_000066.4:intron_variant:MODIFIER:intron11/11:c.1622-20A>G::,C8B:NM_001278543.2:intron_variant:MODIFIER:intron12/12:c.1466-20A>G::,C8B:NM_001278544.2:intron_variant:MODIFIER:intron12/12:c.1436-20A>G::,C8B:XM_017002235.1:intron_variant:MODIFIER:intron12/12:c.1622-20A>G::,C8B:XR_001737397.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/10:n.1481-20A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1168190 [benign DISEASE=not specified,not provided];			rs605648	0.8858	0.7906,0.9243,0.9403,0.8559,0.9700	55308,.	18807	22731	-2.3430			0.13		8.84>8.35		0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56943656	56943656	A	G	wt	het	wt	off-target	QUAL=2747;DP=185,187,229;AF=0.00,0.58,0.00;MQM=60;SAP=52;ABP=14	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:ENST00000535057.5:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::,C8B:ENST00000543257.5:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::	C8B:NM_000066.4:intron_variant:MODIFIER:intron8/11:c.1234+40T>C::,C8B:NM_001278543.2:intron_variant:MODIFIER:intron9/12:c.1078+40T>C::,C8B:NM_001278544.2:intron_variant:MODIFIER:intron9/12:c.1048+40T>C::,C8B:XM_017002235.1:intron_variant:MODIFIER:intron9/12:c.1234+40T>C::,C8B:XR_001737397.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1093+40T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs72670361	0.0308	0.0074,0.0201,0.0001,0.0475,0.0065	92,.	4495	147493	0.1450			1.11				0		31	1148	0 / 0					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56956811	56956811	C	T	hom	hom	hom		QUAL=26277;DP=295,249,267;AF=1.00,1.00,1.00;MQM=60;SAP=156;ABP=0	C8B	missense	C8B:ENST00000371237.9:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000535057.5:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:ENST00000543257.5:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:	C8B:NM_000066.4:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:NM_001278543.2:missense_variant:MODERATE:exon4/13:c.193G>A:p.Gly65Arg:,C8B:NM_001278544.2:missense_variant:MODERATE:exon4/13:c.163G>A:p.Gly55Arg:,C8B:XM_017002235.1:missense_variant:MODERATE:exon4/13:c.349G>A:p.Gly117Arg:,C8B:XR_001737397.1:non_coding_transcript_exon_variant:MODIFIER:exon3/11:n.449G>A::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1169777 [benign DISEASE=not provided];			rs1013579	0.9788	0.9943,0.9755,0.9999,0.9684,0.9896	72908,.	3090	3220	0.9500	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	13.85	0.04			0.09	20438785,29875488,28240269	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63415881	63415881	C	T	het	het	hom		QUAL=7295;DP=245,64,86;AF=0.56,0.44,1.00;MQM=60;SAP=252;ABP=7	ALG6	missense	ALG6:ENST00000263440.6:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]	ALG6:NM_013339.4:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	95531 [benign/likely benign DISEASE=Congenital disorder of glycosylation type 1C,not specified];			rs4630153	0.7573	0.8699,0.8233,0.8607,0.6835,0.8564	44156,.	26767	36879	0.6530	T(0.32)	B(0.00)	21.60	0.19		COSV54765155	0.25	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63437781	63437781	T	C	het	het	hom		QUAL=2157;DP=96,14,21;AF=0.54,0.57,1.00;MQM=60;SAP=84;ABP=5	ALG6	3'UTR	ALG6:ENST00000263440.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::	ALG6:NM_013339.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	297858 [benign DISEASE=Congenital disorder of glycosylation type 1C];			rs3009572	0.6055		29520,.	32690	59762	-0.1410			1.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67000108	67000108	G	A	het	wt	wt	low_conf_region	QUAL=287;DP=76,20,26;AF=0.37,0.05,0.00;MQM=60;SAP=66;ABP=14	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4232C>T::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3935C>T::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4232C>T::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5884C>T::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6669C>T::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu)	rs901342235	0.0013		0,.	162	123622	-0.2800			0.83				0		0	12	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000287	67000287	T	-	wt	wt	het		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=40	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4053del::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3756del::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4053del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5705del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6490del::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			AluJr (SINE/Alu), (T)n (Simple_repeat)	rs377396719	0.0022		0,.	306	136178	1.0070			1.14				0		0	30	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	-	het	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=4;ABP=27	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035del::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3738del::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4035del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5687del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6472del::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs397861605	0.0102		28,.	1406	141480	-2.0130			0.09				0		2	78	0 / 0					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67000305	67000305	A	T	wt	het	wt		QUAL=218;DP=29,7,8;AF=0.21,0.29,0.00;MQM=60;SAP=6;ABP=47	SLC35D1	3'UTR	SLC35D1:ENST00000235345.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::	SLC35D1:NM_015139.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4035T>A::,SLC35D1:XM_006710478.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*3738T>A::,SLC35D1:XM_011541070.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4035T>A::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon15/15:n.5687T>A::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.6472T>A::	regulatory_region_variant:promoter_flanking_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]				rs7540819	0.6460		27960,.	27809	45893	-2.0130			0.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047220	67047220	G	T	hom	hom	hom	off-target	QUAL=12445;DP=171,106,112;AF=1.00,1.00,1.00;MQM=60;SAP=502;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+45C>A::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+45C>A::,SLC35D1:XM_006710478.2:intron_variant:MODIFIER:intron7/13:c.636+45C>A::,SLC35D1:XM_011541070.2:intron_variant:MODIFIER:intron7/12:c.636+45C>A::,SLC35D1:XR_001737057.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/14:n.1046+45C>A::,SLC35D1:XR_001737058.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.1039+45C>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234892 [benign DISEASE=Schneckenbecken dysplasia,not provided];			rs1024229	0.6902	0.7697,0.6619,0.6296,0.6613,0.7501	36445,.	31992	47068	-0.7010			3.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047237	67047237	A	C	hom	hom	hom	off-target	QUAL=13908;DP=180,121,139;AF=0.99,1.00,1.00;MQM=60;SAP=475;ABP=0	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+28T>G::	SLC35D1:NM_015139.3:intron_variant:MODIFIER:intron7/11:c.636+28T>G::,SLC35D1:XM_006710478.2:intron_variant:MODIFIER:intron7/13:c.636+28T>G::,SLC35D1:XM_011541070.2:intron_variant:MODIFIER:intron7/12:c.636+28T>G::,SLC35D1:XR_001737057.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/14:n.1046+28T>G::,SLC35D1:XR_001737058.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/12:n.1039+28T>G::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1270736 [benign DISEASE=Schneckenbecken dysplasia,not provided];			rs1024230	0.6902	0.7700,0.6625,0.6304,0.6618,0.7505	36434,.	31984	47066	-0.2060			6.35				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054377	67054378	CA	-	het	het	hom		QUAL=470;DP=23,8,12;AF=0.39,0.50,1.00;MQM=60;SAP=57;ABP=5	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	SLC35D1:XM_006710478.2:5_prime_UTR_variant:MODIFIER:exon1/14:c.-365_-364del::,SLC35D1:XM_011541070.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-365_-364del::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon1/15:n.46_47del::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon1/13:n.39_40del::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1250615 [benign DISEASE=not provided];			rs3840439	0.6253		29928,.	35044	56862	0.1920			7.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054400	67054400	C	T	het	het	wt		QUAL=196;DP=11,6,7;AF=0.82,0.50,0.00;MQM=60;SAP=29;ABP=9	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	SLC35D1:XM_006710478.2:5_prime_UTR_variant:MODIFIER:exon1/14:c.-387G>A::,SLC35D1:XM_011541070.2:5_prime_UTR_variant:MODIFIER:exon1/13:c.-387G>A::,SLC35D1:XR_001737057.2:non_coding_transcript_exon_variant:MODIFIER:exon1/15:n.24G>A::,SLC35D1:XR_001737058.2:non_coding_transcript_exon_variant:MODIFIER:exon1/13:n.17G>A::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1243207 [benign DISEASE=not provided];			rs3806321	0.1451		1881,.	18297	130015	-0.6420			3.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054457	67054457	T	G	hom	n/a	hom	off-target	QUAL=245;DP=4,2,3;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1282317 [benign DISEASE=not provided];			rs2025087	0.7612		44244,.	27186	36284	-1.1250			4.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	75724531	75724531	G	A	hom	het	het		QUAL=2094;DP=15,71,99;AF=0.93,0.51,0.43;MQM=60;SAP=96;ABP=5	ACADM	5'UTR	ACADM:ENST00000541113.6:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000680805.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::		regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298063 [benign/likely benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs17848068	0.2690		5738,.	29404	111086	-2.2320			1.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728545	75728545	T	-	hom	hom	hom	off-target	QUAL=16886;DP=177,157,206;AF=1.00,1.00,1.00;MQM=60;SAP=415;ABP=0	ACADM	intron	ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3731del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3186del::	ACADM:NM_000016.6:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:NM_001127328.3:intron_variant:MODIFIER:intron2/11:c.130+60del::,ACADM:NM_001286042.2:intron_variant:MODIFIER:intron1/10:c.10+3731del::,ACADM:NM_001286043.2:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:NM_001286044.2:intron_variant:MODIFIER:intron1/8:c.-268+3731del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	226050 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency,not provided];			rs796117827	1.0000		76091,.	1	1	0.0000			0.47				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75763641	75763641	T	C	wt	het	het		QUAL=125;DP=31,6,10;AF=0.03,0.17,0.70;MQM=60;SAP=23;ABP=3	ACADM	3'UTR	ACADM:ENST00000370841.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:ENST00000681790.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::	ACADM:NM_000016.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001127328.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*878T>C::,ACADM:NM_001286042.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*878T>C::,ACADM:NM_001286043.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*878T>C::,ACADM:NM_001286044.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*878T>C::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298081 [benign DISEASE=Medium-chain acyl-coenzyme A dehydrogenase deficiency];			rs1146587	0.6571		32909,.	33993	52097	-1.2740			0.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92474854	92474854	C	T	het	wt	het		QUAL=6067;DP=278,118,165;AF=0.54,0.00,0.49;MQM=60;SAP=86;ABP=4	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::	GFI1:NM_001127215.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_001127216.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_005270749.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_011541245.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:XM_011541246.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs41313373	0.0947		886,.	12630	137630	2.7080			15.72				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92475800	92475800	A	G	wt	het	wt		QUAL=3115;DP=445,227,280;AF=0.00,0.52,0.00;MQM=60;SAP=3;ABP=4	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:ENST00000427103.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::	GFI1:NM_001127215.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_001127216.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:NM_005263.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_005270749.3:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_011541245.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::,GFI1:XM_011541246.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*229T>C::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1271213 [benign DISEASE=not provided];			rs4970714	0.7118		39148,.	29839	43791	-2.9480			0.04			COSV54042587	0	20075157	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478757	92478757	-	AGAGAG	wt	het	wt	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=19;ABP=65	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5dup::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	1170883 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,not specified,not provided];			rs35896485	0.3228		7898,.	28691	93347				7.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478759	AG	-	wt	wt	het	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.68,0.46,0.42;MQM=60;SAP=20;ABP=194	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-6_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298182 [likely benign(replaced by megSAP based on classifications:3x1,2x3) DISEASE=Severe congenital neutropenia 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485	0.1234		1087,.	14857	120989	3.1660			7.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478763	AGAGAG	-	hom	het	het	low_conf_region	QUAL=5313;DP=60,99,154;AF=0.00,0.01,0.33;MQM=60;SAP=127;ABP=12	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::	GFI1:NM_001127215.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_001127216.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:NM_005263.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_005270749.3:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_011541245.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:XM_011541246.2:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298185 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,Severe congenital neutropenia,not provided];		(AG)n (Simple_repeat)	rs35896485	0.1112		941,.	13479	122769	3.1660			6.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483381	92483381	C	T	het	het	wt		QUAL=3343;DP=98,265,322;AF=0.47,0.46,0.00;MQM=60;SAP=106;ABP=8	GFI1	missense	GFI1:ENST00000294702.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	GFI1:NM_001127215.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_001127216.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:NM_005263.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_005270749.3:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_011541245.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:XM_011541246.2:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:promoter	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	259699 [benign DISEASE=Severe congenital neutropenia 2, autosomal dominant,not specified,not provided];			rs34631763	0.0404	0.0094,0.0282,0.0000,0.0564,0.0089	183,.	5785	146091	2.4960	T(0.53),T(0.53),T(0.53)	B(0.02),B(0.02),B(0.02)	16.72	0.06		COSV54042707	0.01	25741868,24033266,20075157,27080012,31013831,31649884,26447191,31508375	48	1498	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486100	92486100	-	A	het	het	het	off-target	QUAL=2441;DP=91,67,106;AF=0.47,0.49,0.32;MQM=60;SAP=3;ABP=19	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	GFI1:NM_005263.5:intron_variant:MODIFIER:intron1/6:c.-100+625dup::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs112925059	0.1223		1259,.	15392	128570				6.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97078196	97078196	G	A	het	het	het		QUAL=16071;DP=471,323,440;AF=0.48,0.50,0.48;MQM=60;SAP=234;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*780C>T::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*780C>T::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*780C>T::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*780C>T::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100064 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291593	0.2898		6936,.	30116	107810	-1.0340			0.19				0	24944790,23960437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078208	97078208	C	T	het	het	het		QUAL=15538;DP=404,340,463;AF=0.49,0.50,0.47;MQM=60;SAP=145;ABP=5	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*768G>A::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*768G>A::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*768G>A::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*768G>A::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100065 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs291592	0.4520		16990,.	34597	83143	0.1450			2.72				0	23960437,28481884	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078403	97078403	C	T	het	het	wt		QUAL=7022;DP=325,212,285;AF=0.52,0.44,0.00;MQM=60;SAP=214;ABP=3	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::	DPYD:NM_000110.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::,DPYD:XM_005270562.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*573G>A::,DPYD:XM_017000507.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*573G>A::,DPYD:XM_017000508.2:3_prime_UTR_variant:MODIFIER:exon25/25:c.*573G>A::,DPYD:XM_017000509.2:3_prime_UTR_variant:MODIFIER:exon24/24:c.*573G>A::,DPYD:XM_017000510.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100067 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided];			rs1042482	0.0625		400,.	8707	142613	0.2650			2.97				0	24944790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97082275	97082275	G	A	hom	hom	hom	off-target	QUAL=15058;DP=185,126,164;AF=1.00,1.00,1.00;MQM=60;SAP=702;ABP=0	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron21/21:c.2691+55C>T::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron21/21:c.2796+55C>T::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron24/24:c.2412+55C>T::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron23/23:c.2412+55C>T::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron22/22:c.2412+55C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1255090 [benign DISEASE=not provided];			rs290854	1.0000		76061,.	3	3	0.2870			2.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97450068	97450068	A	G	het	wt	het		QUAL=4784;DP=202,150,187;AF=0.45,0.00,0.52;MQM=60;SAP=177;ABP=4	DPYD	synonymous	DPYD:ENST00000370192.8:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]	DPYD:NM_000110.4:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:,DPYD:XM_005270562.3:synonymous_variant:LOW:exon13/22:c.1680T>C:p.Phe560=:,DPYD:XM_006710397.3:synonymous_variant:LOW:exon14/21:c.1896T>C:p.Phe632=:,DPYD:XM_017000507.1:synonymous_variant:LOW:exon13/22:c.1785T>C:p.Phe595=:,DPYD:XM_017000508.2:synonymous_variant:LOW:exon16/25:c.1401T>C:p.Phe467=:,DPYD:XM_017000509.2:synonymous_variant:LOW:exon15/24:c.1401T>C:p.Phe467=:,DPYD:XM_017000510.1:synonymous_variant:LOW:exon14/23:c.1401T>C:p.Phe467=:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100088 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];			rs17376848	0.0510	0.0218,0.0873,0.1256,0.0411,0.0347	195,.	6276	145466	0.2880			6.57			COSV100928729	0	25741868,16115930,19104657,26099996,29065426,17697348,21362212,23942539,30545124,25782327,14523039,16007086,31076604,25915935	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515686	97515686	T	C	hom	het	hom	off-target;low_conf_region	QUAL=8027;DP=188,44,54;AF=1.00,0.45,1.00;MQM=60;SAP=546;ABP=4	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron12/21:c.1524+33874A>G::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron13/20:c.1740+40A>G::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron12/21:c.1629+40A>G::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron15/24:c.1245+40A>G::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron14/23:c.1245+40A>G::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron13/22:c.1245+40A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100090 [benign DISEASE=not provided];			rs2811178	0.6357	0.6347,0.7027,0.7442,0.5962,0.6264	29076,.	35535	57971	-0.0810			0.88				0	23960437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97679170	97679170	T	C	wt	wt	het		QUAL=586;DP=168,36,55;AF=0.01,0.00,0.47;MQM=60;SAP=4;ABP=3	DPYD	missense	DPYD:ENST00000370192.8:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:PF07992 [Pyridine nucleotide-disulphide oxidoreductase]	DPYD:NM_000110.4:missense_variant:MODERATE:exon8/23:c.775A>G:p.Lys259Glu:,DPYD:XM_005270562.3:missense_variant:MODERATE:exon8/22:c.775A>G:p.Lys259Glu:,DPYD:XM_006710397.3:missense_variant:MODERATE:exon8/21:c.775A>G:p.Lys259Glu:,DPYD:XM_017000507.1:missense_variant:MODERATE:exon7/22:c.664A>G:p.Lys222Glu:,DPYD:XM_017000508.2:missense_variant:MODERATE:exon10/25:c.280A>G:p.Lys94Glu:,DPYD:XM_017000509.2:missense_variant:MODERATE:exon9/24:c.280A>G:p.Lys94Glu:,DPYD:XM_017000510.1:missense_variant:MODERATE:exon8/23:c.280A>G:p.Lys94Glu:		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	235464 [likely benign(replaced by megSAP based on classifications:4x1,2x2,1x3) DISEASE=Dihydropyrimidine dehydrogenase deficiency,not specified,not provided];	CM033369 [CLASS=DM MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs45589337	0.0062	0.0015,0.0032,0.0000,0.0082,0.0050	6,.	770	151364	3.8740	D(0.00)	B(0.14)	22.80	0.61		COSV99058634	0	25741868,26801900	1	321	0 / 0	1	"[3] Stephan Waldmüller 18.11.2015 [n/a] comment imported from detected variant: HGMD: DM für Dihydropyrimidine dehydrogenase deficiency, Literatur nicht überzeugend, VUS3, swal 151118 [1] ahbuchr1 26.09.2016 MAF>1%, homozygote in ExAC"			DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97719971	97719971	A	G	hom	hom	hom		QUAL=15798;DP=206,123,150;AF=1.00,1.00,1.00;MQM=60;SAP=12;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron5/21:c.483+1539T>C::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron5/20:c.483+1539T>C::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron4/21:c.372+1539T>C::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron6/24:c.-126+854T>C::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron5/23:c.-126+1539T>C::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron4/22:c.-126+1539T>C::,DPYD:XR_001737014.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.722+854T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs2151562	0.9953		75151,.	713	717	0.4060			5.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97720521	97720521	T	C	hom	hom	hom		QUAL=20031;DP=282,136,192;AF=1.00,1.00,1.00;MQM=60;SAP=211;ABP=0	DPYD	3'UTR,intron	DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+989A>G::	DPYD:NM_000110.4:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:NM_001160301.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::,DPYD:XM_005270562.3:intron_variant:MODIFIER:intron5/21:c.483+989A>G::,DPYD:XM_006710397.3:intron_variant:MODIFIER:intron5/20:c.483+989A>G::,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron4/21:c.372+989A>G::,DPYD:XM_017000508.2:intron_variant:MODIFIER:intron6/24:c.-126+304A>G::,DPYD:XM_017000509.2:intron_variant:MODIFIER:intron5/23:c.-126+989A>G::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron4/22:c.-126+989A>G::,DPYD:XR_001737014.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.722+304A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs1333718	0.9953		75164,.	707	711	0.7280			16.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97883329	97883329	A	G	wt	wt	het		QUAL=2645;DP=218,162,215;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4	DPYD	missense	DPYD:ENST00000306031.5:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:,DPYD:ENST00000370192.8:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:	DPYD:NM_000110.4:missense_variant:MODERATE:exon2/23:c.85T>C:p.Cys29Arg:,DPYD:NM_001160301.1:missense_variant:MODERATE:exon2/6:c.85T>C:p.Cys29Arg:,DPYD:XM_005270562.3:missense_variant:MODERATE:exon2/22:c.85T>C:p.Cys29Arg:,DPYD:XM_006710397.3:missense_variant:MODERATE:exon2/21:c.85T>C:p.Cys29Arg:,DPYD:XM_017000507.1:intron_variant:MODIFIER:intron1/21:c.39+37555T>C::,DPYD:XM_017000508.2:5_prime_UTR_variant:MODIFIER:exon2/25:c.-626T>C::,DPYD:XM_017000509.2:5_prime_UTR_variant:MODIFIER:exon2/24:c.-524T>C::,DPYD:XM_017000510.1:intron_variant:MODIFIER:intron1/22:c.-459+37555T>C::,DPYD:XR_001737014.1:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.222T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	435 [drug response DISEASE=capecitabine response - Toxicity,fluorouracil response - Toxicity,Dihydropyrimidine dehydrogenase deficiency,not provided];	CM970421 [CLASS=DFP MUT=ALT PHEN="Dihydropyrimidine dehydrogenase deficiency" GENE=DPYD];		rs1801265	0.2732		6303,.	28901	110407	1.6470	T(0.41),T(0.52)	B(0.00),B(0.00)	18.87				0.04	24944790,29334895,19104657,23988873,25110414,26216193,29065426,29193749,25066213,29372689,18381459,26858644,17697348,30356105,9266349,9439663,20570913,21472143,26785747,28618970,28679691,29681089,23960437,27249515,24401318,24297552,26484159,23588107,29273807,30915274,31076604,24388031,29152729	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97988913	97988913	G	T	wt	wt	het		QUAL=707;DP=245,71,74;AF=0.00,0.00,0.42;MQM=60;SAP=9;ABP=7	MIR137HG	non_coding_transcript_exon,intron&non_coding_transcript	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1726C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-9598C>A::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1556C>A::						rs41285694	0.1171		1418,.	14958	134108	0.4760			1.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97989572	97989572	A	-	het	het	het		QUAL=932;DP=84,17,28;AF=0.38,0.24,0.25;MQM=60;SAP=18;ABP=34	MIR137HG	splice_region&intron&non_coding_transcript,intron&non_coding_transcript	MIR137HG:ENST00000424528.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.1070-3del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-10257del::	MIR137HG:NR_046105.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron4/4:n.900-3del::	regulatory_region_variant:enhancer				AluSp (SINE/Alu)	rs543197080	0.0315		149,.	3660	121810	-0.9170			0.30						1	134	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97990401	97990401	G	A	wt	wt	het		QUAL=1441;DP=174,115,145;AF=0.00,0.00,0.42;MQM=60;SAP=52;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-832C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11086C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-832C>T::					L1PA13 (LINE/L1)	rs61785886	0.1172		1417,.	14967	134141	-1.2530			1.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991087	97991087	G	A	wt	wt	het		QUAL=662;DP=144,45,76;AF=0.00,0.00,0.39;MQM=59;SAP=6;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1518C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11772C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1518C>T::					AluY (SINE/Alu)	rs61785887	0.0851		753,.	11400	138750	-0.3250			1.32						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991175	97991175	C	T	wt	wt	het		QUAL=965;DP=214,57,114;AF=0.00,0.00,0.39;MQM=59;SAP=4;ABP=14	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1606G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-11860G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1606G>A::					AluY (SINE/Alu)	rs61785888	0.1180		1434,.	15039	133899	0.3960			4.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991351	97991351	C	A	wt	wt	het		QUAL=1314;DP=192,87,96;AF=0.00,0.00,0.53;MQM=60;SAP=18;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-1782G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12036G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-1782G>T::						rs4573558	0.1264		1503,.	16211	132827	-1.2890			0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991747	97991747	C	G	wt	wt	het		QUAL=2097;DP=278,105,175;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2178G>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12432G>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2178G>C::						rs2893376	0.1655		2247,.	20656	126776	-1.0200			0.17					27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97991967	97991967	A	T	wt	wt	het		QUAL=1562;DP=205,63,125;AF=0.00,0.00,0.49;MQM=60;SAP=29;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1070-2398T>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-12652T>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.900-2398T>A::						rs2391873	0.1545		1959,.	19563	128541	-0.1440			11.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994504	97994504	A	C	het	wt	het		QUAL=2944;DP=159,63,88;AF=0.48,0.00,0.51;MQM=60;SAP=216;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+412T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15189T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+412T>G::					AluSx (SINE/Alu)							-0.3580			2.70						0	3	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994550	97994550	G	A	hom	hom	het		QUAL=9102;DP=166,85,125;AF=1.00,1.00,0.53;MQM=60;SAP=607;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+366C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15235C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.899+366C>T::					AluSx (SINE/Alu)	rs9440288	0.8401		53798,.	20123	24319	-1.3540			0.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995576	97995576	G	C	hom	hom	het		QUAL=22262;DP=266,282,366;AF=1.00,1.00,0.47;MQM=60;SAP=85;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-576C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16261C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-576C>G::					L2a (LINE/L2)	rs9324380	0.9147		63854,.	11459	12977	-4.7770			0.00					29942086,29326435	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995701	97995701	-	TTGT	hom	hom	het		QUAL=16425;DP=233,209,270;AF=0.99,1.00,0.44;MQM=60;SAP=49;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-702_985-701insACAA::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16387_141-16386insACAA::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-702_815-701insACAA::						rs10655213	0.8736		58158,.	16198	19182				0.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995887	97995887	C	T	het	het	het		QUAL=4939;DP=163,96,103;AF=0.52,0.47,0.52;MQM=60;SAP=43;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-887G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16572G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-887G>A::						rs9662365	0.4913		18442,.	37693	77217	-0.0280			14.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97996398	97996398	T	C	hom	hom	het		QUAL=5956;DP=150,26,33;AF=0.99,1.00,0.58;MQM=60;SAP=260;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-1398A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-17083A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-1398A>G::						rs1938570	0.8676		57259,.	17110	20094	-0.5300			0.32					23910899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97997365	97997365	C	A	het	wt	het		QUAL=5225;DP=252,155,183;AF=0.50,0.00,0.48;MQM=60;SAP=70;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-2365G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-18050G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-2365G>T::						rs146033831	0.0065		27,.	934	150944	-0.1480			0.50						1	33	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97999972	97999972	G	A	hom	hom	het		QUAL=22731;DP=309,252,336;AF=1.00,1.00,0.50;MQM=60;SAP=336;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-4972C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20657C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-4972C>T::	regulatory_region_variant:promoter_flanking_region					rs2154403	0.8819		59505,.	15080	17954	0.9200			3.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98000284	98000284	G	A	het	het	wt		QUAL=5755;DP=282,224,308;AF=0.49,0.42,0.00;MQM=60;SAP=20;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-5284C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20969C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-5284C>T::					L2a (LINE/L2)	rs116319667	0.0095		13,.	1413	150649	-0.3440			0.33						5	164	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98001230	98001230	T	C	wt	het	wt		QUAL=1949;DP=337,144,175;AF=0.01,0.51,0.00;MQM=60;SAP=3;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-6230A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-21915A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-6230A>G::						rs12138817	0.2270		4793,.	24915	117479	-0.8540			0.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98002983	98002984	TA	-	hom	hom	het		QUAL=17172;DP=329,145,205;AF=0.98,1.00,0.54;MQM=60;SAP=241;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-7984_985-7983del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-23669_141-23668del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-7984_815-7983del::	regulatory_region_variant:enhancer					rs5776390	0.8727		58049,.	16270	19308	0.0270			0.30						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004131	98004131	A	-	het	wt	het		QUAL=6972;DP=211,245,312;AF=0.50,0.00,0.51;MQM=60;SAP=10;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9131del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-24816del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9131del::						rs564190891	0.0022		7,.	319	151759	2.0260			15.18						0	15	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004495	98004495	-	AT	hom	hom	het		QUAL=23846;DP=516,128,229;AF=1.00,1.00,0.48;MQM=60;SAP=101;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9496_985-9495insAT::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25181_141-25180insAT::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-9496_815-9495insAT::						rs10655252	0.8471		54611,.	19363	23213				0.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98005049	98005049	A	G	hom	hom	het		QUAL=6773;DP=178,20,25;AF=1.00,1.00,0.44;MQM=60;SAP=228;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-10049T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25734T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-10049T>C::	regulatory_region_variant:promoter_flanking_region					rs10747495	0.8818		59481,.	15077	17973	0.6310			5.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006231	98006231	C	A	wt	het	wt		QUAL=231;DP=278,55,89;AF=0.00,0.33,0.00;MQM=60;SAP=7;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11231G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-26916G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11231G>T::					L1ME4a (LINE/L1)	rs55635742	0.0199		40,.	2947	148899	-0.3040			0.54						3	261	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006652	98006652	A	G	het	wt	het		QUAL=3000;DP=167,75,97;AF=0.46,0.00,0.41;MQM=60;SAP=54;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11652T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-27337T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.0179		129,.	2458	149210	1.1380			5.10						0	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007323	98007323	C	T	hom	hom	het		QUAL=20990;DP=326,193,254;AF=1.00,1.00,0.56;MQM=60;SAP=16;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12323G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28008G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12323G>A::	regulatory_region_variant:open_chromatin_region					rs1938564	0.8048		49545,.	22909	29587	-0.2730			0.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007402	98007402	T	A	hom	hom	het		QUAL=15845;DP=223,170,183;AF=1.00,1.00,0.55;MQM=60;SAP=23;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12402A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28087A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-12402A>T::	regulatory_region_variant:open_chromatin_region					rs1938563	0.8809		59197,.	15166	18058	0.4550			5.87						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98008160	98008160	T	A	hom	hom	het		QUAL=18851;DP=396,116,129;AF=1.00,1.00,0.55;MQM=60;SAP=185;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-13160A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28845A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-13160A>T::						rs1938562	0.8810		59201,.	15155	18041	1.1500			6.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009211	98009211	C	T	hom	hom	het		QUAL=15309;DP=290,116,162;AF=1.00,1.00,0.49;MQM=60;SAP=343;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14211G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-29896G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14211G>A::						rs2391902	0.8116		50263,.	22456	28550	0.3390			13.52						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009966	98009966	T	C	hom	hom	het		QUAL=16449;DP=306,118,172;AF=1.00,1.00,0.52;MQM=60;SAP=172;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14966A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-30651A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-14966A>G::	regulatory_region_variant:promoter_flanking_region					rs2154402	0.9145		63715,.	11455	12991	0.7240			8.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98010357	98010357	G	A	hom	hom	het		QUAL=14289;DP=297,87,125;AF=1.00,1.00,0.55;MQM=60;SAP=8;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-15357C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31042C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-15357C>T::						rs9324381	0.8455		54321,.	19540	23428	0.5390			3.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011162	98011162	G	A	hom	hom	het		QUAL=26059;DP=418,218,279;AF=1.00,1.00,0.59;MQM=60;SAP=3;ABP=25	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16162C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31847C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16162C>T::						rs1938561	0.8818		59488,.	15084	17968	0.2820			2.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011394	98011394	T	C	hom	hom	het		QUAL=25126;DP=338,267,328;AF=1.00,1.00,0.55;MQM=60;SAP=3;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16394A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32079A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16394A>G::					L2c (LINE/L2)	rs9440293	0.8805		59131,.	15215	18115	-1.1320			0.90						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011402	98011402	C	T	hom	hom	het		QUAL=25405;DP=342,268,337;AF=1.00,1.00,0.55;MQM=60;SAP=6;ABP=9	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16402G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32087G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16402G>A::					L2c (LINE/L2)	rs9727941	0.8447		54228,.	19603	23545	-0.2230			3.39						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011410	98011410	G	C	hom	hom	het		QUAL=25206;DP=342,265,340;AF=1.00,1.00,0.56;MQM=60;SAP=17;ABP=12	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16410C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32095C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-16410C>G::					L2c (LINE/L2)	rs9724773	0.8448		54214,.	19606	23524	0.3430			3.96						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012603	98012603	-	AC	het	hom	het		QUAL=11054;DP=251,118,167;AF=0.84,0.92,0.49;MQM=60;SAP=60;ABP=150	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17605_985-17604dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-33290_141-33289dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17605_815-17604dup::					MIRb (SINE/MIR)	rs112555829	0.7835		45614,.	25048	32122				2.93						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012988	98012988	A	T	hom	hom	het		QUAL=29785;DP=410,332,452;AF=1.00,1.00,0.48;MQM=60;SAP=179;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17988T>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+33020T>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-17988T>A::					L2c (LINE/L2)	rs1938565	0.8818		59509,.	15078	17972	0.1560			12.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98013425	98013425	C	T	hom	hom	het		QUAL=5322;DP=127,22,28;AF=1.00,1.00,0.43;MQM=60;SAP=13;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-18425G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+32583G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-18425G>A::						rs1938566	0.8117		50348,.	22491	28587	-1.1710			0.09					32203549	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014572	98014572	T	C	hom	hom	het		QUAL=22105;DP=405,193,218;AF=1.00,1.00,0.49;MQM=60;SAP=88;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19572A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31436A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567	0.8603		56278,.	17832	21174	-0.9230			1.12					25434007	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014656	98014656	C	T	het	het	wt		QUAL=8052;DP=427,147,200;AF=0.54,0.50,0.01;MQM=60;SAP=23;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19656G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31352G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.2957		7354,.	29805	106045	-1.1420			0.43						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014760	98014760	A	-	het	het	het	low_conf_region	QUAL=645;DP=103,34,47;AF=0.12,0.18,0.34;MQM=60;SAP=3;ABP=162	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19760del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31248del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-19760del::					A-rich (Low_complexity)	rs756636800	0.0134		12,.	1422	106314	0.3190			1.28						0	186	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98016194	98016194	C	T	het	het	wt		QUAL=6616;DP=335,216,298;AF=0.46,0.47,0.01;MQM=60;SAP=22;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-21194G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+29814G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-21194G>A::						rs6683447	0.2727		6595,.	28257	110555	-0.8800			0.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017024	98017024	G	A	hom	hom	het		QUAL=14206;DP=266,104,171;AF=1.00,1.00,0.50;MQM=60;SAP=364;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22024C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28984C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22024C>T::					L1MB1 (LINE/L1)	rs2391903	0.9147		63844,.	11446	12978	0.1620			3.34						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017137	98017137	A	G	hom	hom	het		QUAL=16875;DP=242,159,245;AF=1.00,1.00,0.54;MQM=60;SAP=3;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22137T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28871T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22137T>C::					L1MB1 (LINE/L1)	rs1892549	0.8552		55762,.	18487	22021	-0.2100			2.95						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017272	98017272	A	G	hom	hom	het		QUAL=15794;DP=301,122,139;AF=1.00,1.00,0.44;MQM=60;SAP=53;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22272T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28736T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22272T>C::					L1MB1 (LINE/L1)	rs1892550	0.8553		55794,.	18485	22011	-1.3240			0.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017405	98017405	C	T	hom	hom	het		QUAL=14102;DP=278,97,134;AF=1.00,0.99,0.45;MQM=60;SAP=90;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22405G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28603G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22405G>A::					L1MB1 (LINE/L1)	rs1892551	0.8554		55797,.	18492	21988	0.8610			9.10						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017479	98017479	G	A	hom	hom	het		QUAL=9869;DP=216,54,75;AF=1.00,1.00,0.48;MQM=60;SAP=270;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22479C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28529C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22479C>T::						rs1892552	0.8554		55783,.	18474	21986	-0.1480			0.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017594	98017594	A	G	hom	hom	het		QUAL=6154;DP=147,19,34;AF=1.00,1.00,0.62;MQM=60;SAP=4;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22594T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28414T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22594T>C::						rs2391904	0.8552		55774,.	18481	22019	-0.2560			1.50						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017674	98017674	T	A	wt	het	wt		QUAL=148;DP=225,29,54;AF=0.00,0.41,0.00;MQM=60;SAP=6;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22674A>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28334A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22674A>T::						rs116414424	0.0265		68,.	3897	148153	-1.0570			1.35						1	13	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017766	98017766	T	C	hom	hom	het		QUAL=6594;DP=154,33,49;AF=1.00,1.00,0.31;MQM=60;SAP=10;ABP=19	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22766A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28242A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-22766A>G::						rs9324382	0.8537		55543,.	18672	22240	0.5980			8.40						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018596	98018596	T	C	hom	hom	het		QUAL=7937;DP=166,53,91;AF=1.00,1.00,0.35;MQM=60;SAP=3;ABP=20	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23596A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27412A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23596A>G::						rs1938571	0.8049		49686,.	22949	29649	-0.1250			1.56						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018735	98018735	G	A	hom	hom	het		QUAL=11189;DP=210,97,108;AF=1.00,1.00,0.36;MQM=60;SAP=11;ABP=21	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23735C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27273C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23735C>T::						rs4447033	0.8553		55776,.	18478	22002	0.0700			1.21					27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018918	98018918	T	C	hom	hom	het		QUAL=3396;DP=58,40,39;AF=1.00,1.00,0.36;MQM=57;SAP=64;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23918A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27090A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-23918A>G::					AluSx1 (SINE/Alu)	rs1938572	0.8552		55611,.	18448	21950	-2.1630			0.73						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019061	98019061	C	T	hom	hom	het		QUAL=3195;DP=79,12,27;AF=1.00,1.00,0.41;MQM=60;SAP=4;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24061G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26947G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24061G>A::					AluSx1 (SINE/Alu)	rs1938573	0.8564		55598,.	18425	21737	-0.0450			0.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019398	98019398	G	T	hom	hom	het		QUAL=19114;DP=335,156,222;AF=1.00,1.00,0.47;MQM=60;SAP=9;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24398C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26610C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24398C>A::						rs1938558	0.8553		55812,.	18498	22020	1.1900			8.60						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019546	98019546	G	A	hom	hom	het		QUAL=13941;DP=250,126,154;AF=1.00,1.00,0.43;MQM=60;SAP=5;ABP=10	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24546C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26462C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24546C>T::					MIR (SINE/MIR)	rs1938559	0.8552		55788,.	18497	22033	0.7920			6.77						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019636	98019636	C	T	hom	hom	het		QUAL=22291;DP=509,106,138;AF=1.00,1.00,0.43;MQM=60;SAP=50;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24636G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26372G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-24636G>A::	regulatory_region_variant:open_chromatin_region				MIR (SINE/MIR)	rs1938560	0.8553		55808,.	18479	22013	0.0020			2.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020017	98020017	C	T	hom	hom	het		QUAL=8872;DP=148,88,74;AF=1.00,1.00,0.64;MQM=60;SAP=378;ABP=15	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25017G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25991G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25017G>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs9324383	0.8553		55769,.	18481	22005	0.5110			3.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TTT	het	n/a	n/a		QUAL=232;DP=20,2,2;AF=0.55,1.00,0.00;MQM=58;SAP=17;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25145_985-25143dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25863_140+25865dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25145_815-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296	0.8121		48238,.	21791	27361				1.99						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020371	98020371	T	C	hom	hom	het		QUAL=6998;DP=106,83,108;AF=1.00,0.99,0.44;MQM=58;SAP=356;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25371A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25637A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25371A>G::					AluSx1 (SINE/Alu)	rs9725319	0.8552		55749,.	18482	22014	-1.8110			1.46						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020435	98020435	C	T	het	wt	het		QUAL=2544;DP=109,136,159;AF=0.38,0.00,0.45;MQM=60;SAP=55;ABP=19	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25435G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25573G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.815-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.0144		89,.	2014	149854	-1.7430			0.12						0	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020606	98020606	T	C	hom	hom	het		QUAL=7541;DP=149,66,73;AF=1.00,1.00,0.36;MQM=60;SAP=219;ABP=16	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25402A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25402A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25402A>G::						rs4477335	0.8552		55731,.	18468	21996	-0.2530			3.47						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020686	98020686	-	A	hom	hom	het		QUAL=4541;DP=130,19,24;AF=0.95,0.95,0.42;MQM=60;SAP=47;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25321dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25321dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25321dup::						rs61381274	0.8546		55581,.	18522	22058				0.53						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020814	98020814	G	A	hom	hom	het		QUAL=4959;DP=101,32,41;AF=1.00,1.00,0.46;MQM=60;SAP=28;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25194C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25194C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+25194C>T::						rs4480407	0.8738		58306,.	16198	19182	0.4270			3.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021138	98021138	A	C	wt	het	wt		QUAL=1905;DP=497,160,183;AF=0.00,0.50,0.00;MQM=60;SAP=60;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24870T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24870T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24870T>G::						rs79792869	0.0266		69,.	3904	148172	0.4270			2.77						1	13	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021524	98021524	A	G	wt	het	wt		QUAL=3008;DP=492,177,218;AF=0.00,0.62,0.00;MQM=60;SAP=26;ABP=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24484T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24484T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24484T>C::						rs77482155	0.0357		123,.	5190	146746	2.9560			15.00						1	17	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021777	98021777	A	G	hom	hom	het		QUAL=20780;DP=273,220,282;AF=1.00,1.00,0.57;MQM=60;SAP=13;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24231T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24231T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24231T>C::						rs9659624	0.8551		55733,.	18480	22022	0.7530			13.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021954	98021954	C	A	hom	hom	het		QUAL=20765;DP=389,161,203;AF=1.00,1.00,0.55;MQM=60;SAP=13;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24054G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24054G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+24054G>T::						rs5005705	0.8538		55521,.	18653	22211	-1.3150			0.21						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022010	98022010	C	T	hom	hom	het		QUAL=13857;DP=234,129,144;AF=1.00,0.99,0.53;MQM=60;SAP=48;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23998G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23998G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23998G>A::						rs9324384	0.8553		55747,.	18486	21994	-0.6920			0.76						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022207	98022207	G	A	hom	hom	het		QUAL=18181;DP=308,165,181;AF=1.00,0.99,0.50;MQM=60;SAP=42;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23801C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23801C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23801C>T::						rs4634961	0.8554		55740,.	18475	21963	-0.2480			1.66					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022343	98022343	C	A	hom	hom	het		QUAL=19917;DP=273,232,262;AF=1.00,1.00,0.52;MQM=60;SAP=76;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23665G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23665G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23665G>T::						rs9324385	0.8553		55747,.	18483	21989	0.0320			3.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022403	98022403	G	A	hom	hom	het		QUAL=26136;DP=377,265,327;AF=1.00,1.00,0.51;MQM=60;SAP=11;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23605C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23605C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23605C>T::						rs9324386	0.8553		55772,.	18484	21992	-0.1830			0.88						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022474	98022474	G	A	hom	hom	het		QUAL=22613;DP=332,214,330;AF=1.00,1.00,0.50;MQM=60;SAP=106;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23534C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23534C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23534C>T::						rs9324387	0.8554		55778,.	18487	21989	-0.0660			1.57					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022599	98022599	G	A	hom	hom	het		QUAL=17798;DP=284,169,197;AF=1.00,1.00,0.46;MQM=60;SAP=3;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23409C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23409C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+23409C>T::						rs9324388	0.8554		55784,.	18475	21987	0.1320			7.83						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023307	98023307	A	G	hom	hom	het		QUAL=16788;DP=319,127,131;AF=1.00,1.00,0.64;MQM=60;SAP=433;ABP=26	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22701T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22701T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22701T>C::						rs9659996	0.8552		55750,.	18484	22008	1.6210			12.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023339	98023339	C	T	hom	hom	het		QUAL=10349;DP=169,101,92;AF=1.00,1.00,0.58;MQM=60;SAP=129;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22669G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22669G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22669G>A::						rs9658841	0.8552		55756,.	18488	22010	-0.3040			2.64						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023524	98023524	G	A	hom	hom	het		QUAL=7301;DP=173,26,38;AF=1.00,1.00,0.61;MQM=60;SAP=22;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22484C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22484C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22484C>T::						rs9661157	0.8553		55701,.	18461	21965	-0.4100			0.16						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023721	98023721	-	TACTT	het	hom	het		QUAL=5495;DP=140,56,90;AF=0.86,0.96,0.36;MQM=60;SAP=5;ABP=55	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22286_984+22287insAAGTA::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22286_140+22287insAAGTA::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22286_814+22287insAAGTA::						rs71071680	0.8548		55491,.	18460	21992				12.72						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023774	98023774	C	T	hom	hom	het		QUAL=9447;DP=219,52,81;AF=1.00,1.00,0.31;MQM=60;SAP=135;ABP=29	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22234G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22234G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22234G>A::						rs10747496	0.8554		55648,.	18453	21941	0.3660			4.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023922	98023922	A	G	hom	hom	het		QUAL=19522;DP=400,125,163;AF=1.00,1.00,0.42;MQM=60;SAP=5;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22086T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22086T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+22086T>C::						rs4584446	0.8552		55703,.	18455	21983	-0.0180			2.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024179	98024179	T	C	hom	hom	het		QUAL=14470;DP=324,57,130;AF=1.00,1.00,0.51;MQM=60;SAP=355;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21829A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21829A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21829A>G::						rs2391905	0.8553		55684,.	18457	21973	0.2110			6.28					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024456	98024457	TT	-	hom	hom	het		QUAL=11091;DP=310,79,95;AF=0.90,0.92,0.54;MQM=60;SAP=141;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21551_984+21552del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21551_140+21552del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21551_814+21552del::					L2a (LINE/L2)	rs55633609	0.8515		53784,.	18659	22009	0.4400			0.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024609	98024609	C	T	hom	hom	het		QUAL=8595;DP=179,46,72;AF=1.00,1.00,0.44;MQM=60;SAP=9;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21399G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21399G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21399G>A::						rs4950117	0.8744		58291,.	16090	19054	0.2330			3.05					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024802	98024802	G	T	hom	hom	het		QUAL=16080;DP=259,154,169;AF=1.00,0.99,0.51;MQM=60;SAP=20;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21206C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21206C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+21206C>A::						rs4950118	0.8549		55600,.	18493	22005	0.5410			16.19						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025080	98025080	T	C	hom	hom	het		QUAL=18252;DP=373,121,172;AF=0.99,1.00,0.48;MQM=60;SAP=150;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20928A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20928A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20928A>G::						rs10783082	0.8551		55628,.	18440	21974	0.1160			14.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025214	98025214	-	TTAAGTAT	hom	hom	het		QUAL=13723;DP=233,153,151;AF=0.96,1.00,0.56;MQM=60;SAP=6;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20786_984+20793dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20786_140+20793dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20786_814+20793dup::						rs5776392	0.8547		55285,.	18404	21930				1.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025692	98025692	A	C	hom	hom	het		QUAL=18386;DP=338,140,192;AF=1.00,1.00,0.45;MQM=60;SAP=6;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20316T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20316T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20316T>G::					MIR3 (SINE/MIR)	rs4950119	0.8464		54683,.	19001	23299	-0.6610			0.61						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025826	98025826	G	A	hom	hom	het		QUAL=14570;DP=269,105,175;AF=1.00,1.00,0.44;MQM=60;SAP=56;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20182C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20182C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.8553		55570,.	18427	21923	0.1650			3.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025917	98025917	A	C	hom	hom	het		QUAL=17800;DP=354,116,173;AF=1.00,0.99,0.50;MQM=60;SAP=104;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20091T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20091T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+20091T>G::					MIRb (SINE/MIR)	rs4245673	0.8551		55635,.	18444	21978	0.9310			8.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026176	98026176	T	C	hom	hom	het		QUAL=18398;DP=255,193,284;AF=1.00,1.00,0.49;MQM=60;SAP=126;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19832A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19832A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19832A>G::						rs1938568	0.8552		55670,.	18464	21984	0.6240			13.98					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026906	98026906	C	T	hom	hom	het		QUAL=22556;DP=420,185,198;AF=1.00,0.99,0.46;MQM=60;SAP=58;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19102G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19102G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+19102G>A::						rs9440393	0.8552		55613,.	18446	21960	-0.8030			0.18						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027024	98027024	A	G	het	het	het		QUAL=13321;DP=470,260,283;AF=0.49,0.48,0.50;MQM=60;SAP=37;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18984T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18984T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18984T>C::						rs9440302	0.4874		18108,.	37578	77622	0.5020			6.00					32184616,25217366	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027298	98027298	T	C	hom	hom	het		QUAL=16950;DP=356,95,113;AF=1.00,1.00,0.50;MQM=60;SAP=28;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18710A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18710A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18710A>G::						rs9324389	0.8552		55628,.	18428	21950	-2.3170			0.01						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027345	98027345	G	A	wt	het	wt		QUAL=1388;DP=320,92,90;AF=0.00,0.59,0.00;MQM=60;SAP=3;ABP=9	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18663C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18663C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18663C>T::						rs74700717	0.0199		40,.	2937	148753	-1.2760			2.31						3	263	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027707	98027707	A	G	hom	hom	het		QUAL=13427;DP=217,123,187;AF=1.00,1.00,0.45;MQM=60;SAP=238;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18301T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18301T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+18301T>C::	regulatory_region_variant:promoter_flanking_region					rs1938569	0.8549		55540,.	18445	21977	0.7930			5.51						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028229	98028229	G	A	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17779C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17779C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17779C>T::						rs2022864	0.8553		55035,.	18261	21711	-0.7290			1.78						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028233	98028233	A	G	hom	hom	het		QUAL=2323;DP=63,11,14;AF=0.98,1.00,0.36;MQM=60;SAP=90;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17775T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17775T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17775T>C::						rs2022865	0.8551		55020,.	18280	21754	-0.0130			7.71						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028629	98028629	G	A	hom	hom	het		QUAL=12920;DP=215,104,153;AF=1.00,0.99,0.55;MQM=60;SAP=60;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17379C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17379C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17379C>T::						rs10875124	0.8549		55334,.	18394	21898	0.8880			5.41						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028644	98028644	A	C	hom	hom	het		QUAL=12382;DP=217,97,140;AF=1.00,0.99,0.53;MQM=60;SAP=77;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17364T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17364T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17364T>G::						rs10875125	0.8548		55305,.	18395	21913	0.2010			1.80						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028832	98028832	-	A	hom	hom	het		QUAL=7913;DP=174,48,82;AF=0.98,1.00,0.44;MQM=60;SAP=120;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17175dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17175dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+17175dup::						rs11404556	0.8552		55486,.	18400	21904				8.59						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029050	98029050	A	G	hom	hom	het		QUAL=14517;DP=242,132,151;AF=1.00,1.00,0.44;MQM=60;SAP=17;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16958T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16958T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16958T>C::						rs1198574	0.8553		55488,.	18376	21886	0.7640			18.63						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029957	98029957	T	C	hom	hom	het		QUAL=10068;DP=153,96,129;AF=1.00,1.00,0.54;MQM=60;SAP=99;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16051A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16051A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+16051A>G::						rs1198573	0.8552		55357,.	18377	21865	3.3360			16.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98030956	98030956	T	-	het	het	wt		QUAL=4251;DP=222,105,144;AF=0.51,0.60,0.03;MQM=60;SAP=190;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+15052del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+15052del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+15052del::						rs377025796	0.0104		25,.	1485	145883	0.9970			1.85						1	107	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031620	98031620	A	C	hom	hom	het		QUAL=6039;DP=157,15,15;AF=1.00,1.00,0.67;MQM=60;SAP=6;ABP=7	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14388T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14388T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14388T>G::						rs1198572	0.8268		51934,.	21206	26208	-0.4610			6.05						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031799	98031799	A	G	het	het	wt		QUAL=777;DP=53,13,9;AF=0.51,0.62,0.00;MQM=59;SAP=30;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14209T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14209T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14209T>C::						rs188465986	0.0082		7,.	1070	131300	0.2980			4.16						0	116	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031807	98031807	T	C	het	wt	wt	low_conf_region	QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=51;SAP=12;ABP=20	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14201A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14201A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14201A>G::					(AC)n (Simple_repeat)	rs796242776	0.0007		0,.	88	133546	-0.6360			2.76						3	209	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031808	98031811	ACAC	-	wt	het	wt	low_conf_region	QUAL=40;DP=21,9,6;AF=0.00,0.44,0.00;MQM=60;SAP=12;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14197_984+14200del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14197_140+14200del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+14197_814+14200del::					(AC)n (Simple_repeat)	rs34012276	0.0445		109,.	5732	127704	0.3460			1.56						4	7	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032116	98032116	A	G	hom	hom	het		QUAL=4984;DP=120,21,35;AF=1.00,1.00,0.37;MQM=60;SAP=89;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13892T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13892T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13892T>C::						rs1198571	0.8552		55539,.	18398	21928	0.3560			3.24						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032783	98032783	C	T	wt	het	wt		QUAL=2115;DP=592,195,248;AF=0.00,0.47,0.00;MQM=60;SAP=11;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13225G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13225G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+13225G>A::						rs17371457	0.1802		3158,.	20985	124223	-0.5830			1.43					32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98033342	98033342	C	A	hom	hom	het		QUAL=23989;DP=422,189,268;AF=1.00,1.00,0.47;MQM=60;SAP=210;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+12666G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+12666G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+12666G>T::						rs1782815	0.8538		55465,.	18600	22176	0.3820			2.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034034	98034034	A	-	het	wt	het	low_conf_region	QUAL=1635;DP=86,30,36;AF=0.58,0.00,0.53;MQM=58;SAP=67;ABP=8	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11974del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11974del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11974del::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs143336786	0.0379		100,.	2216	61386	0.1540			0.40						0	8	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034095	98034095	G	A	het	het	het	low_conf_region	QUAL=1393;DP=67,17,14;AF=0.52,0.65,0.50;MQM=54;SAP=6;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11913C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11913C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11913C>T::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs1782814	0.2223		2369,.	12402	59964	-0.5910			0.86						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034107	98034107	-	AAAG	hom	hom	het	low_conf_region	QUAL=1400;DP=41,10,7;AF=0.93,0.90,0.29;MQM=59;SAP=3;ABP=6	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11897_984+11900dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11897_140+11900dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11897_814+11900dup::	regulatory_region_variant:promoter_flanking_region				(AGAA)n (Simple_repeat)	rs780129382	0.3190		4122,.	13390	46188				1.07						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034287	98034287	T	C	hom	hom	het		QUAL=10082;DP=168,94,158;AF=0.99,1.00,0.46;MQM=60;SAP=116;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11721A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11721A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11721A>G::	regulatory_region_variant:promoter_flanking_region					rs1782813	0.8682		57430,.	16896	20006	-0.3410			3.00						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034489	98034489	G	C	het	het	wt		QUAL=6863;DP=388,132,168;AF=0.50,0.45,0.01;MQM=60;SAP=20;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11519C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11519C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+11519C>G::	regulatory_region_variant:promoter_flanking_region				UCON1 (Unknown)	rs7554283	0.2730		6620,.	28203	110375	1.4970			14.87					32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98035455	98035455	T	C	het	het	wt		QUAL=7037;DP=316,202,249;AF=0.48,0.53,0.00;MQM=60;SAP=30;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+10553A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+10553A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+10553A>G::	regulatory_region_variant:promoter_flanking_region					rs4950101	0.2385		5010,.	26146	115508	1.6180			9.30					24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036428	98036428	T	C	hom	hom	het		QUAL=13803;DP=275,84,106;AF=0.99,1.00,0.59;MQM=60;SAP=4;ABP=11	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9580A>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9580A>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9580A>G::						rs1702294	0.8211		51425,.	21875	27181	-0.0800			1.44					26836412,31268507,28072415,30518757,28117840,29635364,27072377,30618607,29442441,30038276,31409837,27620842,25056061,31835028,30285260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036603	98036603	G	C	hom	hom	het		QUAL=29063;DP=321,361,438;AF=1.00,1.00,0.51;MQM=60;SAP=58;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9405C>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9405C>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9405C>G::					Tigger3a (DNA/TcMar-Tigger)	rs1702293	0.9146		63761,.	11438	12978	-2.6840			0.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036784	98036784	G	A	hom	hom	het		QUAL=18814;DP=240,231,243;AF=1.00,1.00,0.48;MQM=60;SAP=15;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9224C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9224C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9224C>T::					Tigger3a (DNA/TcMar-Tigger)	rs1782810	0.7830		46957,.	24951	32935	-0.0240			1.79					23871474,28540026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036854	98036854	A	C	hom	hom	het		QUAL=21528;DP=275,249,295;AF=1.00,1.00,0.51;MQM=60;SAP=63;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9154T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9154T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+9154T>G::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.8819		59450,.	15046	17940	-2.7810			0.54						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037038	98037038	A	C	hom	hom	het		QUAL=18013;DP=241,208,270;AF=1.00,1.00,0.49;MQM=60;SAP=283;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8970T>G::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8970T>G::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8970T>G::						rs1628294	0.9146		63749,.	11424	12966	-0.4600			2.03						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037378	98037378	G	T	hom	hom	het		QUAL=10749;DP=212,74,108;AF=1.00,1.00,0.38;MQM=60;SAP=25;ABP=17	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8630C>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8630C>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+8630C>A::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.7827		46893,.	24961	32961	-0.3280			0.73					27895608,24174267,23637625,28798405,25921703,22910404,21926974,22078159,22850735,22883350,22982201,23459466,23507081,23776546,23786914,23871474,23910899,24132022,24275578,24339136,24361663,24391914,24625753,24718684,24820543,25044277,25154622,25241074,25395183,26123324,26429811,26836412,27028512,27095331,27096222,27481827,28234206,28958479,29042896,29118371,29599094,30026708,30035013,30122962,30610940,31586698,32127940,29858046,23637704,26609515,28812221,25250332,27525637,29657307,27650867,25200985,25844328,29529357,28117840,26305006,24566148,29893792,27396304,26005852,31361772,29635364,27072377,25217366,30618607,23453885,25941532,24160291,25884492,28217082,29442441,27196537,25387707,23595788,29665782,31409837,24866554,26925706,25434007,27244233,24403877,24556472,27733313,27620842	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98040554	98040554	A	-	het	het	het		QUAL=822;DP=200,100,133;AF=0.22,0.13,0.17;MQM=60;SAP=6;ABP=388	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+5454del::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+5454del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+5454del::						rs528539462	0.0068		0,.	709	103553	-1.7360			0.04						0	120	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCA	het	wt	het		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=3;ABP=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4940_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4940_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4380_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4940_814+4947dup::						rs35835879	0.1484		1942,.	18469	128277				0.13						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCA	het	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=57;SAP=4;ABP=49	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4936_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4936_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4376_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4936_814+4947dup::						rs35835879	0.5572		23580,.	36759	66689				0.12						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCATTCATTCA	wt	het	wt		QUAL=2641;DP=82,19,37;AF=0.41,0.37,0.03;MQM=60;SAP=6;ABP=6	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4932_984+4947dup::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4932_140+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4372_4387dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+4932_814+4947dup::						rs35835879	0.1196		1300,.	15418	132682				0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042140	98042140	A	G	hom	hom	het		QUAL=6052;DP=154,15,35;AF=0.99,1.00,0.43;MQM=60;SAP=3;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3868T>C::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3868T>C::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3308T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3868T>C::						rs4292998	0.7943		48245,.	24230	31256	-0.1470			5.88					30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042162	98042162	C	A	hom	hom	het		QUAL=7219;DP=183,18,38;AF=1.00,1.00,0.45;MQM=60;SAP=4;ABP=4	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3846G>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3846G>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3286G>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3846G>T::						rs4411173	0.8682		57565,.	16928	20046	0.5130			6.74					29500382	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042702	98042702	C	T	hom	hom	het		QUAL=39548;DP=576,411,500;AF=1.00,1.00,0.52;MQM=60;SAP=244;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3306G>A::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3306G>A::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2746G>A::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3306G>A::	regulatory_region_variant:promoter_flanking_region					rs2802535	0.7925		47936,.	24375	31481	-0.7900			0.61					24566148,26005852,29635364	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042932	98042932	G	A	het	wt	het		QUAL=8629;DP=419,173,196;AF=0.50,0.00,0.56;MQM=60;SAP=191;ABP=5	MIR137HG	intron&non_coding_transcript,non_coding_transcript_exon	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3076C>T::,MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3076C>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2516C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.814+3076C>T::						rs78924727	0.0143		90,.	1992	149938	-0.2050			1.03						0	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98046571	98046571	G	T	hom	hom	het		QUAL=32945;DP=409,411,496;AF=1.00,1.00,0.48;MQM=60;SAP=12;ABP=6	MIR137HG	non_coding_transcript_exon	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.543C>A::	MIR137HG:NR_046105.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.373C>A::	regulatory_region_variant:promoter					rs2660304	0.8267		52012,.	21293	26273	1.2640			18.18					24885463,27004216,28803920,26429811,31059093,24566148,29893792,26005852,27913161,31361772,29635364,30618607,29442441,31409837,25434007,27620842,29483656,26198764	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98047588	98047588	T	A	hom	hom	het		QUAL=13200;DP=231,116,132;AF=1.00,1.00,0.53;MQM=60;SAP=11;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.487-961A>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.317-961A>T::						rs2660303	0.9137		63646,.	11563	13111	-0.2680			0.48					27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CA	wt	wt	het	low_conf_region	QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=60;SAP=9;ABP=4	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1256_486+1257dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1256_316+1257dup::	regulatory_region_variant:promoter					rs1553269771	0.0059		8,.	743	127455				2.81						22	51	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048120	98048120	-	CGCA	het	hom	wt	low_conf_region	QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1257_486+1258insTGCG::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1257_316+1258insTGCG::	regulatory_region_variant:promoter					rs150117500	0.0229		97,.	2742	125280				2.72						0	2	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048156	98048156	-	CACACACACC	het	hom	wt		QUAL=916;DP=18,17,77;AF=0.00,0.00,0.53;MQM=54;SAP=11;ABP=27	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1221_486+1222insGGTGTGTGTG::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1221_316+1222insGGTGTGTGTG::	regulatory_region_variant:promoter				(CA)n (Simple_repeat)	rs750747213	0.0375		149,.	5330	144670				5.84						0	1	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048289	98048289	G	A	hom	hom	het		QUAL=13245;DP=147,183,260;AF=1.00,0.99,0.47;MQM=60;SAP=46;ABP=5	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1089C>T::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+1089C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786696	0.9146		63862,.	11454	12992	0.0740			8.09					27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048403	98048403	A	G	hom	hom	het		QUAL=18181;DP=248,207,277;AF=1.00,1.00,0.50;MQM=60;SAP=17;ABP=3	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+975T>C::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+975T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant					rs61786697	0.9147		63808,.	11434	12974	2.6530			20.00					27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049034	98049034	-	CT	wt	wt	het		QUAL=617;DP=159,97,106;AF=0.13,0.13,0.11;MQM=60;SAP=22;ABP=296	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343dup::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343dup::	regulatory_region_variant:promoter					rs143725104	0.0129		20,.	1802	141548				13.44						5	148	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98049035	98049036	CT	-	het	het	wt		QUAL=617;DP=159,97,106;AF=0.02,0.00,0.33;MQM=60;SAP=5;ABP=447	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+342_486+343del::	MIR137HG:NR_046105.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.316+342_316+343del::	regulatory_region_variant:promoter				(CT)n (Simple_repeat)	rs143725104	0.0105		27,.	1445	141235	2.0910			16.18						0	80	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	99851033	99851033	A	G	wt	het	wt		QUAL=1816;DP=310,107,144;AF=0.00,0.64,0.01;MQM=60;SAP=3;ABP=23	AGL	5'UTR,splice_acceptor	AGL:ENST00000294724.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000361915.8:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370163.7:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:ENST00000370165.7:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::	AGL:NM_000028.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000642.3:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000643.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::,AGL:NM_000644.2:splice_acceptor_variant:HIGH:intron1/33:c.-8-2A>G::,AGL:NM_000646.2:5_prime_UTR_variant:MODIFIER:exon1/34:c.-201A>G::,AGL:XM_005270557.2:5_prime_UTR_variant:MODIFIER:exon2/34:c.-10A>G::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	195096 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2307130	0.4694	0.2635,0.4393,0.5339,0.4925,0.5368	14073,.	35501	88329	0.3570			15.29		3.27>-4.68	COSV54056176	0.24	25741868,16400609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99852537	99852537	T	-	het	het	het	off-target	QUAL=263;DP=11,6,13;AF=0.45,0.17,0.54;MQM=58;SAP=31;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+1432del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron1/33:c.-109-5del::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron2/33:c.82+1432del::	regulatory_region_variant:promoter	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]			AluJo (SINE/Alu)	rs58176899	0.0006		1,.	72	118726	-0.2510			4.91				0.05		6	28	0 / 0					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99861470	99861470	C	T	het	het	het		QUAL=12734;DP=435,201,300;AF=0.53,0.48,0.46;MQM=60;SAP=4;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron1/32:c.35-33C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron2/33:c.35-33C>T::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron2/33:c.83-33C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256750 [benign DISEASE=Glycogen storage disease type III,not specified];			rs2307129	0.2354	0.3863,0.1314,0.1224,0.1714,0.1899	5048,.	25665	116131	-1.0140			2.03			COSV54053030	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864333	99864333	G	C	het	hom	het	off-target	QUAL=2585;DP=97,33,50;AF=0.54,1.00,0.38;MQM=60;SAP=220;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron3/32:c.413-53G>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::	AGL:NM_000028.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000642.3:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000643.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000644.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:NM_000646.2:intron_variant:MODIFIER:intron4/33:c.413-53G>C::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron4/33:c.461-53G>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676092 [benign DISEASE=not provided];			rs535461	0.7310		41149,.	28773	40869	-0.0880			2.44				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870805	99870805	C	T	het	hom	het		QUAL=8603;DP=340,98,117;AF=0.42,1.00,0.51;MQM=60;SAP=24;ABP=14	AGL	synonymous	AGL:ENST00000294724.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000361915.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.6:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]	AGL:NM_000028.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000642.3:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000643.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000644.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:,AGL:NM_000646.2:synonymous_variant:LOW:exon7/34:c.846C>T:p.Leu282=:,AGL:XM_005270557.2:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	198432 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2230306	0.7588	0.9171,0.6906,0.6850,0.7028,0.7519	44424,.	26407	36643	1.0390			11.31				0.12	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99874669	99874669	G	A	het	hom	het	off-target	QUAL=11542;DP=218,169,229;AF=0.49,1.00,0.54;MQM=60;SAP=148;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron6/32:c.911-18G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron7/33:c.959-18G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron7/33:c.911-18G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron7/33:c.959-18G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256751 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs634880	0.7341	0.8453,0.6822,0.7106,0.7096,0.7330	41276,.	28812	40332	-0.9060			5.56		10.97>11.37	COSV54049593	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99877597	99877597	A	G	wt	het	wt	off-target	QUAL=302;DP=175,22,41;AF=0.00,0.68,0.00;MQM=60;SAP=21;ABP=9	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron10/32:c.1376-44A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::	AGL:NM_000028.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000642.3:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000643.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000644.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::,AGL:NM_000646.2:intron_variant:MODIFIER:intron11/33:c.1376-44A>G::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron11/33:c.1424-44A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256722 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2291638	0.3515	0.0899,0.3604,0.4446,0.3883,0.3040	8120,.	28880	106856	-0.5580			8.44			COSV54049682	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99881185	99881185	T	C	wt	het	wt		QUAL=2719;DP=287,209,284;AF=0.00,0.51,0.00;MQM=60;SAP=4;ABP=3	AGL	splice_region&intron	AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron14/32:c.1953+8T>C::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::	AGL:NM_000028.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000642.3:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000643.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000644.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:NM_000646.2:splice_region_variant&intron_variant:LOW:intron15/33:c.1953+8T>C::,AGL:XM_005270557.2:splice_region_variant&intron_variant:LOW:intron15/33:c.2001+8T>C::,AGL:XM_017000501.2:splice_region_variant&intron_variant:LOW:intron3/21:c.261+8T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256725 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3736296	0.5541	0.4313,0.6220,0.6604,0.5444,0.5893	20631,.	37021	73497	2.0820			12.88			COSV54049713	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99888119	99888119	G	A	het	hom	het	off-target	QUAL=12234;DP=173,206,264;AF=0.53,1.00,0.47;MQM=60;SAP=104;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron20/32:c.2764+11G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron21/33:c.2764+11G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron21/33:c.2812+11G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron9/21:c.1072+11G>A::	regulatory_region_variant:open_chromatin_region	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs555929	0.6904	0.5852,0.7226,0.6885,0.6936,0.7307	33501,.	33511	51265	-0.2370			0.59			COSV54049809	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99891585	99891585	T	A	wt	het	wt	off-target	QUAL=1409;DP=198,121,186;AF=0.00,0.47,0.00;MQM=60;SAP=35;ABP=4	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron21/32:c.2902-21T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron22/33:c.2902-21T>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron22/33:c.2950-21T>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron10/21:c.1210-21T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256733 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2035961	0.5367	0.3801,0.6127,0.6593,0.5275,0.5855	18763,.	36706	77476	0.0910			5.65			COSV54051217	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892547	99892547	C	T	het	het	het		QUAL=8382;DP=251,182,223;AF=0.49,0.47,0.51;MQM=60;SAP=8;ABP=4	AGL	missense	AGL:ENST00000294724.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000361915.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.6:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:,AGL:ENST00000370163.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:	AGL:NM_000028.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000642.3:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000643.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000644.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:NM_000646.2:missense_variant:MODERATE:exon24/34:c.3151C>T:p.Pro1051Ser:,AGL:XM_005270557.2:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:XM_017000501.2:missense_variant:MODERATE:exon12/22:c.1459C>T:p.Pro487Ser:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256734 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs3753494	0.1363	0.1169,0.0998,0.0294,0.1496,0.1452	1507,.	17690	131210	7.2800	D(0.04),D(0.04),D(0.03),D(0.04),D(0.04)	B(0.10),B(0.10),B(0.05),B(0.10),B(0.10)	22.20	0.30			0.11	25741868,25803781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892644	99892644	G	A	het	hom	het	off-target	QUAL=5719;DP=136,88,117;AF=0.46,1.00,0.49;MQM=60;SAP=296;ABP=5	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron24/33:c.3211+37G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron12/21:c.1519+37G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256735 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs594249	0.6911	0.5841,0.7229,0.6889,0.6939,0.7346	33579,.	33515	51251	-1.8710			0.01			COSV54049828	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900890	99900890	G	T	het	wt	wt	off-target;low_conf_region	QUAL=1522;DP=81,49,51;AF=0.28,0.78,0.43;MQM=58;SAP=66;ABP=108	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+29G>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+29G>T::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron26/33:c.3588+29G>T::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron14/21:c.1848+29G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1204532 [likely benign DISEASE=not provided];		(T)n (Simple_repeat)	rs201885902	0.0169	0.0243,0.0180,0.0202,0.0153,0.0173	0,.	182	142146	0.6720			2.62				0.02		18	618	0 / 0	2	"[2] auto-classification 22.09.2017  "			AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900891	99900892	TT	-	het	hom	het	off-target;low_conf_region	QUAL=1522;DP=81,49,51;AF=0.27,0.06,0.08;MQM=60;SAP=183;ABP=32	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::	AGL:NM_000028.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000642.3:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000643.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000644.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:NM_000646.2:intron_variant:MODIFIER:intron26/33:c.3540+43_3540+44del::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron14/21:c.1848+43_1848+44del::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1220869 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs35956186	0.5254	0.3430,0.3746,0.3694,0.4285,0.3509	19107,.	36535	67533	2.0190			1.96				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910892	99910892	G	A	wt	het	wt	off-target	QUAL=2103;DP=103,176,266;AF=0.00,0.49,0.00;MQM=60;SAP=9;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+45G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+45G>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron28/33:c.3836+45G>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron16/21:c.2096+45G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256744 [benign DISEASE=Glycogen storage disease type III,not specified,not provided];			rs2274570	0.4822	0.3712,0.5710,0.5425,0.5001,0.3654	16702,.	36933	80963	-0.2940			0.37			COSV54050212	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99910900	99910900	T	A	wt	het	wt	off-target	QUAL=2114;DP=106,173,261;AF=0.00,0.50,0.00;MQM=60;SAP=14;ABP=3	AGL	intron	AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3788+53T>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::	AGL:NM_000028.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000642.3:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000643.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000644.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:NM_000646.2:intron_variant:MODIFIER:intron28/33:c.3788+53T>A::,AGL:XM_005270557.2:intron_variant:MODIFIER:intron28/33:c.3836+53T>A::,AGL:XM_017000501.2:intron_variant:MODIFIER:intron16/21:c.2096+53T>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1224847 [benign DISEASE=not provided];			rs1541041	0.4647		16706,.	36943	81041	-0.3640			1.85			COSV54050222	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99921923	99921923	G	T	wt	het	wt		QUAL=1097;DP=305,85,95;AF=0.00,0.52,0.00;MQM=60;SAP=4;ABP=3	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*272G>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*272G>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*272G>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291351 [benign DISEASE=Glycogen storage disease type III,not provided];			rs1804808	0.3249		9469,.	30260	102210	0.1500			2.81			COSV54050326,COSV54053994	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922383	99922383	C	T	het	hom	het		QUAL=4274;DP=173,41,53;AF=0.49,1.00,0.45;MQM=60;SAP=14;ABP=4	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*732C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291359 [benign DISEASE=Glycogen storage disease type III];			rs3766600	0.6176		29017,.	35358	57836	0.8200			4.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922679	99922679	C	T	wt	het	wt		QUAL=258;DP=191,42,61;AF=0.01,0.38,0.00;MQM=60;SAP=6;ABP=8	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1028C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1028C>T::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1028C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291363 [benign DISEASE=Glycogen storage disease type III];			rs3766601	0.4734		17318,.	37085	79781	0.9610			4.49			COSV54050336	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922947	99922947	A	C	wt	het	wt		QUAL=895;DP=221,61,69;AF=0.00,0.57,0.00;MQM=60;SAP=3;ABP=6	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1296A>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1296A>C::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1296A>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291368 [benign DISEASE=Glycogen storage disease type III];			rs1804809	0.3799		11969,.	33724	94108	0.0970			2.97			COSV54050348	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99923192	99923192	T	C	wt	het	wt		QUAL=1707;DP=266,123,168;AF=0.00,0.54,0.01;MQM=60;SAP=3;ABP=4	AGL	3'UTR	AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1541T>C::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::	AGL:NM_000028.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000642.3:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000643.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000644.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:NM_000646.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:XM_005270557.2:3_prime_UTR_variant:MODIFIER:exon34/34:c.*1541T>C::,AGL:XM_017000501.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1541T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291369 [benign DISEASE=Glycogen storage disease type III];			rs3766603	0.4047		12947,.	35543	90365	-1.4380			0.29			COSV54050357	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100187173	100187173	G	A	wt	het	wt		QUAL=315;DP=111,37,41;AF=0.00,0.43,0.02;MQM=60;SAP=32;ABP=4	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*9082C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291375 [benign DISEASE=Maple syrup urine disease,not provided];			rs72728160	0.1172		1396,.	15030	134192	0.3260			3.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100187701	100187701	T	-	het	het	het		QUAL=159;DP=18,6,10;AF=0.33,0.33,0.30;MQM=59;SAP=8;ABP=12	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*8554del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1195364 [likely benign DISEASE=not provided];		AluJb (SINE/Alu)	rs886044938	0.0092		5,.	1136	122938	-1.4950			0.14				0		1	173	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	-	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903del::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291391 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs71709231	0.8271		49179,.	20233	24799	0.4640			3.74				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189353	AA	-	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.48,0.00,1.00;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902_*6903del::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1200821 [likely benign DISEASE=not provided];		AluSz (SINE/Alu)	rs71709231	0.0072		3,.	1024	142166	0.4640			3.95				0		1	44	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189352	100189352	A	T	het	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=59;SAP=4;ABP=9	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6903T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291392 [benign DISEASE=Maple syrup urine disease,not provided];		AluSz (SINE/Alu)	rs10783125	0.5469		1720,.	15700	15860	0.4640			7.12				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189353	100189353	A	T	het	wt	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=58;SAP=26;ABP=3	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6902T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	875221 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200943386	0.8051		45023,.	22251	27179	0.4640			7.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100189354	100189354	A	T	wt	het	n/a		QUAL=1057;DP=42,8,1;AF=0.38,0.38,0.00;MQM=55;SAP=13;ABP=53	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6901T>A::	regulatory_region_variant:promoter_flanking_region	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291393 [uncertain significance DISEASE=Maple syrup urine disease];		AluSz (SINE/Alu)	rs200062717	0.0074		3,.	1050	140914	0.4640			7.53				0		0	46	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190027	100190027	T	A	hom	hom	hom		QUAL=4322;DP=104,15,13;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291395 [benign DISEASE=Maple syrup urine disease,not provided];		MER3 (DNA/hAT-Charlie)	rs4281338	0.7567		45899,.	23284	36996	-0.7220			0.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190140	100190141	AA	-	het	wt	het		QUAL=3494;DP=180,57,89;AF=0.49,0.02,0.65;MQM=60;SAP=194;ABP=8	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291396 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Maple syrup urine disease,not provided];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711	0.1790		3079,.	21060	124836	0.4950			0.56				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190709	100190709	C	T	hom	hom	hom		QUAL=13994;DP=174,105,140;AF=0.99,1.00,1.00;MQM=60;SAP=30;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291404 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166412	0.7916		49079,.	22067	31647	-0.7530			0.12				0	17998437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190938	100190938	A	G	wt	het	wt		QUAL=1899;DP=403,187,261;AF=0.00,0.43,0.00;MQM=60;SAP=3;ABP=10	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5317T>C::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291406 [benign DISEASE=Maple syrup urine disease,not provided];			rs11166413	0.3056		8651,.	29150	105578	0.6970			8.55			COSV64497182	0	32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191105	100191105	T	C	hom	hom	hom		QUAL=24023;DP=361,156,207;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291407 [benign DISEASE=Maple syrup urine disease,not provided];			rs6701655	0.7590		46145,.	23087	36631	0.1090			2.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191773	ATACACACACACACACACACACACAC	-	het	wt	het		QUAL=1931;DP=28,26,51;AF=0.43,0.88,0.39;MQM=58;SAP=3;ABP=4	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4482_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1228726 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs1418854977	0.0429		241,.	5799	140077	0.6740			0.29				0		1	9	0 / 0					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191748	100191775	ATACACACACACACACACACACACACAC	-	het	hom	het		QUAL=1931;DP=28,26,51;AF=0.36,0.00,0.53;MQM=59;SAP=5;ABP=9	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4480_*4507del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1251386 [benign DISEASE=not provided];		(AC)n (Simple_repeat)	rs140341302	0.6814		34782,.	30103	46595	0.6740			0.28				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100193022	100193022	G	A	hom	hom	hom		QUAL=34953;DP=339,320,473;AF=0.99,1.00,1.00;MQM=60;SAP=4;ABP=0	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::	DBT:NM_001918.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	291424 [benign DISEASE=Maple syrup urine disease,not provided];			rs2784174	0.7592		46156,.	23090	36612	0.1950			1.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100206310	100206310	T	A	wt	het	wt	low_conf_region	QUAL=295;DP=244,77,112;AF=0.00,0.25,0.00;MQM=60;SAP=3;ABP=46	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron10/11:c.1336-9A>T::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron10/11:c.667-9A>T::	DBT:NM_001918.5:intron_variant:MODIFIER:intron9/10:c.1210-9A>T::,DBT:XM_005270545.4:intron_variant:MODIFIER:intron10/11:c.667-9A>T::,DBT:XM_017000468.2:intron_variant:MODIFIER:intron11/12:c.667-9A>T::,DBT:XM_017000469.2:intron_variant:MODIFIER:intron7/8:c.667-9A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	93987 [benign DISEASE=Maple syrup urine disease,not specified];			rs34229137	0.4005	0.1865,0.4504,0.3281,0.4141,0.3893	7976,.	29850	100356	0.7320			1.51		6.05>7.40	COSV64494912,COSV64495481	0.02	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100206504	100206504	T	C	hom	hom	hom		QUAL=29048;DP=343,245,303;AF=1.00,1.00,1.00;MQM=60;SAP=9;ABP=0	DBT	missense	DBT:ENST00000370132.8:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681617.1:missense_variant:MODERATE:exon10/12:c.1276A>G:p.Ser426Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681780.1:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)]	DBT:NM_001918.5:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:,DBT:XM_005270545.4:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:,DBT:XM_017000468.2:missense_variant:MODERATE:exon11/13:c.607A>G:p.Ser203Gly:,DBT:XM_017000469.2:missense_variant:MODERATE:exon7/9:c.607A>G:p.Ser203Gly:		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	128885 [benign DISEASE=Maple syrup urine disease,not specified,not provided];			rs12021720	0.9174	0.7628,0.9547,0.9692,0.9082,0.9519	58703,.	15816	18828	1.9390	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	12.46	0.12			0.01	30409984,29334895,21827660,9621512,30541556	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100215037	100215037	-	T	het	het	het	off-target;low_conf_region	QUAL=1313;DP=96,25,24;AF=0.55,0.48,0.42;MQM=60;SAP=125;ABP=3	DBT	intron	DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::,DBT:ENST00000370132.8:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron6/11:c.773-55dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron7/11:c.230-55dup::	DBT:NM_001918.5:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:XM_005270545.4:intron_variant:MODIFIER:intron7/11:c.230-55dup::,DBT:XM_017000468.2:intron_variant:MODIFIER:intron8/12:c.230-55dup::,DBT:XM_017000469.2:intron_variant:MODIFIER:intron4/8:c.230-55dup::,DBT:XR_946560.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.790-55dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1291007 [benign DISEASE=not provided];			rs11431894	0.7788		44764,.	23283	32037				0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100249898	100249898	G	A	hom	hom	hom	off-target	QUAL=12961;DP=46,191,275;AF=1.00,0.99,1.00;MQM=60;SAP=182;ABP=0		non_coding_transcript_exon	:ENST00000648283.1:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.272G>A::		regulatory_region_variant:promoter,TF_binding_site_variant	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 248600 (3), Autosomal recessive]	1263587 [benign DISEASE=not provided];			rs3806235	0.7239		43135,.	23715	41953	-1.2050			0.49						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	109228441	109228441	T	C	hom	hom	hom		QUAL=21691;DP=237,204,230;AF=1.00,1.00,1.00;MQM=60;SAP=24;ABP=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.288+9T>C::	SARS1:NM_001330669.1:intron_variant:MODIFIER:intron3/11:c.288+9T>C::,SARS1:NM_006513.4:intron_variant:MODIFIER:intron3/10:c.288+9T>C::	regulatory_region_variant:promoter_flanking_region	607529_[GENE=SARS1_PHENOS=?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327978 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs683182	0.7679	0.4629,0.8116,0.8993,0.7960,0.6581	39240,.	28373	45129	-0.6230			1.81			COSV52320213	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235955	109235955	T	C	hom	hom	hom	off-target	QUAL=18717;DP=176,160,262;AF=1.00,1.00,1.00;MQM=60;SAP=443;ABP=0	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::	SARS1:NM_001330669.1:intron_variant:MODIFIER:intron7/11:c.970-22T>C::,SARS1:NM_006513.4:intron_variant:MODIFIER:intron7/10:c.970-22T>C::		607529_[GENE=SARS1_PHENOS=?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327979 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures];			rs658092	0.7692	0.4870,0.8138,0.8988,0.7962,0.6586	39725,.	28416	44078	0.7830			9.53			COSV52320257	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110167097	110167097	T	C	het	het	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=76;ABP=202	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.522A>G::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1912A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333111 [benign DISEASE=Mental retardation, autosomal recessive 48];			rs7527375	0.4958	0.5055,0.2634,0.2103,0.5324,0.3637	18666,.	36772	75374	-5.6260			0.64			COSV58991969	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167098	110167098	G	A	het	wt	hom		QUAL=19106;DP=263,330,391;AF=0.46,0.00,1.00;MQM=60;SAP=231;ABP=7	SLC6A17,SLC6A17-AS1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.521C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::	SLC6A17:NM_001010898.4:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17:XM_006710643.2:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1911C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333112 [benign DISEASE=Mental retardation, autosomal recessive 48];			rs12737742	0.3725	0.0887,0.2113,0.2096,0.4562,0.3459	10397,.	29608	99698	0.6810	T(0.47), , 	B(0.05), , 	13.12	0.08		COSV58993671	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167112	110167112	G	A	wt	het	wt		QUAL=4215;DP=251,312,375;AF=0.00,0.55,0.00;MQM=60;SAP=104;ABP=9	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:PF00209 [Sodium neurotransmitter symporter family],SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.507C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.492C>T::	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon2/12:c.183G>A:p.Pro61=:,SLC6A17-AS1:XR_947695.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1897C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41281364	0.0584	0.0526,0.0342,0.0002,0.0745,0.0145	279,.	8279	142411	-3.5070			3.74			COSV58997789	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110195674	110195674	G	A	het	het	het		QUAL=16462;DP=306,383,543;AF=0.50,0.54,0.53;MQM=60;SAP=48;ABP=9	SLC6A17	synonymous	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	SLC6A17:NM_001010898.4:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:,SLC6A17:XM_006710643.2:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784140	0.4162	0.0971,0.3307,0.2726,0.4960,0.3911	12538,.	30838	96070	-2.0460			6.89			COSV58991975,COSV58995492	0.16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197651	110197651	G	T	het	het	het	off-target	QUAL=4715;DP=246,57,72;AF=0.54,0.40,0.58;MQM=60;SAP=372;ABP=5	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::,SLC6A17:XM_006710643.2:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603581	0.4147	0.1791,0.3314,0.2731,0.4937,0.3907	13008,.	33323	92627	-0.2150			2.45				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198066	110198066	C	T	het	het	het	off-target	QUAL=8883;DP=177,255,329;AF=0.47,0.50,0.47;MQM=60;SAP=138;ABP=5	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::	SLC6A17:NM_001010898.4:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::,SLC6A17:XM_006710643.2:intron_variant:MODIFIER:intron11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761445	0.4263	0.1831,0.3383,0.2739,0.5055,0.3988	13475,.	33361	91511	-0.7130			4.71		0.77>0.84	COSV58993252	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198459	110198459	C	G	het	het	wt		QUAL=2436;DP=136,119,157;AF=0.50,0.34,0.01;MQM=60;SAP=29;ABP=15	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::,SLC6A17:XM_006710643.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761446	0.0359	0.0071,0.0140,0.0000,0.0516,0.0315	145,.	4985	146903	1.2140			4.22			COSV58992447	0		65	1528	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198464	110198464	C	T	wt	het	wt		QUAL=1787;DP=135,140,207;AF=0.00,0.54,0.00;MQM=60;SAP=4;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::,SLC6A17:XM_006710643.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs41306175	0.0843	0.0844,0.0451,0.0045,0.1070,0.0165	569,.	11687	139299	-2.6300			0.06			COSV58995363	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198727	110198727	G	T	het	hom	het		QUAL=17097;DP=357,269,331;AF=0.47,1.00,0.57;MQM=60;SAP=4;ABP=5	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603580	0.6379		31868,.	33260	55072	-0.3460			0.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198961	110198961	C	G	het	hom	het		QUAL=10090;DP=171,176,215;AF=0.39,1.00,0.53;MQM=60;SAP=4;ABP=7	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784141	0.6381		31876,.	33240	55008	-1.1710			0.26				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199463	110199463	T	C	het	hom	het		QUAL=27438;DP=292,502,680;AF=0.44,1.00,0.49;MQM=60;SAP=23;ABP=8	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603579	0.6395		32025,.	33182	54816	0.6570			7.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199880	110199880	A	G	het	het	het	low_conf_region	QUAL=1558;DP=167,84,101;AF=0.32,0.25,0.26;MQM=59;SAP=156;ABP=146	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			(GATG)n (Simple_repeat)	rs2361044	0.4032		9505,.	26810	67814	-0.1920			5.40			COSV58997534	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199993	110199993	A	G	het	het	het		QUAL=2566;DP=123,70,108;AF=0.42,0.34,0.44;MQM=60;SAP=205;ABP=25	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			GA-rich (Low_complexity)	rs12133992	0.3558		11522,.	28249	92869	0.3660			3.70				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200370	110200370	T	G	het	het	het		QUAL=7293;DP=173,180,266;AF=0.51,0.53,0.45;MQM=60;SAP=4;ABP=3	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784142	0.3856		12839,.	32618	92898	0.3880			8.85				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200966	110200966	G	C	het	wt	het		QUAL=8420;DP=164,388,476;AF=0.53,0.00,0.52;MQM=60;SAP=12;ABP=6	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs151008748	0.0201		61,.	2933	148965	-0.6850			6.89				0		0	10	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201213	110201213	G	A	wt	het	wt		QUAL=2274;DP=218,164,183;AF=0.00,0.54,0.00;MQM=60;SAP=6;ABP=6	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2769G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12138403	0.0841		565,.	11661	139323	0.1650			2.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110201559	110201559	C	T	wt	het	wt		QUAL=1082;DP=101,96,123;AF=0.01,0.46,0.00;MQM=60;SAP=3;ABP=4	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	SLC6A17:NM_001010898.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3115C>T::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs62621393	0.0841		568,.	11661	139309	-4.2660			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202252	110202252	G	A	wt	wt	het	off-target	QUAL=1733;DP=60,110,162;AF=0.00,0.00,0.46;MQM=60;SAP=20;ABP=6	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs45445195	0.0216		59,.	3166	148896	-0.7690			0.43						0	7	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	114705129	114705129	A	-	wt	het	wt		QUAL=990;DP=203,75,113;AF=0.00,0.59,0.01;MQM=60;SAP=6;ABP=8	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2965del::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291946 [likely benign DISEASE=Noonan syndrome];			rs61652108	0.2028		3575,.	23651	121059	-0.3060			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114707222	114707222	G	A	wt	het	wt		QUAL=1561;DP=407,125,196;AF=0.00,0.51,0.01;MQM=60;SAP=27;ABP=3	NRAS	3'UTR	NRAS:ENST00000369535.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::	NRAS:NM_002524.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*872C>T::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	291967 [benign DISEASE=Noonan syndrome 6];			rs14804	0.2028		3569,.	23687	121159	0.3720			8.30			COSV65733786	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19)
chr1	114716780	114716780	C	T	het	wt	het		QUAL=3750;DP=185,111,128;AF=0.61,0.00,0.38;MQM=60;SAP=188;ABP=4	CSDE1,NRAS	downstream_gene,upstream_gene	CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,NRAS:ENST00000369535.5:upstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.4:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]										2.4560			21.10				0		0	2	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115029744	115029744	A	G	het	hom	het	off-target	QUAL=8194;DP=163,122,179;AF=0.48,1.00,0.48;MQM=60;SAP=183;ABP=4	TSHB	upstream_gene	TSHB:ENST00000256592.3:upstream_gene_variant:MODIFIER::::			188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs1321108	0.4225		14276,.	35489	87553	1.2730			14.76					24366283,26180634,27362444,25506236	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033402	115033402	A	G	hom	hom	hom		QUAL=17936;DP=259,135,149;AF=1.00,1.00,1.00;MQM=60;SAP=58;ABP=0	TSHB	missense	TSHB:ENST00000256592.3:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:	TSHB:NM_000549.5:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:,TSHB:XM_011542065.2:missense_variant:MODERATE:exon1/2:c.40A>G:p.Thr14Ala:		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	256640 [benign DISEASE=Congenital hypothyroidism,Secondary hypothyroidism,not specified,not provided];			rs10776792	0.9766	0.9947,0.9916,0.9999,0.9634,0.9611	72526,.	3454	3564	0.2070	T(0.63)	B(0.00)	3.81	0.05			0.04	25741868,28515030	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115286692	115286692	G	A	hom	het	hom		QUAL=20215;DP=183,276,388;AF=0.99,0.51,0.99;MQM=60;SAP=140;ABP=3	NGF,NGF-AS1	missense,intron&non_coding_transcript,5'UTR	NGF:ENST00000369512.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:ENST00000675637.2:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:ENST00000676038.2:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000679806.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680116.1:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000680540.1:missense_variant:MODERATE:exon1/1:c.104C>T:p.Ala35Val:,NGF:ENST00000680752.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000681124.1:5_prime_UTR_variant:MODIFIER:exon3/3:c.-368C>T::	NGF:NM_002506.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF-AS1:NR_157569.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:XM_006710663.3:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:XM_011541518.2:missense_variant:MODERATE:exon3/3:c.269C>T:p.Ala90Val:		162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers,not specified,not provided];			rs6330	0.3695	0.1882,0.3459,0.1629,0.4483,0.2346	10904,.	32263	97937	1.7880	D(0.04), ,D(0.04),D(0.04),D(0.04),D(0.04),D(0.04),D(0.04), 	B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), 	22.80	0.10		COSV65687373	0	21294249,21358750,19063739,17192954,17212826,18520591,18763222,22330829,23195334,23772677,23964269,25162994,26989097,27486327,28413930,29499660,30214536,30981636,28507530,28751869,26215504,30983028,26675984,22832952,23388219,23565345,27196537,29453651,19038326,18179783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119422896	119422896	C	T	het	wt	het		QUAL=10751;DP=464,297,355;AF=0.54,0.00,0.41;MQM=60;SAP=11;ABP=5	HSD3B2	3'UTR	HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:NM_001166120.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292274 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency,not provided];			rs1819698	0.2430		6732,.	23476	115062	0.6820			4.06				0	21708280,28652652,19197249,20660004,22638611,25114582,23284679,19168589,27814623,23593537,19230916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422941	119422941	C	G	het	wt	het		QUAL=10544;DP=434,291,354;AF=0.54,0.00,0.42;MQM=60;SAP=5;ABP=5	HSD3B2	3'UTR	HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::	HSD3B2:NM_000198.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:NM_001166120.2:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency];			rs1361530	0.1919		3633,.	21932	122972	-0.6320			0.57				0	21708280,28652652,23284679,19168589	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	147756396	147756396	G	A	wt	het	wt		QUAL=1649;DP=350,145,217;AF=0.00,0.46,0.00;MQM=60;SAP=15;ABP=5	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1766C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1766C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-21165G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1404290876	0.0001		0,.	6	152120	0.5250			3.18				0		0	2	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147756741	147756741	C	T	het	het	wt		QUAL=6287;DP=265,195,300;AF=0.51,0.55,0.00;MQM=60;SAP=5;ABP=6	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1421G>A::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20820C>T::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11240121	0.3140		8585,.	30492	104126	-0.2490			1.23				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757166	147757166	A	G	wt	wt	het		QUAL=2009;DP=214,134,161;AF=0.00,0.00,0.50;MQM=60;SAP=54;ABP=3	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*996T>C::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*996T>C::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20395A>G::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043806	0.1914		2906,.	23275	122917	1.5780			10.62					21076161,23134779,17412882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757430	147757430	G	A	het	het	wt		QUAL=7609;DP=351,316,383;AF=0.43,0.48,0.00;MQM=60;SAP=40;ABP=14	GJA5	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.138G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*732C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20131G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043802	0.2579		5551,.	28073	112747	0.3330			4.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757496	147757520	GGGCATTTGCCAGAGGTACATACCA	-	het	het	het	low_conf_region	QUAL=10324;DP=250,333,408;AF=0.54,0.51,0.44;MQM=60;SAP=3;ABP=5	GJA5	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.229_253del::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*642_*666del::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20040_744-20016del::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11267274	0.4875		18185,.	37258	77394	0.2250			2.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757554	147757554	G	A	wt	wt	het		QUAL=5574;DP=432,380,483;AF=0.00,0.00,0.45;MQM=60;SAP=3;ABP=15	GJA5	3'UTR,non_coding_transcript_exon	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,:ENST00000622634.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.262G>A::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*608C>T::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*608C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-20007G>A::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]	292441 [likely benign DISEASE=Familial atrial fibrillation];			rs36005900	0.1431		2113,.	17493	130061	0.6610			6.97				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147758109	147758109	C	T	wt	wt	het		QUAL=2632;DP=318,191,231;AF=0.00,0.01,0.45;MQM=60;SAP=37;ABP=7	GJA5	3'UTR,intron&non_coding_transcript	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,:ENST00000622634.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.480-245C>T::	GJA5:NM_005266.7:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:NM_181703.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:XM_005272951.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJA5:XM_017001044.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*53G>A::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-19452C>T::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1692141	0.1774		2590,.	21775	125029	-0.5590			4.27					23134779,22713807,17412882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760538	147760538	G	A	wt	het	wt		QUAL=3088;DP=307,250,365;AF=0.00,0.52,0.00;MQM=60;SAP=5;ABP=4	GJA5	5'UTR,intron	GJA5:ENST00000579774.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::	GJA5:NM_005266.7:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:NM_181703.4:5_prime_UTR_variant:MODIFIER:exon1/2:c.-73C>T::,GJA5:XM_005272951.4:intron_variant:MODIFIER:intron1/1:c.-33-1267C>T::,GJA5:XM_017001044.1:5_prime_UTR_variant:MODIFIER:exon2/3:c.-73C>T::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-17023G>A::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs191717313	0.0021		0,.	316	151834	-0.0050			7.22				0.12		0	34	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760632	147760632	T	C	het	het	het	off-target	QUAL=8401;DP=197,169,236;AF=0.49,0.56,0.58;MQM=60;SAP=257;ABP=14	GJA5	intron	GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::	GJA5:NM_005266.7:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::,GJA5:XM_005272951.4:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::,GJA5:XM_017001044.1:5_prime_UTR_variant:MODIFIER:exon2/3:c.-167A>G::,LOC102723321:XR_922079.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.744-16929T>C::	regulatory_region_variant:promoter_flanking_region	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]		CR112614 [CLASS=DFP MUT=ALT PHEN="Atrial fibrillation association with" GENE=GJA5];	L2c (LINE/L2)	rs10465885	0.4568		15874,.	37633	82519	-0.3630			1.03					21076161,23134779,23040431,27826129,22690879,28496873,24065925,26516624,29915175,28775688,30061737,29504899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150799227	150799227	T	C	hom	hom	hom		QUAL=34915;DP=350,341,363;AF=1.00,1.00,1.00;MQM=60;SAP=16;ABP=0	CTSK	synonymous,intron	CTSK:ENST00000271651.8:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000443913.2:synonymous_variant:LOW:exon7/8:c.1008A>G:p.Ala336=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676716.1:synonymous_variant:LOW:exon5/6:c.708A>G:p.Ala236=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron6/6:c.784+317A>G::,CTSK:ENST00000676824.1:synonymous_variant:LOW:exon8/9:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676966.1:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676970.1:synonymous_variant:LOW:exon7/8:c.843A>G:p.Ala281=:PF00112 [Papain family cysteine protease],CTSK:ENST00000677887.1:synonymous_variant:LOW:exon8/9:c.873A>G:p.Ala291=:PF00112 [Papain family cysteine protease],CTSK:ENST00000678337.1:synonymous_variant:LOW:exon6/7:c.867A>G:p.Ala289=:PF00112 [Papain family cysteine protease],CTSK:ENST00000679260.1:synonymous_variant:LOW:exon6/7:c.612A>G:p.Ala204=:PF00112 [Papain family cysteine protease]	CTSK:NM_000396.4:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:		601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]	1166561 [benign DISEASE=Pyknodysostosis,not provided];			rs10788796	0.9897	0.9221,0.9930,0.9930,0.9987,0.9776	72569,.	3402	3630	-7.3880			1.90				0.05		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151341298	151341298	A	G	het	hom	wt		QUAL=6590;DP=285,90,138;AF=0.49,1.00,0.01;MQM=60;SAP=37;ABP=3	RFX5	3'UTR,intron&non_coding_transcript	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,:ENST00000422153.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.255+396A>G::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	RFX5:NM_000449.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379412.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379413.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379414.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379415.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379416.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379417.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379418.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:NM_001379419.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*888T>C::,RFX5:NM_001379420.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*888T>C::,RFX5:XM_017001999.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:XM_017002000.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:XM_024448791.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292600 [benign DISEASE=Bare lymphocyte syndrome 2];			rs7552906	0.6292		30201,.	35155	56321	0.2160			5.21				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151341903	151341903	T	C	het	hom	het		QUAL=8308;DP=199,113,157;AF=0.56,1.00,0.47;MQM=60;SAP=416;ABP=4	RFX5	3'UTR,non_coding_transcript_exon	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.6:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,:ENST00000422153.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.295T>C::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	RFX5:NM_000449.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001025603.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379412.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379413.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379414.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379415.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379416.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379417.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379418.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:NM_001379419.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*283A>G::,RFX5:NM_001379420.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*283A>G::,RFX5:XM_017001999.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:XM_017002000.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:XM_024448791.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:promoter_flanking_region	601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292605 [benign DISEASE=Bare lymphocyte syndrome 2];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.7836		46919,.	25212	32872	-1.7860			1.28			COSV51841510	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151342811	151342811	G	C	het	het	wt		QUAL=3185;DP=118,137,186;AF=0.49,0.51,0.00;MQM=60;SAP=14;ABP=3	RFX5	missense	RFX5:ENST00000290524.8:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.6:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.7:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain]	RFX5:NM_000449.4:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001025603.2:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379412.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379413.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379414.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379415.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379416.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379417.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379418.1:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:,RFX5:NM_001379419.1:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:,RFX5:NM_001379420.1:missense_variant:MODERATE:exon10/10:c.1106C>G:p.Pro369Arg:,RFX5:XM_017001999.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:,RFX5:XM_017002000.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:,RFX5:XM_024448791.1:missense_variant:MODERATE:exon11/11:c.713C>G:p.Pro238Arg:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	292612 [benign DISEASE=Bare lymphocyte syndrome 2,not specified,not provided];			rs2233854	0.1172	0.0253,0.0720,0.0004,0.1665,0.0990	1332,.	14570	134848	1.7820	D(0.00),D(0.00),D(0.00)	B(0.11),B(0.11),B(0.11)	20.80	0.03		COSV51839208	0.01	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151343685	151343685	G	A	hom	hom	hom		QUAL=13278;DP=188,94,132;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0	RFX5	synonymous	RFX5:ENST00000290524.8:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.6:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452671.7:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:	RFX5:NM_000449.4:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001025603.2:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379412.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379413.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379414.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379415.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379416.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379417.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379418.1:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:NM_001379419.1:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:NM_001379420.1:synonymous_variant:LOW:exon8/10:c.633C>T:p.Leu211=:,RFX5:XM_017001999.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:,RFX5:XM_017002000.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:,RFX5:XM_024448791.1:synonymous_variant:LOW:exon9/11:c.240C>T:p.Leu80=:		601863_[GENE=RFX5_PHENOS=Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessive; Bare lymphocyte syndrome, type II, complementation group E, 209920 (3), Autosomal recessive]	403373 [benign DISEASE=Bare lymphocyte syndrome 2,not specified];			rs1752386	0.9945	0.9251,0.9964,1.0000,0.9999,0.9998	72963,.	2965	3231	0.0830			6.86				0.03	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152302209	152302209	T	A	hom	hom	hom		QUAL=8567;DP=95,63,107;AF=1.00,1.00,1.00;MQM=60;SAP=180;ABP=0	FLG,FLG-AS1	3'UTR,intron&non_coding_transcript	FLG:ENST00000368799.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-30374T>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-30374T>A::	FLG:NM_002016.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs1933061	0.9980		75809,.	304	304	-2.4350			0.05				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303673	152303673	C	T	het	het	het		QUAL=43645;DP=466,1277,1871;AF=0.49,0.50,0.51;MQM=59;SAP=52;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28910C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28910C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs77422831	0.2423	0.0294,0.4284,0.5593,0.1422,0.3682	3119,.	17606	127972	-2.0090	T(0.43), , , 	B(0.07), , , 	0.41	0.02		COSV64245538	0	27678121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303901	152303901	C	G	wt	het	het		QUAL=10141;DP=502,1476,2042;AF=0.05,0.19,0.31;MQM=28;SAP=456;ABP=1783	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2068C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28682C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28682C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10985G>C:p.Ser3662Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206244 [benign DISEASE=not specified,not provided];			rs75235053	0.0225	0.0002,0.0292,0.0645,0.0041,0.0201	0,.	2960	128916	-0.4810	D(0.01), , , 	P(0.76), , , 	14.34	0.03		COSV64238890	0	29281699	0	3788	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303983	152303983	C	T	wt	het	het		QUAL=17475;DP=424,1550,2203;AF=0.09,0.22,0.39;MQM=31;SAP=491;ABP=1094	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28600C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28600C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246453 [benign DISEASE=not provided];			rs75448155	0.0941	0.0104,0.1571,0.2732,0.0600,0.1449	0,.	4627	125523	1.6980	D(0.00), , , 	D(0.97), , , 	22.20	0.10		COSV64238118	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304107	152304107	C	G	het	het	het	low_conf_region	QUAL=11150;DP=352,899,632;AF=0.15,0.19,0.69;MQM=33;SAP=49;ABP=363	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2274C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28476C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28476C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10779G>C:p.Glu3593Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274774 [benign DISEASE=not provided];			rs12083389	0.1826	0.4017,0.1810,0.2813,0.0226,0.1261	2272,.	17836	100178	0.0220	T(1.00), , , 	B(0.01), , , 	0.24	0.04		COSV64240501	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304122	152304122	G	A	wt	het	hom	low_conf_region	QUAL=11614;DP=387,808,429;AF=0.07,0.21,0.98;MQM=31;SAP=140;ABP=607	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2289G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28461G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28461G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10764C>T:p.His3588=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1274484 [benign DISEASE=not provided];			rs12742178	0.0890	0.0246,0.1379,0.3089,0.0141,0.1036	712,.	9196	108730	-2.4390			0.12			COSV64237396	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304150	152304150	G	C	het	het	hom	low_conf_region	QUAL=6363;DP=445,754,313;AF=0.12,0.15,0.98;MQM=33;SAP=240;ABP=1339	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2317G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28433G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28433G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10736C>G:p.Thr3579Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1225072 [benign DISEASE=not provided];			rs3126075	0.2207	0.4692,0.1227,0.3199,0.0121,0.0769	5466,.	15324	92720	-4.9740	T(0.57), , , 	B(0.00), , , 	0.00	0.01		COSV64238703	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304195	152304195	C	T	wt	het	het	low_conf_region	QUAL=1743;DP=609,884,484;AF=0.10,0.13,0.26;MQM=45;SAP=277;ABP=1243	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2362C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28388C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28388C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10691G>A:p.Arg3564His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263753 [benign DISEASE=not provided];			rs7518080	0.0886	0.2098,0.2029,0.3318,0.0226,0.1590	1,.	6288	100524	-0.4320	T(1.00), , , 	B(0.00), , , 	0.21	0.01		COSV64235950	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304223	152304223	A	G	het	het	het	low_conf_region	QUAL=7750;DP=517,893,547;AF=0.25,0.14,0.55;MQM=36;SAP=808;ABP=795	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2390A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28360A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28360A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10663T>C:p.Trp3555Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265104 [benign DISEASE=not provided];			rs12728605	0.1377	0.2392,0.2063,0.3023,0.0353,0.1825	24,.	16253	102113	-0.2880	T(0.58), , , 	B(0.12), , , 	1.06	0.01		COSV64235956	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304296	152304296	C	A	het	het	het	low_conf_region	QUAL=32012;DP=411,1141,670;AF=0.45,0.44,0.86;MQM=57;SAP=60;ABP=99	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28287C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28287C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1237029 [benign DISEASE=not provided];			rs72697000	0.2461	0.0291,0.4311,0.5574,0.1447,0.3866	2021,.	17794	127888	-1.4330	T(0.73), , , 	D(1.00), , , 	6.17	0.06		COSV64247197	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304395	152304395	A	G	het	het	hom	low_conf_region	QUAL=38505;DP=531,1125,642;AF=0.41,0.47,0.99;MQM=59;SAP=8;ABP=36	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28188A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28188A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1231010 [benign DISEASE=not provided];			rs3126066	0.2861	0.4821,0.4531,0.5950,0.1468,0.3918	8359,.	26244	107212	-1.9970			0.22			COSV64245547,COSV64251897	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304413	152304413	A	G	het	het	hom	low_conf_region	QUAL=37803;DP=529,1141,633;AF=0.40,0.46,0.99;MQM=59;SAP=12;ABP=49	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28170A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28170A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1272130 [benign DISEASE=not provided];			rs3126067	0.3537	0.7179,0.4684,0.5971,0.1488,0.3926	14148,.	24670	96764	-2.0410			0.23			COSV64247205	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304579	152304579	C	G	het	het	het	low_conf_region	QUAL=26788;DP=484,851,546;AF=0.38,0.46,0.89;MQM=54;SAP=36;ABP=65	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-28004C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28004C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065955	0.3460	0.7135,0.4648,0.5895,0.1467,0.3798	13368,.	24748	97300	-0.7110	T(0.08), , , 	P(0.75), , , 	11.40	0.03		COSV64245550	0	29281699,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304692	152304692	A	G	het	het	hom		QUAL=45471;DP=527,1061,910;AF=0.47,0.45,0.99;MQM=51;SAP=250;ABP=26	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27891A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27891A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs3091276	0.3026	0.5216,0.4581,0.6032,0.1510,0.4066	9175,.	26245	102759	-1.2340			0.95			COSV64246356	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304833	152304833	G	A	wt	wt	het		QUAL=25932;DP=619,1360,2025;AF=0.00,0.00,0.51;MQM=54;SAP=3;ABP=6	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3000G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27750G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27750G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10053C>T:p.Asp3351=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs34687484	0.0039	0.0006,0.0035,0.0001,0.0051,0.0057	3,.	534	151388	-4.7750			0.07				0		5	224	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304869	152304869	C	T	het	het	het	low_conf_region	QUAL=47271;DP=573,1337,1985;AF=0.45,0.48,0.48;MQM=59;SAP=4;ABP=26	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27714C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27714C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs2065956	0.2428	0.0290,0.4286,0.5598,0.1423,0.3712	3146,.	17459	127937	-0.3080			0.30			COSV64237848	0	29281699,21163515,19733298,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304920	152304920	T	C	het	het	hom	low_conf_region	QUAL=80827;DP=521,1283,1870;AF=0.45,0.49,0.99;MQM=59;SAP=47;ABP=10	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27663T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27663T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302748 [benign DISEASE=not provided];			rs6681433	0.2728	0.1272,0.4468,0.5789,0.1653,0.4282	4067,.	22282	121018	-1.1510			0.19			COSV64251428	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305078	152305078	G	A	wt	wt	het		QUAL=19203;DP=503,1192,1542;AF=0.00,0.00,0.49;MQM=60;SAP=27;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3245G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27505G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27505G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9808C>T:p.Arg3270Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs35621145	0.0228	0.0041,0.0137,0.0191,0.0225,0.0564	54,.	2603	149035	-0.2850	D(0.04), , , 	P(0.84), , , 	16.54	0.11		COSV64237541	0		23	780	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305241	152305241	C	A	het	het	hom	low_conf_region	QUAL=41729;DP=296,897,1119;AF=0.35,0.35,1.00;MQM=48;SAP=289;ABP=232	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27342C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27342C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246798 [benign DISEASE=not provided];			rs9436066	0.3044	0.4829,0.4618,0.6400,0.1669,0.4309	8533,.	27741	104837	-4.7800			0.06			COSV64238716	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305346	152305346	T	C	het	wt	hom	low_conf_region	QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3513T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27237T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27237T>C::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.9540A>G:p.Ser3180=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174667 [benign DISEASE=not specified,not provided];			rs3126069	0.1576	0.0331,0.2724,0.4288,0.0439,0.2553	2574,.	16557	115991	-4.2200			0.79			COSV64242448,COSV64251192	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305350	152305350	A	C	het	wt	hom	low_conf_region	QUAL=8024;DP=322,656,340;AF=0.18,0.00,0.98;MQM=38;SAP=850;ABP=289	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-27233A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27233A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175078 [benign DISEASE=not specified,not provided];			rs2065957	0.2652	0.4397,0.3037,0.4669,0.0473,0.2644	6657,.	23041	100727	-1.7610	T(1.00), , , 	B(0.00), , , 	0.25	0.03		COSV64246955	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305958	152305958	T	G	het	het	wt	low_conf_region	QUAL=2702;DP=443,489,551;AF=0.23,0.24,0.00;MQM=39;SAP=487;ABP=558	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4125T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26625T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26625T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8928A>C:p.Glu2976Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1175150 [benign DISEASE=not specified,not provided];			rs61816760	0.3726	0.3544,0.3002,0.1149,0.3919,0.3118	607,.	39412	68406	-1.9480	T(0.54), , , 	B(0.25), , , 	0.04	0.02		COSV64235961	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306008	152306008	C	T	wt	wt	het		QUAL=3359;DP=437,702,878;AF=0.00,0.00,0.25;MQM=39;SAP=485;ABP=469	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4175C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26575C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26575C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8878G>A:p.Gly2960Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205931 [benign DISEASE=not specified,not provided];			rs61690342	0.0348	0.0988,0.0148,0.0170,0.0185,0.0459	4,.	4620	128396	-2.2770	T(0.29), , , 	B(0.00), , , 	0.24	0.04			0		0	819	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306079	152306079	T	C	het	het	het		QUAL=26888;DP=442,1310,1612;AF=0.25,0.25,0.50;MQM=46;SAP=834;ABP=480	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26504T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26504T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1242222 [benign DISEASE=not provided];			rs80221306	0.2073	0.0902,0.3298,0.4025,0.1353,0.3092	5,.	21103	112011	-0.3070	T(0.38), , , 	B(0.01), , , 	7.29	0.02		COSV64237772	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306213	152306213	C	A	het	het	hom		QUAL=149780;DP=692,2559,3381;AF=0.55,0.55,1.00;MQM=50;SAP=65;ABP=87	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26370C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26370C>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222401 [benign DISEASE=not provided];			rs57672167	0.2792	0.2106,0.4529,0.5810,0.1651,0.4244	5985,.	20434	107850	-4.9140			0.19			COSV64247949	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306338	152306338	C	T	wt	het	het	low_conf_region	QUAL=21671;DP=1099,2993,4213;AF=0.09,0.18,0.25;MQM=39;SAP=184;ABP=4853	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4505C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26245C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26245C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8548G>A:p.Gly2850Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1260709 [benign DISEASE=not provided];			rs2184952	0.0725	0.0452,0.1831,0.2761,0.0226,0.1603	0,.	3563	107117	-0.3030	T(0.85), , , 	B(0.12), , , 	1.83	0.02		COSV64238707	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306380	152306380	T	G	het	het	het		QUAL=16088;DP=851,2690,3957;AF=0.22,0.21,0.18;MQM=51;SAP=3;ABP=6147	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26203T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26203T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1246169 [benign DISEASE=not provided];			rs11582087	0.1781	0.0255,0.3147,0.3953,0.1105,0.2619	0,.	15921	117599	-0.6650	D(0.04), , , 	B(0.09), , , 	13.19	0.03		COSV64235994	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306543	152306543	G	A	het	het	het		QUAL=8471;DP=998,2435,4113;AF=0.15,0.19,0.17;MQM=35;SAP=11;ABP=7088	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4710G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-26040G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26040G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.8343C>T:p.Asp2781=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178454 [benign DISEASE=not provided];			rs57670307	0.1244	0.0176,0.2495,0.3700,0.0663,0.1923	0,.	12963	121019	-3.2420			0.77			COSV64241227,COSV64246502	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307253	152307253	C	T	het	het	hom		QUAL=71302;DP=588,1193,1542;AF=0.47,0.52,0.99;MQM=59;SAP=3;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25330C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25330C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302747 [benign DISEASE=not provided];			rs3126072	0.3095	0.5242,0.4626,0.6041,0.1658,0.4260	9449,.	27134	102714	-1.6190	T(0.45), , , 	B(0.00), , , 	1.64	0.02		COSV64248815	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307365	152307365	G	C	het	het	hom		QUAL=72640;DP=476,1191,1577;AF=0.49,0.51,1.00;MQM=59;SAP=29;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25218G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25218G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302746 [benign DISEASE=not provided];			rs3126074	0.3011	0.4833,0.4609,0.6037,0.1658,0.4261	8618,.	28172	105402	-5.2830	T(1.00), , , 	B(0.00), , , 	0.00	0.02		COSV100910597	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307444	152307444	A	G	het	het	hom		QUAL=75444;DP=456,1213,1666;AF=0.50,0.53,1.00;MQM=59;SAP=23;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25139A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25139A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1302745 [benign DISEASE=not provided];			rs55650366	0.2723	0.1323,0.4464,0.5791,0.1649,0.4241	4056,.	22438	120068	-1.1930	T(1.00), , , 	B(0.00), , , 	0.03	0.01		COSV64245556	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307488	152307488	C	T	wt	wt	het		QUAL=22736;DP=627,1226,1675;AF=0.00,0.00,0.52;MQM=60;SAP=23;ABP=10	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5655C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25095C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25095C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.7398G>A:p.Pro2466=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265210 [benign DISEASE=not provided];			rs71625199	0.0227	0.0034,0.0137,0.0191,0.0225,0.0559	47,.	2576	148776	-9.3410			0.11			COSV64236421	0	29281699	15	787	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307556	152307556	T	C	het	het	hom		QUAL=82483;DP=548,1329,1841;AF=0.47,0.51,1.00;MQM=58;SAP=87;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-25027T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25027T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1222131 [benign DISEASE=not provided];			rs71625200	0.2723	0.1324,0.4465,0.5790,0.1647,0.4240	4069,.	22510	120486	-1.0410	T(1.00), , , 	B(0.00), , , 	1.36	0.03		COSV64248823	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307694	152307694	C	G	het	het	hom		QUAL=56696;DP=464,1162,1440;AF=0.45,0.44,0.97;MQM=47;SAP=536;ABP=53	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24889C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24889C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239802 [benign DISEASE=not provided];			rs71625201	0.2585	0.1263,0.4148,0.5201,0.1622,0.4039	1665,.	23326	121884	-1.6180	T(0.37), , , 	B(0.01), , , 	0.20	0.02		COSV64237400	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307789	152307789	C	G	het	het	het		QUAL=34967;DP=503,1100,1084;AF=0.38,0.31,0.86;MQM=38;SAP=537;ABP=54	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24794C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24794C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1265666 [benign DISEASE=not provided];			rs71625202	0.2131	0.0305,0.3389,0.4093,0.1431,0.3311	414,.	21156	127046	-0.1640	D(0.01), , , 	D(0.97), , , 	14.30	0.09		COSV64236000	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307871	152307871	C	T	het	het	het	low_conf_region	QUAL=29872;DP=487,1151,1013;AF=0.34,0.29,0.79;MQM=37;SAP=262;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24712C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24712C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs139476473	0.1517	0.0218,0.2926,0.3790,0.0742,0.2640	1049,.	20538	126556	1.6960	D(0.02), , , 	D(0.94), , , 	22.80	0.14		COSV64236201	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307896	152307896	G	A	het	het	hom		QUAL=40990;DP=507,1116,1041;AF=0.48,0.34,0.99;MQM=36;SAP=1192;ABP=187	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24687G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24687G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179883 [benign DISEASE=not provided];			rs6664985	0.3001	0.4379,0.4447,0.6132,0.1053,0.4062	8554,.	27935	105053	-5.0360			0.07			COSV64242880	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307995	152307995	C	G	het	het	het	low_conf_region	QUAL=9792;DP=667,1350,1875;AF=0.23,0.14,0.29;MQM=37;SAP=139;ABP=2459	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6162C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24588C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24588C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6891G>C:p.Glu2297Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1286180 [benign DISEASE=not provided];			rs78179835	0.1955	0.0979,0.3197,0.3852,0.1256,0.3042	102,.	14442	105024	-1.2630	T(1.00), , , 	B(0.00), , , 	0.00	0.03		COSV64236496	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308209	152308209	C	A	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6376C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24374C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24374C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6677G>T:p.Gly2226Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs544807449	0.0214	0.0573,0.0448,0.1537,0.0034,0.0303	0,.	173	96461	-0.0090	T(0.07), , , 	B(0.37), , , 	9.62	0.17		COSV64242592,COSV64251050			0	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308211	152308211	C	T	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6378C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24372C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24372C>T::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6675G>A:p.Val2225=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244717 [benign DISEASE=not provided];			rs564482396	0.0235	0.0637,0.0529,0.1703,0.0039,0.0338	0,.	194	93928	-0.8000			0.36			COSV64243287,COSV64244530			0	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308212	152308212	A	G	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6379A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24371A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24371A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6674T>C:p.Val2225Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1255099 [benign DISEASE=not provided];			rs116918835	0.0334	0.0770,0.0904,0.2047,0.0070,0.0495	0,.	197	92835	-1.7780	T(0.52), , , 	B(0.00), , , 	0.36	0.04		COSV64243288			0	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308215	152308215	A	T	wt	wt	het	low_conf_region	QUAL=1916;DP=404,1243,1788;AF=0.03,0.06,0.15;MQM=55;SAP=127;ABP=1895	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6382A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24368A>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24368A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6671T>A:p.Leu2224Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235186 [benign DISEASE=not provided];			rs117945779	0.0410	0.1132,0.1120,0.2285,0.0089,0.0603	0,.	648	90562	-1.5680	T(0.99), , , 	B(0.00), , , 	1.12	0.03		COSV64235963	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308260	152308260	T	C	het	het	het		QUAL=23848;DP=788,1503,2391;AF=0.31,0.18,0.33;MQM=55;SAP=72;ABP=1994	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6427T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24323T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24323T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6626A>G:p.His2209Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1287967 [benign DISEASE=not provided];			rs66977240	0.2191	0.3443,0.3420,0.4132,0.1283,0.3119	0,.	23242	102886	-1.7600	T(0.75), , , 	B(0.00), , , 	0.00	0.01		COSV64235967	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308283	152308283	A	G	het	het	het		QUAL=36254;DP=855,1557,2674;AF=0.34,0.23,0.40;MQM=54;SAP=96;ABP=1154	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6450A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24300A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24300A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6603T>C:p.Asp2201=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1182765 [benign DISEASE=not provided];			rs2338554	0.2427	0.4274,0.3505,0.4200,0.1478,0.3295	2529,.	29172	107224	-1.1410			0.51			COSV64236535	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308306	152308306	A	G	het	het	hom		QUAL=131893;DP=886,1655,2790;AF=0.65,0.63,1.00;MQM=57;SAP=49;ABP=428	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24277A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24277A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1244740 [benign DISEASE=not provided];			rs2184953	0.3696	0.7165,0.4761,0.6055,0.1680,0.4295	14547,.	26803	95339	-5.5540	T(0.34), , , 	B(0.00), , , 	0.14	0.01		COSV64235971	0	29281699,28487959,18434257,27206134,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308312	152308312	T	G	het	het	het		QUAL=71680;DP=890,1660,2827;AF=0.31,0.27,0.73;MQM=55;SAP=110;ABP=18	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6479T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24271T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24271T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6574A>C:p.Lys2192Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1239242 [benign DISEASE=not provided];			rs66954353	0.2410	0.3644,0.3513,0.4198,0.1511,0.3321	51,.	34160	111858	-0.3510	T(1.00), , , 	B(0.00), , , 	0.66	0.02		COSV64236338	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308388	152308388	A	G	het	het	hom		QUAL=112027;DP=509,1512,2563;AF=0.61,0.66,1.00;MQM=55;SAP=3;ABP=378	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24195A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24195A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1223320 [benign DISEASE=not provided];			rs2184954	0.3044	0.4840,0.4611,0.6040,0.1658,0.4263	8796,.	28321	104897	-3.3990			0.94			COSV100910603	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308424	152308424	T	G	het	het	het		QUAL=32395;DP=702,1473,2391;AF=0.31,0.30,0.36;MQM=51;SAP=7;ABP=1059	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24159T>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24159T>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1174419 [benign DISEASE=not provided];			rs74129452	0.2384	0.3643,0.3503,0.4198,0.1470,0.3280	0,.	32860	112046	-4.1840	T(1.00), , , 	B(0.00), , , 	0.01	0.11		COSV64235975	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308531	152308531	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24052A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24052A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1221916 [benign DISEASE=not provided];			rs7512553	0.2288	0.3638,0.3437,0.4134,0.1326,0.2979	0,.	34101	114975	-0.1890	T(1.00), , , 	B(0.00), , , 	2.22	0.04		COSV64247222	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308532	152308532	A	G	het	het	het		QUAL=32683;DP=834,1597,2398;AF=0.29,0.31,0.32;MQM=59;SAP=54;ABP=1478	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24051A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24051A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179898 [benign DISEASE=not provided];			rs7512554	0.2286	0.3638,0.3437,0.4134,0.1326,0.2979	0,.	34116	115152	-2.6100			0.38			COSV64247223	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308563	152308563	G	A	het	het	het		QUAL=33540;DP=940,1648,2393;AF=0.30,0.32,0.31;MQM=60;SAP=26;ABP=1487	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-24020G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24020G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1179724 [benign DISEASE=not provided];			rs7522925	0.2282	0.3649,0.3438,0.4134,0.1327,0.2980	0,.	34194	115662	-3.2620	T(0.06), , , 	B(0.02), , , 	0.04	0.07		COSV64245563	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308752	152308752	C	G	het	het	het		QUAL=38189;DP=738,1968,2612;AF=0.25,0.35,0.33;MQM=53;SAP=26;ABP=1397	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6154C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23831C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23831C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6134G>C:p.Ser2045Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266034 [benign DISEASE=not provided];			rs7546186	0.2233	0.3448,0.3391,0.4078,0.1243,0.2958	0,.	33363	116073	1.0670	T(0.09), , , 	P(0.72), , , 	15.34	0.09		COSV64238126	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308814	152308814	A	G	het	het	het		QUAL=35392;DP=658,1993,2597;AF=0.22,0.34,0.33;MQM=51;SAP=15;ABP=1494	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6092A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23769A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23769A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.6072T>C:p.His2024=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1263645 [benign DISEASE=not provided];			rs80353812	0.2251	0.3573,0.3430,0.4129,0.1309,0.2980	0,.	33452	115158	-6.8100			0.14			COSV64245566	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308828	152308828	A	C	het	het	het		QUAL=36883;DP=666,1969,2608;AF=0.26,0.34,0.34;MQM=51;SAP=32;ABP=1376	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23755A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23755A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1266162 [benign DISEASE=not provided];			rs7512857	0.2234	0.3420,0.3425,0.4133,0.1323,0.2975	0,.	32559	116177	0.0140	T(0.18), , , 	D(0.93), , , 	10.79	0.03		COSV64245569	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308841	152308841	G	T	wt	wt	het		QUAL=21012;DP=793,2032,2642;AF=0.00,0.00,0.34;MQM=60;SAP=20;ABP=594	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6065G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23742G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23742G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.6045C>A:p.Asp2015Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1251416 [benign DISEASE=not provided];			rs71626704	0.0227	0.0034,0.0136,0.0190,0.0224,0.0559	47,.	2584	149470	-0.1350	T(0.20), , , 	B(0.23), , , 	2.51	0.05			0	29281699	15	787	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309003	152309003	G	T	het	het	hom		QUAL=106329;DP=888,1621,1993;AF=0.60,0.68,1.00;MQM=56;SAP=144;ABP=486	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23580G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23580G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278608 [benign DISEASE=not provided];			rs3126079	0.3684	0.7162,0.4760,0.6056,0.1679,0.4270	14548,.	26818	95850	-7.0030	T(0.81), , , 	B(0.00), , , 	0.00	0.02		COSV64242281	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309047	152309047	A	C	het	het	het		QUAL=20251;DP=816,1554,1835;AF=0.19,0.30,0.30;MQM=49;SAP=188;ABP=1818	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5859A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23536A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23536A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5839T>G:p.Trp1947Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1270895 [benign DISEASE=not specified,not provided];			rs80059102	0.2160	0.3165,0.3198,0.4060,0.1120,0.2686	0,.	31205	113269	-1.9190	T(0.31), , , 	B(0.00), , , 	2.79	0.01		COSV100912331,COSV64235980	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309058	152309058	A	T	het	het	het		QUAL=17143;DP=761,1514,1781;AF=0.18,0.28,0.28;MQM=48;SAP=241;ABP=2035	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5848A>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23525A>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23525A>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5828T>A:p.Leu1943His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1205946 [benign/likely benign DISEASE=not specified,not provided];			rs113544881	0.2002	0.2351,0.2815,0.3878,0.0756,0.2233	1,.	28162	112544	-2.1680	T(1.00), , , 	B(0.00), , , 	0.06	0.05		COSV64235983	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309214	152309214	C	T	het	het	het		QUAL=41084;DP=540,1169,1371;AF=0.47,0.51,0.53;MQM=59;SAP=4;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23369C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23369C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1247656 [benign DISEASE=not provided];			rs12407748	0.2422	0.0292,0.4282,0.5601,0.1421,0.3676	3092,.	17513	127639	-2.7720	T(0.46), , , 	B(0.17), , , 	0.01	0.05		COSV64235683	0	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309215	152309215	G	A	wt	wt	het		QUAL=16228;DP=558,1171,1371;AF=0.00,0.00,0.47;MQM=60;SAP=7;ABP=16	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5691G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23368G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23368G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5671C>T:p.Arg1891Trp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs36006086	0.0227	0.0041,0.0136,0.0190,0.0225,0.0559	48,.	2620	148856	-1.2590	D(0.01), , , 	D(0.98), , , 	18.13	0.04		COSV64237885,COSV64241834	0		17	785	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309269	152309269	G	T	wt	wt	het		QUAL=16358;DP=630,1185,1419;AF=0.00,0.00,0.45;MQM=60;SAP=10;ABP=33	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5637G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23314G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23314G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5617C>A:p.Gln1873Lys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1235678 [benign DISEASE=not provided];			rs62623409	0.0227	0.0041,0.0136,0.0189,0.0224,0.0557	50,.	2619	149073	2.7110	T(0.09), , , 	B(0.04), , , 	11.52	0.04		COSV64237889	0	29281699	17	785	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309472	152309472	G	A	het	het	het		QUAL=37609;DP=455,1118,1941;AF=0.48,0.51,0.39;MQM=58;SAP=12;ABP=110	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-23111G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23111G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1248526 [benign DISEASE=not provided];			rs12405241	0.2422	0.0290,0.4278,0.5603,0.1421,0.3679	3081,.	17510	127330	-5.8650	T(0.20), , , 	D(0.96), , , 	0.15	0.10		COSV64247244	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309616	152309616	T	C	wt	wt	het		QUAL=2595;DP=521,1243,1981;AF=0.00,0.00,0.17;MQM=52;SAP=3;ABP=1910	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5290T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22967T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22967T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5270A>G:p.Glu1757Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs778942937	0.0038	0.0000,0.0000,0.0000,0.0001,0.0001	0,.	569	147627	0.5620	T(0.11), , , 	B(0.08), , , 	15.12	0.03		COSV64244851	0		0	27	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309791	152309791	G	A	het	het	het		QUAL=36454;DP=420,1225,1518;AF=0.48,0.47,0.48;MQM=60;SAP=11;ABP=16	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22792G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22792G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12405278	0.2422	0.0290,0.4279,0.5603,0.1421,0.3680	3128,.	17559	127861	-0.0710	D(0.02), , , 	D(0.91), , , 	19.54	0.05		COSV64245576	0	22209813	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309835	152309835	C	T	het	het	het		QUAL=39271;DP=513,1234,1507;AF=0.46,0.48,0.51;MQM=60;SAP=28;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22748C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22748C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs12407807	0.2447	0.0644,0.4288,0.5603,0.1421,0.3681	3222,.	18836	126568	-4.5020	T(0.55), , , 	D(0.97), , , 	2.50	0.07		COSV64247251	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310046	152310046	C	T	wt	het	wt		QUAL=11248;DP=553,1012,1246;AF=0.00,0.48,0.00;MQM=60;SAP=11;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4860C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22537C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22537C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4840G>A:p.Ala1614Thr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]										-1.3830	T(0.20), , , 	B(0.16), , , 	3.62	0.03		COSV64246735	0		0	1	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310318	152310318	G	A	wt	wt	het		QUAL=16949;DP=442,1154,1462;AF=0.00,0.00,0.48;MQM=60;SAP=3;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4588G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22265G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22265G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4568C>T:p.Thr1523Ile:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1293919 [benign DISEASE=not provided];			rs12750081	0.0227	0.0041,0.0136,0.0190,0.0225,0.0559	50,.	2612	149214	-0.5980	D(0.04), , , 	B(0.04), , , 	7.59	0.01		COSV64247535	0		17	783	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310434	152310434	G	C	wt	wt	het		QUAL=18572;DP=490,1078,1491;AF=0.00,0.00,0.49;MQM=60;SAP=11;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4472G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22149G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22149G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4452C>G:p.Asp1484Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1278160 [benign DISEASE=not provided];			rs71626706	0.0227	0.0034,0.0136,0.0190,0.0225,0.0560	50,.	2593	148765	-4.7510	T(1.00), , , 	B(0.00), , , 	0.00	0.05		COSV64250380	0	29281699	17	786	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310441	152310441	G	T	het	het	het		QUAL=38082;DP=478,1070,1522;AF=0.49,0.50,0.50;MQM=59;SAP=13;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22142G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22142G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1277512 [benign DISEASE=not provided];			rs11204978	0.2422	0.0290,0.4279,0.5602,0.1420,0.3678	3082,.	17505	127733	0.0040	D(0.00), , , 	B(0.34), , , 	12.42	0.06		COSV64247255	0	29281699,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310476	152310476	A	G	wt	wt	het		QUAL=19714;DP=548,1142,1570;AF=0.00,0.00,0.49;MQM=60;SAP=15;ABP=5	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4430A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22107A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22107A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.4410T>C:p.His1470=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1241427 [benign DISEASE=not provided];			rs12732920	0.0227	0.0034,0.0136,0.0190,0.0225,0.0562	48,.	2603	148881	-7.1290			0.15				0		17	786	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310577	152310577	G	A	wt	wt	het		QUAL=20704;DP=588,1195,1684;AF=0.00,0.00,0.49;MQM=60;SAP=3;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4329G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-22006G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22006G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4309C>T:p.Arg1437Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	916211 [likely benign DISEASE=not provided];			rs12750571	0.0050	0.0006,0.0049,0.0002,0.0067,0.0066	4,.	717	151249	0.4170	D(0.01), , , 	P(0.64), , , 	22.40	0.04			0		4	351	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310760	152310760	T	C	het	het	hom		QUAL=76306;DP=531,1305,1681;AF=0.49,0.49,1.00;MQM=55;SAP=6;ABP=6	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21823T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21823T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1178727 [benign DISEASE=not provided];			rs11581433	0.2728	0.1321,0.4483,0.5792,0.1650,0.4241	4077,.	22549	121045	-3.1550	T(1.00), , , 	B(0.00), , , 	0.00	0.01		COSV64246547	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310807	152310807	C	T	het	het	het		QUAL=40127;DP=523,1245,1653;AF=0.49,0.50,0.49;MQM=54;SAP=15;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21776C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21776C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1253040 [benign DISEASE=not provided];			rs11586631	0.2423	0.0295,0.4279,0.5602,0.1420,0.3678	3117,.	17592	127692	-3.9920	T(0.83), , , 	B(0.05), , , 	0.02	0.02		COSV64245581	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311386	152311386	G	C	het	het	hom		QUAL=65048;DP=545,1105,1462;AF=0.48,0.50,1.00;MQM=54;SAP=4;ABP=4	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21197G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21197G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1298018 [benign DISEASE=not provided];			rs58001094	0.3655	0.6886,0.4595,0.5991,0.1656,0.4086	14267,.	26645	95809	-2.4700	T(1.00), , , 	B(0.01), , , 	0.03	0.05		COSV64238211	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311499	152311499	A	G	het	het	hom		QUAL=75643;DP=587,1206,1698;AF=0.51,0.50,1.00;MQM=52;SAP=14;ABP=4	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-21084A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21084A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1245184 [benign DISEASE=not provided];			rs66831674	0.3011	0.4836,0.4608,0.6036,0.1657,0.4260	8653,.	28269	105779	-2.6140			0.53			COSV64248837	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311901	152311901	G	A	het	wt	het		QUAL=30466;DP=613,1314,1577;AF=0.53,0.02,0.54;MQM=56;SAP=3;ABP=30	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20682G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20682G>A::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs373872833	0.0001	0.0000,0.0004,0.0001,0.0001,0.0001	0,.	15	149535	-1.2540			0.12			COSV64236179	0		0	4	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311948	152311948	G	C	wt	wt	het		QUAL=21818;DP=730,1324,1653;AF=0.02,0.04,0.51;MQM=55;SAP=85;ABP=5	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2958G>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20635G>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20635G>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2938C>G:p.His980Asp:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	402869 [benign DISEASE=not specified,not provided];			rs12756586	0.0251	0.0149,0.0140,0.0190,0.0225,0.0565	52,.	3345	134223	-3.1850	T(1.00), , , 	B(0.00), , , 	0.00	0.02		COSV64236115	0	24033266,29281699	17	826	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312002	152312002	A	G	wt	wt	het	low_conf_region	QUAL=622;DP=539,1303,1789;AF=0.01,0.07,0.13;MQM=39;SAP=112;ABP=2096	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2904A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20581A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20581A>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2884T>C:p.Trp962Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1200762 [likely benign DISEASE=not specified,not provided];			rs199888588	0.0222	0.0127,0.0002,0.0002,0.0001,0.0001	0,.	2695	118737	-1.9140	T(0.91), , , 	B(0.00), , , 	0.11	0.02		COSV64239582	0		0	271	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312021	152312021	A	G	wt	wt	het	low_conf_region	QUAL=2110;DP=517,1341,1947;AF=0.02,0.07,0.16;MQM=40;SAP=12;ABP=2015	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2885A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20562A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20562A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2865T>C:p.His955=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs144437056	0.0325	0.0280,0.0002,0.0003,0.0001,0.0001	0,.	3836	114286	-5.4140			0.18			COSV64248679	0		0	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312029	152312029	C	G	wt	wt	het		QUAL=2717;DP=545,1373,2009;AF=0.02,0.07,0.16;MQM=41;SAP=5;ABP=1993	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2877C>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20554C>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20554C>G::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2857G>C:p.Glu953Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206179 [benign DISEASE=not specified,not provided];			rs201137357	0.0468	0.1388,0.0031,0.0004,0.0005,0.0003	55,.	5530	114898	-0.1500	T(0.10), , , 	P(0.89), , , 	12.90	0.06		COSV64235720	0		0	0	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312065	152312065	G	A	wt	wt	het		QUAL=5;DP=529,1437,2146;AF=0.00,0.00,0.13;MQM=45;SAP=7;ABP=2613	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2841G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20518G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20518G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2821C>T:p.Arg941Cys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs138002269	0.0014	0.0001,0.0003,0.0001,0.0004,0.0012	0,.	212	149164	-0.4950	D(0.01), , , 	D(0.96), , , 	18.67	0.05		COSV64245372,COSV64246254	0		0	617	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312100	152312100	C	A	wt	wt	het		QUAL=1884;DP=584,1429,2116;AF=0.03,0.05,0.15;MQM=43;SAP=110;ABP=2300	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2806C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20483C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20483C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2786G>T:p.Gly929Val:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1206107 [likely benign DISEASE=not provided];			rs143382793	0.0141	0.0037,0.0001,0.0001,0.0001,0.0001	0,.	1725	120833	-0.6740	D(0.04), , , 	P(0.85), , , 	15.32	0.03		COSV64242745	0		0	814	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312121	152312121	A	C	wt	wt	het		QUAL=220;DP=519,1423,2109;AF=0.02,0.04,0.12;MQM=43;SAP=117;ABP=2583	FLG,FLG-AS1	missense,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2785A>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20462A>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20462A>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2765T>G:p.Ile922Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs201928359	0.0088	0.0000,0.0001,0.0000,0.0000,0.0000	0,.	1088	122926	-1.6050	T(1.00), , , 	B(0.00), , , 	2.17	0.02		COSV64236204	0		0	272	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312378	152312378	A	G	het	het	hom		QUAL=57578;DP=484,875,1247;AF=0.49,0.51,0.99;MQM=59;SAP=23;ABP=3	FLG,FLG-AS1	synonymous,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-20205A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20205A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1230019 [benign DISEASE=not provided];			rs3120653	0.3105	0.5223,0.4630,0.6035,0.1663,0.4245	9079,.	28150	102852	-2.3270			0.35			COSV104425295,COSV64244277	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312623	152312623	C	T	het	het	hom		QUAL=86295;DP=491,1419,1884;AF=0.51,0.50,1.00;MQM=60;SAP=24;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19960C>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.48C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19960C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	377878 [benign DISEASE=not specified];			rs74129461	0.2681	0.0746,0.4437,0.5790,0.1649,0.4238	3756,.	20635	123423	-0.4630	D(0.03), , , , 	B(0.22), , , , 	12.23	0.03		COSV64248843	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312705	152312705	G	T	wt	wt	het		QUAL=22886;DP=475,1377,1844;AF=0.00,0.00,0.48;MQM=60;SAP=31;ABP=7	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:PF03516 [Filaggrin],FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2201G>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19878G>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.130G>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19878G>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.2181C>A:p.His727Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs7512779	0.0227	0.0041,0.0137,0.0190,0.0225,0.0558	51,.	2615	149239	-4.9160	T(0.07), , , , 	B(0.15), , , , 	0.00	0.01			0		17	784	0 / 0					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313454	152313454	G	A	het	het	hom		QUAL=70473;DP=524,1174,1569;AF=0.51,0.49,0.99;MQM=60;SAP=10;ABP=3	FLG,FLG-AS1	missense,intron&non_coding_transcript,non_coding_transcript_exon	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19129G>A::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.879G>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19129G>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666623 [benign DISEASE=not specified,not provided];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.2726	0.1354,0.4467,0.5789,0.1649,0.4241	4065,.	22639	120535	-1.8060	T(1.00), , , , 	B(0.03), , , , 	0.00	0.04		COSV64239594	0	29281699,28866311,18193244,29774148,24521637	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313526	152313526	T	C	het	het	hom		QUAL=68625;DP=461,1149,1578;AF=0.48,0.49,0.99;MQM=60;SAP=6;ABP=5	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19057T>C::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.951T>C::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19057T>C::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.68T>C::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	666624 [benign DISEASE=not specified,not provided];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.3025	0.4865,0.4623,0.6050,0.1660,0.4262	8757,.	28312	105664	-1.3090	T(1.00), , , , , 	B(0.01), , , , , 	0.74	0.08		COSV64245598	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313556	152313556	C	T	het	het	het		QUAL=40828;DP=564,1210,1562;AF=0.48,0.50,0.46;MQM=60;SAP=5;ABP=17	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-19027C>T::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.981C>T::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19027C>T::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.98C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1249558 [benign DISEASE=not provided];			rs11588170	0.2421	0.0290,0.4281,0.5599,0.1419,0.3677	3090,.	17551	127743	-0.3500	T(0.18), , , , , 	P(0.82), , , , , 	14.31	0.04		COSV64247273	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313650	152313650	A	G	het	het	wt		QUAL=20668;DP=461,1206,1514;AF=0.50,0.50,0.00;MQM=60;SAP=4;ABP=3	FLG,FLG-AS1	synonymous,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18933A>G::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1075A>G::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18933A>G::	FLG:NM_002016.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.192A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]	1259919 [benign DISEASE=not specified,not provided];			rs11582620	0.1159	0.0178,0.0931,0.1025,0.1188,0.2011	914,.	12006	137552	-4.6310			0.81			COSV64236548	0	29281699,21163515,27206134,19733298,29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313891	152313891	C	A	het	het	hom		QUAL=59514;DP=569,910,1279;AF=0.51,0.50,1.00;MQM=60;SAP=142;ABP=3	FLG,FLG-AS1	missense,non_coding_transcript_exon,intron&non_coding_transcript	FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:ENST00000392688.7:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::,FLG-AS1:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG-AS1:ENST00000653548.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.390-18692C>A::,FLG-AS1:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1316C>A::,FLG-AS1:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18692C>A::	FLG:NM_002016.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,FLG-AS1:NR_103778.1:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.433C>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal dominant, Autosomal recessive; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)]				rs41267154	0.2719	0.1270,0.4463,0.5787,0.1648,0.4240	4024,.	22448	121326	-0.4760	D(0.04), , , , , 	D(1.00), , , , , 	14.12	0.02		COSV64246426	0	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FLG-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154156196	154156196	G	A	wt	het	wt		QUAL=797;DP=183,86,125;AF=0.01,0.45,0.00;MQM=60;SAP=7;ABP=5	TPM3	3'UTR	TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2773C>T::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001278190.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1443C>T::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1522C>T::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1443C>T::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2773C>T::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1443C>T::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.2285C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]			AluSq2 (SINE/Alu)	rs4540651	0.6116		29444,.	34008	59006	0.0330			1.28						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154156789	154156789	A	G	wt	het	wt		QUAL=132;DP=105,11,19;AF=0.00,0.73,0.00;MQM=60;SAP=7;ABP=8	TPM3	3'UTR	TPM3:ENST00000330188.13:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000368533.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:ENST00000611659.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::	TPM3:NM_001043351.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001043352.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001043353.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2180T>C::,TPM3:NM_001278188.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278189.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001278190.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*850T>C::,TPM3:NM_001278191.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NM_001349679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*929T>C::,TPM3:NM_001364679.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364680.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*850T>C::,TPM3:NM_001364681.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2180T>C::,TPM3:NM_153649.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*850T>C::,TPM3:NR_103461.2:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.1692T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]				rs1051370	0.3058		8025,.	30453	105547	-0.3650			9.61					18957677,20022891,23196875,24388127,26981122,27805284,18957674	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NUP210L (inh=n/a oe_syn=0.95 oe_mis=0.76 oe_lof=0.27), TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37)
chr1	154162081	154162081	A	C	wt	het	wt		QUAL=1949;DP=461,217,366;AF=0.00,0.44,0.00;MQM=60;SAP=22;ABP=10	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.665-3033T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.467-4360T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.602-4360T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.395-4360T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.744-4360T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.776-4360T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.776-3033T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*5856T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5856T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.665-4360T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.760-4360T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	292625 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs3196889	0.3024		7823,.	30283	105979	0.3690			5.62						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165752	154165752	G	A	wt	het	wt		QUAL=640;DP=198,37,56;AF=0.01,0.76,0.00;MQM=60;SAP=36;ABP=24	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4648C>T::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+4648C>T::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4648C>T::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3553C>T::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4648C>T::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2185C>T::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2185C>T::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4648C>T::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4648C>T::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	292666 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs10908723	0.3196		7583,.	29370	94818	-0.0240			2.22						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154165790	154165790	A	-	het	het	het		QUAL=1014;DP=145,27,40;AF=0.21,0.22,0.30;MQM=59;SAP=68;ABP=141	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+4610del::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+4610del::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+4610del::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+3515del::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+4610del::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2147del::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2147del::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+4610del::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+4610del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	292667 [likely benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSq2 (SINE/Alu)	rs68185418	0.2384		1418,.	16735	62523	-0.4990			0.20						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166689	154166689	-	T	wt	het	wt		QUAL=117;DP=183,36,38;AF=0.12,0.00,0.08;MQM=60;SAP=8;ABP=350	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3710dup::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3710dup::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3710dup::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2615dup::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3710dup::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1247dup::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247dup::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3710dup::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3710dup::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	292677 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];			rs72189266	0.4314		13897,.	35940	83994				6.06						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166690	154166690	T	-	het	wt	wt		QUAL=117;DP=183,36,38;AF=0.03,0.31,0.00;MQM=60;SAP=23;ABP=232	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3710del::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3710del::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3710del::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2615del::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3710del::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1247del::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1247del::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3710del::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3710del::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]			AluSx1 (SINE/Alu)	rs72189266	0.0004		0,.	57	147745	0.8190			5.50						0	11	0 / 0					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154166905	154166905	A	C	wt	het	wt		QUAL=552;DP=147,61,71;AF=0.00,0.44,0.01;MQM=60;SAP=18;ABP=5	TPM3	intron,3'UTR	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:ENST00000651641.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+3495T>G::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+3495T>G::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+3495T>G::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron8/8:c.743+2400T>G::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+3495T>G::,TPM3:NM_001364682.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_001364683.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1032T>G::,TPM3:NM_152263.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1032T>G::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+3495T>G::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+3495T>G::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	292682 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy];		AluSx1 (SINE/Alu)	rs6673171	0.3035		7855,.	30375	105761	0.7390			4.45						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154169432	154169432	A	G	wt	het	wt	off-target	QUAL=3050;DP=183,250,303;AF=0.00,0.50,0.00;MQM=60;SAP=50;ABP=3	TPM3	intron	TPM3:ENST00000271850.11:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:ENST00000302206.9:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:ENST00000323144.12:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000328159.9:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:ENST00000330188.13:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000368530.7:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:ENST00000368531.6:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000368533.8:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:ENST00000611659.4:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:ENST00000651641.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::	TPM3:NM_001043351.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043352.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001043353.2:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NM_001278188.2:intron_variant:MODIFIER:intron6/6:c.466+968T>C::,TPM3:NM_001278189.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001278190.2:intron_variant:MODIFIER:intron6/6:c.601+968T>C::,TPM3:NM_001278191.2:intron_variant:MODIFIER:intron7/7:c.394+968T>C::,TPM3:NM_001349679.2:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_001364679.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364680.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364681.2:intron_variant:MODIFIER:intron8/8:c.775+968T>C::,TPM3:NM_001364682.1:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_001364683.1:intron_variant:MODIFIER:intron7/8:c.665-49T>C::,TPM3:NM_152263.4:intron_variant:MODIFIER:intron8/9:c.776-49T>C::,TPM3:NM_153649.4:intron_variant:MODIFIER:intron7/7:c.664+968T>C::,TPM3:NR_103461.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.759+968T>C::		191030_[GENE=TPM3_PHENOS=CAP myopathy 1, 609284 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion, 255310 (3), Autosomal dominant, Autosomal recessive; Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3), Autosomal dominant, Autosomal recessive]	262627 [benign DISEASE=Congenital myopathy with fiber type disproportion,Nemaline myopathy 1,not specified,not provided];			rs4845364	0.6275	0.8127,0.7172,0.8686,0.5117,0.6475	31338,.	32644	56596	1.1000			18.83				0.01	25741868,32317632	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TPM3 (inh=AR+AD oe_syn=0.96 oe_mis=0.45 oe_lof=0.37), RN7SL431P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	154272666	154272666	T	G	wt	wt	het		QUAL=2989;DP=377,166,244;AF=0.00,0.02,0.50;MQM=60;SAP=3;ABP=3	HAX1	5'UTR	HAX1:ENST00000328703.12:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000457918.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:ENST00000483970.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	HAX1:NM_001018837.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::,HAX1:NM_006118.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-58T>G::	regulatory_region_variant:promoter	605998_[GENE=HAX1_PHENOS=Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessive]	292700 [benign DISEASE=Kostmann syndrome,not provided];			rs11265425	0.2172		4607,.	23808	119030	-2.1040			2.40			COSV55171217	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBAP2L (inh=n/a oe_syn=1.01 oe_mis=0.62 oe_lof=0.03), HAX1 (inh=AR oe_syn=0.87 oe_mis=0.97 oe_lof=0.85)
chr1	154576245	154576245	T	C	hom	hom	het		QUAL=9000;DP=115,126,108;AF=0.98,1.00,0.52;MQM=60;SAP=12;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2074T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072660	0.7061		38418,.	30466	44666	-2.5390			0.27				0	21467728,17373692,18593715,15154117,17503330,18534558,18571741,19259974,19760673,20854418,25036316,21606948,16314871,20736995,22180580,23691092,24667010,25640319,25778907,23350800,24486638,24057800,25774163,25259584,28054193,19698703,19665479,19854014	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576404	154576404	G	A	wt	wt	het		QUAL=1186;DP=76,62,106;AF=0.00,0.02,0.48;MQM=60;SAP=3;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*472G>A::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2233G>A::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072661	0.2534		4804,.	28896	113476	0.5620			5.30				0	22992668,21808284,25819021,18593715,18165968,15154117,17503330,18534558,19859904,20854418,25036316,21606948,20736995,22180580,23691092,24667010,25778907,19238175,19482438,19755656,20981002,22103610,22290489,23249876,23943838,29196725,18618000,23350800,24486638,22002450,24428733	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154576994	154576994	T	C	wt	wt	het		QUAL=3420;DP=299,241,299;AF=0.00,0.00,0.45;MQM=60;SAP=16;ABP=10	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1062T>C::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.2823T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs12130403	0.2979		6706,.	31846	106678	-0.0680			6.02				0.05	31832568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154578468	154578469	AG	-	wt	wt	het		QUAL=3336;DP=271,211,267;AF=0.00,0.00,0.49;MQM=60;SAP=23;ABP=3	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2538_*2539del::,CHRNB2:XR_001736952.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/6:n.4014+285_4014+286del::	regulatory_region_variant:promoter_flanking_region	118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs3841062	0.2699		5508,.	29993	110911	0.4920			1.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	154579534	154579534	C	G	het	het	wt		QUAL=8445;DP=296,338,412;AF=0.55,0.48,0.00;MQM=60;SAP=3;ABP=4	CHRNB2	3'UTR,intron&non_coding_transcript	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,:ENST00000421866.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.47+83G>C::	CHRNB2:NM_000748.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,CHRNB2:XM_017000180.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,CHRNB2:XR_001736952.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.4549C>G::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs1049998302	0.0001		0,.	2	152176	-0.4080			1.19				0		0	2	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155234893	155234893	A	G	wt	het	wt		QUAL=74;DP=52,18,27;AF=0.00,0.56,0.00;MQM=27;SAP=25;ABP=3	GBA1	3'UTR	GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::	GBA:NM_000157.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*102T>C::,GBA:NM_001005741.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA:NM_001005742.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*102T>C::,GBA:NM_001171811.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::,GBA:NM_001171812.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*102T>C::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial]				rs368275143	0.0194		14,.	235	13287	1.0560			6.97				0		0	6	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155234903	155234903	C	T	wt	het	wt		QUAL=123;DP=49,24,31;AF=0.00,0.58,0.00;MQM=28;SAP=33;ABP=4	GBA1	3'UTR	GBA1:ENST00000327247.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA1:ENST00000368373.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA1:ENST00000427500.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA1:ENST00000428024.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::	GBA:NM_000157.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*92G>A::,GBA:NM_001005741.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA:NM_001005742.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*92G>A::,GBA:NM_001171811.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::,GBA:NM_001171812.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*92G>A::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial]				rs708606	0.0071		1,.	127	18171	0.5230			6.12			COSV59168994	0	31077260	5	40	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155235878	155235878	G	T	hom	hom	hom	off-target;low_conf_region	QUAL=21497;DP=144,252,338;AF=0.98,1.00,1.00;MQM=56;SAP=755;ABP=0	GBA1	intron	GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::	regulatory_region_variant:promoter_flanking_region	606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial]	256871 [benign DISEASE=Gaucher disease type I,Gaucher disease, perinatal lethal,Gaucher disease,not specified,not provided];			rs3115534	0.9866	0.8399,0.9923,0.9996,0.9975,0.9983	68942,.	5961	7075	0.1160			1.83				0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155237596	155237596	A	T	het	het	wt	off-target	QUAL=4084;DP=191,140,174;AF=0.52,0.54,0.00;MQM=53;SAP=333;ABP=5	GBA1	intron	GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron5/9:c.615-18T>A::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron5/9:c.501-18T>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron5/9:c.615-18T>A::		606463_[GENE=GBA_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial]	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0086	0.0026,0.0034,0.0001,0.0130,0.0014	6,.	1300	150916	0.7750			7.07		10.84>7.92		0.03	25741868	4	514	0 / 0					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155754524	155754524	G	T	het	het	wt	off-target;low_conf_region	QUAL=212;DP=59,47,81;AF=0.41,0.11,0.04;MQM=50;SAP=72;ABP=50	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron28/30:c.*1298-1937C>A::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron27/31:c.5002-36C>A::,GON4L:XM_005245286.3:intron_variant:MODIFIER:intron12/16:c.3106-36C>A::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron27/31:c.5518-36C>A::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron26/30:c.5431-36C>A::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron27/31:c.5002-36C>A::					AluSg (SINE/Alu)	rs200722936	0.0585	0.0370,0.0498,0.0430,0.0547,0.0982	0,.	43	98949	0.1270			1.70			COSV55185833			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767594	155767594	C	T	hom	hom	hom	off-target	QUAL=8270;DP=38,118,156;AF=1.00,1.00,1.00;MQM=45;SAP=151;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron19/30:c.2647-53G>A::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron19/21:c.2647-53G>A::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron19/31:c.2131-53G>A::,GON4L:XM_005245286.3:intron_variant:MODIFIER:intron4/16:c.235-53G>A::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron18/30:c.2560-53G>A::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron19/31:c.2131-53G>A::						rs849712	0.9365		67305,.	7491	9633	-0.1340			3.66				0.12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785306	155785306	G	A	hom	hom	hom	off-target	QUAL=25676;DP=234,248,305;AF=1.00,1.00,1.00;MQM=60;SAP=188;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron13/30:c.1788+28C>T::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron13/21:c.1788+28C>T::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron13/31:c.1272+28C>T::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron13/30:c.1788+28C>T::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron13/31:c.1272+28C>T::						rs822021	0.9836	0.7734,0.9901,0.9999,0.9996,0.9996	67377,.	7548	9682	-1.0920			5.37				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815788	155815791	AACT	-	hom	hom	hom	off-target	QUAL=22150;DP=249,210,270;AF=1.00,1.00,1.00;MQM=60;SAP=212;ABP=0	GON4L	intron	GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000620426.4:intron_variant:MODIFIER:intron8/30:c.1161+14_1161+17del::,GON4L:ENST00000622608.1:intron_variant:MODIFIER:intron8/21:c.1161+14_1161+17del::	GON4L:NM_001282856.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282858.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282860.2:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:NM_001282861.2:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:NM_032292.6:intron_variant:MODIFIER:intron8/20:c.1161+14_1161+17del::,GON4L:XM_005245284.3:intron_variant:MODIFIER:intron8/31:c.645+14_645+17del::,GON4L:XM_006711393.3:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:XM_006711394.4:intron_variant:MODIFIER:intron8/31:c.1161+14_1161+17del::,GON4L:XM_011509658.2:intron_variant:MODIFIER:intron8/30:c.1161+14_1161+17del::,GON4L:XM_011509659.2:intron_variant:MODIFIER:intron8/31:c.645+14_645+17del::						rs148569012	0.9332	0.6358,0.9666,0.9991,0.9504,0.9506	57983,.	14913	20703	-0.2520			6.23				0.19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156055305	156055305	C	T	wt	het	wt		QUAL=1260;DP=86,108,167;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3	LAMTOR2	synonymous	LAMTOR2:ENST00000368302.3:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368304.9:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain],LAMTOR2:ENST00000368305.9:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:PF03259 [Roadblock/LC7 domain]	LAMTOR2:NM_001145264.2:synonymous_variant:LOW:exon2/3:c.111C>T:p.Tyr37=:,LAMTOR2:NM_014017.4:synonymous_variant:LOW:exon2/4:c.111C>T:p.Tyr37=:	regulatory_region_variant:promoter	610389_[GENE=LAMTOR2_PHENOS=Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessive]	1165734 [benign DISEASE=not provided];			rs7541	0.1214	0.0514,0.0910,0.0004,0.1614,0.0814	1270,.	15402	134156	-0.9160			8.58			COSV64145997	0	23341997	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UBQLN4 (inh=n/a oe_syn=0.86 oe_mis=0.56 oe_lof=0.12), LAMTOR2 (inh=AR oe_syn=1.11 oe_mis=0.57 oe_lof=0.30)
chr1	156135237	156135237	T	C	wt	het	wt		QUAL=341;DP=91,36,54;AF=0.01,0.47,0.00;MQM=60;SAP=20;ABP=3	LMNA	synonymous	LMNA:ENST00000361308.9:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:PF00038 [Intermediate filament protein],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000368301.6:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:PF00038 [Intermediate filament protein],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon6/13:c.564T>C:p.Ala188=:PF00038 [Intermediate filament protein],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon7/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon6/12:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon6/13:c.861T>C:p.Ala287=:PF00038 [Intermediate filament protein]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon5/13:c.525T>C:p.Ala175=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon6/11:c.618T>C:p.Ala206=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon8/13:c.861T>C:p.Ala287=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon5/10:c.861T>C:p.Ala287=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon5/12:c.861T>C:p.Ala287=:,LMNA:NM_170708.4:synonymous_variant:LOW:exon5/11:c.861T>C:p.Ala287=:,LMNA:XM_011509533.1:synonymous_variant:LOW:exon5/12:c.525T>C:p.Ala175=:,LMNA:XM_011509534.2:missense_variant:MODERATE:exon5/12:c.197T>C:p.Leu66Pro:,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon5/12:n.1108T>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48088 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM217020 [CLASS=DM? MUT=ALT PHEN="Cardiomyopathy dilated modifier of" GENE=LMNA];		rs538089	0.1760	0.4582,0.0653,0.0191,0.0722,0.1383	4475,.	17838	125380	-7.5680			5.54				0	25741868,24033266,15637659,20127487,28785654,18344805,23861362,23757202,29104234	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136137	156136137	G	A	wt	het	wt	off-target	QUAL=3073;DP=90,261,311;AF=0.01,0.49,0.00;MQM=60;SAP=14;ABP=3	LMNA	intron	LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron7/12:c.860+16G>A::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron7/11:c.1157+16G>A::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron8/12:c.1157+16G>A::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron7/11:c.1157+16G>A::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron7/12:c.1157+16G>A::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron6/12:c.821+16G>A::,LMNA:NM_001282624.2:intron_variant:MODIFIER:intron7/10:c.914+16G>A::,LMNA:NM_001282625.2:intron_variant:MODIFIER:intron9/12:c.1157+16G>A::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_005572.4:intron_variant:MODIFIER:intron6/9:c.1157+16G>A::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron6/11:c.1157+16G>A::,LMNA:NM_170708.4:intron_variant:MODIFIER:intron6/10:c.1157+16G>A::,LMNA:XM_011509533.1:intron_variant:MODIFIER:intron6/11:c.821+16G>A::,LMNA:XM_011509534.2:intron_variant:MODIFIER:intron6/11:c.533+16G>A::,LMNA:XR_921781.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.1444+16G>A::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	36474 [benign/likely benign DISEASE=Primary dilated cardiomyopathy,Charcot-Marie-Tooth disease,not specified,not provided];			rs534807	0.1757	0.4589,0.0650,0.0191,0.0713,0.1322	4477,.	17759	125349	0.5750			3.25				0	25741868,24033266,28785654,18344805,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156136394	156136394	T	C	wt	het	wt		QUAL=1107;DP=46,108,140;AF=0.00,0.46,0.00;MQM=60;SAP=14;ABP=4	LMNA	synonymous	LMNA:ENST00000361308.9:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368297.5:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368299.7:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368300.9:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000368301.6:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000448611.6:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:PF00932 [Lamin Tail Domain],LMNA:ENST00000473598.6:synonymous_variant:LOW:exon8/13:c.1041T>C:p.Asp347=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675667.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000675939.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000676385.2:synonymous_variant:LOW:exon9/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000677389.1:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000682650.1:synonymous_variant:LOW:exon8/12:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain],LMNA:ENST00000683032.1:synonymous_variant:LOW:exon8/13:c.1338T>C:p.Asp446=:PF00932 [Lamin Tail Domain]	LMNA:NM_001257374.3:synonymous_variant:LOW:exon7/13:c.1002T>C:p.Asp334=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon8/11:c.1095T>C:p.Asp365=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon10/13:c.1338T>C:p.Asp446=:,LMNA:NM_001282626.2:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon7/10:c.1338T>C:p.Asp446=:,LMNA:NM_170707.4:synonymous_variant:LOW:exon7/12:c.1338T>C:p.Asp446=:,LMNA:NM_170708.4:synonymous_variant:LOW:exon7/11:c.1338T>C:p.Asp446=:,LMNA:XM_011509533.1:synonymous_variant:LOW:exon7/12:c.1002T>C:p.Asp334=:,LMNA:XM_011509534.2:synonymous_variant:LOW:exon7/12:c.714T>C:p.Asp238=:,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon7/12:n.1625T>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48037 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];			rs505058	0.2268	0.6399,0.0747,0.0198,0.0734,0.1436	8429,.	17626	117582	-0.5110			5.62			COSV61542738	0	25741868,24033266,17327460,17994215,20127487,28785654,18344805,23861362,23757202,18780302,18830724,18848371,20574532,20594621,21537449,21903150,23164068,21132329,30781626,29104234,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137072	156137072	C	T	wt	het	wt	off-target	QUAL=2815;DP=183,239,371;AF=0.00,0.53,0.00;MQM=60;SAP=33;ABP=5	LMNA	intron	LMNA:ENST00000361308.9:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000368297.5:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:ENST00000368299.7:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368300.9:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:ENST00000368301.6:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:ENST00000473598.6:intron_variant:MODIFIER:intron9/12:c.1192-41C>T::,LMNA:ENST00000675667.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000675939.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron10/12:c.1489-41C>T::,LMNA:ENST00000677389.1:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron9/11:c.1489-41C>T::,LMNA:ENST00000683032.1:intron_variant:MODIFIER:intron9/12:c.1489-41C>T::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron8/12:c.1153-41C>T::,LMNA:NM_001282624.2:intron_variant:MODIFIER:intron9/10:c.1246-41C>T::,LMNA:NM_001282625.2:intron_variant:MODIFIER:intron11/12:c.1489-41C>T::,LMNA:NM_001282626.2:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_005572.4:intron_variant:MODIFIER:intron8/9:c.1489-41C>T::,LMNA:NM_170707.4:intron_variant:MODIFIER:intron8/11:c.1489-41C>T::,LMNA:NM_170708.4:intron_variant:MODIFIER:intron8/10:c.1489-41C>T::,LMNA:XM_011509533.1:intron_variant:MODIFIER:intron8/11:c.1153-41C>T::,LMNA:XM_011509534.2:intron_variant:MODIFIER:intron8/11:c.865-41C>T::,LMNA:XR_921781.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.1776-41C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66834 [benign DISEASE=not specified,not provided];			rs553016	0.1672	0.4276,0.0634,0.0192,0.0716,0.1376	3896,.	17618	126548	0.3860			6.84			COSV61542554	0.01	25741868,15637659,16262891,18344805	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156137743	156137743	C	T	het	wt	het		QUAL=6933;DP=148,261,349;AF=0.61,0.00,0.55;MQM=60;SAP=26;ABP=21	LMNA	splice_region&synonymous,synonymous,intron	LMNA:ENST00000361308.9:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000368297.5:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000368299.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368300.9:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368301.6:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000448611.6:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000473598.6:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:,LMNA:ENST00000675667.1:splice_region_variant&synonymous_variant:LOW:exon11/12:c.1698C>T:p.His566=:,LMNA:ENST00000675939.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron11/12:c.1608+511C>T::,LMNA:ENST00000677389.1:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron10/11:c.1608+511C>T::,LMNA:ENST00000683032.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:	LMNA:NM_001257374.3:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:NM_001282624.2:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:NM_001282625.2:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:NM_001282626.2:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_005572.4:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:NM_170707.4:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:NM_170708.4:intron_variant:MODIFIER:intron9/10:c.1608+511C>T::,LMNA:XM_011509533.1:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1362C>T:p.His454=:,LMNA:XM_011509534.2:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1074C>T:p.His358=:,LMNA:XR_921781.2:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon10/12:n.1985C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48048 [benign DISEASE=Cardiomyopathy,Dilated cardiomyopathy 1A,Familial partial lipodystrophy 2,Hutchinson-Gilford syndrome,Mandibuloacral dysplasia with type A lipodystrophy,Lethal tight skin contracture syndrome,Charcot-Marie-Tooth disease type 2B1,Congenital muscular dystrophy, LMNA-related,Charcot-Marie-Tooth disease,Emery-Dreifuss muscular dystrophy,Charcot-Marie-Tooth disease, type 2,Benign scapuloperoneal muscular dystrophy with cardiomyopathy,not specified,Cardiovascular phenotype,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-Girdle Muscular Dystrophy, Recessive,not provided];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.2627	0.0906,0.3237,0.2650,0.2651,0.2933	4003,.	24349	119727	-1.6030			8.23		9.30>7.83	COSV61541921	0	25741868,24033266,15637659,16262891,17327437,17327460,17327461,17994215,19841875,20127487,20501691,21108632,22303384,22340368,24244950,26365620,26379929,26602028,27182706,28785654,25649378,21980471,27409638,25151201,23090008,24019745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139185	156139185	G	C	wt	het	wt		QUAL=36;DP=68,7,15;AF=0.00,0.57,0.00;MQM=60;SAP=5;ABP=3	LMNA	3'UTR,intron	LMNA:ENST00000361308.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:ENST00000473598.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000675667.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*206G>C::,LMNA:ENST00000675939.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::,LMNA:ENST00000682650.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:ENST00000683032.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*79G>C::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+83G>C::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:NM_170708.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*79G>C::,LMNA:XM_011509533.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:XM_011509534.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*79G>C::,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2361G>C::	regulatory_region_variant:promoter_flanking_region	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	66756 [benign DISEASE=not specified,not provided];			rs7339	0.1697		4048,.	17640	125952	-0.0620			2.75			COSV61542559	0	16262891,28785654,18344805	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156139303	156139303	-	A	wt	het	wt		QUAL=51;DP=57,33,51;AF=0.02,0.24,0.04;MQM=60;SAP=8;ABP=22	LMNA	3'UTR,intron	LMNA:ENST00000368299.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000368300.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:ENST00000448611.6:intron_variant:MODIFIER:intron12/12:c.1655+215dup::	LMNA:NM_001257374.3:intron_variant:MODIFIER:intron12/12:c.1655+215dup::,LMNA:NM_001282626.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170707.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:NM_170708.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*211dup::,LMNA:XM_011509533.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:XM_011509534.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*211dup::,LMNA:XR_921781.2:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2493dup::		150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3); Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	1267964 [benign DISEASE=not provided];			rs200317083	0.1338		1718,.	13777	111481				13.27				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156815825	156815825	G	A	hom	hom	hom		QUAL=22395;DP=196,210,298;AF=1.00,1.00,1.00;MQM=60;SAP=54;ABP=0	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000392302.7:5_prime_UTR_variant:MODIFIER:exon1/17:c.-77G>A::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000674537.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-217G>A::	NTRK1:NM_001007792.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-5G>A::,SH2D2A:NM_001161441.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:NM_001161442.2:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:NM_001161443.2:intron_variant:MODIFIER:intron1/7:c.39+181C>T::,SH2D2A:NM_001161444.2:intron_variant:MODIFIER:intron2/7:c.123+181C>T::,SH2D2A:NM_003975.4:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:XM_006711615.2:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002762.2:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002763.1:intron_variant:MODIFIER:intron2/8:c.141+181C>T::,SH2D2A:XM_017002764.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:XM_017002765.1:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:XM_017002766.1:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:XM_017002767.1:intron_variant:MODIFIER:intron2/7:c.141+181C>T::	regulatory_region_variant:promoter	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	380853 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs1800601	0.6740	0.4989,0.6951,0.8177,0.6775,0.6549	31197,.	34046	55384	-1.8390			0.22			COSV63884607	0.04	20219210,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GT	wt	wt	het	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=15;ABP=82	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70dup::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70dup::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291502 [benign DISEASE=not provided];			rs56185968	0.0960		1280,.	11098	128600				1.16				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875700	156875700	-	GTGT	wt	wt	het	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.56,0.00;MQM=60;SAP=24;ABP=3	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+67_1321+70dup::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+67_1321+70dup::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+67_1393+70dup::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+67_1483+70dup::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+67_1501+70dup::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1236121 [benign DISEASE=not provided];			rs56185968	0.5038		19739,.	32345	70749				1.11				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156875701	156875702	GT	-	wt	het	wt	off-target;low_conf_region	QUAL=932;DP=16,39,44;AF=0.06,0.03,0.30;MQM=60;SAP=24;ABP=4	NTRK1	intron	NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron12/16:c.1321+69_1321+70del::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::,NTRK1:ENST00000674537.1:intron_variant:MODIFIER:intron13/17:c.1321+69_1321+70del::	NTRK1:NM_001007792.1:intron_variant:MODIFIER:intron12/16:c.1393+69_1393+70del::,NTRK1:NM_001012331.2:intron_variant:MODIFIER:intron11/15:c.1483+69_1483+70del::,NTRK1:NM_002529.4:intron_variant:MODIFIER:intron12/16:c.1501+69_1501+70del::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1291500 [benign DISEASE=not provided];		(GT)n (Simple_repeat)	rs56185968	0.1423		1561,.	17177	122379	0.3490			0.83				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156876441	156876441	G	A	het	hom	wt		QUAL=6437;DP=146,147,146;AF=0.51,1.00,0.00;MQM=60;SAP=50;ABP=3	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon14/17:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon15/18:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon14/17:c.1566G>A:p.Gln522=:,NTRK1:NM_001012331.2:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:,NTRK1:NM_002529.4:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	292889 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified,not provided];			rs6334	0.2203	0.1314,0.2163,0.3494,0.2144,0.2352	3221,.	24110	121520	0.2210			8.92			COSV62323674	0	23195334,21178826,29054434,20003389,29453651,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879203	156879203	C	T	het	wt	hom		QUAL=3877;DP=48,104,128;AF=0.33,0.01,0.97;MQM=60;SAP=11;ABP=15	NTRK1	synonymous	NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon15/17:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000674537.1:synonymous_variant:LOW:exon16/18:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase]	NTRK1:NM_001007792.1:synonymous_variant:LOW:exon15/17:c.1779C>T:p.Ala593=:,NTRK1:NM_001012331.2:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:,NTRK1:NM_002529.4:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	138564 [benign DISEASE=Hereditary insensitivity to pain with anhidrosis,not specified];			rs6337	0.5779	0.1981,0.5752,0.0396,0.7242,0.3929	25959,.	29030	70892	-3.9860			1.64			COSV62325231	0.04	26384852,20003389,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160039331	160039331	A	C	het	het	wt		QUAL=3042;DP=172,68,80;AF=0.50,0.46,0.00;MQM=60;SAP=7;ABP=3	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2715T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1171T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293090 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs1053074	0.4563		16600,.	35475	81821	1.6730			8.27			COSV63635370	0	16451705,25874548,19864112	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039353	160039353	G	C	hom	hom	hom		QUAL=8538;DP=143,59,69;AF=1.00,0.97,1.00;MQM=60;SAP=24;ABP=0	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2693C>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1149C>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293091 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs2486254	0.9977		74911,.	350	354	0.1670			3.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039375	AC	-	wt	wt	het		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=16	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2671_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2018_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1127_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2018_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293094 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.1202		987,.	14167	118131	0.6770			0.96				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039377	ACAC	-	wt	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=6;ABP=39	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2669_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2016_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1125_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293095 [benign/likely benign DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.1668		1898,.	18601	111851	0.6770			5.44				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039374	160039379	ACACAC	-	het	het	wt		QUAL=1024;DP=15,37,41;AF=0.33,0.46,0.07;MQM=60;SAP=5;ABP=46	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2667_487+2672del::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2014_*2019del::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+1123_587+1128del::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2014_*2019del::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293097 [uncertain significance(replaced by megSAP based on classifications:1x1,3x3) DISEASE=Pendred syndrome,Seizures, Sensorineural Deafness, Ataxia, Intellectual Disability, and Electrolyte Imbalance Syndrome,Nonsyndromic Hearing Loss, Mixed,not provided];		(AC)n (Simple_repeat)	rs56656397	0.0898		549,.	10978	122382	0.6770			5.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039629	160039629	A	C	hom	hom	hom		QUAL=31991;DP=368,263,345;AF=1.00,1.00,1.00;MQM=60;SAP=37;ABP=0	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2417T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+873T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293102 [benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome,not provided];			rs2486253	0.8189		51070,.	22339	27535	0.2820			7.94				0	25008907,32021205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160040361	160040361	C	T	wt	het	wt		QUAL=2265;DP=332,195,282;AF=0.00,0.50,0.00;MQM=60;SAP=6;ABP=3	KCNJ10	intron,3'UTR	KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+1685G>A::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1032G>A::,KCNJ10:ENST00000639408.1:intron_variant:MODIFIER:intron3/3:c.587+141G>A::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::	KCNJ10:NM_002241.5:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1032G>A::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	874513 [benign/likely benign DISEASE=Deafness, autosomal recessive 4, with enlarged vestibular aqueduct,EAST syndrome];			rs17375748	0.0447		208,.	6388	145408	0.2860			1.55				0	28520217	1	20	0 / 0					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160277200	160277200	T	-	het	het	het		QUAL=1365;DP=292,136,193;AF=0.18,0.22,0.17;MQM=60;SAP=3;ABP=538	PEX19	3'UTR,intron	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,:ENST00000485079.1:intron_variant:MODIFIER:intron5/6:c.487+931del::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2359del::,PEX19:NM_002857.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2351del::,PEX19:NR_036492.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3150del::,PEX19:NR_036493.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3174del::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]			Charlie10 (DNA/hAT-Charlie)	rs751979135	0.2519	0.2253,0.2326,0.2514,0.2578,0.2549	0,.	164	144762	-0.5870			0.23				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160277395	160277395	G	C	het	wt	hom		QUAL=10190;DP=282,165,217;AF=0.44,0.01,1.00;MQM=60;SAP=12;ABP=13	PEX19	3'UTR,intron	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,:ENST00000485079.1:intron_variant:MODIFIER:intron5/6:c.487+736C>G::	PEX19:NM_001193644.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2164C>G::,PEX19:NM_002857.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::,PEX19:NR_036492.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2955C>G::,PEX19:NR_036493.2:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2979C>G::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.4950	0.3382,0.4808,0.3476,0.5072,0.6152	16142,.	36891	82771	0.4650			3.34			COSV63619513	0.18	20819849,16451705,19001172,25284319	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160282002	160282002	A	G	het	wt	hom	off-target	QUAL=6879;DP=209,91,148;AF=0.44,0.00,1.00;MQM=60;SAP=298;ABP=9	PEX19	intron	PEX19:ENST00000368072.10:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,:ENST00000485079.1:intron_variant:MODIFIER:intron2/6:c.204+37T>C::	PEX19:NM_001193644.1:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NM_002857.4:intron_variant:MODIFIER:intron5/7:c.594+37T>C::,PEX19:NR_036492.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.493+37T>C::,PEX19:NR_036493.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.517+37T>C::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	1227462 [benign DISEASE=Peroxisome biogenesis disorder 12A,not provided];			rs2795067	0.6435	0.8687,0.5589,0.4645,0.5555,0.7045	32988,.	31799	54179	-1.4240			0.16			COSV63619299	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161170488	161170488	A	-	het	wt	het		QUAL=6439;DP=229,326,376;AF=0.46,0.00,0.46;MQM=60;SAP=80;ABP=12	PPOX	frameshift,intron	PPOX:ENST00000352210.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-132del::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-132del::	PPOX:NM_000309.5:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001122764.3:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001350128.2:frameshift_variant:HIGH:exon9/12:c.968del:p.Gln323ArgfsTer10:,PPOX:NM_001350129.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001350130.2:frameshift_variant:HIGH:exon10/13:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001350131.2:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:NM_001365398.1:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:NM_001365399.1:intron_variant:MODIFIER:intron9/11:c.988-132del::,PPOX:NM_001365400.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:NM_001365401.1:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_005245291.4:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:XM_005245295.3:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_006711402.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_006711403.2:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:,PPOX:XM_006711404.4:frameshift_variant:HIGH:exon10/13:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_006711406.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509663.2:frameshift_variant:HIGH:exon10/13:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_011509664.1:frameshift_variant:HIGH:exon10/13:c.1181del:p.Gln394ArgfsTer10:,PPOX:XM_011509665.2:frameshift_variant:HIGH:exon10/12:c.1196del:p.Gln399ArgfsTer10:,PPOX:XM_011509666.2:intron_variant:MODIFIER:intron9/11:c.1117-132del::,PPOX:XM_011509667.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509668.2:frameshift_variant:HIGH:exon10/13:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509670.2:frameshift_variant:HIGH:exon9/12:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509671.1:frameshift_variant:HIGH:exon10/13:c.1181del:p.Gln394ArgfsTer10:,PPOX:XM_011509672.3:frameshift_variant:HIGH:exon9/12:c.1082del:p.Gln361ArgfsTer10:,PPOX:XM_011509673.2:frameshift_variant:HIGH:exon8/11:c.932del:p.Gln311ArgfsTer10:,PPOX:XM_011509674.2:intron_variant:MODIFIER:intron7/9:c.937-132del::,PPOX:XM_011509678.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509679.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_011509681.1:frameshift_variant:HIGH:exon9/12:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_011509682.1:frameshift_variant:HIGH:exon9/12:c.365del:p.Gln122ArgfsTer10:,PPOX:XM_017001559.1:intron_variant:MODIFIER:intron9/11:c.1117-132del::,PPOX:XM_017001562.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001563.2:frameshift_variant:HIGH:exon10/13:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_017001564.1:frameshift_variant:HIGH:exon6/9:c.581del:p.Gln194ArgfsTer10:,PPOX:XM_017001566.2:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001567.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_017001570.1:frameshift_variant:HIGH:exon7/10:c.365del:p.Gln122ArgfsTer10:,PPOX:XM_017001571.1:intron_variant:MODIFIER:intron3/5:c.337-132del::,PPOX:XM_024447864.1:frameshift_variant:HIGH:exon8/11:c.932del:p.Gln311ArgfsTer10:,PPOX:XM_024447865.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_024447866.1:frameshift_variant:HIGH:exon10/13:c.659del:p.Gln220ArgfsTer10:,PPOX:XM_024447867.1:frameshift_variant:HIGH:exon9/12:c.659del:p.Gln220ArgfsTer10:,PPOX:XR_921850.2:non_coding_transcript_exon_variant:MODIFIER:exon9/12:n.1300del::		600923_[GENE=PPOX_PHENOS=Porphyria variegata, 176200 (3), Autosomal dominant]										7.2260							0.12		0	2	0 / 0					USP21 (inh=n/a oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=n/a oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161214269	161214269	-	TG	wt	wt	het		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=69;ABP=729	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359dup::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107dup::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359dup::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*149_*150dup::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107dup::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1621_1622dup::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293284 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Mitochondrial complex I deficiency,not provided];			rs10629771	0.2807		5962,.	29248	105488				1.48				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214269	161214269	-	TGTG	wt	het	wt		QUAL=1662;DP=228,160,212;AF=0.19,0.08,0.13;MQM=60;SAP=42;ABP=454	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*104_*107dup::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*356_*359dup::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*104_*107dup::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*356_*359dup::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*147_*150dup::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*104_*107dup::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1619_1622dup::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*104_*107dup::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	1253405 [benign DISEASE=not provided];			rs10629771	0.1292		1280,.	16401	127849				1.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214270	161214271	TG	-	het	wt	wt		QUAL=1662;DP=228,160,212;AF=0.02,0.08,0.27;MQM=60;SAP=92;ABP=691	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:ENST00000677579.1:3_prime_UTR_variant:MODIFIER:exon15/15:::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*106_*107del::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*358_*359del::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*106_*107del::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*358_*359del::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*149_*150del::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*106_*107del::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1621_1622del::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*106_*107del::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293286 [uncertain significance DISEASE=Mitochondrial complex I deficiency];		(TG)n (Simple_repeat)	rs10629771	0.0013		0,.	194	146494	0.3460			2.26				0		0	26	0 / 0					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161214307	161214307	A	G	wt	wt	het		QUAL=2153;DP=361,186,251;AF=0.00,0.00,0.39;MQM=60;SAP=112;ABP=29	NDUFS2	3'UTR	NDUFS2:ENST00000367993.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000392179.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000676600.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000676972.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000677231.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:ENST00000677453.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000677550.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:ENST00000677846.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*114A>G::,NDUFS2:ENST00000678507.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678511.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:ENST00000678783.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::,NDUFS2:ENST00000678911.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:ENST00000679176.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::	NDUFS2:NM_001166159.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*366A>G::,NDUFS2:NM_001377298.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:NM_001377299.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*114A>G::,NDUFS2:NM_001377300.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:NM_001377301.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*366A>G::,NDUFS2:NM_001377302.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*157A>G::,NDUFS2:NM_004550.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*114A>G::,NDUFS2:NR_165188.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.1629A>G::,NDUFS2:XM_005245209.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*114A>G::	regulatory_region_variant:promoter	602985_[GENE=NDUFS2_PHENOS=Mitochondrial complex I deficiency, nuclear type 6, 618228 (3), Autosomal recessive]	293289 [benign DISEASE=Mitochondrial complex I deficiency, nuclear type 1,not provided];			rs1136224	0.1418		1776,.	16859	123515	-0.8360			1.40				0	18682780,22545919,30782949,26053550,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS2 (inh=AR oe_syn=1.16 oe_mis=0.74 oe_lof=0.34), FCER1G (inh=n/a oe_syn=0.85 oe_mis=1.01 oe_lof=0.13)
chr1	161304858	161304858	G	C	wt	het	het		QUAL=71;DP=35,28,33;AF=0.00,0.29,0.30;MQM=60;SAP=42;ABP=25	MPZ	3'UTR	MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1018C>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1018C>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*826C>G::,MPZ:XM_017001321.2:intron_variant:MODIFIER:intron5/5:c.676-517C>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]				rs185093979	0.2822		1,.	20069	51057	-0.5840			0.46				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	161305115	161305115	T	C	wt	het	wt		QUAL=172;DP=68,29,18;AF=0.00,0.38,0.00;MQM=60;SAP=3;ABP=7	MPZ	3'UTR	MPZ:ENST00000491222.5:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000533357.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:ENST00000672287.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*761A>G::,MPZ:ENST00000672602.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::	MPZ:NM_000530.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*761A>G::,MPZ:NM_001315491.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*569A>G::,MPZ:XM_017001321.2:intron_variant:MODIFIER:intron5/5:c.676-774A>G::	regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal dominant, Autosomal recessive; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	293304 [benign DISEASE=Charcot-Marie-Tooth disease, demyelinating, type 1b,Roussy-Levy syndrome,Congenital hypomyelinating neuropathy 1, autosomal recessive,Charcot-Marie-Tooth disease dominant intermediate d,Congenital hypomyelinating neuropathy 2,not provided];			rs16832786	0.1292		1547,.	16520	132212	-1.1360			2.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	167430631	167430631	-	AG	hom	hom	hom		QUAL=15215;DP=189,147,177;AF=0.99,0.99,0.99;MQM=60;SAP=781;ABP=0	CD247,POU2F1	downstream_gene	CD247:ENST00000362089.10:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.3:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs5778549	0.9877		74289,.	1791	1873				0.42						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430725	167430725	T	C	hom	hom	hom		QUAL=39572;DP=382,380,464;AF=1.00,1.00,1.00;MQM=60;SAP=331;ABP=0	CD247	3'UTR	CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:NM_001378515.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:NM_001378516.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:NM_198053.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:XM_011510144.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:XM_011510145.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::	regulatory_region_variant:promoter_flanking_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs947480	0.9877		74309,.	1788	1868	-1.3400			1.51				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430837	167430837	T	A	hom	hom	hom		QUAL=44558;DP=402,433,558;AF=1.00,1.00,1.00;MQM=60;SAP=15;ABP=0	CD247	3'UTR	CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000392122.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::	CD247:NM_000734.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:NM_001378515.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:NM_001378516.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:NM_198053.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:XM_011510144.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:XM_011510145.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs1052231	0.8188		51196,.	22197	27575	-0.1800			2.97				0	25569266,18178846,30064597,19422667,23861880	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167439433	167439433	C	T	het	het	hom	off-target	QUAL=11562;DP=76,218,288;AF=0.54,0.49,0.99;MQM=60;SAP=166;ABP=3	CD247	intron	CD247:ENST00000362089.10:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron2/7:c.163-33G>A::	CD247:NM_000734.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:NM_001378515.1:intron_variant:MODIFIER:intron3/8:c.256-33G>A::,CD247:NM_001378516.1:intron_variant:MODIFIER:intron3/8:c.256-33G>A::,CD247:NM_198053.3:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:XM_011510144.2:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:XM_011510145.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1179252 [benign DISEASE=not provided];			rs840016	0.3109	0.0805,0.2358,0.1048,0.3992,0.2976	7499,.	28012	109122	0.5350			10.89			COSV62980812	0	20453842,20933377,22294642,22355377	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167518349	167518349	C	G	het	het	wt	off-target	QUAL=1448;DP=49,67,87;AF=0.53,0.55,0.00;MQM=60;SAP=115;ABP=5	CD247	intron	CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.3:intron_variant:MODIFIER:intron1/7:c.58+59G>C::	CD247:NM_000734.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:NM_001378515.1:intron_variant:MODIFIER:intron1/8:c.58+59G>C::,CD247:NM_001378516.1:intron_variant:MODIFIER:intron1/8:c.58+59G>C::,CD247:NM_198053.3:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:XM_011510144.2:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:XM_011510145.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1237879 [benign DISEASE=not provided];		(CCACTC)n (Simple_repeat)	rs35864197	0.1429		1771,.	18179	130325	0.8050			6.53				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	173826666	173826666	T	-	het	het	het	off-target;low_conf_region	QUAL=777;DP=119,21,45;AF=0.22,0.33,0.22;MQM=60;SAP=96;ABP=118	DARS2	intron	DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron1/14:c.128-5del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron1/16:c.128-5del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron1/15:c.128-5del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron1/13:c.128-5del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron1/16:c.128-5del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]	559192 [benign DISEASE=not provided];		(T)n (Simple_repeat)	rs746151025	0.4237	0.3542,0.4108,0.4051,0.4329,0.4481	4,.	1456	127406	0.0210			1.78				0.04		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CENPL (inh=n/a oe_syn=0.92 oe_mis=0.84 oe_lof=0.30), DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	173850284	173850284	A	-	het	het	het	off-target;low_conf_region	QUAL=443;DP=66,19,29;AF=0.23,0.26,0.24;MQM=60;SAP=62;ABP=72	DARS2	intron	DARS2:ENST00000647645.1:intron_variant:MODIFIER:intron11/15:c.1129-29del::,DARS2:ENST00000648458.1:intron_variant:MODIFIER:intron12/13:c.1192-29del::,DARS2:ENST00000648807.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:ENST00000648960.1:intron_variant:MODIFIER:intron12/13:c.1191+5007del::,DARS2:ENST00000649067.1:intron_variant:MODIFIER:intron12/14:c.1192-3051del::,DARS2:ENST00000649689.2:intron_variant:MODIFIER:intron12/16:c.1192-29del::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron12/15:c.1192-3051del::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron12/13:c.1192-29del::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron12/16:c.1192-29del::		610956_[GENE=DARS2_PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive]				rs199872112	0.1305	0.0973,0.1303,0.0955,0.1534,0.1207	0,.	153	115811	-2.2710			0.11						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr1	179550503	179550506	TTTC	-	wt	wt	het	off-target	QUAL=485;DP=124,52,58;AF=0.00,0.00,0.41;MQM=60;SAP=55;ABP=7	AXDND1	intron	AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4006_*1207-4003del::	AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-4006_3032-4003del::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-4006_3080-4003del::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-4006_3038-4003del::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-4006_2975-4003del::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-4006_2930-4003del::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-4006_2816-4003del::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-4006_2810-4003del::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-4006_2741-4003del::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-4006_2402-4003del::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-4006_1961-4003del::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-4006_2297-4003del::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-4006_2159-4003del::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-4006_2912-4003del::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs147171656	0.2023		3759,.	23206	121150	0.8130			9.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550745	179550745	T	C	hom	hom	hom		QUAL=27861;DP=267,272,327;AF=1.00,1.00,1.00;MQM=60;SAP=214;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3767T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3767T>C::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*428A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3767T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3767T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3767T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3767T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3767T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3767T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3767T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3767T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3767T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3767T>C::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*428A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3767T>C::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224486 [benign DISEASE=Nephrotic syndrome, type 2];			rs1060775	0.9045		62357,.	12792	14520	0.2640			3.71				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550915	179550915	T	C	het	hom	wt		QUAL=7961;DP=328,121,177;AF=0.45,1.00,0.00;MQM=60;SAP=42;ABP=9	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3597T>C::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3597T>C::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*258A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3597T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3597T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3597T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3597T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3597T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3597T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3597T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3597T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3597T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3597T>C::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*258A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3597T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224485 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs2274622	0.2418		4892,.	26967	115233	0.2590			6.33				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551016	179551016	C	T	hom	hom	hom		QUAL=24187;DP=285,194,263;AF=1.00,1.00,0.99;MQM=60;SAP=29;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3496C>T::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3496C>T::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*157G>A::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3496C>T::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3496C>T::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3496C>T::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3496C>T::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3496C>T::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3496C>T::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3496C>T::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3496C>T::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3496C>T::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3496C>T::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*157G>A::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3496C>T::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224483 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs1410590	0.9072		62758,.	12506	14114	-1.5440			0.37				0	23269701	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551119	179551119	C	G	hom	hom	hom		QUAL=22283;DP=391,131,174;AF=0.99,0.99,0.99;MQM=60;SAP=195;ABP=0	NPHS2,AXDND1	3'UTR,intron	NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3393C>G::	NPHS2:NM_001297575.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::,NPHS2:NM_014625.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3393C>G::,NPHS2:XM_005245483.3:3_prime_UTR_variant:MODIFIER:exon6/6:c.*54G>C::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3393C>G::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3393C>G::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3393C>G::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3393C>G::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3393C>G::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3393C>G::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3393C>G::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3393C>G::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3393C>G::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3393C>G::,NPHS2:XM_017002298.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*54G>C::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3393C>G::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	293845 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs1410591	0.6147		28851,.	35685	58533	0.9520			5.38			COSV62634863	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551371	179551371	G	A	hom	hom	hom		QUAL=20877;DP=349,128,184;AF=0.99,0.99,1.00;MQM=60;SAP=27;ABP=0	NPHS2,AXDND1	synonymous,intron	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3141G>A::	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-3141G>A::,NPHS2:XM_005245483.3:synonymous_variant:LOW:exon6/6:c.777C>T:p.Ala259=:,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-3141G>A::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-3141G>A::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-3141G>A::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-3141G>A::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-3141G>A::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-3141G>A::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-3141G>A::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-3141G>A::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-3141G>A::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-3141G>A::,NPHS2:XM_017002298.1:synonymous_variant:LOW:exon5/5:c.621C>T:p.Ala207=:,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-3141G>A::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260432 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs1410592	0.6190	0.6004,0.6654,0.4727,0.6310,0.6037	28786,.	35685	58617	-0.5620			2.36			COSV62634578	0	25741868,20947785,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552549	179552549	T	C	het	wt	het	off-target	QUAL=3037;DP=147,83,124;AF=0.44,0.00,0.47;MQM=60;SAP=156;ABP=8	NPHS2,AXDND1	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1963T>C::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron6/6:c.669+54A>G::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1963T>C::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron5/5:c.696+54A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-1963T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-1963T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-1963T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-1963T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-1963T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-1963T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-1963T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-1963T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-1963T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-1963T>C::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron4/4:c.540+54A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-1963T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1227202 [benign DISEASE=not provided];			rs11808359	0.0468		265,.	6582	144998	-0.1000			4.38				0		71	1771	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552596	179552596	T	C	wt	het	wt		QUAL=1100;DP=137,113,196;AF=0.01,0.44,0.00;MQM=60;SAP=18;ABP=6	NPHS2,AXDND1	splice_region&intron,intron	NPHS2:ENST00000367615.9:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,NPHS2:ENST00000367616.4:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1916T>C::	NPHS2:NM_001297575.2:splice_region_variant&intron_variant:LOW:intron6/6:c.669+7A>G::,NPHS2:NM_014625.4:splice_region_variant&intron_variant:LOW:intron7/7:c.873+7A>G::,AXDND1:NM_144696.6:intron_variant:MODIFIER:intron25/25:c.3032-1916T>C::,AXDND1:NR_073544.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron25/25:n.3080-1916T>C::,NPHS2:XM_005245483.3:splice_region_variant&intron_variant:LOW:intron5/5:c.696+7A>G::,AXDND1:XM_011509165.1:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509166.3:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509167.3:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509168.1:intron_variant:MODIFIER:intron26/26:c.3038-1916T>C::,AXDND1:XM_011509169.1:intron_variant:MODIFIER:intron25/25:c.2975-1916T>C::,AXDND1:XM_011509170.1:intron_variant:MODIFIER:intron25/25:c.2930-1916T>C::,AXDND1:XM_011509171.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::,AXDND1:XM_011509174.1:intron_variant:MODIFIER:intron24/24:c.2816-1916T>C::,AXDND1:XM_011509175.1:intron_variant:MODIFIER:intron23/23:c.2810-1916T>C::,AXDND1:XM_011509176.1:intron_variant:MODIFIER:intron24/24:c.2741-1916T>C::,AXDND1:XM_011509179.2:intron_variant:MODIFIER:intron21/21:c.2402-1916T>C::,AXDND1:XM_011509181.2:intron_variant:MODIFIER:intron16/16:c.1961-1916T>C::,AXDND1:XM_017000257.2:intron_variant:MODIFIER:intron20/20:c.2297-1916T>C::,AXDND1:XM_017000258.2:intron_variant:MODIFIER:intron20/20:c.2159-1916T>C::,NPHS2:XM_017002298.1:splice_region_variant&intron_variant:LOW:intron4/4:c.540+7A>G::,AXDND1:XM_024453104.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::,AXDND1:XM_024453107.1:intron_variant:MODIFIER:intron25/25:c.2912-1916T>C::	regulatory_region_variant:promoter_flanking_region	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260430 [benign/likely benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs115778946	0.0305	0.0082,0.0236,0.0000,0.0488,0.0103	97,.	4326	147484	-0.3160			1.92				0.06	25741868	60	1760	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559782	179559782	G	A	wt	wt	het	off-target	QUAL=2053;DP=167,134,157;AF=0.00,0.00,0.53;MQM=60;SAP=12;ABP=4	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-21C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-21C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-21C>T::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron1/5:c.275-21C>T::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron2/4:c.379-21C>T::,NPHS2:XM_017002299.1:intron_variant:MODIFIER:intron3/4:c.452-21C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180466 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs12401708	0.2376	0.0633,0.2414,0.0433,0.2751,0.2021	3794,.	23157	121243	0.0840			2.16				0	20947785,26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559807	179559807	G	A	wt	wt	het	off-target	QUAL=1838;DP=145,114,138;AF=0.00,0.00,0.54;MQM=60;SAP=21;ABP=5	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-46C>T::	NPHS2:NM_001297575.2:intron_variant:MODIFIER:intron3/6:c.452-46C>T::,NPHS2:NM_014625.4:intron_variant:MODIFIER:intron3/7:c.452-46C>T::,NPHS2:XM_005245483.3:intron_variant:MODIFIER:intron1/5:c.275-46C>T::,NPHS2:XM_017002298.1:intron_variant:MODIFIER:intron2/4:c.379-46C>T::,NPHS2:XM_017002299.1:intron_variant:MODIFIER:intron3/4:c.452-46C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1180467 [benign DISEASE=Nephrotic syndrome, type 2,not provided];			rs12401711	0.2370	0.0631,0.2396,0.0434,0.2736,0.2011	3795,.	23177	121203	-0.3660			1.72			COSV62635112	0	26820844	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179575763	179575763	T	C	n/a	hom	hom		QUAL=442;DP=1,3,13;AF=1.00,1.00,1.00;MQM=60;SAP=4;ABP=0	NPHS2	synonymous	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:	NPHS2:NM_001297575.2:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:,NPHS2:NM_014625.4:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:XM_005245483.3:synonymous_variant:LOW:exon1/6:c.102A>G:p.Gly34=:,NPHS2:XM_017002298.1:synonymous_variant:LOW:exon1/5:c.102A>G:p.Gly34=:,NPHS2:XM_017002299.1:synonymous_variant:LOW:exon1/5:c.102A>G:p.Gly34=:		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260424 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not specified,not provided];			rs1079292	0.9774	0.8073,0.9855,0.9753,0.9928,0.9446	68551,.	6873	7987	-0.4120			2.12			COSV62634486	0	25741868,20947785,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575915	179575915	C	A	n/a	wt	het		QUAL=196;DP=1,9,18;AF=0.00,0.00,0.61;MQM=60;SAP=3;ABP=5	NPHS2	5'UTR	NPHS2:ENST00000367615.9:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:ENST00000367616.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::	NPHS2:NM_001297575.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-51G>T::,NPHS2:NM_014625.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-51G>T::,NPHS2:XM_005245483.3:5_prime_UTR_variant:MODIFIER:exon1/6:c.-51G>T::,NPHS2:XM_017002298.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-51G>T::,NPHS2:XM_017002299.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-51G>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	225144 [benign DISEASE=Nephrotic syndrome, type 2,not specified,not provided]; 225143 [pathogenic DISEASE=Nephrotic syndrome, type 2];	CR068160 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs12406197	0.2545	0.1427,0.3448,0.0981,0.2766,0.1991	4502,.	26994	116076	-1.1430			4.19			COSV62635817	0	20947785,16900088,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179575980	179575980	G	A	n/a	hom	wt	off-target	QUAL=67;DP=1,4,7;AF=1.00,1.00,0.00;MQM=60;SAP=14;ABP=0	NPHS2,RNU5F-2P	upstream_gene	NPHS2:ENST00000367615.9:upstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:upstream_gene_variant:MODIFIER::::,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::	NPHS2:XM_017002298.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-116C>T::,NPHS2:XM_017002299.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-116C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1165811 [benign DISEASE=Steroid-resistant nephrotic syndrome,Nephrotic syndrome, type 2,not provided];	CR068161 [CLASS=FP MUT=ALT PHEN="Reduced expression" GENE=NPHS2];		rs1079291	0.2331		4745,.	25907	116435	-4.5670			0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180230249	180230249	-	AG	het	hom	wt	off-target	QUAL=207;DP=30,8,9;AF=0.37,1.00,0.00;MQM=60;SAP=44;ABP=8	LHX4	upstream_gene	LHX4:ENST00000263726.4:upstream_gene_variant:MODIFIER::::	LHX4:XM_011510105.2:intron_variant:MODIFIER:intron1/5:c.-108+1339_-108+1340dup::,LHX4:XM_011510106.3:intron_variant:MODIFIER:intron1/5:c.-108+1099_-108+1100dup::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]			G-rich (Low_complexity)	rs138033992	0.4142		13157,.	35628	87604				18.33						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180266593	180266593	C	T	het	wt	het		QUAL=1863;DP=74,91,107;AF=0.51,0.00,0.42;MQM=60;SAP=88;ABP=6	LHX4	splice_region&synonymous	LHX4:ENST00000263726.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:	LHX4:NM_033343.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:,LHX4:XM_011510105.2:splice_region_variant&synonymous_variant:LOW:exon3/6:c.267C>T:p.Asn89=:,LHX4:XM_011510106.3:splice_region_variant&synonymous_variant:LOW:exon3/6:c.267C>T:p.Asn89=:,LHX4:XM_011510108.2:splice_region_variant&synonymous_variant:LOW:exon3/6:c.225C>T:p.Asn75=:,LHX4:XM_017002755.1:splice_region_variant&synonymous_variant:LOW:exon2/5:c.225C>T:p.Asn75=:	regulatory_region_variant:promoter_flanking_region	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262223 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified,not provided];			rs16855642	0.0389	0.1045,0.0092,0.0111,0.0105,0.0175	261,.	5396	146194	-0.7690			8.34		9.89>9.26		0	25741868	9	539	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271375	180271375	T	C	het	het	wt		QUAL=1647;DP=67,77,115;AF=0.52,0.47,0.00;MQM=60;SAP=76;ABP=3	LHX4,ACBD6	splice_region&intron,3'UTR	LHX4:ENST00000263726.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1850A>G::	LHX4:NM_033343.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,LHX4-AS1:NR_037642.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.945A>G::,LHX4:XM_011510105.2:splice_region_variant&intron_variant:LOW:intron3/5:c.269-5T>C::,LHX4:XM_011510106.3:splice_region_variant&intron_variant:LOW:intron3/5:c.269-5T>C::,LHX4:XM_011510108.2:splice_region_variant&intron_variant:LOW:intron3/5:c.227-5T>C::,LHX4:XM_017002755.1:splice_region_variant&intron_variant:LOW:intron2/4:c.227-5T>C::,ACBD6:XR_001737484.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.5372A>G::,ACBD6:XR_001737485.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.5355A>G::,ACBD6:XR_002957801.1:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.5274A>G::,ACBD6:XR_921977.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.5499A>G::,ACBD6:XR_921978.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.5503A>G::	regulatory_region_variant:promoter_flanking_region	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	293866 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not provided];			rs2764449	0.0658	0.0140,0.0291,0.0113,0.0780,0.0791	357,.	8038	143352	1.0550			8.63		10.03>9.20	COSV55378051	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180274389	180274389	A	G	het	het	het		QUAL=7700;DP=210,155,203;AF=0.48,0.48,0.57;MQM=60;SAP=6;ABP=4	LHX4,ACBD6	missense,intron	LHX4:ENST00000263726.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron10/13:c.*936+262T>C::	LHX4:NM_033343.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,LHX4-AS1:NR_037642.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.31+262T>C::,LHX4:XM_011510105.2:missense_variant:MODERATE:exon6/6:c.800A>G:p.Asn267Ser:,LHX4:XM_011510106.3:missense_variant:MODERATE:exon6/6:c.800A>G:p.Asn267Ser:,LHX4:XM_011510108.2:missense_variant:MODERATE:exon6/6:c.758A>G:p.Asn253Ser:,LHX4:XM_017002755.1:missense_variant:MODERATE:exon5/5:c.758A>G:p.Asn253Ser:,ACBD6:XR_001737484.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.2358T>C::,ACBD6:XR_001737485.2:non_coding_transcript_exon_variant:MODIFIER:exon10/10:n.2341T>C::,ACBD6:XR_002957801.1:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.2260T>C::,ACBD6:XR_921977.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2485T>C::,ACBD6:XR_921978.3:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2489T>C::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	262225 [benign DISEASE=Short stature-pituitary and cerebellar defects-small sella turcica syndrome,not specified];			rs7536561	0.4824	0.1826,0.2569,0.5889,0.5227,0.6011	15297,.	33139	88125	2.5250	T(1.00), 	B(0.00), 	13.78	0.26		COSV55374116	0	25741868,25938945,23199197	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180288557	180288557	A	C	hom	hom	hom	off-target	QUAL=19073;DP=249,155,202;AF=1.00,1.00,1.00;MQM=60;SAP=827;ABP=0	ACBD6	intron	ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.695-40T>G::	ACBD6:NM_032360.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::,ACBD6:XR_001737484.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1006-40T>G::,ACBD6:XR_001737485.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1006-40T>G::,ACBD6:XR_002957801.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1006-40T>G::,ACBD6:XR_921977.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1006-40T>G::,ACBD6:XR_921978.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/10:n.1006-40T>G::	regulatory_region_variant:promoter_flanking_region					rs2254465	0.9499	0.9632,0.9680,0.9876,0.9423,0.9138	68664,.	7144	7628	-3.9170			0.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183186093	183186093	C	A	wt	het	wt		QUAL=2642;DP=173,249,306;AF=0.00,0.49,0.01;MQM=60;SAP=59;ABP=3	LAMC2	upstream_gene	LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	293975 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276544	0.1395		1751,.	17696	130766	0.1400			13.66						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186170	183186170	G	A	het	wt	hom		QUAL=19348;DP=265,354,500;AF=0.54,0.00,1.00;MQM=60;SAP=65;ABP=7	LAMC2	upstream_gene	LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	293977 [benign DISEASE=Junctional epidermolysis bullosa,not provided];			rs2276543	0.2732		5955,.	29601	110453	3.4730			21.50					29875488,30072576	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186264	183186264	A	G	wt	het	wt		QUAL=3317;DP=364,283,397;AF=0.00,0.48,0.00;MQM=60;SAP=3;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::,LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-89A>G::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-89A>G::,LAMC2:XM_017001273.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-89A>G::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	293979 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs2276542	0.1811		2655,.	22236	124534	1.7150			17.56			COSV51459231			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186347	183186347	C	A	wt	wt	het		QUAL=791;DP=26,68,90;AF=0.00,0.00,0.47;MQM=60;SAP=28;ABP=4	LAMC2	5'UTR	LAMC2:ENST00000264144.5:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:ENST00000493293.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::	LAMC2:NM_005562.3:5_prime_UTR_variant:MODIFIER:exon1/23:c.-6C>A::,LAMC2:NM_018891.3:5_prime_UTR_variant:MODIFIER:exon1/22:c.-6C>A::,LAMC2:XM_017001273.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-6C>A::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	293983 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];			rs684527	0.3122	0.0999,0.3338,0.4192,0.2979,0.3598	5789,.	27397	112971	0.4330			18.61				0	30048462,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	T	het	het	het	off-target;low_conf_region	QUAL=1124;DP=55,54,46;AF=0.13,0.39,0.28;MQM=60;SAP=84;ABP=78	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-31dup::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron1/14:c.80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	1224645 [benign DISEASE=not provided];			rs10668798	0.2688	0.2697,0.2585,0.3149,0.2623,0.2771	2244,.	19899	115183				7.18			COSV51458071	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	TT	wt	wt	het	off-target;low_conf_region	QUAL=1124;DP=55,54,46;AF=0.11,0.06,0.39;MQM=60;SAP=62;ABP=146	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron1/22:c.80-32_80-31dup::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron1/21:c.80-32_80-31dup::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron1/14:c.80-32_80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	1229395 [benign DISEASE=not provided];			rs10668798	0.3407	0.2093,0.2541,0.2462,0.1999,0.1521	8267,.	30995	91997				6.90			COSV51458071	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208083	183208083	A	G	het	wt	hom	off-target	QUAL=9050;DP=136,212,242;AF=0.47,0.00,1.00;MQM=60;SAP=220;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron2/21:c.268+14A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron2/22:c.268+14A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron2/21:c.268+14A>G::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron2/14:c.268+14A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259785 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];		GA-rich (Low_complexity)	rs647347	0.4732	0.4660,0.5096,0.5629,0.4381,0.5155	16114,.	37313	82133	-1.3710			0.14			COSV51456075,COSV51458451	0.07	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183215481	183215481	C	T	wt	het	wt		QUAL=2930;DP=271,244,345;AF=0.00,0.48,0.01;MQM=60;SAP=3;ABP=4	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon3/23:c.297C>T:p.Ser99=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon3/22:c.297C>T:p.Ser99=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon3/15:c.297C>T:p.Ser99=:	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259787 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2274980	0.2562	0.3883,0.3782,0.3433,0.1766,0.3155	5744,.	27419	112937	-0.4250			9.04			COSV51453066	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218359	183218359	T	C	wt	het	wt	off-target	QUAL=3569;DP=342,295,465;AF=0.00,0.48,0.00;MQM=60;SAP=8;ABP=4	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron3/21:c.405-31T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron3/22:c.405-31T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron3/21:c.405-31T>C::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron3/14:c.405-31T>C::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	1180478 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided];			rs10911285	0.2563	0.3884,0.3788,0.3433,0.1766,0.3153	5750,.	27447	113033	-1.1210			6.51			COSV51453509	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183218468	183218468	C	T	wt	het	wt		QUAL=3073;DP=195,249,323;AF=0.00,0.50,0.00;MQM=60;SAP=28;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:PF00053 [Laminin EGF domain]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon4/23:c.483C>T:p.Val161=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon4/22:c.483C>T:p.Val161=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon4/15:c.483C>T:p.Val161=:	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259789 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1129723	0.2563	0.3875,0.3784,0.3423,0.1762,0.3155	5756,.	27447	113035	0.7460			12.32			COSV51453519	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223169	183223169	T	G	wt	het	wt		QUAL=2777;DP=226,207,280;AF=0.00,0.53,0.00;MQM=60;SAP=14;ABP=5	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)],LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:PF00052 [Laminin B (Domain IV)]	LAMC2:NM_005562.3:synonymous_variant:LOW:exon7/23:c.798T>G:p.Gly266=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon7/22:c.798T>G:p.Gly266=:,LAMC2:XM_017001273.2:synonymous_variant:LOW:exon7/15:c.798T>G:p.Gly266=:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259790 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047980	0.2931	0.5145,0.3869,0.3442,0.1779,0.3165	8160,.	28216	107412	-0.3900			10.35			COSV51453536	0.02	25741868,31151762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183223361	183223361	A	G	wt	het	wt	off-target	QUAL=2028;DP=216,137,173;AF=0.00,0.59,0.00;MQM=60;SAP=123;ABP=13	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron7/21:c.953+37A>G::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron7/22:c.953+37A>G::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron7/21:c.953+37A>G::,LAMC2:XM_017001273.2:intron_variant:MODIFIER:intron7/14:c.953+37A>G::	regulatory_region_variant:enhancer	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	1268335 [benign DISEASE=not provided];			rs3738824	0.1316	0.1116,0.1648,0.1782,0.1267,0.0906	1242,.	16826	132814	0.4220			5.28			COSV51456347	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183232835	183232835	G	C	wt	het	wt		QUAL=907;DP=128,109,163;AF=0.00,0.39,0.00;MQM=60;SAP=28;ABP=15	LAMC2	missense	LAMC2:ENST00000264144.5:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:ENST00000493293.5:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:	LAMC2:NM_005562.3:missense_variant:MODERATE:exon14/23:c.2198G>C:p.Ser733Thr:,LAMC2:NM_018891.3:missense_variant:MODERATE:exon14/22:c.2198G>C:p.Ser733Thr:,LAMC2:XM_017001273.2:missense_variant:MODERATE:exon14/15:c.2198G>C:p.Ser733Thr:		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259784 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2296303	0.1609	0.2289,0.1701,0.1797,0.1272,0.0914	2136,.	20179	127555	1.3040	D(0.05),D(0.05)	B(0.13),B(0.17)	13.16	0.07		COSV51456358	0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183237438	183237438	G	A	wt	het	wt		QUAL=3682;DP=364,276,404;AF=0.00,0.51,0.00;MQM=60;SAP=27;ABP=3	LAMC2	synonymous	LAMC2:ENST00000264144.5:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:ENST00000493293.5:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:	LAMC2:NM_005562.3:synonymous_variant:LOW:exon18/23:c.2688G>A:p.Gln896=:,LAMC2:NM_018891.3:synonymous_variant:LOW:exon18/22:c.2688G>A:p.Gln896=:	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	259786 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1047981	0.2922	0.5110,0.3851,0.3431,0.1779,0.3162	8099,.	28220	107584	-0.3600			0.17			COSV51453550	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183238468	183238468	T	C	wt	het	wt	off-target	QUAL=1090;DP=197,82,112;AF=0.00,0.56,0.00;MQM=60;SAP=45;ABP=6	LAMC2	intron	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron19/22:c.2869+47T>C::,LAMC2:NM_018891.3:intron_variant:MODIFIER:intron19/21:c.2869+47T>C::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]				rs1925043	0.2989	0.5345,0.3875,0.3445,0.1784,0.3163	8644,.	28132	106542	-1.2890			0.62			COSV51453562	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183241246	183241246	A	-	het	het	wt	low_conf_region	QUAL=143;DP=18,9,4;AF=0.28,0.67,0.00;MQM=60;SAP=5;ABP=5	LAMC2	intron,3'UTR	LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:ENST00000493293.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	LAMC2:NM_005562.3:intron_variant:MODIFIER:intron22/22:c.3328+870del::,LAMC2:NM_018891.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*862del::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]			AluSx1 (SINE/Alu)	rs11318188	0.1926		1395,.	17578	85392	0.4720			0.78				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183243413	183243413	T	G	wt	het	wt		QUAL=2485;DP=214,174,247;AF=0.00,0.56,0.00;MQM=60;SAP=9;ABP=8	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*13T>G::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	294025 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa];			rs3768593	0.2421	0.3628,0.3779,0.3678,0.1651,0.3129	5110,.	26584	115198	0.2590			7.28			COSV51452226	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244275	183244275	G	T	wt	het	wt		QUAL=2295;DP=275,178,200;AF=0.00,0.49,0.01;MQM=60;SAP=3;ABP=3	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*875G>T::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	294036 [benign DISEASE=Junctional epidermolysis bullosa];			rs10797863	0.0988		861,.	13288	136976	-0.1160			0.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183244798	183244798	C	T	wt	wt	het		QUAL=4919;DP=472,284,395;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=6	LAMC2	3'UTR	LAMC2:ENST00000264144.5:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	LAMC2:NM_005562.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1398C>T::	regulatory_region_variant:promoter_flanking_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3); Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3)]	294053 [uncertain significance DISEASE=Junctional epidermolysis bullosa];			rs564740740	0.0023		0,.	349	151837	0.4890			4.86			COSV51452086	0		0	38	0 / 0					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48), NMNAT2 (inh=n/a oe_syn=0.99 oe_mis=0.57 oe_lof=0.06)
chr1	183555720	183555720	C	A	hom	hom	hom		QUAL=43677;DP=452,380,543;AF=1.00,0.99,0.99;MQM=60;SAP=109;ABP=0	NCF2	3'UTR	NCF2:ENST00000367535.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:ENST00000367536.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000413720.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::	NCF2:NM_000433.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:NM_001127651.3:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:NM_001190789.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:NM_001190794.2:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:XM_005245207.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:XM_011509580.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:XM_011509581.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	294066 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2];			rs796860	0.9016		61925,.	13237	14955	-2.0460			1.14				0	24163247	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183565800	183565800	C	T	hom	hom	het	off-target	QUAL=13707;DP=147,193,253;AF=1.00,1.00,0.51;MQM=60;SAP=61;ABP=3	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron7/12:c.682-21G>A::	NCF2:NM_000433.4:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:NM_001127651.3:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:NM_001190789.2:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:NM_001190794.2:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:XM_005245207.1:intron_variant:MODIFIER:intron8/13:c.817-21G>A::,NCF2:XM_011509580.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:XM_011509581.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1235081 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2,not provided];			rs2296164	0.4930	0.3535,0.6456,0.6096,0.4669,0.4657	16095,.	36866	82666	-2.9130			0.01			COSV62315476	0	25416100,24163247	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183573252	183573252	T	C	hom	hom	het		QUAL=18366;DP=257,192,266;AF=0.98,1.00,0.55;MQM=60;SAP=6;ABP=8	NCF2	missense,intron	NCF2:ENST00000367535.8:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000367536.5:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.5:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::	NCF2:NM_000433.4:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:NM_001127651.3:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:NM_001190789.2:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:NM_001190794.2:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:XM_005245207.1:intron_variant:MODIFIER:intron4/13:c.501+1235A>G::,NCF2:XM_011509580.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:XM_011509581.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:	regulatory_region_variant:promoter_flanking_region	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	256116 [benign DISEASE=Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2,not specified,not provided];			rs2274064	0.4988	0.3588,0.6448,0.6234,0.4659,0.5073	16259,.	36951	82419	0.6150	T(0.81),T(0.81),T(0.88), 	B(0.00),B(0.00),B(0.00), 	16.25	0.08		COSV62314890	0	25741868,24033266,16608528,23821607,25416100,24163247	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196672942	196672942	C	T	wt	het	wt	off-target	QUAL=324;DP=121,48,74;AF=0.00,0.38,0.00;MQM=60;SAP=15;ABP=10	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron1/8:c.59-36C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron1/21:c.59-36C>T::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron1/9:c.59-36C>T::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/22:n.144-36C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1209735 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,not provided];			rs551397	0.3977	0.7248,0.3721,0.4170,0.2314,0.3114	15215,.	29929	91431	-0.1450			1.01			COSV62776788	0	17314151,24453474,22618592,24692129,18421087,20161815,23289807,30179527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673103	196673103	G	A	wt	het	wt		QUAL=924;DP=231,83,139;AF=0.00,0.48,0.00;MQM=60;SAP=5;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon2/9:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon2/22:c.184G>A:p.Val62Ile:,CFH:NM_001014975.3:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:,CFH:XM_017001108.2:missense_variant:MODERATE:exon2/10:c.184G>A:p.Val62Ile:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon2/23:n.269G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	16550 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs800292	0.3968	0.7254,0.3751,0.4206,0.2350,0.3144	15151,.	29949	91577	1.6040	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	7.64	0.14		COSV62776782	0.08	18162041,25537509,19961953,18541031,29700787,27730450,19861685,20203157,26559391,31118930,16080115,17314151,30696427,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,23873044,25132797,29312345,17167412,19026761,19958499,20181037,20961462,22618592,25276841,25883802,22936692,23577725,19825847,20157618,23620142,24069533,18787502,24692129,18421087,20161815,23289807,17591627,20157352,8072530,15870199,16299065,17022693,17877809,17947292,17962488,18316707,18515590,19187823,19259132,19823576,19933189,20132989,20538655,20581873,20678803,20689796,21394116,21397333,21555552,21609242,21784901,21811649,21850184,21856016,21896867,21899915,21909106,22019782,22046503,22065918,22065928,22174912,22509112,22534080,22536038,22558131,22666427,22714898,22876110,23103884,23111182,23233260,23289808,23687431,23864767,23919682,24120328,24365176,24393350,24403817,24520367,24558588,24675670,24860613,24865190,24865191,24906858,25205864,25277308,25388911,25558172,25612476,25732348,25771815,25792034,26171855,26217379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196673839	196673839	-	TT	wt	het	wt	off-target	QUAL=947;DP=98,110,131;AF=0.00,0.39,0.00;MQM=60;SAP=5;ABP=14	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron2/8:c.245-10_245-9dup::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::	CFH:NM_000186.4:intron_variant:MODIFIER:intron2/21:c.245-10_245-9dup::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron2/9:c.245-10_245-9dup::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/22:n.330-10_330-9dup::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1166414 [benign DISEASE=not specified,not provided];	CI063658 [CLASS=DM MUT=ALT PHEN="Membranoproliferative glomerulonephritis" GENE=CFH];		rs35507625	0.2426		4684,.	27266	114360				1.21				0.02	19796758,27239600	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196685194	196685194	A	C	het	het	het		QUAL=9406;DP=284,209,266;AF=0.49,0.48,0.48;MQM=60;SAP=61;ABP=5	CFH	synonymous	CFH:ENST00000359637.2:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:,CFH:NM_001014975.3:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:XM_017001108.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon7/23:n.1006A>C::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294488 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061147	0.6762	0.5734,0.8312,0.9540,0.6166,0.6976	30581,.	34356	56166	-0.1750			6.10			COSV62778986	0	17314151,18043728,19796758,27239600,24453474,21637784,24586071,17167412,19026761,16936733,22558131,28011711,20339564,27068115,31031394,28729648,29854987,25756647,29706360,27239594,23326517,29606303,28293111,15163532	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689367	196689367	G	T	het	het	het	off-target;low_conf_region	QUAL=1495;DP=93,15,17;AF=0.55,0.53,0.18;MQM=60;SAP=138;ABP=3	CFH	intron	CFH:ENST00000359637.2:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::	CFH:NM_000186.4:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:NM_001014975.3:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:XM_017001108.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/22:n.1050-53G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1276326 [benign DISEASE=not provided];			rs482934	0.6916		37045,.	30974	46850	-0.1410			1.48			COSV62776949	0	19796758,24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196690107	196690107	C	T	het	het	het		QUAL=5483;DP=190,104,108;AF=0.57,0.41,0.49;MQM=57;SAP=134;ABP=3	CFH	missense	CFH:ENST00000359637.2:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:,CFH:NM_001014975.3:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:,CFH:XM_017001108.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon9/23:n.1289C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294490 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];			rs1061170	0.6797	0.6270,0.8335,0.9541,0.6159,0.6976	31967,.	33902	53948	-8.3310	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.00	0.09		COSV62776341	0.01	18248681,16519819,16723442,17697822,18162041,19076828,19692124,18541031,29334895,29700787,23820649,19861685,20203157,23251215,26559391,31118930,27306948,16080115,17314151,22022419,22253485,30696427,24498017,18043728,19796758,22035603,22059990,26152901,27239600,24453474,21637784,22969267,23873044,25132797,24586071,25786237,15761122,17167412,17917691,19026761,19958499,20961462,21072178,22259222,22618592,24526414,25276841,25883802,22936692,26681391,16936733,21807600,23523162,23577725,19825847,26493033,20157618,22694956,23620142,20378180,24692129,23289807,32034129,20385826,22155603,29579787,26490493,17591627,20157352,23112570,15870199,17022693,17877809,17962488,18316707,18515590,19187823,19259132,19823576,20132989,20581873,20678803,20689796,21394116,21555552,21609242,21784901,21811649,21850184,21856016,22019782,22046503,22174912,22509112,22536038,22558131,22666427,23103884,23111182,23289808,23687431,23919682,24120328,24403817,24558588,24675670,24860613,25205864,25558172,25612476,25792034,26171855,26217379,2624327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196713817	196713817	G	A	het	het	het		QUAL=8591;DP=262,192,257;AF=0.42,0.49,0.48;MQM=60;SAP=100;ABP=13	CFH	synonymous	CFH:ENST00000367429.9:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.1504G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294491 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Factor H deficiency,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not provided];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.4435	0.4618,0.4590,0.4312,0.4121,0.5459	14776,.	37072	85016	0.4850			1.75			COSV66406791	0.01	29700787,22022419,18043728,19796758,22035603,27239600,24453474,21637784,23873044,26838040,17917691,22618592,22936692,26681391,16936733,21807600,23523162,19825847,24692129,18421087,20161815,30179527,16299065,17962488,20132989,20678803,22046503,22558131,23687431,24860613,25612476,25771815,27778189,27832277,30225264,22905135,20339564,16612335,17327825,18081690,20843825,21402993,22324898,22699975,22848687,24289920,28358029,26852301,19692168,27625572,31819893,29875488,29376001,23441108,19025119,29854987,29033536,29263899,24391822,26634245,15163532,18596911	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196736796	196736796	C	A	het	het	het	off-target;low_conf_region	QUAL=139;DP=16,4,13;AF=0.25,0.50,0.38;MQM=60;SAP=19;ABP=11	CFH	intron	CFH:ENST00000367429.9:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::	CFH:NM_000186.4:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:XR_001737134.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/22:n.2600-28C>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	1274202 [benign DISEASE=not provided];		(TTAATT)n (Simple_repeat)	rs375046	0.6730	0.7404,0.7100,0.9333,0.5543,0.6854	35062,.	31009	49135	-1.3850			0.85				0.05	24453474,22834933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196740686	196740686	G	T	het	wt	het		QUAL=6993;DP=283,187,216;AF=0.53,0.00,0.51;MQM=60;SAP=40;ABP=5	CFH	missense	CFH:ENST00000367429.9:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)]	CFH:NM_000186.4:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon19/23:n.3036G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294510 [likely benign(replaced by megSAP based on classifications:1x1,6x2,1x3) DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.0040	0.0008,0.0019,0.0000,0.0060,0.0001	0,.	607	151421	-0.6000	D(0.04)	D(0.99)	16.35	0.32		COSV99054698	0	14583443,27007659,28056875,25814826	0	193	0 / 0	2	"[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743447	196743447	T	C	wt	het	wt		QUAL=305;DP=179,132,120;AF=0.00,0.23,0.00;MQM=45;SAP=70;ABP=84	CFH	splice_region&intron	CFH:ENST00000367429.9:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::	CFH:NM_000186.4:splice_region_variant&intron_variant:LOW:intron19/21:c.3134-5T>C::,CFH:XR_001737134.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron20/22:n.3320-5T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	875337 [uncertain significance DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified,not provided];			rs513699	0.0468	0.0370,0.0684,0.1172,0.0401,0.0177	0,.	3010	99962	3.0890			9.48		9.26>8.55	COSV66406795	0.04		0	5898	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196743456	196743456	C	T	wt	het	wt		QUAL=512;DP=192,149,135;AF=0.00,0.26,0.00;MQM=47;SAP=57;ABP=76	CFH	synonymous	CFH:ENST00000367429.9:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:	CFH:NM_000186.4:synonymous_variant:LOW:exon20/22:c.3138C>T:p.Thr1046=:,CFH:XR_001737134.2:non_coding_transcript_exon_variant:MODIFIER:exon21/23:n.3324C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3); Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal dominant, Autosomal recessive; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal dominant, Autosomal recessive]	294519 [benign DISEASE=Basal laminar drusen,Atypical hemolytic-uremic syndrome 1,Age-related macular degeneration 4,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,not specified];			rs61822181	0.1278	0.1049,0.1903,0.2414,0.1127,0.0746	0,.	5432	92896	-0.2980			2.55			COSV66406800	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197084243	197084243	G	A	hom	hom	hom		QUAL=19004;DP=240,138,197;AF=1.00,1.00,1.00;MQM=60;SAP=66;ABP=0	ASPM	3'UTR	ASPM:ENST00000294732.11:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:ENST00000367409.9:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::,ASPM:ENST00000680265.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*81C>T::	ASPM:NM_001206846.2:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:NM_018136.5:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	294591 [benign DISEASE=Primary autosomal recessive microcephaly 5,not provided];			rs12677	0.7844		49972,.	19223	32749	3.0170			4.41				0	18541031	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084432	197084432	A	-	het	het	het	low_conf_region	QUAL=420;DP=97,26,41;AF=0.21,0.12,0.29;MQM=59;SAP=48;ABP=120	ASPM	splice_region&intron	ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10554-6del::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10308-6del::	ASPM:NM_001206846.2:splice_region_variant&intron_variant:LOW:intron26/26:c.5577-6del::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10332-6del::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1204775 [likely benign DISEASE=not provided];			rs200839523	0.2071	0.2939,0.2902,0.2922,0.1565,0.2351	2,.	496	142552	-0.4390			0.01				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086795	197086795	T	C	hom	hom	hom		QUAL=13633;DP=168,108,137;AF=1.00,1.00,1.00;MQM=60;SAP=199;ABP=0	ASPM	splice_region&intron	ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10553+8A>G::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10307+8A>G::	ASPM:NM_001206846.2:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:NM_018136.5:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157775 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs10754213	0.8877	0.4435,0.9346,0.9998,0.9062,0.8985	49988,.	19226	32816	-0.0560			1.86				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090798	197090798	A	G	hom	hom	hom	off-target	QUAL=8873;DP=104,80,101;AF=1.00,1.00,1.00;MQM=60;SAP=483;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+52T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+52T>C::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673922 [benign DISEASE=Primary autosomal recessive microcephaly 5,not provided];			rs4915316	0.7625		48460,.	18909	36079	1.5570			5.16				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101391	197101391	C	G	wt	het	wt		QUAL=1189;DP=299,97,129;AF=0.00,0.49,0.00;MQM=60;SAP=12;ABP=3	ASPM	intron,missense	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7860G>C:p.Gln2620His:,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5227G>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7860G>C:p.Gln2620His:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21609 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs12138336	0.0507	0.0130,0.0317,0.0001,0.0715,0.0310	237,.	6911	144317	-0.9070	 ,T(0.10),T(0.08),T(0.12)	 ,B(0.03),B(0.05),B(0.00)	2.86	0.08		COSV54130527	0	25741868,18414213,20301772,16631353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101646	197101646	C	T	het	het	het		QUAL=8718;DP=227,189,246;AF=0.55,0.46,0.49;MQM=60;SAP=13;ABP=3	ASPM	intron,synonymous	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21603 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs10922162	0.2570	0.0395,0.4648,0.7055,0.1568,0.2767	3827,.	18942	124952	0.1710			1.00			COSV54139486	0	25741868,18414213,20301772,21297427,15355437,23381943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101685	197101685	T	C	hom	hom	hom		QUAL=19698;DP=237,155,197;AF=1.00,1.00,1.00;MQM=60;SAP=35;ABP=0	ASPM	intron,synonymous	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:NM_018136.5:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21602 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1412640	0.8954	0.5426,0.9393,0.9997,0.9064,0.8990	52003,.	19083	28509	-0.3560			1.00				0	25741868,20301772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101771	197101771	A	G	hom	hom	hom		QUAL=23179;DP=318,167,205;AF=1.00,1.00,1.00;MQM=60;SAP=17;ABP=0	ASPM	intron,missense	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:NM_018136.5:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:promoter_flanking_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21599 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs964201	0.9967	0.9990,0.9992,1.0000,0.9936,0.9974	75383,.	507	507	3.0690	 ,T(1.00),T(1.00),T(1.00)	 ,B(0.00),B(0.00),B(0.01)	15.59	0.19			0	25741868,18414213,20301772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197122407	197122407	A	T	hom	hom	hom		QUAL=24410;DP=311,201,250;AF=1.00,1.00,1.00;MQM=60;SAP=141;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000367409.9:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon14/29:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain]	ASPM:NM_001206846.2:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21578 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs4915337	0.8873	0.4432,0.9345,0.9998,0.9060,0.8986	49965,.	19236	32836	-0.2950			7.32				0.01	25741868,18541031,20301772,16631353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124900	197124900	C	T	het	het	het		QUAL=9389;DP=392,152,183;AF=0.50,0.48,0.48;MQM=60;SAP=298;ABP=4	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon12/29:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21573 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs6676084	0.2794	0.1541,0.2515,0.1110,0.3145,0.3089	5398,.	28171	112803	-1.3250			0.48			COSV54127589,COSV54135932	0.03	25741868,18414213,20301772,21297427	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133615	197133615	A	G	het	het	het	off-target	QUAL=3220;DP=142,70,73;AF=0.49,0.40,0.45;MQM=60;SAP=228;ABP=8	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2174-20T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron5/26:c.2174-20T>C::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron5/27:c.2174-20T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95887 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified];			rs4915344	0.2574	0.0421,0.4639,0.7053,0.1566,0.2815	3862,.	19095	125223	0.8830			16.16		6.91>6.50	COSV54132578	0.18	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197139816	197139816	A	G	het	het	wt		QUAL=4128;DP=256,109,143;AF=0.42,0.44,0.00;MQM=60;SAP=27;ABP=21	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon4/29:c.1977T>C:p.Ile659=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21561 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs17550662	0.0444	0.0080,0.0217,0.0001,0.0655,0.0106	178,.	5880	145940	2.0950			6.35				0.2	18414213,20301772,21297427	69	1998	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139912	197139912	C	T	hom	hom	hom	off-target	QUAL=12561;DP=234,65,88;AF=1.00,1.00,1.00;MQM=60;SAP=452;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron3/28:c.1922-41G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157788 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1332663	0.8877	0.4400,0.9344,0.9998,0.9052,0.8984	50010,.	19234	32822	-0.9920			5.70			COSV54136485	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143403	197143403	G	A	hom	hom	hom		QUAL=7450;DP=111,61,52;AF=1.00,0.98,1.00;MQM=60;SAP=10;ABP=0	ASPM	synonymous	ASPM:ENST00000294732.11:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000367409.9:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon3/29:c.849C>T:p.Ser283=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	ASPM:NM_001206846.2:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:NM_018136.5:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95890 [benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs6677082	0.8802	0.3650,0.9303,0.9816,0.9055,0.8983	48487,.	18925	36061	0.2230			2.02				0	25741868,18541031,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143943	197143943	G	A	hom	hom	hom	off-target	QUAL=4412;DP=107,14,21;AF=1.00,1.00,1.00;MQM=60;SAP=311;ABP=0	ASPM	intron	ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron2/27:c.441+14C>T::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron2/28:c.441+14C>T::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	ASPM:NM_001206846.2:intron_variant:MODIFIER:intron2/26:c.441+14C>T::,ASPM:NM_018136.5:intron_variant:MODIFIER:intron2/27:c.441+14C>T::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95888 [benign/likely benign DISEASE=Primary autosomal recessive microcephaly 5,not specified,not provided];			rs1571964	0.8798	0.3621,0.9305,0.9817,0.9049,0.8982	48485,.	18932	36040	0.1980			4.14				0	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	198692539	198692539	G	A	het	het	wt		QUAL=808;DP=56,7,5;AF=0.46,0.86,0.00;MQM=60;SAP=10;ABP=3	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000367364.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000413409.6:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.100+166G>A::	PTPRC:NM_001267798.2:intron_variant:MODIFIER:intron3/3:c.100+166G>A::,PTPRC:NM_002838.5:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:NR_052021.2:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.407G>A::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron3/31:c.100+166G>A::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron3/31:c.100+166G>A::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron3/30:c.100+166G>A::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]				rs115067628	0.0098		17,.	1459	150195	-0.7680			0.15				0		1	111	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198696788	198696788	C	G	wt	het	wt		QUAL=3192;DP=449,205,293;AF=0.00,0.58,0.00;MQM=60;SAP=8;ABP=15	PTPRC	intron,synonymous	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:ENST00000442510.8:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:	PTPRC:NM_002838.5:synonymous_variant:LOW:exon4/33:c.177C>G:p.Pro59=:,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron3/29:c.100+4415C>G::,PTPRC:XM_006711472.4:synonymous_variant:LOW:exon4/32:c.177C>G:p.Pro59=:,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron3/31:c.101-2776C>G::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron3/30:c.101-2776C>G::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]	378444 [benign/likely benign DISEASE=Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive,Susceptibility to hepatitis C virus,not specified,not provided];	CS952043 [CLASS=DFP MUT=ALT PHEN="Defective splicing" GENE=PTPRC];		rs17612648	0.0088	0.0022,0.0038,0.0001,0.0134,0.0117	8,.	1252	150872	0.5270			3.33			COSV100723197	0	25147926,16400609,19898481,20158892,18634151,19879912,22095823,22524693,28759630,30332657,31572362,21067564,19111528	3	490	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198708291	198708291	T	A	wt	wt	het	off-target	QUAL=521;DP=105,37,45;AF=0.00,0.00,0.51;MQM=60;SAP=24;ABP=3	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron10/32:c.1033+30T>A::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron7/29:c.550+30T>A::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron9/31:c.889+30T>A::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron9/31:c.835+30T>A::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron8/30:c.691+30T>A::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]	1271164 [benign DISEASE=not provided];			rs2274368	0.0597	0.0735,0.1212,0.1401,0.0311,0.0774	282,.	7606	143898	-0.3250			0.39				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198748089	198748089	-	T	het	het	het	off-target;low_conf_region	QUAL=700;DP=50,16,33;AF=0.30,0.56,0.24;MQM=60;SAP=42;ABP=30	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron23/29:c.2365-4dup::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron26/32:c.2848-4dup::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron26/32:c.2848-4dup::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron23/29:c.2365-4dup::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron25/31:c.2704-4dup::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron25/31:c.2650-4dup::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron24/30:c.2506-4dup::		151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]			(T)n (Simple_repeat)	rs57296163	0.2602	0.1448,0.2047,0.2027,0.2855,0.2463	5361,.	24396	100450				0.22				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198749603	198749603	A	G	het	wt	het	off-target	QUAL=3828;DP=213,80,109;AF=0.47,0.00,0.50;MQM=60;SAP=298;ABP=4	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::	PTPRC:NM_002838.5:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:NM_080921.4:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:XM_006711472.4:intron_variant:MODIFIER:intron27/31:c.2928+54A>G::,PTPRC:XM_006711473.3:intron_variant:MODIFIER:intron27/31:c.2874+54A>G::,PTPRC:XM_006711474.3:intron_variant:MODIFIER:intron26/30:c.2730+54A>G::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3), Autosomal recessive; {Hepatitis C virus, susceptibility to}, 609532 (3)]				rs549239314	0.0010		0,.	150	151734	-0.6400			0.07				0		0	39	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201039454	201039454	-	G	hom	het	het	off-target	QUAL=1995;DP=46,29,54;AF=0.91,0.52,0.50;MQM=60;SAP=185;ABP=3		intron&non_coding_transcript	:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-2397dup::	LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-2397dup::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-2397dup::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-2397dup::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-2397dup::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-2397dup::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-2397dup::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-2397dup::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-2397dup::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-2397dup::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-2397dup::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-2397dup::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-2397dup::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-2397dup::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-2397dup::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-2397dup::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-2397dup::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs35360610	0.5501		24814,.	33943	68347				0.94						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040428	201040428	A	G	hom	het	het	off-target	QUAL=5964;DP=131,63,83;AF=0.99,0.52,0.48;MQM=60;SAP=125;ABP=3	CACNA1S	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::,:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1427A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron41/42:c.5167-54T>C::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::,LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-1427A>G::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-1427A>G::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-1427A>G::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-1427A>G::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-1427A>G::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-1427A>G::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-1427A>G::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-1427A>G::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-1427A>G::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-1427A>G::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-1427A>G::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-1427A>G::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-1427A>G::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-1427A>G::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-1427A>G::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-1427A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678243 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs1546416	0.3581		9989,.	34460	97588	-0.3470			0.78			COSV62945146	0.03	19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040769	201040769	T	C	hom	hom	hom	off-target	QUAL=3848;DP=54,30,46;AF=1.00,1.00,1.00;MQM=60;SAP=121;ABP=0	CACNA1S	intron,intron&non_coding_transcript	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::,:ENST00000415359.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.211-1086T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron40/42:c.5075-56A>G::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::,LOC101929305:XR_001738364.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1652-1086T>C::,LOC101929305:XR_001738365.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1562-1086T>C::,LOC101929305:XR_001738366.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1355-1086T>C::,LOC101929305:XR_001738367.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/8:n.1568-1086T>C::,LOC101929305:XR_001738368.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/7:n.1464-1086T>C::,LOC101929305:XR_001738369.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1240-1086T>C::,LOC101929305:XR_001738370.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1192-1086T>C::,LOC101929305:XR_001738371.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.586-1086T>C::,LOC101929305:XR_001738372.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1058-1086T>C::,LOC101929305:XR_922405.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2113-1086T>C::,LOC101929305:XR_922407.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.2301-1086T>C::,LOC101929305:XR_922408.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1374-1086T>C::,LOC101929305:XR_922410.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1383-1086T>C::,LOC101929305:XR_922414.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1292-1086T>C::,LOC101929305:XR_922416.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/6:n.1301-1086T>C::,LOC101929305:XR_922417.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/5:n.1997-1086T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678241 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs6427875	0.9933		75086,.	1002	1020	-4.2510			0.00				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201043469	201043469	G	A	hom	wt	hom		QUAL=365;DP=10,3,4;AF=1.00,0.00,1.00;MQM=60;SAP=25;ABP=0	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:,CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon39/43:c.4800C>T:p.Pro1600=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254841 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified];			rs41267497	0.1051	0.0262,0.0673,0.0004,0.1612,0.0264	1167,.	13549	136047	-1.2030			0.12				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201047168	201047168	G	A	wt	wt	het		QUAL=3275;DP=343,183,245;AF=0.00,0.00,0.52;MQM=60;SAP=14;ABP=4	CACNA1S	missense	CACNA1S:ENST00000362061.4:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:ENST00000367338.7:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:,CACNA1S:ENST00000681874.1:missense_variant:MODERATE:exon37/43:c.4555C>T:p.Arg1519Cys:	CACNA1S:NM_000069.3:missense_variant:MODERATE:exon38/44:c.4615C>T:p.Arg1539Cys:,CACNA1S:XM_005245478.3:missense_variant:MODERATE:exon37/43:c.4558C>T:p.Arg1520Cys:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	197021 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs3850625	0.1157	0.0206,0.0958,0.0333,0.1184,0.2102	823,.	12123	138313	7.7080	D(0.01),D(0.01),D(0.01)	B(0.30),B(0.30),B(0.09)	26.80	0.28		COSV62938023	0.01	25741868,23139751,19825159,26831199,24029420,28452372,30604766,31440704,31152163,31511532,31015462,33097823,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201050977	201050977	A	G	wt	het	het		QUAL=6114;DP=131,211,276;AF=0.01,0.53,0.49;MQM=60;SAP=98;ABP=3	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron32/42:c.4053+7T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:XM_005245478.3:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	199680 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs6702590	0.7786	0.9371,0.8682,0.9959,0.6687,0.8663	47206,.	23958	33666	-0.1500			3.11				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201069559	201069559	A	G	het	wt	het		QUAL=8030;DP=214,341,426;AF=0.47,0.00,0.51;MQM=60;SAP=19;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254814 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs7415038	0.4211	0.5285,0.2185,0.0030,0.4491,0.1847	14602,.	34746	87922	4.8560			12.17			COSV62939654	0.01	25741868,19825159,20681998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073490	201073490	G	A	het	wt	hom	off-target	QUAL=4972;DP=80,101,140;AF=0.49,0.00,1.00;MQM=60;SAP=127;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678298 [benign DISEASE=Hypokalemic periodic paralysis 1,not provided];			rs9333652	0.4396		16095,.	34542	85068	0.1200			1.76				0	19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201075620	201075620	A	G	het	wt	hom		QUAL=10528;DP=149,258,278;AF=0.52,0.00,1.00;MQM=60;SAP=25;ABP=4	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::	CACNA1S:NM_000069.3:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:XM_005245478.3:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254804 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs1998721	0.7819	0.5463,0.7202,0.9604,0.7765,0.8902	40463,.	28673	42455	-0.5120			0.14		11.27>10.69		0	25741868,27182706	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201076897	201076897	G	T	het	wt	het	off-target	QUAL=4279;DP=79,275,331;AF=0.48,0.01,0.52;MQM=60;SAP=313;ABP=4	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1293266 [benign DISEASE=not provided];		L2c (LINE/L2)	rs7549030	0.0679	0.0773,0.0392,0.0001,0.0739,0.0251	411,.	9510	141812	-0.1210			1.74				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077934	201077934	G	A	hom	hom	het		QUAL=15001;DP=139,260,266;AF=0.99,1.00,0.48;MQM=60;SAP=126;ABP=4	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254801 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.2250	0.2594,0.2751,0.0403,0.2290,0.1119	4045,.	26128	117868	4.9060			9.80			COSV62944479	0	25741868,26648445,11940049	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077947	201077947	A	G	hom	hom	het		QUAL=17369;DP=184,267,286;AF=0.99,1.00,0.50;MQM=60;SAP=117;ABP=3	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254800 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs4915477	0.6848	0.8959,0.5864,0.2246,0.6543,0.3215	37747,.	28592	47920	-1.1500			3.40			COSV62938741	0	25741868,26648445,18325191	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201085069	201085069	G	T	wt	het	wt	off-target	QUAL=923;DP=82,88,113;AF=0.00,0.50,0.00;MQM=60;SAP=19;ABP=3	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::	CACNA1S:NM_000069.3:intron_variant:MODIFIER:intron8/43:c.1151-38C>A::,CACNA1S:XM_005245478.3:intron_variant:MODIFIER:intron8/42:c.1151-38C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678295 [benign DISEASE=not provided];			rs41267505	0.1585	0.1434,0.2471,0.0363,0.1667,0.0878	2027,.	19736	128238	-0.0120			0.41			COSV62945385	0	32572223	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201091737	201091737	G	A	wt	wt	het		QUAL=2468;DP=165,158,185;AF=0.01,0.00,0.54;MQM=60;SAP=6;ABP=5	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:PF00520 [Ion transport protein]	CACNA1S:NM_000069.3:synonymous_variant:LOW:exon5/44:c.597C>T:p.Ile199=:,CACNA1S:XM_005245478.3:synonymous_variant:LOW:exon5/43:c.597C>T:p.Ile199=:	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254852 [benign DISEASE=Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis 1,not specified,not provided];			rs2296383	0.3897	0.1009,0.3501,0.3592,0.4292,0.4506	9768,.	30358	102112	-0.7110			8.08			COSV62936330	0.01	25741868,19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	209614868	209614868	T	C	hom	het	het		QUAL=5677;DP=152,41,72;AF=0.99,0.59,0.46;MQM=60;SAP=455;ABP=3	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.9:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	368859 [benign DISEASE=Junctional epidermolysis bullosa];			rs926387	0.7480		43642,.	26417	38297	-1.4470			0.23						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209615169	209615169	G	A	het	wt	het		QUAL=5466;DP=185,240,262;AF=0.53,0.00,0.46;MQM=60;SAP=108;ABP=3	LAMB3	3'UTR	LAMB3:ENST00000356082.9:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000367030.7:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::	LAMB3:NM_000228.3:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:NM_001017402.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:NM_001127641.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:XM_005273124.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:XM_017001272.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	295059 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not provided];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.2740		5818,.	30008	110364	1.1420			8.92			COSV50521190	0	20163849,21627860,21692980,23554684,23614619,28584635,23320911,29963045,25337271,25132800	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618670	209618670	-	C	hom	hom	hom	off-target	QUAL=12635;DP=161,131,180;AF=0.94,0.94,0.98;MQM=60;SAP=697;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron17/21:c.2702-12dup::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:NM_001017402.2:intron_variant:MODIFIER:intron17/21:c.2702-12dup::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:XM_005273124.4:intron_variant:MODIFIER:intron18/22:c.2702-12dup::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron17/21:c.2510-12dup::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255590 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs397807887	0.9574	0.9896,0.9832,0.9998,0.9314,0.9883	69717,.	6171	6617				12.76				0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209625908	209625908	A	G	het	hom	het		QUAL=21487;DP=299,382,547;AF=0.41,1.00,0.50;MQM=60;SAP=292;ABP=10	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:,LAMB3:XM_017001272.2:synonymous_variant:LOW:exon13/22:c.1524T>C:p.Cys508=:	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255587 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2179402	0.7542	0.7692,0.7728,0.8231,0.7368,0.7431	42675,.	28549	38217	-0.9660			1.56			COSV61918520	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209630750	209630750	G	A	hom	hom	hom	off-target	QUAL=12072;DP=112,124,157;AF=1.00,1.00,1.00;MQM=60;SAP=153;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron7/21:c.823-15C>T::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:NM_001017402.2:intron_variant:MODIFIER:intron7/21:c.823-15C>T::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:XM_005273124.4:intron_variant:MODIFIER:intron8/22:c.823-15C>T::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron7/21:c.631-15C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255598 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs4844863	0.8455	0.8295,0.8277,0.8233,0.8546,0.8121	53847,.	20115	24093	-1.8920			1.56		8.37>7.66	COSV61919103	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209634627	209634627	G	A	hom	hom	hom		QUAL=5400;DP=34,58,91;AF=1.00,1.00,1.00;MQM=60;SAP=81;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron5/21:c.373-1494C>T::	regulatory_region_variant:promoter_flanking_region	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255596 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs1130667	0.3424	0.1309,0.2131,0.2290,0.4051,0.3404	8286,.	30464	104660	-4.0090			0.33			COSV61916410	0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638541	209638541	T	G	hom	hom	hom		QUAL=19054;DP=255,137,210;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	LAMB3:NM_000228.3:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:NM_001017402.2:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:,LAMB3:NM_001127641.1:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:XM_005273124.4:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:,LAMB3:XM_017001272.2:synonymous_variant:LOW:exon4/22:c.291A>C:p.Ser97=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255592 [benign DISEASE=Amelogenesis imperfecta, type IA,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa,not specified,not provided];			rs2076356	0.5679	0.4101,0.4441,0.2859,0.6558,0.4959	25022,.	34984	66904	-0.8890			5.33			COSV61915034	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209651362	209651362	A	T	hom	hom	hom	off-target	QUAL=9345;DP=169,80,84;AF=0.99,1.00,1.00;MQM=60;SAP=724;ABP=0	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::	LAMB3:NM_000228.3:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:NM_001017402.2:5_prime_UTR_variant:MODIFIER:exon1/22:c.-418T>A::,LAMB3:NM_001127641.1:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:XM_005273124.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-312T>A::,LAMB3:XM_017001272.2:intron_variant:MODIFIER:intron1/21:c.-37-381T>A::	regulatory_region_variant:promoter,TF_binding_site_variant	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1252656 [benign DISEASE=not provided];			rs10779510	0.8772		58763,.	15921	18677	-0.3030			3.32				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209786269	209786269	G	T	het	wt	het		QUAL=6852;DP=337,125,185;AF=0.53,0.00,0.50;MQM=58;SAP=12;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295175 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs1044516	0.2288		4638,.	25498	117204	-0.3060			0.98				0.02	20652317,31495697,31122291,27033726	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786527	209786527	G	A	hom	hom	hom		QUAL=19090;DP=313,125,150;AF=1.00,0.99,0.99;MQM=57;SAP=4;ABP=0	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295178 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs680331	0.8087		49753,.	23355	29055	-0.0200			1.32				0	21319277,23248214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786742	209786742	A	-	wt	wt	het		QUAL=1633;DP=253,130,118;AF=0.00,0.00,0.53;MQM=60;SAP=3;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1678del::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1678del::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295181 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs141112353	0.1927		2876,.	23547	122761	0.4050			0.86				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786807	209786807	T	A	wt	wt	het		QUAL=1217;DP=263,101,104;AF=0.00,0.00,0.48;MQM=60;SAP=9;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1613A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1613A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs1195550606						-0.6430			0.75				0		0	1	0 / 0					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787091	209787091	G	A	het	wt	het		QUAL=6312;DP=254,200,249;AF=0.46,0.00,0.51;MQM=60;SAP=56;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295184 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		AluJo (SINE/Alu)	rs2235372	0.2258		4426,.	25436	117562	-1.0050			1.31			COSV50551228	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787577	209787577	A	C	het	hom	wt		QUAL=2820;DP=123,44,124;AF=0.47,1.00,0.00;MQM=60;SAP=13;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295189 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs599021	0.3629		10686,.	33703	96675	0.2660			4.92				0	18278815,17438386,20652317,19388848	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787580	209787580	T	C	het	wt	het		QUAL=3153;DP=129,44,123;AF=0.54,0.00,0.45;MQM=60;SAP=35;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295190 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742214	0.2246		4383,.	25341	117721	-0.9660			0.99				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787678	209787678	T	A	het	wt	het		QUAL=2226;DP=97,51,81;AF=0.51,0.02,0.49;MQM=60;SAP=19;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295193 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs742215	0.2306		4595,.	25625	116195	0.9740			10.13			COSV54213600	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787969	209787969	T	C	het	wt	het		QUAL=6617;DP=266,188,239;AF=0.52,0.01,0.47;MQM=60;SAP=3;ABP=3	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295199 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];			rs17317411	0.1074		1158,.	13998	135614	0.3090			13.74			COSV54213602	0	20652317,28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209788009	209788009	G	A	wt	wt	het		QUAL=2560;DP=332,163,207;AF=0.00,0.00,0.47;MQM=60;SAP=4;ABP=4	IRF6	3'UTR	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::	IRF6:NM_001206696.2:3_prime_UTR_variant:MODIFIER:exon7/7:c.*411C>T::,IRF6:NM_006147.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*411C>T::		607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295200 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to];		MIR3 (SINE/MIR)	rs187379424	0.0047		4,.	710	151342	1.8520			10.32				0		0	48	0 / 0					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209790458	209790458	G	A	het	wt	het	off-target	QUAL=3830;DP=194,88,127;AF=0.52,0.00,0.52;MQM=60;SAP=363;ABP=4	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron5/6:c.775+37C>T::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::	regulatory_region_variant:promoter_flanking_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291060 [benign DISEASE=not provided];			rs2235373	0.2356	0.2316,0.3481,0.4833,0.1761,0.2970	4031,.	24733	119293	-0.8660			0.88			COSV65418889	0	18278815,17438386,20652317,19388848,25592222,19444471,28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209792242	209792242	G	C	het	wt	hom	off-target	QUAL=10466;DP=195,213,261;AF=0.46,0.00,1.00;MQM=60;SAP=256;ABP=6	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron4/6:c.382+27C>G::,IRF6:NM_006147.4:intron_variant:MODIFIER:intron6/8:c.667+27C>G::	regulatory_region_variant:promoter_flanking_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259926 [benign DISEASE=Autosomal dominant popliteal pterygium syndrome,not specified,not provided];			rs2235375	0.4101	0.2825,0.5576,0.5725,0.3734,0.4171	10636,.	34569	96133	0.0730			2.36			COSV65418892	0	25741868,17318851,18278815,17438386,20215007,15558496,25853057,23940636,19734457,28712851,20631690	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795339	209795339	C	A	het	wt	hom		QUAL=18555;DP=339,325,459;AF=0.45,0.00,1.00;MQM=60;SAP=7;ABP=10	IRF6	synonymous	IRF6:ENST00000367021.8:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.5:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	IRF6:NM_001206696.2:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:,IRF6:NM_006147.4:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259925 [benign DISEASE=van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs2013162	0.4098	0.2750,0.5605,0.5730,0.3733,0.4156	10523,.	34453	96473	-1.7160			0.79			COSV65418898	0.01	25741868,20403199,29065370,18278815,20436469,18978678,27511269,17438386,20652317,19521098,19937600,21319277,23029012,31448957,18209213,29211286,21859832,21204206,15558496,25853057,23940636,16096995,19734457,22440537,31156544,17616516,28593555,25663376,29291710,18452891	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796557	209796557	G	C	het	wt	hom		QUAL=4842;DP=209,51,86;AF=0.47,0.02,0.99;MQM=60;SAP=346;ABP=4	IRF6	splice_region&intron	IRF6:ENST00000367021.8:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.5:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	IRF6:NM_001206696.2:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::,IRF6:NM_006147.4:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259923 [benign DISEASE=van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,not specified,not provided];			rs7552506	0.3223	0.2672,0.2976,0.1538,0.3585,0.3323	7901,.	32663	103027	1.3340			13.91		9.65>6.86	COSV65419346	0.02	25741868,20652317,19937600,18209213,17551329,28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209802041	209802041	A	G	het	hom	wt		QUAL=11934;DP=284,263,350;AF=0.49,1.00,0.00;MQM=60;SAP=57;ABP=3	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.8:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	IRF6:NM_001206696.2:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::,IRF6:NM_006147.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295214 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,not specified,not provided];			rs861019	0.4329		14686,.	36369	86125	-0.2070			2.01		10.77>11.03	COSV65419778	0	17318851,18278815,17438386,20652317,19388848,23029012,31495697,16160700,18209213,19561605,21834040,29211286,28593555,18452891	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806173	209806173	T	A	wt	wt	het		QUAL=1266;DP=34,94,126;AF=0.00,0.00,0.54;MQM=60;SAP=71;ABP=5	IRF6	5'UTR	IRF6:ENST00000542854.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-338A>T::		regulatory_region_variant:promoter,TF_binding_site_variant	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295219 [benign DISEASE=van der Woude syndrome 1,Cleft Lip +/- Cleft Palate, Autosomal Dominant];			rs12403006	0.1588		2392,.	19356	127908	-0.0070			6.99			COSV65419508		28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806184	209806184	A	T	wt	wt	het		QUAL=1207;DP=25,83,117;AF=0.00,0.00,0.53;MQM=60;SAP=98;ABP=4	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter,TF_binding_site_variant	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	368864 [benign DISEASE=van der Woude syndrome 1,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome,Cleft Lip +/- Cleft Palate, Autosomal Dominant];	CR173661 [CLASS=R MUT=ALT PHEN="Orofacial clefting" GENE=IRF6];		rs34743335	0.1589		2397,.	19353	127779	0.0190			16.03					28593555	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215622854	215622854	-	TTATT	het	het	wt	off-target	QUAL=649;DP=95,18,34;AF=0.35,0.22,0.00;MQM=60;SAP=83;ABP=32	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::			608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs75551431	0.2360		4938,.	25925	115885				1.74						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215623008	215623008	T	G	het	wt	hom		QUAL=13548;DP=353,178,266;AF=0.52,0.00,1.00;MQM=60;SAP=224;ABP=4	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::	USH2A:NM_206933.4:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs6667509	0.1045		856,.	14176	136146	2.2060			5.40				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215624672	215624672	G	A	hom	hom	hom		QUAL=33458;DP=445,226,327;AF=1.00,1.00,1.00;MQM=60;SAP=39;ABP=0	USH2A	3'UTR	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::	USH2A:NM_206933.4:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]				rs2797255	0.9908		74692,.	1339	1405	-0.3060			0.14				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215634665	215634665	G	A	het	het	wt		QUAL=3678;DP=174,136,193;AF=0.48,0.50,0.00;MQM=60;SAP=189;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:	USH2A:NM_206933.4:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48455 [benign/likely benign DISEASE=Usher syndrome, type 2A,Retinitis pigmentosa 39,not specified,not provided];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.0156	0.0031,0.0030,0.0000,0.0192,0.0102	24,.	1982	150118	3.1780	D(0.02),D(0.02)	B(0.15),B(0.30)	16.64	0.09		COSV99048303	0.01	24033266,18273898	6	569	0 / 0	1	"[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215674720	215674720	C	T	het	het	wt		QUAL=8189;DP=377,246,314;AF=0.51,0.50,0.01;MQM=60;SAP=28;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48413 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs2009923	0.2029	0.0531,0.1748,0.3522,0.1842,0.2862	2361,.	19397	127887	0.2990			0.97			COSV56336645	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675245	215675245	T	C	wt	het	wt		QUAL=3267;DP=276,245,319;AF=0.00,0.51,0.00;MQM=60;SAP=12;ABP=3	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12666A>G:p.Thr4222=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.12666A>G:p.Thr4222=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48403 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs2797234	0.3698	0.2132,0.4699,0.3257,0.3857,0.3019	9406,.	32729	100521	-0.4260			0.69			COSV56342646	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675299	215675299	T	C	het	het	hom		QUAL=20675;DP=383,280,374;AF=0.47,0.50,0.99;MQM=60;SAP=40;ABP=4	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177993 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs2797235	0.7669	0.6285,0.8089,0.6474,0.8124,0.6953	43036,.	27640	38318	0.1010			0.59			COSV56342874	0	24033266,21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680407	215680407	T	-	het	het	het	off-target	QUAL=3605;DP=149,53,68;AF=0.52,0.62,0.85;MQM=60;SAP=320;ABP=40	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-31del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron61/71:c.12067-31del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1225305 [benign DISEASE=not provided];			rs5780842	0.8933	0.6261,0.6573,0.7264,0.7176,0.6117	58941,.	13199	15659	1.7360			0.52				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215728150	215728150	C	T	hom	het	hom		QUAL=39513;DP=410,542,641;AF=0.99,0.42,0.99;MQM=60;SAP=125;ABP=34	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48387 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs2820718	0.1684	0.1669,0.0795,0.0013,0.1845,0.1444	2287,.	21016	126404	0.7290			4.65				0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215741409	215741409	G	T	het	het	wt		QUAL=5393;DP=207,192,253;AF=0.53,0.52,0.00;MQM=60;SAP=65;ABP=5	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48380 [benign/likely benign DISEASE=Usher syndrome, type 2A,not specified,not provided];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.0158	0.0033,0.0035,0.0000,0.0225,0.0137	19,.	1916	150028	6.1100	D(0.03),D(0.03)	D(0.98),D(1.00)	24.80	0.34		COSV99048391	0.01	24033266,18273898,17405132	10	634	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign; gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215758586	215758586	T	A	wt	wt	het		QUAL=2193;DP=223,176,196;AF=0.00,0.00,0.46;MQM=60;SAP=42;ABP=6	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron58/72:c.11389+9A>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron58/71:c.11389+9A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48372 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs12095085	0.1232	0.1320,0.0683,0.0003,0.1292,0.0526	1271,.	16185	133265	0.4490			5.50				0.02	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215759615	215759615	G	A	wt	het	wt	off-target	QUAL=1056;DP=203,82,122;AF=0.00,0.55,0.00;MQM=60;SAP=76;ABP=5	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron57/72:c.11231+45C>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron57/71:c.11231+45C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177014 [benign/likely benign DISEASE=Usher syndrome, type 2A,not provided];			rs17025373	0.1066	0.0135,0.2038,0.3716,0.0655,0.0847	739,.	9213	141369	-1.3310			0.20			COSV56338606	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782962	215782962	A	G	hom	hom	hom	off-target	QUAL=3921;DP=79,22,27;AF=0.99,1.00,1.00;MQM=60;SAP=262;ABP=0	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177015 [benign DISEASE=Usher syndrome, type 2A,not provided];			rs7518466	0.5906	0.7315,0.5765,0.6322,0.5268,0.4964	27103,.	35480	62166	-0.8160			0.04				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786825	215786825	T	G	hom	hom	hom		QUAL=26925;DP=220,286,366;AF=1.00,1.00,1.00;MQM=60;SAP=226;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48344 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs10864198	0.5798	0.6867,0.5749,0.6342,0.5215,0.4946	25934,.	36153	63793	2.9590	T(1.00),T(1.00)	B(0.00),B(0.00)	11.04	0.09		COSV56336661	0.02	25741868,24033266,23757202,21686329,29986705	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215790032	215790032	G	A	wt	wt	het	off-target	QUAL=1532;DP=129,110,128;AF=0.00,0.00,0.50;MQM=60;SAP=109;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron51/72:c.10182+27C>T::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron51/71:c.10182+27C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1290575 [benign DISEASE=not provided];			rs11120629	0.1279	0.1483,0.0687,0.0004,0.1292,0.0529	1381,.	16574	131822	0.0070			3.33			COSV56371467	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215813880	215813880	T	C	wt	wt	het		QUAL=3234;DP=271,169,280;AF=0.00,0.00,0.46;MQM=60;SAP=22;ABP=6	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon49/73:c.9595A>G:p.Asn3199Asp:	USH2A:NM_206933.4:missense_variant:MODERATE:exon49/72:c.9595A>G:p.Asn3199Asp:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48631 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs4129843	0.0557	0.0814,0.0613,0.1694,0.0373,0.0812	299,.	7864	143596	0.1950	T(1.00),T(1.00)	B(0.00),B(0.00)	0.54	0.04		COSV56343447	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215838019	215838019	T	C	wt	wt	het		QUAL=3248;DP=340,238,263;AF=0.00,0.00,0.49;MQM=60;SAP=5;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon47/73:c.9343A>G:p.Thr3115Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon47/72:c.9343A>G:p.Thr3115Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48623 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs56032526	0.0497	0.0089,0.0581,0.1691,0.0373,0.0814	169,.	5154	146686	0.0680	T(1.00),T(1.00)	B(0.00),B(0.00)	0.79	0.14		COSV56343459	0	25741868,24033266,18273898	0	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215846085	215846085	A	-	wt	wt	het	off-target	QUAL=404;DP=124,42,44;AF=0.02,0.00,0.50;MQM=60;SAP=55;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron44/71:c.8846-52del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron44/72:c.8846-52del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron44/71:c.8846-52del::	regulatory_region_variant:promoter_flanking_region	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1256903 [benign DISEASE=not provided];			rs77889398	0.0657	0.0131,0.0781,0.2087,0.0500,0.1034	173,.	5152	143776	0.0850			0.15			COSV56391224	0.09		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877783	215877783	G	A	wt	wt	het		QUAL=2907;DP=195,198,215;AF=0.00,0.00,0.52;MQM=60;SAP=12;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon43/73:c.8656C>T:p.Leu2886Phe:	USH2A:NM_206933.4:missense_variant:MODERATE:exon43/72:c.8656C>T:p.Leu2886Phe:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48607 [benign/likely benign DISEASE=Usher syndrome, type 2A,not specified,not provided];	CM1413302 [CLASS=R MUT=ALT PHEN="Hearing loss" GENE=USH2A];		rs41277200	0.0523	0.0607,0.0625,0.1561,0.0365,0.0799	222,.	7088	144464	6.8370	T(1.00),T(1.00)	B(0.00),B(0.00)	18.56	0.14		COSV56343477	0.01	25741868,24033266,18273898,17085681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215993112	215993112	T	G	het	het	wt		QUAL=2819;DP=125,94,98;AF=0.48,0.57,0.00;MQM=60;SAP=11;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	USH2A:NM_206933.4:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48568 [benign/likely benign DISEASE=Usher syndrome, type 2A,not specified,not provided];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.0222	0.0052,0.0173,0.0001,0.0284,0.0151	47,.	2833	149243	4.8150	D(0.00),D(0.00)	P(0.91),D(0.99)	25.00	0.27		COSV56370381	0	24033266,18273898,17085681	21	864	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999038	215999038	A	G	hom	hom	hom		QUAL=18994;DP=180,188,228;AF=0.99,1.00,1.00;MQM=60;SAP=432;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48562 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs10864219	0.5628	0.4335,0.6697,0.8405,0.5004,0.5979	20294,.	36736	74396	2.3650	T(0.12),T(0.12)	B(0.02),B(0.08)	17.40	0.11		COSV56370398	0.04	25741868,24033266,21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216046439	216046439	A	G	het	het	hom		QUAL=8822;DP=201,124,147;AF=0.49,0.51,1.00;MQM=60;SAP=328;ABP=3	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:	USH2A:NM_206933.4:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	167815 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs6657250	0.6674	0.7709,0.3526,0.4408,0.6711,0.5082	34516,.	32185	50453	1.2600	T(1.00),T(1.00)	B(0.00),B(0.00)	9.86	0.13		COSV56342913	0.05	24033266,21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216073334	216073334	G	-	het	het	het	off-target	QUAL=5119;DP=174,98,132;AF=0.51,0.53,0.55;MQM=60;SAP=423;ABP=6	USH2A,USH2A-AS2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron27/72:c.5573-34del::	USH2A:NM_206933.4:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A-AS2:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A-AS2:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.136+736del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1243806 [benign DISEASE=not provided];			rs35944387	0.7336	0.7474,0.7849,0.9538,0.6880,0.7713	39926,.	29804	42040	0.8790			13.09				0.01	21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216084852	216084852	G	T	het	het	het		QUAL=6000;DP=155,133,176;AF=0.49,0.51,0.51;MQM=60;SAP=170;ABP=3	USH2A,USH2A-AS2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,USH2A-AS2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A:ENST00000674083.1:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain]	USH2A:NM_206933.4:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:,USH2A-AS2:NR_125992.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A-AS2:NR_125993.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.137-1870G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48527 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs56110889	0.1624	0.1935,0.0944,0.0001,0.1752,0.0772	2189,.	20293	127253	0.1710			8.24			COSV56425186	0.01	25741868,24033266,23757202,17085681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216174110	216174110	C	A	het	het	wt		QUAL=3548;DP=218,108,121;AF=0.41,0.45,0.00;MQM=60;SAP=3;ABP=18	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::	USH2A:NM_007123.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295405 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs401269	0.2034		3220,.	24450	120948	-0.1820			4.30				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216174214	216174214	A	G	het	het	wt		QUAL=3712;DP=224,56,55;AF=0.48,0.54,0.00;MQM=60;SAP=78;ABP=3	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::	USH2A:NM_007123.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A];			rs439940	0.2042		3243,.	24564	120978	0.8240			7.15				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216175422	216175422	C	T	het	het	hom		QUAL=29624;DP=479,455,509;AF=0.53,0.49,1.00;MQM=60;SAP=151;ABP=4	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:	USH2A:NM_007123.6:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:,USH2A:NM_206933.4:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	177992 [benign DISEASE=Usher syndrome, type 2A,not specified,not provided];			rs1805049	0.6605	0.5814,0.7160,0.7813,0.6225,0.6986	30303,.	34966	56360	-1.5240	T(0.56),T(0.30),T(0.57)	B(0.03),B(0.03),B(0.05)	6.63	0.02		COSV56346078	0.29	24033266,21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216196766	216196766	C	T	het	het	wt	off-target	QUAL=3479;DP=188,93,127;AF=0.51,0.51,0.00;MQM=60;SAP=278;ABP=3	USH2A,USH2A-AS1	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::	USH2A:NM_007123.6:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A-AS1:XR_922595.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.1076+841C>T::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1076+841C>T::,USH2A-AS1:XR_922598.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.484+841C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177619 [benign DISEASE=Usher syndrome, type 2A,not provided];			rs447102	0.2094	0.0693,0.1891,0.2103,0.2388,0.2321	2763,.	21449	124947	-1.2300			0.01			COSV56445389	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216198592	216198592	A	C	het	het	wt		QUAL=4100;DP=223,82,90;AF=0.54,0.55,0.00;MQM=60;SAP=336;ABP=7	USH2A,USH2A-AS1	splice_region&intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::	USH2A:NM_007123.6:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A:NM_206933.4:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A-AS1:XR_922595.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.1076+2667A>C::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1076+2667A>C::,USH2A-AS1:XR_922598.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.484+2667A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48508 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,not provided];			rs646094	0.2133	0.1641,0.1892,0.2059,0.2339,0.2298	3257,.	24576	120886	2.6310			8.66		9.73>8.94		0.14	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216217352	216217352	C	T	het	het	hom	off-target	QUAL=7335;DP=178,110,125;AF=0.48,0.52,1.00;MQM=60;SAP=358;ABP=3	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::	USH2A:NM_007123.6:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::,USH2A:NM_206933.4:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A-AS1:XR_922596.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.1077-8035C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	1177621 [benign DISEASE=Usher syndrome, type 2A,not provided];		L3b (LINE/CR1)	rs1324330	0.6376	0.3347,0.7025,0.7786,0.6182,0.6829	25206,.	34456	66924	0.1690			2.32			COSV56329695	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216418661	216418661	T	C	hom	hom	hom		QUAL=18986;DP=160,189,255;AF=1.00,0.99,1.00;MQM=60;SAP=131;ABP=0	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]	USH2A:NM_007123.6:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:,USH2A:NM_206933.4:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48528 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,not provided];			rs4253963	0.6527	0.4930,0.6943,0.8390,0.6474,0.6011	29431,.	34781	58049	-0.5650			0.35				0.03	25741868,24033266,22876132,21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216421964	216421964	C	T	hom	hom	hom		QUAL=33057;DP=294,279,443;AF=1.00,1.00,1.00;MQM=60;SAP=3;ABP=0	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:	USH2A:NM_007123.6:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:,USH2A:NM_206933.4:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)]	48507 [benign DISEASE=Retinitis pigmentosa,Usher syndrome, type 2A,not specified,not provided];			rs10779261	0.7323	0.7567,0.7303,0.8364,0.7049,0.7321	40838,.	29559	40667	0.3580	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.92	0.08			0	25741868,24033266,21686329,30419932	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220150107	220150107	T	-	het	het	het		QUAL=1404;DP=143,38,46;AF=0.27,0.37,0.26;MQM=60;SAP=13;ABP=93	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295627 [uncertain significance DISEASE=Warburg micro syndrome,Martsolf syndrome];		FLAM_C (SINE/Alu)	rs11316594	0.4708		14619,.	33260	70264	-2.8380			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150452	T	-	het	het	het		QUAL=699;DP=53,14,21;AF=0.30,0.43,0.29;MQM=60;SAP=41;ABP=28	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.1647		2069,.	16481	104543	-0.1300			3.64				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150452	220150453	TT	-	het	wt	wt		QUAL=699;DP=53,14,21;AF=0.25,0.21,0.14;MQM=60;SAP=12;ABP=65	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*798_*799del::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			(T)n (Simple_repeat)	rs35147354	0.0015		0,.	188	124964	-0.1300			3.62				0		0	54	0 / 0					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150847	220150847	A	G	het	wt	het		QUAL=9846;DP=414,217,267;AF=0.55,0.00,0.53;MQM=60;SAP=283;ABP=13	RAB3GAP2	3'UTR	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::	RAB3GAP2:NM_012414.4:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295635 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome];			rs1059140	0.0717		520,.	9860	141232	0.2210			6.90				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157330	220157330	C	T	het	wt	het		QUAL=9501;DP=416,209,288;AF=0.55,0.00,0.48;MQM=60;SAP=266;ABP=5	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.7:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130080 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs11547779	0.0866	0.0150,0.0479,0.0566,0.0976,0.1336	510,.	9769	141097	-0.5860			5.52			COSV62784001	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157863	220157863	C	G	het	wt	het		QUAL=6490;DP=291,182,248;AF=0.45,0.00,0.46;MQM=60;SAP=3;ABP=11	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.7:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]	RAB3GAP2:NM_012414.4:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130079 [benign DISEASE=Warburg micro syndrome 2,Martsolf syndrome,not specified];			rs2289189	0.0859	0.0150,0.0456,0.0565,0.0969,0.1333	507,.	9756	141356	7.3560	D(0.05)	P(0.86)	25.70	0.18		COSV62784008	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220196404	220196404	A	-	wt	het	wt		QUAL=829;DP=165,91,94;AF=0.05,0.48,0.01;MQM=60;SAP=88;ABP=3	RAB3GAP2	splice_region&intron	RAB3GAP2:ENST00000358951.7:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::	RAB3GAP2:NM_012414.4:splice_region_variant&intron_variant:LOW:intron9/34:c.812-6del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295665 [benign DISEASE=Warburg micro syndrome 2,Warburg micro syndrome,Martsolf syndrome,not provided];			rs35396665	0.3794	0.3400,0.4778,0.4509,0.3419,0.3871	5003,.	28498	106966	-0.0030			1.96				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), MIR664A (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SNORA36B (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222928597	222928597	A	C	het	het	het	off-target	QUAL=5401;DP=179,136,156;AF=0.42,0.47,0.50;MQM=60;SAP=264;ABP=9	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-14210A>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron1/7:c.-17-14210A>C::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-18+27A>C::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron1/8:c.-99+27A>C::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron1/7:c.-17-14210A>C::	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs35491159	0.3181		8061,.	32228	103652	-0.0850			5.90				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222942767	222942767	C	T	het	het	het	off-target	QUAL=3237;DP=101,91,104;AF=0.48,0.51,0.48;MQM=60;SAP=316;ABP=3	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron2/8:c.-904-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron3/9:c.-17-40C>T::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::			1247665 [benign DISEASE=not provided];			rs75109669	0.1771		2527,.	21846	124978	-0.0570			8.58				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222983040	222983040	C	T	hom	hom	hom	off-target	QUAL=17389;DP=272,113,154;AF=1.00,1.00,1.00;MQM=60;SAP=477;ABP=0	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron3/8:c.-378-40C>T::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron4/9:c.510-40C>T::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_006711594.3:intron_variant:MODIFIER:intron2/7:c.-73-40C>T::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron2/7:c.510-40C>T::,DISP1:XM_017002612.1:intron_variant:MODIFIER:intron2/8:c.-242-40C>T::			1250961 [benign DISEASE=not provided];			rs2926159	0.9999	0.9992,1.0000,1.0000,1.0000,1.0000	75769,.	39	39	1.0190			10.88				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222994871	222994871	T	C	wt	wt	het	off-target	QUAL=1100;DP=181,56,93;AF=0.00,0.00,0.48;MQM=60;SAP=7;ABP=3	DISP1	intron	DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::	DISP1:NM_001350630.2:intron_variant:MODIFIER:intron7/8:c.161-14T>C::,DISP1:NM_001369594.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:NM_001377228.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:NM_001377229.1:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:NM_032890.5:intron_variant:MODIFIER:intron8/9:c.890-14T>C::,DISP1:XM_006711592.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_006711594.3:intron_variant:MODIFIER:intron6/7:c.308-14T>C::,DISP1:XM_011510072.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510073.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510074.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_011510075.2:intron_variant:MODIFIER:intron7/8:c.890-14T>C::,DISP1:XM_017002611.1:intron_variant:MODIFIER:intron6/7:c.890-14T>C::,DISP1:XM_017002612.1:intron_variant:MODIFIER:intron7/8:c.308-14T>C::	regulatory_region_variant:promoter_flanking_region		262132 [benign DISEASE=not specified,not provided];			rs2609359	0.3510	0.4328,0.3755,0.3002,0.3011,0.4574	9713,.	33854	98528	0.0770			8.15		10.87>9.80	COSV52656379	0.01	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223004232	223004232	A	G	wt	wt	het		QUAL=5304;DP=505,262,406;AF=0.00,0.00,0.50;MQM=60;SAP=28;ABP=3	DISP1	synonymous	DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.2106A>G:p.Lys702=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:NM_001377228.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:NM_001377229.1:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.2835A>G:p.Lys945=:,DISP1:XM_006711592.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_006711594.3:synonymous_variant:LOW:exon8/8:c.2253A>G:p.Lys751=:,DISP1:XM_011510072.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510073.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510074.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_011510075.2:synonymous_variant:LOW:exon9/9:c.2835A>G:p.Lys945=:,DISP1:XM_017002611.1:synonymous_variant:LOW:exon8/8:c.2835A>G:p.Lys945=:,DISP1:XM_017002612.1:synonymous_variant:LOW:exon9/9:c.2253A>G:p.Lys751=:			262128 [benign DISEASE=not specified,not provided];			rs2609355	0.2896	0.1816,0.2986,0.2129,0.3013,0.3117	5579,.	29190	111554	-0.5890			3.67			COSV52659190	0	25741868,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223005219	223005219	A	C	hom	hom	het		QUAL=20467;DP=190,288,371;AF=1.00,1.00,0.53;MQM=60;SAP=3;ABP=6	DISP1	synonymous	DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:	DISP1:NM_001350630.2:synonymous_variant:LOW:exon9/9:c.3093A>C:p.Pro1031=:,DISP1:NM_001369594.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:NM_001377228.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:NM_001377229.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:NM_032890.5:synonymous_variant:LOW:exon10/10:c.3822A>C:p.Pro1274=:,DISP1:XM_006711592.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_006711594.3:synonymous_variant:LOW:exon8/8:c.3240A>C:p.Pro1080=:,DISP1:XM_011510072.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510073.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510074.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_011510075.2:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:XM_017002611.1:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:,DISP1:XM_017002612.1:synonymous_variant:LOW:exon9/9:c.3240A>C:p.Pro1080=:			262131 [benign DISEASE=not specified,not provided];			rs9441941	0.5467	0.4474,0.5375,0.5131,0.5771,0.4763	21985,.	37268	70692	-0.9000			1.93			COSV52656581	0	25741868,22952568,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225401771	225401771	C	T	het	wt	het		QUAL=8397;DP=322,266,352;AF=0.50,0.00,0.44;MQM=60;SAP=9;ABP=8	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:NM_194442.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:XM_005273125.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1532G>A::,LBR:XM_011544185.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.3403G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295917 [benign DISEASE=Greenberg dysplasia];			rs7406	0.2527		6962,.	24479	113573	0.7850			9.24				0	30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225403048	225403048	G	C	het	wt	het		QUAL=4482;DP=310,46,55;AF=0.47,0.00,0.51;MQM=60;SAP=150;ABP=4	LBR	3'UTR	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::	LBR:NM_002296.4:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:NM_194442.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:XM_005273125.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*255C>G::,LBR:XM_011544185.3:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.2126C>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295928 [benign DISEASE=Greenberg dysplasia,not provided];			rs11551874	0.0917		844,.	12258	138074	0.6960			2.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225412650	225412650	A	-	het	het	het	low_conf_region	QUAL=185;DP=88,28,35;AF=0.20,0.11,0.17;MQM=59;SAP=62;ABP=138	LBR	splice_region&intron	LBR:ENST00000272163.9:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:ENST00000338179.6:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::	LBR:NM_002296.4:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:NM_194442.3:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:XM_005273125.3:splice_region_variant&intron_variant:LOW:intron7/12:c.893-5del::,LBR:XM_011544185.3:splice_region_variant&intron_variant:LOW:intron7/13:c.893-5del::,LBR:XR_001737168.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron7/12:n.1020-5del::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	439855 [benign/likely benign DISEASE=not specified,not provided];			rs78306811	0.3160	0.3032,0.3126,0.3256,0.3146,0.3230	5,.	1209	132231	-0.0670			2.55				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225419442	225419442	C	T	het	hom	het		QUAL=1842;DP=75,20,47;AF=0.40,1.00,0.45;MQM=60;SAP=45;ABP=10	LBR	missense	LBR:ENST00000272163.9:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.6:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:	LBR:NM_002296.4:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:NM_194442.3:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:XM_005273125.3:missense_variant:MODERATE:exon5/13:c.461G>A:p.Ser154Asn:,LBR:XM_011544185.3:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon5/13:n.588G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258619 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs2230419	0.8115	0.4185,0.8721,0.9579,0.8381,0.6987	43266,.	24388	41110	-0.1670	T(0.41),T(0.41)	B(0.01),B(0.01)	0.00	0.17		COSV55291160	0.01	25741868,24033266,26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225422182	225422182	A	G	het	hom	het		QUAL=2336;DP=123,15,17;AF=0.57,1.00,0.59;MQM=60;SAP=7;ABP=9	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.6:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	LBR:NM_002296.4:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:NM_194442.3:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:XM_005273125.3:synonymous_variant:LOW:exon3/13:c.261T>C:p.Pro87=:,LBR:XM_011544185.3:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon3/13:n.388T>C::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258617 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056608	0.7631	0.3854,0.8478,0.8973,0.7866,0.6557	38101,.	27720	48000	-0.7860			2.29				0.01	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225423959	225423959	C	T	het	het	hom		QUAL=17163;DP=364,210,283;AF=0.53,0.49,1.00;MQM=60;SAP=13;ABP=4	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.6:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]	LBR:NM_002296.4:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:NM_194442.3:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:XM_005273125.3:synonymous_variant:LOW:exon2/13:c.117G>A:p.Val39=:,LBR:XM_011544185.3:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:,LBR:XR_001737168.2:non_coding_transcript_exon_variant:MODIFIER:exon2/13:n.244G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258616 [benign DISEASE=Pelger-Huet anomaly,Greenberg dysplasia,Reynolds syndrome,not specified,not provided];			rs1056607	0.7177	0.6399,0.7860,0.7681,0.7349,0.5212	38809,.	30508	43838	-3.1000			1.22			COSV55289527	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225424143	225424143	C	T	wt	het	het	off-target;low_conf_region	QUAL=2274;DP=183,83,110;AF=0.00,0.43,0.52;MQM=60;SAP=114;ABP=4	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::	LBR:NM_002296.4:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:NM_194442.3:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:XM_005273125.3:intron_variant:MODIFIER:intron1/12:c.-14-54G>A::,LBR:XM_011544185.3:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:XR_001737168.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.114-54G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	810884 [benign DISEASE=not specified,not provided];			rs1340867	0.6202		29478,.	35252	57694	-1.5450			0.31				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225428676	225428676	G	C	het	het	wt	off-target	QUAL=4190;DP=197,179,249;AF=0.55,0.50,0.00;MQM=60;SAP=305;ABP=5	LBR	intron	LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	LBR:NM_194442.3:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::	regulatory_region_variant:promoter	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; Pelger-Huet anomaly with mild skeletal anomalies, 618019 (3); ?Reynolds syndrome, 613471 (3), Autosomal dominant; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]				rs75691342	0.0776		565,.	10677	140267	-0.4380			4.82						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226360853	226360853	A	G	wt	het	wt		QUAL=860;DP=168,77,97;AF=0.01,0.49,0.00;MQM=60;SAP=38;ABP=3	PARP1	3'UTR	PARP1:ENST00000366794.10:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::,PARP1:ENST00000677203.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*607T>C::	PARP1:NM_001618.4:3_prime_UTR_variant:MODIFIER:exon23/23:c.*607T>C::				CR122378 [CLASS=DP MUT=ALT PHEN="Bladder cancer increased risk association with" GENE=PARP1];		rs8679	0.1659		2639,.	19952	126876	-0.5110			1.46				0	31637880,23614619,21976407,25114582,21767974,22166496,25003827,27746584,29048575,31413734,29937070,28537887,26261599,25139788,22964086,24616890,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367601	226367601	A	G	het	wt	het		QUAL=5930;DP=196,218,300;AF=0.49,0.00,0.47;MQM=60;SAP=64;ABP=5	PARP1	missense	PARP1:ENST00000366794.10:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain],PARP1:ENST00000677203.1:missense_variant:MODERATE:exon16/22:c.2156T>C:p.Val719Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]	PARP1:NM_001618.4:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:			1261945 [benign DISEASE=not provided];	CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.2131	0.0487,0.4231,0.4477,0.1664,0.1026	2589,.	18737	128135	8.9420	D(0.02),D(0.01)	P(0.68),B(0.15)	27.40	0.18		COSV64689246	0	21976407,21767974,31413734,30337837,25111588,23139751,19249341,26648684,18191955,17267408,21989229,31288058,21606320,16465622,16857995,17203305,17220334,18701435,19109789,19124499,19318434,19822020,20150366,20211558,20353610,20486200,20559012,21037106,21129811,21385363,21420246,21700777,21810555,22127734,22687647,22740911,22792228,22850545,22969958,23608917,23633189,23644255,23720673,24172093,24203816,24340057,24500421,25106941,25179837,25231222,25493225,25911198,26921778,27055523,27099827,27285066,27323894,27415837,27588484,27840165,27866211,28765340,28956850,29399184,29484706,29662639,30183716,31489712,31584889,31609976,31762827,31983162,28206966,22430443,29937070,31415677,22868256,25837821,31171785,26316174,27959887,25356504,24392019,27209488,28423490,26261599,25374063,26388025,29184509,23755158,27081507,27324896,31921313,28599464,24853559,25139788,26019482,27895737,23857046,23537197,24489833,20725763,17214964,17560163,20113831,17055652	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367647	226367647	G	A	wt	het	wt	off-target	QUAL=2128;DP=205,175,243;AF=0.00,0.49,0.00;MQM=60;SAP=37;ABP=3	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron15/21:c.2149-39C>T::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron16/22:c.2278-39C>T::						rs3219123	0.0445	0.0086,0.0237,0.0004,0.0601,0.0452	198,.	5733	146027	0.4890			3.05				0	31134135,21767974,20158304,21537398,17560163	67	1964	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226383139	226383139	T	C	het	hom	het		QUAL=4875;DP=92,72,92;AF=0.58,1.00,0.51;MQM=60;SAP=35;ABP=6	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:,PARP1:ENST00000677203.1:synonymous_variant:LOW:exon8/22:c.1056A>G:p.Lys352=:	PARP1:NM_001618.4:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:						rs1805415	0.8276	0.9002,0.5748,0.5531,0.8337,0.8974	52662,.	20600	26226	-0.1010			8.59			COSV64689254	0.03	19249341,17267408,27153553,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226385663	226385663	A	G	het	wt	het		QUAL=4736;DP=157,208,247;AF=0.54,0.00,0.45;MQM=60;SAP=152;ABP=4	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon7/22:c.852T>C:p.Ala284=:PF08063 [PADR1 (NUC008) domain]	PARP1:NM_001618.4:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.4262	0.5525,0.5538,0.8133,0.3377,0.3647	14726,.	35019	87471	-2.5750			0.42			COSV64689261	0	18805967,21767974,27746584,29662639,30183716,31609976,19604089,21695249,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390398	226390398	T	C	hom	het	hom	off-target	QUAL=8987;DP=90,121,162;AF=1.00,0.55,0.99;MQM=60;SAP=435;ABP=5	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron4/22:c.617+12A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron4/21:c.617+12A>G::	PARP1:NM_001618.4:intron_variant:MODIFIER:intron4/22:c.617+12A>G::						rs1805403	0.8340	0.9411,0.8703,0.9388,0.7678,0.7385	53408,.	19974	25232	-5.7450			0.01				0	27746584,19657367	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402257	226402257	G	A	het	wt	het		QUAL=9316;DP=297,299,469;AF=0.46,0.00,0.48;MQM=60;SAP=6;ABP=7	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon2/22:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]	PARP1:NM_001618.4:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:						rs1805404	0.2184	0.1230,0.4261,0.4479,0.1663,0.1030	2944,.	21335	124861	3.1620			11.98			COSV64687027	0	17267408,20486200,30183716,31609976,27462201,31415677,20113831,32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226407946	226407946	C	G	het	wt	het		QUAL=2211;DP=42,138,146;AF=0.52,0.00,0.50;MQM=60;SAP=3;ABP=3	PARP1	5'UTR	PARP1:ENST00000366794.10:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::,PARP1:ENST00000677203.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-17G>C::	PARP1:NM_001618.4:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::	regulatory_region_variant:promoter,TF_binding_site_variant					rs907187	0.2135	0.0465,0.4177,0.4433,0.1652,0.1020	2724,.	19075	127461	0.9510			12.41			COSV64687065	0	21767974,17267408,21989229,31288058,32103589,26261599,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226961502	226961502	G	A	wt	het	wt		QUAL=294;DP=72,31,35;AF=0.00,0.48,0.00;MQM=60;SAP=4;ABP=3	COQ8A	synonymous,splice_region&intron,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron1/14:c.-34-6G>A::,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon19/32:c.*4844G>A::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon4/17:c.117G>A:p.Ala39=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon2/15:c.117G>A:p.Ala39=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon3/16:c.117G>A:p.Ala39=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128273 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs11549708	0.1645	0.0465,0.0978,0.0005,0.2379,0.0769	2570,.	19281	127743	-3.5600			3.92		-0.47>-4.84	COSV64658484	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226964961	226964961	C	T	wt	het	wt	off-target	QUAL=926;DP=82,67,85;AF=0.01,0.63,0.00;MQM=60;SAP=80;ABP=12	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron2/14:c.22-39C>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron19/31:c.*4905-39C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron4/16:c.178-39C>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron2/14:c.178-39C>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron3/15:c.178-39C>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759581953	0.0001	0.0000,0.0000,0.0001,0.0001,0.0001	0,.	2	152224	-1.1540			0.06				0		0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226977534	226977534	C	T	het	wt	het	off-target	QUAL=433;DP=18,31,24;AF=0.50,0.00,0.50;MQM=60;SAP=3;ABP=3	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron5/14:c.574+11C>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron22/31:c.*5457+11C>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron7/16:c.730+11C>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron5/14:c.730+11C>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron6/15:c.730+11C>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759489004	0.0001	0.0000,0.0000,0.0000,0.0001,0.0000	0,.	1	152147	0.7940			6.46				0		0	3	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982842	226982842	C	G	het	het	wt	off-target	QUAL=3779;DP=114,177,294;AF=0.61,0.47,0.01;MQM=60;SAP=90;ABP=4	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron24/31:c.*5667-52C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron9/16:c.940-52C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron7/14:c.940-52C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron8/15:c.940-52C>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671531 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs2297413	0.2028		3383,.	24082	121244	0.6420			2.96			COSV64657732	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983509	226983509	G	A	het	wt	hom	off-target	QUAL=5893;DP=84,143,175;AF=0.49,0.00,0.99;MQM=60;SAP=204;ABP=3	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron25/31:c.*5808-43G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron10/16:c.1081-43G>A::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron9/15:c.1081-43G>A::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671619 [benign DISEASE=not provided];			rs12739480	0.1248	0.0331,0.0460,0.0446,0.1408,0.2082	1139,.	13844	135926	-0.4310			0.57			COSV64659018	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983884	226983884	T	-	het	hom	wt	off-target	QUAL=1937;DP=103,40,77;AF=0.44,1.00,0.00;MQM=60;SAP=69;ABP=7	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1100+32del::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5983+32del::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1256+32del::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1256+32del::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1256+32del::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1183738 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs3215919	0.3693	0.2910,0.2790,0.1388,0.4449,0.2053	10965,.	34216	95890	-0.8150			0.16				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984035	226984035	-	T	wt	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-59_1101-58insT::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-59_*5984-58insT::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-59_1257-58insT::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-59_1257-58insT::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-59_1257-58insT::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1294314 [benign DISEASE=not provided];			rs149374145	0.1614		2411,.	18625	121807				3.95				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984036	226984036	G	T	het	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-58G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-58G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-58G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1291028 [benign DISEASE=not provided];			rs1574184	0.2469		4060,.	26254	104872	1.7960			4.23			COSV64656763	0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984037	226984037	G	T	wt	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=4;ABP=3	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-57G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-57G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-57G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-57G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-57G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1262417 [benign DISEASE=not provided];			rs377335668	0.1554		2351,.	18470	125934	0.2130			0.99				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984038	226984038	G	T	het	het	wt	off-target	QUAL=2157;DP=65,57,41;AF=0.63,0.53,0.00;MQM=60;SAP=54;ABP=10	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron27/31:c.*5984-56G>T::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron12/16:c.1257-56G>T::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron11/15:c.1257-56G>T::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1188901 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs1574185	0.2348		3739,.	25551	107637	-0.1650			0.81				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984257	226984257	G	C	wt	het	wt	off-target	QUAL=1013;DP=114,75,107;AF=0.00,0.53,0.00;MQM=60;SAP=4;ABP=4	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron11/14:c.1242+22G>C::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron28/31:c.*6125+22G>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron13/16:c.1398+22G>C::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron11/14:c.1398+22G>C::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron12/15:c.1398+22G>C::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1247645 [benign DISEASE=not provided];			rs7530213	0.2505	0.1551,0.2011,0.0930,0.3134,0.1314	5196,.	27711	113999	0.7580			6.30			COSV64657987	0.32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984589	226984589	C	T	het	hom	wt		QUAL=15686;DP=331,380,506;AF=0.47,0.98,0.00;MQM=60;SAP=6;ABP=5	COQ8A	synonymous,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon29/32:c.*6167C>T::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon14/17:c.1440C>T:p.Phe480=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon13/16:c.1440C>T:p.Phe480=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128274 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs12593	0.3534	0.1976,0.2696,0.1758,0.4533,0.2031	10345,.	32521	98771	-0.2170			4.88			COSV64656797	0	31816047	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226985202	226985202	G	A	het	hom	wt	off-target	QUAL=8133;DP=101,230,303;AF=0.60,0.98,0.00;MQM=60;SAP=98;ABP=12	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron30/31:c.*6300-52G>A::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron15/16:c.1573-52G>A::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron14/15:c.1573-52G>A::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	676090 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not provided];			rs2297415	0.3780		11508,.	34414	94486	-2.2820			1.16			COSV62011699,COSV62017351	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226985234	226985234	C	G	het	hom	wt	off-target	QUAL=9709;DP=115,265,340;AF=0.62,1.00,0.00;MQM=60;SAP=18;ABP=17	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-20C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron30/31:c.*6300-20C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron15/16:c.1573-20C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron13/14:c.1573-20C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron14/15:c.1573-20C>G::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	518313 [benign/likely benign DISEASE=Coenzyme Q10 deficiency, primary, 4,not specified,not provided];			rs2297416	0.3737	0.2678,0.2816,0.1674,0.4597,0.2070	11314,.	34149	95149	0.0300			3.50		12.28>10.93	COSV62011473	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986421	226986421	C	G	wt	het	wt	off-target	QUAL=940;DP=87,73,139;AF=0.00,0.56,0.00;MQM=60;SAP=6;ABP=5	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-32C>G::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron31/31:c.*6387-32C>G::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron16/16:c.1660-32C>G::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron14/14:c.1660-32C>G::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron15/15:c.1660-32C>G::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671534 [benign DISEASE=not provided];			rs41303131	0.1980	0.0873,0.1155,0.0030,0.2805,0.1235	3668,.	22710	121816	-1.9210			0.17			COSV62005838	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986444	226986444	T	C	het	hom	wt		QUAL=4063;DP=103,89,168;AF=0.53,1.00,0.00;MQM=60;SAP=50;ABP=4	COQ8A	intron,intron&NMD_transcript	COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron14/14:c.1504-9T>C::,:ENST00000366779.6:intron_variant&NMD_transcript_variant:MODIFIER:intron31/31:c.*6387-9T>C::	COQ8A:NM_020247.5:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_005273201.1:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_011544238.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::,COQ8A:XM_011544239.2:intron_variant:MODIFIER:intron16/16:c.1660-9T>C::,COQ8A:XM_011544241.2:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_017001852.1:intron_variant:MODIFIER:intron14/14:c.1660-9T>C::,COQ8A:XM_024448517.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::,COQ8A:XM_024448518.1:intron_variant:MODIFIER:intron15/15:c.1660-9T>C::	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296024 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs7552783	0.4430	0.4148,0.3047,0.2207,0.5014,0.2758	15302,.	36558	84446	-3.6360			5.40		11.51>10.71	COSV62011703,COSV62011928	0	26503814,32439900	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986509	226986509	T	C	het	hom	wt		QUAL=5374;DP=162,118,185;AF=0.45,1.00,0.00;MQM=60;SAP=3;ABP=6	COQ8A	synonymous,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:c.*6443T>C::	COQ8A:NM_020247.5:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_005273201.1:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_011544238.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:,COQ8A:XM_011544239.2:synonymous_variant:LOW:exon17/17:c.1716T>C:p.Ser572=:,COQ8A:XM_011544241.2:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_017001852.1:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,COQ8A:XM_024448517.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:,COQ8A:XM_024448518.1:synonymous_variant:LOW:exon16/16:c.1716T>C:p.Ser572=:	regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128275 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,not specified,not provided];			rs3738725	0.4134	0.3106,0.2982,0.2240,0.5020,0.2756	13639,.	35310	88830	-5.5320			0.04			COSV62011476	0.18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987122	226987122	-	T	het	hom	wt		QUAL=13740;DP=246,373,474;AF=0.46,1.00,0.00;MQM=60;SAP=75;ABP=7	COQ8A	3'UTR,3'UTR&NMD_transcript	COQ8A:ENST00000366777.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366778.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:c.*7060dup::	COQ8A:NM_020247.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_005273201.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_011544238.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::,COQ8A:XM_011544239.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*389dup::,COQ8A:XM_011544241.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_017001852.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:XM_024448517.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::,COQ8A:XM_024448518.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*389dup::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type];			rs11420839	0.4035		13225,.	34851	90637				1.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987544	226987544	-	T	het	hom	wt		QUAL=7958;DP=163,221,329;AF=0.45,0.96,0.00;MQM=60;SAP=26;ABP=6		3'UTR&NMD_transcript	:ENST00000366779.6:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon32/32:::		regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296050 [benign DISEASE=Coenzyme Q10 deficiency, primary, 4,Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs3215920	0.3726		12089,.	32416	95286				1.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987552	226987552	C	T	het	hom	wt		QUAL=8644;DP=165,214,324;AF=0.48,1.00,0.00;MQM=60;SAP=45;ABP=4	CDC42BPA,COQ8A	downstream_gene,upstream_gene	CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366764.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,:ENST00000366779.6:downstream_gene_variant:MODIFIER::::,:ENST00000433837.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	368867 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,not provided];			rs10495274	0.5257		22087,.	35663	72025	-0.9260			0.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228159235	228159235	G	A	het	wt	het		QUAL=2189;DP=43,92,130;AF=0.53,0.00,0.54;MQM=60;SAP=25;ABP=5	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]	1265470 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Hereditary spastic paraplegia,not provided];			rs45491398	0.0576		366,.	8039	143449	-1.8580			0.34				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228159651	228159651	A	G	hom	hom	hom		QUAL=1506;DP=30,8,13;AF=1.00,1.00,1.00;MQM=60;SAP=105;ABP=0	GJC2	3'UTR	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::	GJC2:NM_020435.4:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]				rs6668719	0.8480		55985,.	16902	23106	0.0710			4.20				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228425137	228425137	G	T	het	het	hom		QUAL=18667;DP=288,285,384;AF=0.51,0.46,1.00;MQM=60;SAP=428;ABP=4	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]	H3-4:NM_003493.3:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:	regulatory_region_variant:CTCF_binding_site					rs2230656	0.8318	0.3976,0.9254,0.6604,0.8863,0.8559	44714,.	22742	39988	2.0500			8.50			COSV64210568	0.06	29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425191	228425191	G	A	wt	wt	het		QUAL=2236;DP=186,211,259;AF=0.00,0.00,0.47;MQM=60;SAP=158;ABP=5	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:PF00125 [Core histone H2A/H2B/H3/H4]	H3-4:NM_003493.3:synonymous_variant:LOW:exon1/1:c.135C>T:p.Gly45=:	regulatory_region_variant:CTCF_binding_site					rs56336130	0.0708	0.0128,0.0359,0.0198,0.0923,0.0907	417,.	8772	142644	0.1770			6.19			COSV64210887	0.67	29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425351	228425351	T	C	het	het	hom	off-target	QUAL=1615;DP=58,34,30;AF=0.40,0.41,1.00;MQM=60;SAP=148;ABP=11	H3-4	5'UTR	H3-4:ENST00000366696.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::	H3-4:NM_003493.3:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::						rs1188474	0.8923	0.9285,0.9608,0.6693,0.8916,0.8646	60765,.	14215	16383	-2.8600			0.35						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229432484	229432484	T	G	hom	hom	hom	off-target	QUAL=2169;DP=8,34,46;AF=1.00,1.00,1.00;MQM=60;SAP=194;ABP=0	ACTA1	intron	ACTA1:ENST00000366683.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000366684.7:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000684723.1:intron_variant:MODIFIER:intron2/5:c.320-53A>C::	ACTA1:NM_001100.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:promoter_flanking_region	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal dominant, Autosomal recessive]	676564 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Myopathy, scapulohumeroperoneal,not provided];			rs527621	0.9984		72810,.	228	228	-1.3790			3.26				0.03	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434056	229434056	A	G	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5	ACTA1	5'UTR	ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-59T>C::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal dominant, Autosomal recessive]	296060 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605430	0.6324		30966,.	33954	55736	0.5810			19.39			COSV64203106	0	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434057	229434057	G	A	het	het	het		QUAL=3207;DP=64,74,110;AF=0.56,0.49,0.55;MQM=60;SAP=38;ABP=5	ACTA1	5'UTR	ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-60C>T::	ACTA1:NM_001100.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:promoter	102610_[GENE=ACTA1_PHENOS=?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, actin, congenital, with cores, 161800 (3), Autosomal dominant, Autosomal recessive; Myopathy, congenital, with fiber-type disproportion 1, 255310 (3), Autosomal dominant, Autosomal recessive]	296062 [benign DISEASE=Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,not provided];			rs605428	0.6322		30962,.	33957	55781	0.2370			17.21			COSV64204088	0	19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231241335	231241335	C	T	hom	hom	het		QUAL=18934;DP=293,250,316;AF=0.98,0.99,0.55;MQM=60;SAP=187;ABP=10	GNPAT	5'UTR	GNPAT:ENST00000366647.9:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::	GNPAT:NM_001316350.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-44C>T::,GNPAT:NM_014236.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::,GNPAT:XM_005273313.4:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::,GNPAT:XM_011544303.3:5_prime_UTR_variant:MODIFIER:exon1/17:c.-459C>T::,GNPAT:XM_011544304.2:5_prime_UTR_variant:MODIFIER:exon1/16:c.-276C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified];			rs518686	0.5542	0.5701,0.6072,0.5936,0.5291,0.6243	23065,.	37246	68560	0.1320			10.49			COSV59641814	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265458	231265458	T	C	hom	het	het	off-target	QUAL=12319;DP=212,178,232;AF=1.00,0.48,0.51;MQM=60;SAP=114;ABP=3	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron5/15:c.696+38T>C::	GNPAT:NM_001316350.2:intron_variant:MODIFIER:intron4/14:c.513+38T>C::,GNPAT:NM_014236.4:intron_variant:MODIFIER:intron5/15:c.696+38T>C::,GNPAT:XM_005273313.4:intron_variant:MODIFIER:intron5/15:c.693+38T>C::,GNPAT:XM_011544303.3:intron_variant:MODIFIER:intron6/16:c.369+38T>C::,GNPAT:XM_011544304.2:intron_variant:MODIFIER:intron5/15:c.369+38T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1256935 [benign DISEASE=not provided];			rs6702011	0.2745	0.2822,0.3909,0.2137,0.2542,0.2725	5526,.	29624	111314	-0.6780			7.53			COSV64154015	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231266156	231266156	G	A	hom	het	het		QUAL=17595;DP=348,202,257;AF=1.00,0.49,0.50;MQM=60;SAP=91;ABP=3	GNPAT	synonymous	GNPAT:ENST00000366647.9:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:	GNPAT:NM_001316350.2:synonymous_variant:LOW:exon6/15:c.732G>A:p.Glu244=:,GNPAT:NM_014236.4:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:,GNPAT:XM_005273313.4:synonymous_variant:LOW:exon7/16:c.912G>A:p.Glu304=:,GNPAT:XM_011544303.3:synonymous_variant:LOW:exon8/17:c.588G>A:p.Glu196=:,GNPAT:XM_011544304.2:synonymous_variant:LOW:exon7/16:c.588G>A:p.Glu196=:		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided];			rs574553	0.5883	0.6931,0.6150,0.5972,0.5398,0.6247	26756,.	35868	62554	1.6320			5.21			COSV64153484	0.04	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231364607	231364607	-	T	hom	het	hom		QUAL=17883;DP=350,162,185;AF=0.97,0.44,0.97;MQM=60;SAP=15;ABP=7	EGLN1	3'UTR	EGLN1:ENST00000366641.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::,:ENST00000653908.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1909dup::	EGLN1:NM_001377260.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1864dup::,EGLN1:NM_001377261.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1909dup::,EGLN1:NM_022051.3:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2277+3227dup::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]				rs541569859	0.5742		25902,.	35393	64653				7.84				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	-	het	wt	het	off-target;low_conf_region	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=50;ABP=587	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24del::,:ENST00000653908.1:intron_variant:MODIFIER:intron4/4:c.*42-24del::,:ENST00000662216.1:intron_variant:MODIFIER:intron6/6:c.356-24del::	EGLN1:NM_001377260.1:intron_variant:MODIFIER:intron3/3:c.1149-24del::,EGLN1:NM_001377261.1:intron_variant:MODIFIER:intron3/3:c.*42-24del::,EGLN1:NM_022051.3:intron_variant:MODIFIER:intron4/4:c.1217-24del::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2278-3052del::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1243379 [benign DISEASE=not provided];			rs371204614	0.1471	0.0682,0.1075,0.1613,0.1716,0.1280	0,.	140	149942	-0.5900			2.38			COSV64150067			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	A	het	het	het	off-target;low_conf_region	QUAL=9735;DP=158,167,198;AF=0.65,0.32,0.69;MQM=60;SAP=211;ABP=17	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::,:ENST00000653908.1:intron_variant:MODIFIER:intron4/4:c.*42-24A>T::,:ENST00000662216.1:intron_variant:MODIFIER:intron6/6:c.356-24A>T::	EGLN1:NM_001377260.1:intron_variant:MODIFIER:intron3/3:c.1149-24A>T::,EGLN1:NM_001377261.1:intron_variant:MODIFIER:intron3/3:c.*42-24A>T::,EGLN1:NM_022051.3:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::,LOC107985360:XR_001738520.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.2278-3055T>A::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1292828 [benign DISEASE=not provided];			rs1435167	0.5720	0.3345,0.3784,0.4142,0.4517,0.4127	25166,.	35803	64463	-0.5900			5.73			COSV64150067	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231421509	231421509	C	G	het	hom	wt		QUAL=206;DP=3,9,3;AF=0.67,1.00,0.00;MQM=60;SAP=27;ABP=4	EGLN1	missense,intron	EGLN1:ENST00000366641.4:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:,:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+40929G>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+40929G>C::	EGLN1:NM_001377260.1:missense_variant:MODERATE:exon1/4:c.380G>C:p.Cys127Ser:,EGLN1:NM_001377261.1:missense_variant:MODERATE:exon1/4:c.380G>C:p.Cys127Ser:,EGLN1:NM_022051.3:missense_variant:MODERATE:exon1/5:c.380G>C:p.Cys127Ser:,EGLN1:XM_024447734.1:missense_variant:MODERATE:exon1/3:c.380G>C:p.Cys127Ser:	regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	242640 [benign DISEASE=Erythrocytosis, familial, 3,not provided]; 156155 [affects DISEASE=Hemoglobin, high altitude adaptation];	CM140742 [CLASS=DFP MUT=ALT PHEN="Reduced haemoglobin levels" GENE=EGLN1];	(GCC)n (Simple_repeat)	rs12097901	0.1558	0.4444,0.2239,0.5097,0.0939,0.3281	2912,.	17741	127717	1.2680	T(0.74), , 	B(0.00), , 	12.82	0.21		COSV64149723	0	29625625,25129147,28116332,30719713,31824328,24711448,28096303,24030663,30188897,28036300,27325755,28819001	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231423480	231423480	A	G	het	hom	wt		QUAL=5114;DP=197,71,82;AF=0.51,1.00,0.02;MQM=60;SAP=19;ABP=3		intron	:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+38958T>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+38958T>C::		regulatory_region_variant:promoter	606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296223 [benign DISEASE=Erythrocytosis, familial, 3];			rs12406290	0.1928		3232,.	22855	122765	2.9670			10.08				0	25431923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231424474	231424474	A	G	het	hom	wt		QUAL=15143;DP=598,209,205;AF=0.52,1.00,0.00;MQM=60;SAP=357;ABP=5		intron	:ENST00000653908.1:intron_variant:MODIFIER:intron2/4:c.30+37964T>C::,:ENST00000662216.1:intron_variant:MODIFIER:intron3/6:c.30+37964T>C::			606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296240 [benign DISEASE=Erythrocytosis, familial, 3];			rs2153364	0.1935		3262,.	22902	122686	0.2220			4.11				0	25431923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235380162	235380165	TGTG	-	wt	wt	het	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=4;ABP=10	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+62_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+62_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+62_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+62_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+62_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+62_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34222_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+62_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+62_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+62_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]			(TG)n (Simple_repeat)	rs10524346	0.0584	0.0194,0.0288,0.0438,0.0234,0.0253	275,.	7596	131308	0.5040			1.36				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380175	TGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=8;ABP=45	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+52_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+52_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+52_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+52_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+52_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34232_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245486 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.2817	0.1041,0.1006,0.0754,0.2091,0.0685	6200,.	26941	100307	0.6670			1.46				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380177	TGTGTGTGTGTGTGTG	-	het	wt	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=59;SAP=38;ABP=78	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+50_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+50_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+50_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+50_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+50_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+50_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34234_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+50_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+50_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+50_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1232644 [benign DISEASE=not provided];		(TG)n (Simple_repeat)	rs10524346	0.0770	0.0784,0.0478,0.0847,0.0917,0.0437	199,.	5961	133353	0.6670			1.54				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235380162	235380179	TGTGTGTGTGTGTGTGTG	-	wt	het	wt	off-target;low_conf_region	QUAL=1646;DP=25,93,30;AF=0.04,0.37,0.00;MQM=60;SAP=6;ABP=11	TBCE	intron	TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+48_100+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+48_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000644604.1:intron_variant:MODIFIER:intron3/17:c.100+48_100+65del::,TBCE:ENST00000645205.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645351.1:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:ENST00000645655.1:intron_variant:MODIFIER:intron5/19:c.100+48_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+48_100+65del::,TBCE:ENST00000646624.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000647186.1:intron_variant:MODIFIER:intron4/18:c.100+48_100+65del::,TBCE:ENST00000647428.1:intron_variant:MODIFIER:intron1/14:c.-210-34236_-210-34219del::,TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::	TBCE:NM_001079515.3:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::,TBCE:NM_001287801.2:intron_variant:MODIFIER:intron2/17:c.100+48_100+65del::,TBCE:NM_001287802.2:intron_variant:MODIFIER:intron2/15:c.-211+48_-211+65del::,TBCE:NM_003193.5:intron_variant:MODIFIER:intron2/16:c.100+48_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	403520 [benign/likely benign DISEASE=not specified,not provided];		(TG)n (Simple_repeat)	rs10524346	0.1407	0.1339,0.2137,0.3190,0.0680,0.1604	1830,.	16003	120077	0.6670			1.55				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235449005	235449005	C	T	het	hom	wt	off-target	QUAL=4405;DP=134,84,91;AF=0.54,0.99,0.00;MQM=60;SAP=268;ABP=5	B3GALNT2,TBCE	3'UTR	B3GALNT2:ENST00000366600.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::,TBCE:ENST00000406207.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:ENST00000642610.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::	TBCE:NM_001079515.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:NM_001287801.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*243C>T::,TBCE:NM_001287802.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*243C>T::,TBCE:NM_003193.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:NM_152490.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::,B3GALNT2:XM_006711749.3:intron_variant:MODIFIER:intron12/12:c.1469+1235G>A::,B3GALNT2:XM_017000394.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1201G>A::,B3GALNT2:XM_017000395.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1380G>A::,B3GALNT2:XR_001736987.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2808G>A::,B3GALNT2:XR_001736989.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2729G>A::,B3GALNT2:XR_001736990.1:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2691G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]&610194_[GENE=B3GALNT2_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3), Autosomal recessive]				rs704705	0.7373		42460,.	27164	39946	0.6550			9.48			COSV64003592			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235662343	235662343	G	A	het	het	wt		QUAL=2801;DP=205,30,66;AF=0.47,0.33,0.00;MQM=60;SAP=20;ABP=7	LYST	3'UTR	LYST:ENST00000389793.7:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon52/53:c.*7427C>T::	LYST:NM_000081.4:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:NM_001301365.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:XM_011544031.1:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544032.1:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544033.2:3_prime_UTR_variant:MODIFIER:exon54/54:c.*597C>T::,LYST:XM_011544034.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::,LYST:XM_011544036.2:3_prime_UTR_variant:MODIFIER:exon50/50:c.*597C>T::,LYST:XM_017000150.1:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs1400168809	0.0001		0,.	3	152139	1.0680			4.70				0		0	2	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663083	235663083	A	-	hom	het	hom		QUAL=15554;DP=238,195,277;AF=0.90,0.51,0.91;MQM=60;SAP=137;ABP=3	LYST	splice_region&intron	LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:ENST00000389794.7:splice_region_variant&intron_variant:LOW:intron51/52:c.*6692-5del::	LYST:NM_000081.4:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:NM_001301365.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::,LYST:XM_011544031.1:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544032.1:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544033.2:splice_region_variant&intron_variant:LOW:intron53/53:c.11430-5del::,LYST:XM_011544034.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11292-5del::,LYST:XM_011544036.2:splice_region_variant&intron_variant:LOW:intron49/49:c.9093-5del::,LYST:XM_017000150.1:splice_region_variant&intron_variant:LOW:intron52/52:c.11199-5del::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994	0.5533	0.6809,0.4483,0.2392,0.5340,0.4148	24831,.	32904	66654	-0.6940			1.92				0.05	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235697040	235697040	C	T	hom	het	hom	off-target	QUAL=3255;DP=69,29,23;AF=1.00,0.59,1.00;MQM=60;SAP=190;ABP=5	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron45/52:c.*5988+43G>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron47/53:c.10726+43G>A::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron46/52:c.10588+43G>A::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron43/49:c.8389+43G>A::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron46/52:c.10495+43G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254908 [benign DISEASE=not specified,not provided];			rs7541057	0.5321	0.7306,0.2734,0.0498,0.5150,0.1857	23439,.	34003	71123	-1.8750			0.01				0.02	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235709365	235709365	T	C	hom	het	hom	off-target;low_conf_region	QUAL=7693;DP=179,47,56;AF=0.99,0.51,1.00;MQM=60;SAP=563;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron42/52:c.*5350-57A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron44/53:c.10088-57A>G::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron43/52:c.9950-57A>G::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron40/49:c.7751-57A>G::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron44/52:c.10088-57A>G::	regulatory_region_variant:promoter_flanking_region	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684363 [benign DISEASE=not provided];			rs2275856	0.4999		22426,.	31098	75976	-0.7320			1.43				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235723976	235723976	G	T	hom	het	hom	off-target	QUAL=9236;DP=134,99,116;AF=0.99,0.52,1.00;MQM=60;SAP=399;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron38/52:c.*4739+52C>A::	LYST:NM_000081.4:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron40/53:c.9477+52C>A::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron39/52:c.9339+52C>A::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron40/43:c.9477+52C>A::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron36/49:c.7140+52C>A::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron40/52:c.9477+52C>A::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron40/42:n.10350+52C>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684361 [benign DISEASE=not provided];			rs6667717	0.4978		22275,.	31050	76278	-2.6600			0.00			COSV67704991	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235758928	235758928	T	C	het	wt	het	off-target	QUAL=2274;DP=140,28,43;AF=0.56,0.04,0.44;MQM=60;SAP=216;ABP=4	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron22/52:c.*2305+44A>G::	LYST:NM_000081.4:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron23/53:c.6881+44A>G::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron22/52:c.6743+44A>G::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron23/43:c.6881+44A>G::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron19/49:c.4544+44A>G::,LYST:XM_011544037.2:intron_variant:MODIFIER:intron23/32:c.6881+44A>G::,LYST:XM_011544039.2:intron_variant:MODIFIER:intron23/27:c.6881+44A>G::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::,LYST:XR_001736946.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/33:n.7063+44A>G::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/42:n.7063+44A>G::,LYST:XR_001736948.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/27:n.7063+44A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254935 [benign DISEASE=not specified,not provided];			rs3738519	0.2969	0.4262,0.1913,0.0094,0.2694,0.1679	7328,.	30461	106847	-3.8310			0.03				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235777150	235777150	C	T	hom	het	hom		QUAL=17693;DP=240,202,237;AF=1.00,0.43,1.00;MQM=60;SAP=220;ABP=13	LYST	synonymous,3'UTR	LYST:ENST00000389793.7:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon16/53:c.*797G>A::	LYST:NM_000081.4:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon17/54:c.5373G>A:p.Lys1791=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon17/44:c.5373G>A:p.Lys1791=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon13/50:c.3036G>A:p.Lys1012=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon17/33:c.5373G>A:p.Lys1791=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon17/28:c.5373G>A:p.Lys1791=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon17/22:c.5373G>A:p.Lys1791=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon17/34:n.5555G>A::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon17/43:n.5555G>A::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon17/28:n.5555G>A::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon17/24:n.5555G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254927 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs2273584	0.4042	0.5010,0.2776,0.0588,0.4050,0.2022	13083,.	35163	90409	0.6210			6.01			COSV67705051	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781886	235781886	G	A	het	het	het	off-target	QUAL=4553;DP=135,92,152;AF=0.44,0.53,0.51;MQM=60;SAP=171;ABP=3	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron14/52:c.*447+41C>T::	LYST:NM_000081.4:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:NM_001301365.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_011544031.1:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544033.2:intron_variant:MODIFIER:intron15/53:c.5023+41C>T::,LYST:XM_011544034.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_011544035.2:intron_variant:MODIFIER:intron15/43:c.5023+41C>T::,LYST:XM_011544036.2:intron_variant:MODIFIER:intron11/49:c.2686+41C>T::,LYST:XM_011544037.2:intron_variant:MODIFIER:intron15/32:c.5023+41C>T::,LYST:XM_011544039.2:intron_variant:MODIFIER:intron15/27:c.5023+41C>T::,LYST:XM_017000150.1:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::,LYST:XM_017000151.1:intron_variant:MODIFIER:intron15/21:c.5023+41C>T::,LYST:XR_001736946.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/33:n.5205+41C>T::,LYST:XR_001736947.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/42:n.5205+41C>T::,LYST:XR_001736948.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/27:n.5205+41C>T::,LYST:XR_002959252.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/23:n.5205+41C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254924 [benign DISEASE=not specified,not provided];		AluJo (SINE/Alu)	rs72763416	0.1070	0.0709,0.0880,0.0493,0.1372,0.0408	971,.	14312	135698	-0.9540			0.38			COSV67705060	0.01	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781994	235781994	T	C	hom	het	hom		QUAL=15483;DP=184,150,232;AF=0.99,0.51,1.00;MQM=60;SAP=5;ABP=3	LYST	synonymous,3'UTR	LYST:ENST00000389793.7:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:ENST00000389794.7:3_prime_UTR_variant:MODIFIER:exon14/53:c.*380A>G::	LYST:NM_000081.4:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon15/54:c.4956A>G:p.Leu1652=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon15/44:c.4956A>G:p.Leu1652=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon11/50:c.2619A>G:p.Leu873=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon15/33:c.4956A>G:p.Leu1652=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon15/28:c.4956A>G:p.Leu1652=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon15/22:c.4956A>G:p.Leu1652=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon15/34:n.5138A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon15/43:n.5138A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon15/28:n.5138A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon15/24:n.5138A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254923 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs6696123	0.4050	0.5020,0.2780,0.0588,0.4053,0.2079	13154,.	35190	90358	-0.3850			2.91			COSV67705068	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235791850	235791850	G	A	wt	wt	het		QUAL=6557;DP=587,414,524;AF=0.00,0.00,0.48;MQM=60;SAP=8;ABP=4	LYST	synonymous,intron	LYST:ENST00000389793.7:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:ENST00000389794.7:intron_variant:MODIFIER:intron11/52:c.4116+1653C>T::	LYST:NM_000081.4:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon12/54:c.4392C>T:p.Asn1464=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon12/44:c.4392C>T:p.Asn1464=:,LYST:XM_011544036.2:synonymous_variant:LOW:exon8/50:c.2055C>T:p.Asn685=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon12/33:c.4392C>T:p.Asn1464=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon12/28:c.4392C>T:p.Asn1464=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon12/53:c.4392C>T:p.Asn1464=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon12/22:c.4392C>T:p.Asn1464=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon12/34:n.4574C>T::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon12/43:n.4574C>T::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon12/28:n.4574C>T::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon12/24:n.4574C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254921 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs11583387	0.0908	0.0660,0.0778,0.0491,0.1125,0.0381	711,.	12387	138325	3.0790			8.58				0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235808463	235808463	A	G	het	het	het		QUAL=8421;DP=201,197,267;AF=0.53,0.51,0.51;MQM=60;SAP=50;ABP=4	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.2355T>C:p.Leu785=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.2355T>C:p.Leu785=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.2355T>C:p.Leu785=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.2355T>C:p.Leu785=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.2355T>C:p.Leu785=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.2537T>C::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.2537T>C::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.2537T>C::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.2537T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254915 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3768066	0.1073	0.0716,0.0882,0.0494,0.1374,0.0413	975,.	14305	135199	-0.0390			6.68				0.07	25741868,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809135	235809135	T	C	hom	het	hom		QUAL=27836;DP=481,195,286;AF=0.99,0.52,1.00;MQM=60;SAP=24;ABP=4	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.1683A>G:p.Leu561=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.1683A>G:p.Leu561=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.1683A>G:p.Leu561=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.1683A>G:p.Leu561=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.1683A>G:p.Leu561=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.1865A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.1865A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.1865A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.1865A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254912 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs3820553	0.4052	0.5025,0.2785,0.0589,0.4057,0.2077	13166,.	35199	90337	-0.4290			0.53			COSV67705097	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809567	235809567	T	C	hom	het	hom		QUAL=27986;DP=456,190,307;AF=1.00,0.56,0.99;MQM=60;SAP=22;ABP=10	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:ENST00000389794.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	LYST:NM_000081.4:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:NM_001301365.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_011544031.1:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544032.1:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544033.2:synonymous_variant:LOW:exon5/54:c.1251A>G:p.Gln417=:,LYST:XM_011544034.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_011544035.2:synonymous_variant:LOW:exon5/44:c.1251A>G:p.Gln417=:,LYST:XM_011544037.2:synonymous_variant:LOW:exon5/33:c.1251A>G:p.Gln417=:,LYST:XM_011544039.2:synonymous_variant:LOW:exon5/28:c.1251A>G:p.Gln417=:,LYST:XM_017000150.1:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:,LYST:XM_017000151.1:synonymous_variant:LOW:exon5/22:c.1251A>G:p.Gln417=:,LYST:XR_001736946.2:non_coding_transcript_exon_variant:MODIFIER:exon5/34:n.1433A>G::,LYST:XR_001736947.1:non_coding_transcript_exon_variant:MODIFIER:exon5/43:n.1433A>G::,LYST:XR_001736948.1:non_coding_transcript_exon_variant:MODIFIER:exon5/28:n.1433A>G::,LYST:XR_002959252.1:non_coding_transcript_exon_variant:MODIFIER:exon5/24:n.1433A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254910 [benign DISEASE=Chediak-Higashi syndrome,not specified,not provided];			rs1063128	0.4054	0.5029,0.2784,0.0588,0.4057,0.2078	13165,.	35203	90257	-0.0510			4.14			COSV67705101	0	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235866977	235866977	C	G	n/a	n/a	het	off-target	QUAL=25;DP=0,1,6;AF=,0.00,0.50;MQM=60;SAP=4;ABP=3	LYST	upstream_gene	LYST:ENST00000389793.7:upstream_gene_variant:MODIFIER::::,LYST:ENST00000389794.7:upstream_gene_variant:MODIFIER::::	LYST:NM_001301365.1:intron_variant:MODIFIER:intron1/52:c.-98+16210G>C::,LYST:NR_102436.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.527+16210G>C::,LYST:XM_011544032.1:intron_variant:MODIFIER:intron1/53:c.-98+16210G>C::	regulatory_region_variant:promoter	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs3820556	0.0876		745,.	11817	138639	0.7070			16.17						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236394471	236394471	G	A	hom	hom	hom		QUAL=24570;DP=251,225,289;AF=1.00,1.00,1.00;MQM=60;SAP=104;ABP=0	EDARADD	missense,intron	EDARADD:ENST00000334232.9:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14745G>A::	EDARADD:NM_145861.4:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:	regulatory_region_variant:promoter	606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs966365	0.8410	0.5373,0.9067,0.9186,0.8370,0.9121	46074,.	24391	35515	-0.0690	T(0.45), 	B(0.00), 	9.15	0.13		COSV62061862	0.07	25741868,18466582,31452656	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409175	236409175	A	G	het	hom	het	off-target	QUAL=10261;DP=180,171,161;AF=0.50,1.00,0.55;MQM=60;SAP=68;ABP=5	EDARADD	intron	EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-41A>G::,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-41A>G::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron1/5:c.32-41A>G::,EDARADD:NM_145861.4:intron_variant:MODIFIER:intron1/5:c.62-41A>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255368 [benign DISEASE=Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not provided];			rs669710	0.5331	0.4768,0.4369,0.2597,0.5943,0.4913	22044,.	36820	70854	0.2780			4.54			COSV62061755	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427359	236427359	G	C	het	hom	het	off-target	QUAL=6538;DP=150,89,153;AF=0.51,0.99,0.51;MQM=60;SAP=87;ABP=3	EDARADD	intron	EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-33G>C::,EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-33G>C::	EDARADD:NM_080738.4:intron_variant:MODIFIER:intron3/5:c.131-33G>C::,EDARADD:NM_145861.4:intron_variant:MODIFIER:intron3/5:c.161-33G>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255369 [benign DISEASE=Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not provided];		(T)n (Simple_repeat)	rs636048	0.4936	0.1851,0.4187,0.2266,0.5866,0.4570	17437,.	32889	83191	0.8960			5.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236482370	236482370	C	T	wt	wt	het		QUAL=5233;DP=210,356,479;AF=0.00,0.01,0.44;MQM=60;SAP=4;ABP=17	EDARADD	synonymous	EDARADD:ENST00000334232.9:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:,EDARADD:ENST00000359362.6:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:,EDARADD:ENST00000637660.1:synonymous_variant:LOW:exon6/6:c.303C>T:p.Asp101=:	EDARADD:NM_080738.4:synonymous_variant:LOW:exon6/6:c.339C>T:p.Asp113=:,EDARADD:NM_145861.4:synonymous_variant:LOW:exon6/6:c.369C>T:p.Asp123=:		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262602 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive,not specified,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs604070	0.1998	0.0709,0.1097,0.0906,0.2558,0.1497	3128,.	21811	123855	0.1980			4.39			COSV62061161	0	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484211	236484211	T	C	het	het	hom		QUAL=13064;DP=276,142,225;AF=0.54,0.49,1.00;MQM=60;SAP=16;ABP=4	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296476 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs7513402	0.3140		8022,.	31665	104237	-1.7820			3.08			COSV62064204			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484250	236484250	C	G	het	het	hom		QUAL=13847;DP=328,127,225;AF=0.54,0.53,1.00;MQM=60;SAP=3;ABP=8	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296479 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs3916983	0.2326		4538,.	26285	116657	0.7020			3.23			COSV62063742			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484436	236484436	C	T	het	het	hom		QUAL=7196;DP=153,73,129;AF=0.55,0.53,0.99;MQM=60;SAP=3;ABP=7	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296481 [benign/likely benign DISEASE=Hypohidrotic ectodermal dysplasia,Hypohidrotic Ectodermal Dysplasia, Recessive,not provided];			rs6428955	0.1786		2989,.	21142	124706	-0.0630			0.74			COSV62066249			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484708	236484708	G	-	het	het	wt	low_conf_region	QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=59;SAP=23;ABP=8	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2059del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296489 [uncertain significance DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive];		AluSc (SINE/Alu)	rs886046200	0.0001		0,.	9	99393	-4.5470			0.09						1	4	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484709	A	-	wt	wt	het		QUAL=140;DP=14,12,19;AF=0.21,0.17,0.42;MQM=60;SAP=27;ABP=29	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1270976 [benign DISEASE=not provided];		AluSc (SINE/Alu)	rs11358746	0.4615		12220,.	30321	63911	-2.6210			0.09						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484709	236484710	AA	-	het	wt	het		QUAL=140;DP=14,12,19;AF=0.29,0.42,0.00;MQM=60;SAP=31;ABP=20	EDARADD	3'UTR	EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::	EDARADD:NM_080738.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::,EDARADD:NM_145861.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2077_*2078del::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]			AluSc (SINE/Alu)	rs11358746	0.0009		0,.	102	118614	-2.3440			0.11						2	32	0 / 0					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236795232	236795232	G	T	het	het	hom	off-target	QUAL=1137;DP=14,23,29;AF=0.50,0.48,1.00;MQM=60;SAP=105;ABP=3	MTR	upstream_gene	MTR:ENST00000366577.10:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.6:upstream_gene_variant:MODIFIER::::,MTR:ENST00000674797.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:upstream_gene_variant:MODIFIER::::	MTR:XM_011544194.3:5_prime_UTR_variant:MODIFIER:exon1/32:c.-89G>T::,MTR:XM_017001329.2:5_prime_UTR_variant:MODIFIER:exon1/31:c.-89G>T::,MTR:XM_017001330.2:5_prime_UTR_variant:MODIFIER:exon1/30:c.-89G>T::	regulatory_region_variant:promoter	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1249677 [benign DISEASE=not provided];			rs28372871	0.4633		16574,.	37249	81547	-0.5370			2.91					27808252	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236815692	236815692	-	TCTG	het	het	het	off-target;low_conf_region	QUAL=7150;DP=161,110,172;AF=0.46,0.48,0.90;MQM=60;SAP=80;ABP=75	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.321+32_321+33insGTCT::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.669+32_669+33insGTCT::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.669+32_669+33insGTCT::	MTR:NM_000254.3:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron7/31:c.-440+32_-440+33insGTCT::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron7/32:c.666+32_666+33insGTCT::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron3/26:c.-105+32_-105+33insGTCT::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron6/31:c.837+32_837+33insGTCT::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron6/30:c.837+32_837+33insGTCT::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron6/29:c.837+32_837+33insGTCT::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1263040 [benign DISEASE=not provided];			rs5781924	0.7224	0.9264,0.6865,0.8106,0.6222,0.7313	40879,.	27766	42088				2.49				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236825293	236825293	-	T	het	het	hom	off-target	QUAL=3942;DP=137,36,48;AF=0.56,0.67,1.00;MQM=60;SAP=209;ABP=14	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron8/31:c.518-40dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron9/30:c.866-40dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron9/29:c.866-40dup::	MTR:NM_000254.3:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron9/31:c.-243-40dup::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron9/32:c.863-40dup::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron4/26:c.-9-1531dup::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron8/31:c.1034-40dup::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron8/30:c.1034-40dup::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron8/29:c.1034-40dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1236260 [benign DISEASE=not provided];			rs5781926	0.3832	0.2055,0.4468,0.4037,0.4058,0.3105	9854,.	32834	98962				0.79				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236826841	236826841	G	A	wt	het	wt		QUAL=1794;DP=295,153,221;AF=0.00,0.47,0.00;MQM=60;SAP=3;ABP=4	MTR	missense	MTR:ENST00000366577.10:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000535889.6:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000674797.2:missense_variant:MODERATE:exon10/32:c.592G>A:p.Asp198Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000679842.1:missense_variant:MODERATE:exon11/31:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681102.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase],MTR:ENST00000681177.1:missense_variant:MODERATE:exon11/30:c.940G>A:p.Asp314Asn:PF02574 [Homocysteine S-methyltransferase]	MTR:NM_000254.3:missense_variant:MODERATE:exon11/33:c.940G>A:p.Asp314Asn:,MTR:NM_001291939.1:missense_variant:MODERATE:exon11/32:c.940G>A:p.Asp314Asn:,MTR:NM_001291940.2:5_prime_UTR_variant:MODIFIER:exon11/32:c.-169G>A::,MTR:XM_005273141.5:missense_variant:MODERATE:exon11/33:c.937G>A:p.Asp313Asn:,MTR:XM_006711770.3:missense_variant:MODERATE:exon5/27:c.4G>A:p.Asp2Asn:,MTR:XM_011544194.3:missense_variant:MODERATE:exon10/32:c.1108G>A:p.Asp370Asn:,MTR:XM_017001329.2:missense_variant:MODERATE:exon10/31:c.1108G>A:p.Asp370Asn:,MTR:XM_017001330.2:missense_variant:MODERATE:exon10/30:c.1108G>A:p.Asp370Asn:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296556 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified,not provided];			rs2229274	0.0186	0.0080,0.0152,0.0001,0.0255,0.0049	30,.	2702	149382	4.1030	T(0.26),T(0.26),T(0.26),T(0.30),T(0.16),T(0.37)	B(0.19),B(0.19),B(0.19),B(0.01),B(0.01),B(0.05)	22.50	0.12			0	19112534	17	838	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838626	236838626	A	G	het	het	hom	off-target	QUAL=12894;DP=177,180,256;AF=0.51,0.51,1.00;MQM=60;SAP=492;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+27A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+27A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+27A>G::	MTR:NM_000254.3:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron14/31:c.294+27A>G::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron15/32:c.1512+27A>G::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron9/26:c.579+27A>G::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron14/31:c.1683+27A>G::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron14/30:c.1683+27A>G::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron14/29:c.1683+27A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278171 [benign DISEASE=not provided];			rs3820568	0.3931	0.2101,0.4522,0.4331,0.4117,0.3140	10400,.	33289	97911	-0.9150			0.09				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874699	236874699	T	-	het	het	hom	off-target;low_conf_region	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-18del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-18del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-18del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-18del::	MTR:NM_000254.3:intron_variant:MODIFIER:intron23/32:c.2474-18del::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18del::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18del::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron23/32:c.2471-18del::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron17/26:c.1538-18del::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron22/31:c.2642-18del::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron21/30:c.2489-18del::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-6047del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1220586 [benign DISEASE=Methylcobalamin deficiency type cblG,not provided];			rs150727404	0.6418	0.5590,0.4889,0.5359,0.4505,0.4878	30382,.	32905	52287	0.3150			0.07				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874708	236874708	T	A	het	het	hom	off-target;low_conf_region	QUAL=1451;DP=47,24,46;AF=0.30,0.46,0.74;MQM=60;SAP=14;ABP=16	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-18T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-18T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-18T>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron23/32:c.2474-18T>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron22/31:c.2321-18T>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron22/31:c.1253-18T>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron23/32:c.2471-18T>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron17/26:c.1538-18T>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron22/31:c.2642-18T>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron21/30:c.2489-18T>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-6047T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	378884 [benign DISEASE=Methylcobalamin deficiency type cblG,not specified];			rs10925256	0.4559	0.4750,0.4576,0.4459,0.4159,0.3773	12428,.	35521	72055	-0.6490			1.12		-1.58>-1.77	COSV63966075	0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874861	236874861	T	C	het	het	wt	off-target	QUAL=2570;DP=81,126,168;AF=0.47,0.52,0.00;MQM=60;SAP=38;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron23/31:c.2246+15T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-5894T>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron23/31:c.2414+15T>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron21/29:c.2156+15T>C::	MTR:NM_000254.3:intron_variant:MODIFIER:intron24/32:c.2594+15T>C::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron23/31:c.2441+15T>C::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron23/31:c.1373+15T>C::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron24/32:c.2591+15T>C::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron18/26:c.1658+15T>C::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron23/31:c.2762+15T>C::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron22/30:c.2609+15T>C::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron21/29:c.2574-5894T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138288 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1770449	0.3220	0.0701,0.3134,0.1923,0.3749,0.2791	7111,.	27690	110150	-0.1570			3.53			COSV63964725	0	25741868,19493349,21254359,22496743,20180013,21743092,30911047	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236885262	236885262	G	A	het	het	hom	off-target	QUAL=11132;DP=332,113,149;AF=0.55,0.50,1.00;MQM=60;SAP=438;ABP=9	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2427+43G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2586+43G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2595+43G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2337+43G>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron25/31:c.1554+43G>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron26/32:c.2772+43G>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron20/26:c.1839+43G>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron25/31:c.2943+43G>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron24/30:c.2790+43G>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron23/29:c.2754+43G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1258762 [benign DISEASE=not provided];			rs2275566	0.7161	0.9063,0.6827,0.8081,0.6227,0.7187	40112,.	28586	43136	-1.2850			0.29				0	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891269	236891269	A	G	het	het	hom		QUAL=7199;DP=98,101,144;AF=0.55,0.50,1.00;MQM=60;SAP=21;ABP=4	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon28/32:c.2796A>G:p.Ala932=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon27/31:c.2955A>G:p.Ala985=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon28/32:c.2964A>G:p.Ala988=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon26/30:c.2706A>G:p.Ala902=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon28/32:c.1923A>G:p.Ala641=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon29/33:c.3141A>G:p.Ala1047=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon23/27:c.2208A>G:p.Ala736=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon28/32:c.3312A>G:p.Ala1104=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon27/31:c.3159A>G:p.Ala1053=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon26/30:c.3123A>G:p.Ala1041=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138290 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs2229276	0.3896	0.1936,0.4474,0.4430,0.4047,0.3210	9993,.	32777	99159	-1.1170			0.76			COSV63966508	0.01	19493349,22496743,19683694,21960995,20718043,18842806,21597034	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236894308	236894308	G	A	het	het	hom	off-target	QUAL=7988;DP=96,140,175;AF=0.51,0.50,1.00;MQM=60;SAP=510;ABP=3	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2857-49G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3016-49G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3025-49G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2767-49G>A::	MTR:NM_000254.3:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron28/31:c.1984-49G>A::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron29/32:c.3202-49G>A::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron23/26:c.2269-49G>A::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron28/31:c.3373-49G>A::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron27/30:c.3220-49G>A::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron26/29:c.3184-49G>A::	regulatory_region_variant:open_chromatin_region	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1270532 [benign DISEASE=not provided];			rs2297965	0.5905	0.4581,0.6321,0.5411,0.5949,0.6252	24176,.	36537	66791	-0.5020			2.45			COSV63966743	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895444	236895444	C	A	het	het	hom		QUAL=14604;DP=215,222,309;AF=0.50,0.45,1.00;MQM=60;SAP=12;ABP=5	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3144C>A:p.Arg1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3303C>A:p.Arg1101=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3312C>A:p.Arg1104=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3054C>A:p.Arg1018=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2271C>A:p.Arg757=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon31/33:c.3489C>A:p.Arg1163=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon25/27:c.2556C>A:p.Arg852=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon30/32:c.3660C>A:p.Arg1220=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon29/31:c.3507C>A:p.Arg1169=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon28/30:c.3471C>A:p.Arg1157=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138283 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs12070777	0.3869	0.1981,0.4453,0.4322,0.4014,0.3121	10032,.	32959	98933	0.0910			2.36			COSV63966512	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895528	236895528	C	T	wt	het	het		QUAL=4192;DP=136,168,182;AF=0.00,0.43,0.53;MQM=60;SAP=117;ABP=4	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3228C>T:p.Leu1076=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3387C>T:p.Leu1129=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3396C>T:p.Leu1132=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3138C>T:p.Leu1046=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]	MTR:NM_000254.3:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:,MTR:NM_001291939.1:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:,MTR:NM_001291940.2:synonymous_variant:LOW:exon30/32:c.2355C>T:p.Leu785=:,MTR:XM_005273141.5:synonymous_variant:LOW:exon31/33:c.3573C>T:p.Leu1191=:,MTR:XM_006711770.3:synonymous_variant:LOW:exon25/27:c.2640C>T:p.Leu880=:,MTR:XM_011544194.3:synonymous_variant:LOW:exon30/32:c.3744C>T:p.Leu1248=:,MTR:XM_017001329.2:synonymous_variant:LOW:exon29/31:c.3591C>T:p.Leu1197=:,MTR:XM_017001330.2:synonymous_variant:LOW:exon28/30:c.3555C>T:p.Leu1185=:		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138284 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs1131449	0.5762	0.4608,0.6146,0.5430,0.5720,0.6205	22891,.	36890	69192	-3.3670			0.04			COSV63964165	0	19683694,20615890,21274745,21960995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897133	236897133	G	T	het	het	hom	off-target	QUAL=12444;DP=205,200,245;AF=0.42,0.50,0.99;MQM=60;SAP=228;ABP=9	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron31/31:c.3363+15G>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron30/30:c.3522+15G>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron31/31:c.3531+15G>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron29/29:c.3273+15G>T::	MTR:NM_000254.3:intron_variant:MODIFIER:intron32/32:c.3711+15G>T::,MTR:NM_001291939.1:intron_variant:MODIFIER:intron31/31:c.3558+15G>T::,MTR:NM_001291940.2:intron_variant:MODIFIER:intron31/31:c.2490+15G>T::,MTR:XM_005273141.5:intron_variant:MODIFIER:intron32/32:c.3708+15G>T::,MTR:XM_006711770.3:intron_variant:MODIFIER:intron26/26:c.2775+15G>T::,MTR:XM_011544194.3:intron_variant:MODIFIER:intron31/31:c.3879+15G>T::,MTR:XM_017001329.2:intron_variant:MODIFIER:intron30/30:c.3726+15G>T::,MTR:XM_017001330.2:intron_variant:MODIFIER:intron29/29:c.3690+15G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138285 [benign DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified];			rs3820571	0.7079	0.8870,0.6808,0.8080,0.6181,0.7188	39138,.	29282	44392	-0.2020			0.40				0.08	19493349	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897646	236897646	T	-	het	het	het	low_conf_region	QUAL=502;DP=153,73,117;AF=0.18,0.19,0.11;MQM=60;SAP=8;ABP=347	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*16del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*16del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*16del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*16del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*16del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296586 [likely benign(replaced by megSAP based on classifications:2x1,1x3) DISEASE=Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not provided];		(T)n (Simple_repeat)	rs67705775	0.4627	0.4550,0.4608,0.4615,0.4659,0.4674	1955,.	21471	115741	1.2650			10.14				0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897756	236897756	A	C	het	het	hom		QUAL=10723;DP=308,80,153;AF=0.54,0.53,1.00;MQM=60;SAP=19;ABP=7	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*112A>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*112A>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*112A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296587 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,not provided];			rs2853522	0.5619		24345,.	36486	66402	-1.1490			3.07				0	22856873,30884202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898405	236898405	T	-	het	het	hom		QUAL=2222;DP=96,26,38;AF=0.55,0.58,0.82;MQM=58;SAP=90;ABP=6	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*773del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*773del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*773del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs796166778	0.6811		32753,.	30219	44825	0.1060			0.92				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898549	236898549	G	A	het	het	wt		QUAL=1308;DP=82,34,65;AF=0.44,0.59,0.00;MQM=51;SAP=71;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*905G>A::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*905G>A::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*905G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296598 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		AluY (SINE/Alu)	rs1131450	0.2844		6957,.	29081	108207	0.1710			1.57				0	27808252	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898898	236898898	A	C	het	het	hom		QUAL=16901;DP=263,243,297;AF=0.55,0.47,1.00;MQM=60;SAP=15;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*1254A>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*1254A>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1254A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296610 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs2853523	0.7192		40590,.	28101	42669	-0.2280			4.71				0.08	21146954,22856873,18381459,23940529,20871623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236899005	236899005	A	G	het	het	hom		QUAL=22005;DP=413,294,370;AF=0.53,0.52,0.99;MQM=60;SAP=5;ABP=7	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*1361A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*1361A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1361A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296611 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs1050993	0.7193		40616,.	28105	42661	-0.4520			1.96				0	19493349,21254359,22496743,18381459,19064578,20180013,21743092,30911047	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900035	236900035	G	C	het	het	hom		QUAL=12882;DP=227,207,221;AF=0.49,0.53,1.00;MQM=60;SAP=134;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2391G>C::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2391G>C::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2391G>C::	regulatory_region_variant:CTCF_binding_site	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296631 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1050996	0.6886		36703,.	31250	47322	-0.1630			3.37				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900204	236900204	A	G	het	het	hom		QUAL=11976;DP=379,107,148;AF=0.50,0.54,1.00;MQM=60;SAP=7;ABP=3	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2560A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2560A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2560A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296633 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs9779	0.3704	0.1885,0.4325,0.4310,0.3913,0.2992	9841,.	32861	99349	-1.1570			0.18				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900409	236900409	-	A	het	het	hom		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=3;ABP=22	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2774dup::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2774dup::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2774dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs34686098	0.7261		32750,.	33321	37281				0.29				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900418	236900419	AG	-	het	het	wt		QUAL=13769;DP=188,138,184;AF=0.41,0.42,0.94;MQM=60;SAP=11;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*2775_*2776del::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*2775_*2776del::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*2775_*2776del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L1ME3F (LINE/L1)	rs1553332314	0.2796		7193,.	27959	109089	0.5750			1.01				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236901326	236901326	T	G	het	het	hom		QUAL=33907;DP=419,512,670;AF=0.50,0.48,0.99;MQM=60;SAP=22;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*3682T>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*3682T>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*3682T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296655 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6676866	0.5628		24374,.	36540	66252	1.5210			7.27				0	21146954,19493349,18381459,21274745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902026	236902026	C	T	het	het	hom		QUAL=8138;DP=170,112,157;AF=0.55,0.47,1.00;MQM=60;SAP=141;ABP=4	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4382C>T::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4382C>T::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4382C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296668 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs4659746	0.5684		24904,.	36500	65534	-0.6270			0.80				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902283	236902283	G	T	het	het	hom		QUAL=13218;DP=219,175,256;AF=0.51,0.57,1.00;MQM=60;SAP=8;ABP=8	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4639G>T::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4639G>T::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4639G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296673 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs10925264	0.7190		40491,.	28061	42611	-0.3300			0.95				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902510	236902510	T	G	het	wt	het		QUAL=4890;DP=179,178,171;AF=0.53,0.00,0.55;MQM=60;SAP=145;ABP=8	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*4866T>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*4866T>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*4866T>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];		L2c (LINE/L2)	rs45563435	0.0156		21,.	2328	149800	-0.3180			2.04				0		5	202	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902814	236902814	A	G	het	het	wt		QUAL=3170;DP=157,84,113;AF=0.50,0.58,0.00;MQM=60;SAP=99;ABP=5	MTR	3'UTR	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::	MTR:NM_000254.3:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:NM_001291939.1:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:NM_001291940.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:XM_005273141.5:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:XM_006711770.3:3_prime_UTR_variant:MODIFIER:exon27/27:c.*5170A>G::,MTR:XM_011544194.3:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:XM_017001329.2:3_prime_UTR_variant:MODIFIER:exon31/31:c.*5170A>G::,MTR:XM_017001330.2:3_prime_UTR_variant:MODIFIER:exon30/30:c.*5170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism];			rs6680753	0.0197		53,.	2888	149098	0.5290			2.80				0		1	166	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240775804	240775804	G	A	het	hom	wt		QUAL=9113;DP=345,146,165;AF=0.48,0.99,0.00;MQM=60;SAP=178;ABP=4	RGS7	3'UTR,splice_acceptor&non_coding_transcript	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,:ENST00000644500.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron6/6:n.1110-1G>A::,:ENST00000653456.1:splice_acceptor_variant&non_coding_transcript_variant:HIGH:intron4/4:n.670-1G>A::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*359C>T::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*359C>T::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*359C>T::						rs35557904	0.1723		3026,.	20113	125711	0.6560			19.19		11.28>2.53		0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775852	240775852	A	G	het	hom	wt		QUAL=9495;DP=318,181,209;AF=0.44,0.99,0.00;MQM=60;SAP=90;ABP=13	RGS7	3'UTR,non_coding_transcript_exon	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,:ENST00000644500.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1157A>G::,:ENST00000653456.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.717A>G::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*311T>C::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*311T>C::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*311T>C::						rs16840577	0.1721		3026,.	20106	125870	2.4410			16.55				0.01		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776091	240776091	C	T	het	het	wt		QUAL=12747;DP=505,550,687;AF=0.46,0.47,0.00;MQM=60;SAP=22;ABP=16	RGS7	3'UTR,non_coding_transcript_exon	RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,:ENST00000653456.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.956C>T::	RGS7:NM_001282773.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:NM_001282775.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:NM_001282778.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001350113.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350114.2:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001350115.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:NM_001350116.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001364886.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374806.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374807.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_001374808.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374809.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:NM_001374810.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:NM_001374811.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*72G>A::,RGS7:NM_001374812.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_001374813.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*72G>A::,RGS7:NM_001374814.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374815.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:NM_001374816.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:NM_002924.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:XM_006711800.4:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_011544246.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_011544247.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002001.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002002.2:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:XM_017002005.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:XM_017002009.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:XM_017002011.2:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:XM_017002012.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:XM_017002013.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*72G>A::						rs12757054	0.0610		353,.	8570	142814	1.5850			10.68			COSV58544216	0	21698121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240811913	240811913	T	C	het	wt	hom		QUAL=11013;DP=254,201,238;AF=0.54,0.00,1.00;MQM=60;SAP=132;ABP=6	RGS7	splice_region&intron	RGS7:ENST00000348120.6:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::	RGS7:NM_001282773.2:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:NM_001282775.2:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:NM_001282778.2:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:NM_001350113.2:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350114.2:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001350115.2:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:NM_001350116.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1004+5A>G::,RGS7:NM_001364886.1:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:NM_001374806.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1031+5A>G::,RGS7:NM_001374807.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1031+5A>G::,RGS7:NM_001374808.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:NM_001374809.1:splice_region_variant&intron_variant:LOW:intron14/16:c.803+5A>G::,RGS7:NM_001374810.1:splice_region_variant&intron_variant:LOW:intron14/18:c.803+5A>G::,RGS7:NM_001374811.1:splice_region_variant&intron_variant:LOW:intron12/14:c.923+5A>G::,RGS7:NM_001374812.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1007+5A>G::,RGS7:NM_001374813.1:splice_region_variant&intron_variant:LOW:intron11/13:c.569+5A>G::,RGS7:NM_001374814.1:splice_region_variant&intron_variant:LOW:intron12/16:c.923+5A>G::,RGS7:NM_001374815.1:splice_region_variant&intron_variant:LOW:intron13/16:c.971+5A>G::,RGS7:NM_001374816.1:splice_region_variant&intron_variant:LOW:intron13/15:c.971+5A>G::,RGS7:NM_002924.6:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:XM_006711800.4:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_011544246.3:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_011544247.3:splice_region_variant&intron_variant:LOW:intron13/17:c.1004+5A>G::,RGS7:XM_017002001.2:splice_region_variant&intron_variant:LOW:intron13/17:c.1031+5A>G::,RGS7:XM_017002002.2:splice_region_variant&intron_variant:LOW:intron15/19:c.1004+5A>G::,RGS7:XM_017002005.2:splice_region_variant&intron_variant:LOW:intron14/17:c.1004+5A>G::,RGS7:XM_017002009.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1004+5A>G::,RGS7:XM_017002011.2:splice_region_variant&intron_variant:LOW:intron11/15:c.830+5A>G::,RGS7:XM_017002012.2:splice_region_variant&intron_variant:LOW:intron11/14:c.830+5A>G::,RGS7:XM_017002013.1:splice_region_variant&intron_variant:LOW:intron11/13:c.830+5A>G::	regulatory_region_variant:CTCF_binding_site					rs2275742	0.5076	0.2546,0.4101,0.4598,0.5768,0.4338	18434,.	34505	80475	0.2170			8.97		8.38>10.57	COSV58534718	0.02		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814664	240814664	G	T	hom	het	hom	off-target	QUAL=9579;DP=169,64,108;AF=0.99,0.44,1.00;MQM=60;SAP=300;ABP=5	RGS7	intron	RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron12/18:c.845+52C>A::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron12/16:c.767+52C>A::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron11/16:c.794+52C>A::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron11/15:c.794+52C>A::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron12/16:c.566+52C>A::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron12/18:c.566+52C>A::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron10/14:c.686+52C>A::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron11/15:c.770+52C>A::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron9/13:c.332+52C>A::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron10/16:c.686+52C>A::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron12/15:c.845+52C>A::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:XM_006711800.4:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_011544246.3:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_011544247.3:intron_variant:MODIFIER:intron11/17:c.767+52C>A::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron11/17:c.794+52C>A::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron13/19:c.767+52C>A::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron12/17:c.767+52C>A::,RGS7:XM_017002009.1:intron_variant:MODIFIER:intron11/15:c.767+52C>A::,RGS7:XM_017002011.2:intron_variant:MODIFIER:intron9/15:c.593+52C>A::,RGS7:XM_017002012.2:intron_variant:MODIFIER:intron9/14:c.593+52C>A::,RGS7:XM_017002013.1:intron_variant:MODIFIER:intron9/13:c.593+52C>A::						rs12744536	0.6105		29908,.	32951	59187	-1.0950			0.01			COSV58534726	0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240983022	240983022	A	G	het	wt	het	off-target	QUAL=4096;DP=215,57,82;AF=0.52,0.00,0.54;MQM=60;SAP=217;ABP=5	RGS7	intron	RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.226+57T>C::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:NM_001350116.1:intron_variant:MODIFIER:intron4/16:c.148+57T>C::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron3/16:c.176-46316T>C::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron3/15:c.176-46316T>C::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron4/16:c.-64+57T>C::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron4/18:c.-64+57T>C::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron4/14:c.226+57T>C::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron4/13:c.-64+57T>C::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:XM_006711800.4:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_011544246.3:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_011544247.3:intron_variant:MODIFIER:intron3/17:c.148+57T>C::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron3/17:c.176-46316T>C::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron5/19:c.148+57T>C::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron4/17:c.148+57T>C::,RGS7:XM_017002009.1:intron_variant:MODIFIER:intron3/15:c.148+57T>C::						rs7520707	0.3710		10701,.	34971	95579	0.7580			3.57				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241355798	241355798	T	A	hom	hom	hom		QUAL=35403;DP=440,286,418;AF=1.00,1.00,1.00;MQM=60;SAP=68;ABP=0	RGS7	5'UTR	RGS7:ENST00000366563.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.5:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000440928.6:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::	RGS7:NM_001282773.2:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001282775.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:NM_001282778.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001350113.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-204A>T::,RGS7:NM_001350114.2:5_prime_UTR_variant:MODIFIER:exon2/19:c.-172A>T::,RGS7:NM_001350115.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:NM_001350116.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-172A>T::,RGS7:NM_001364886.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:NM_001374806.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374807.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001374808.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-246A>T::,RGS7:NM_001374809.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-311A>T::,RGS7:NM_001374810.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-311A>T::,RGS7:NM_001374811.1:5_prime_UTR_variant:MODIFIER:exon2/15:c.-22A>T::,RGS7:NM_001374812.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_001374813.1:5_prime_UTR_variant:MODIFIER:exon2/14:c.-311A>T::,RGS7:NM_001374814.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374815.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:NM_001374816.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:NM_002924.6:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:XM_017002001.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:XM_017002002.2:5_prime_UTR_variant:MODIFIER:exon2/20:c.-204A>T::,RGS7:XM_017002005.2:5_prime_UTR_variant:MODIFIER:exon2/18:c.-1222A>T::						rs4659599	0.9795	0.8691,0.9883,0.9973,0.9877,0.9871	69621,.	6092	6760	1.4650			12.93				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356888	241356888	T	C	n/a	hom	hom	off-target	QUAL=980;DP=0,17,16;AF=,1.00,1.00;MQM=60;SAP=14;ABP=0	RGS7	intron	RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron1/18:c.-51+11A>G::	RGS7:NM_001282773.2:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001282775.2:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:NM_001282778.2:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001350113.2:intron_variant:MODIFIER:intron1/18:c.-233+11A>G::,RGS7:NM_001350114.2:intron_variant:MODIFIER:intron1/18:c.-201+11A>G::,RGS7:NM_001350115.2:intron_variant:MODIFIER:intron1/17:c.-233+11A>G::,RGS7:NM_001364886.1:intron_variant:MODIFIER:intron1/18:c.-51+11A>G::,RGS7:NM_001374806.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374807.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001374808.1:intron_variant:MODIFIER:intron1/18:c.-275+11A>G::,RGS7:NM_001374809.1:intron_variant:MODIFIER:intron1/16:c.-340+11A>G::,RGS7:NM_001374810.1:intron_variant:MODIFIER:intron1/18:c.-340+11A>G::,RGS7:NM_001374811.1:intron_variant:MODIFIER:intron1/14:c.-51+11A>G::,RGS7:NM_001374812.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_001374813.1:intron_variant:MODIFIER:intron1/13:c.-340+11A>G::,RGS7:NM_001374814.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374815.1:intron_variant:MODIFIER:intron1/16:c.-51+11A>G::,RGS7:NM_001374816.1:intron_variant:MODIFIER:intron1/15:c.-51+11A>G::,RGS7:NM_002924.6:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:XM_017002001.2:intron_variant:MODIFIER:intron1/17:c.-51+11A>G::,RGS7:XM_017002002.2:intron_variant:MODIFIER:intron1/19:c.-233+11A>G::,RGS7:XM_017002005.2:intron_variant:MODIFIER:intron1/17:c.-1251+11A>G::	regulatory_region_variant:promoter					rs1891130	0.9558		69329,.	6040	6698	-0.1090			15.45				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241500602	241500602	-	GAGA	wt	het	het	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.17,0.28;MQM=60;SAP=38;ABP=96	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-16_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-16_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-16_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296866 [uncertain significance(replaced by megSAP based on classifications:1x1,1x2,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.2551		4472,.	25141	99523				0.08				0.04	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGA	wt	het	wt	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.00,0.26;MQM=60;SAP=22;ABP=191	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-18_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-18_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-18_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296867 [uncertain significance(replaced by megSAP based on classifications:1x1,4x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not specified,not provided];			rs144131869	0.2022		2678,.	21638	106508				0.07				0.02	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241500602	241500602	-	GAGAGAGAGA	wt	wt	het	off-target;low_conf_region	QUAL=1184;DP=3,59,94;AF=0.00,0.20,0.07;MQM=60;SAP=16;ABP=52	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron8/8:c.1237-22_1237-13dup::	FH:NM_000143.4:intron_variant:MODIFIER:intron8/9:c.1237-22_1237-13dup::,FH:XM_011544132.2:intron_variant:MODIFIER:intron8/9:c.1009-22_1009-13dup::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	296869 [likely benign(replaced by megSAP based on classifications:2x1,3x3) DISEASE=Hereditary leiomyomatosis and renal cell cancer,Fumarase deficiency,not provided];			rs144131869	0.0401		146,.	5058	128174				0.07				0.08	24033266	28	203	0 / 0					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247418258	247418258	A	T	het	wt	het		QUAL=12752;DP=501,340,454;AF=0.51,0.00,0.53;MQM=60;SAP=51;ABP=7	NLRP3	5'UTR	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-543A>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543A>T::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-537A>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::	NLRP3:NM_001079821.3:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-537A>T::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-543A>T::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-537A>T::,NLRP3:XM_017000181.1:5_prime_UTR_variant:MODIFIER:exon2/11:c.-126A>T::,NLRP3:XM_017000182.1:5_prime_UTR_variant:MODIFIER:exon2/11:c.-71A>T::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-537A>T::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-537A>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];			rs116502550	0.0069		13,.	1009	149955	0.2370			6.13				0.01		0	90	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418390	247418390	T	C	hom	hom	hom		QUAL=17863;DP=268,161,168;AF=1.00,1.00,1.00;MQM=59;SAP=749;ABP=0	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-411T>C::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-411T>C::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-405T>C::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-405T>C::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-411T>C::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-405T>C::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron2/10:c.-94+100T>C::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron2/10:c.-39+100T>C::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-405T>C::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-405T>C::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296931 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs7523422	0.9978		75709,.	319	329	-2.9180			2.76				0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418570	247418570	G	A	het	het	het		QUAL=5099;DP=217,68,85;AF=0.54,0.56,0.44;MQM=59;SAP=22;ABP=5	NLRP3	5'UTR,intron	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-231G>A::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-231G>A::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-225G>A::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-225G>A::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-231G>A::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-225G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron2/10:c.-93-132G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron2/10:c.-38-187G>A::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-225G>A::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-225G>A::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296932 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome];		AluSx1 (SINE/Alu)	rs138900557	0.0347		139,.	5002	146888	0.3990			4.10				0		1	18	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418761	247418761	G	T	het	het	het		QUAL=9847;DP=332,231,285;AF=0.48,0.41,0.50;MQM=60;SAP=28;ABP=11	NLRP3	5'UTR	NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-40G>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-40G>T::,NLRP3:ENST00000366497.6:5_prime_UTR_variant:MODIFIER:exon2/9:c.-34G>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:ENST00000474792.2:5_prime_UTR_variant:MODIFIER:exon1/3:c.-40G>T::,NLRP3:ENST00000643234.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::	NLRP3:NM_001079821.3:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:NM_001127461.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:NM_001127462.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:NM_001243133.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:NM_004895.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-34G>T::,NLRP3:NM_183395.3:5_prime_UTR_variant:MODIFIER:exon2/8:c.-40G>T::,NLRP3:XM_011544048.2:5_prime_UTR_variant:MODIFIER:exon2/10:c.-34G>T::,NLRP3:XM_017000181.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::,NLRP3:XM_017000182.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-34G>T::,NLRP3:XM_024452862.1:5_prime_UTR_variant:MODIFIER:exon2/8:c.-34G>T::,NLRP3:XM_024452874.1:5_prime_UTR_variant:MODIFIER:exon2/7:c.-34G>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296937 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,not provided];			rs73136263	0.0437	0.0360,0.0125,0.0009,0.0471,0.0219	166,.	6310	145470	-0.3700			2.48				0.01		48	1369	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424175	247424175	G	A	het	het	het		QUAL=6254;DP=161,152,190;AF=0.48,0.41,0.57;MQM=60;SAP=66;ABP=3	NLRP3	synonymous	NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366497.6:synonymous_variant:LOW:exon4/9:c.732G>A:p.Ala244=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain]	NLRP3:NM_001079821.3:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:,NLRP3:NM_001127461.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:,NLRP3:NM_001127462.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:,NLRP3:NM_001243133.2:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:,NLRP3:NM_004895.5:synonymous_variant:LOW:exon4/10:c.732G>A:p.Ala244=:,NLRP3:NM_183395.3:synonymous_variant:LOW:exon4/8:c.726G>A:p.Ala242=:,NLRP3:XM_011544048.2:synonymous_variant:LOW:exon4/10:c.732G>A:p.Ala244=:,NLRP3:XM_017000181.1:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:,NLRP3:XM_017000182.1:synonymous_variant:LOW:exon5/11:c.732G>A:p.Ala244=:,NLRP3:XM_024452862.1:synonymous_variant:LOW:exon4/8:c.732G>A:p.Ala244=:,NLRP3:XM_024452874.1:synonymous_variant:LOW:exon4/7:c.732G>A:p.Ala244=:		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	138528 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,not provided];			rs3806268	0.5025	0.1030,0.4077,0.5315,0.5585,0.5436	16379,.	31050	87926	-2.2250			1.72			COSV60221462	0	25741868,24033266,30131971,30123371,28116820,31467293,28847925,26722603,20940146,22318840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424229	247424229	A	G	hom	hom	hom		QUAL=14061;DP=154,117,161;AF=1.00,1.00,1.00;MQM=60;SAP=49;ABP=0	NLRP3	synonymous	NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366497.6:synonymous_variant:LOW:exon4/9:c.786A>G:p.Arg262=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain]	NLRP3:NM_001079821.3:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:,NLRP3:NM_001127461.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:,NLRP3:NM_001127462.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:,NLRP3:NM_001243133.2:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:,NLRP3:NM_004895.5:synonymous_variant:LOW:exon4/10:c.786A>G:p.Arg262=:,NLRP3:NM_183395.3:synonymous_variant:LOW:exon4/8:c.780A>G:p.Arg260=:,NLRP3:XM_011544048.2:synonymous_variant:LOW:exon4/10:c.786A>G:p.Arg262=:,NLRP3:XM_017000181.1:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:,NLRP3:XM_017000182.1:synonymous_variant:LOW:exon5/11:c.786A>G:p.Arg262=:,NLRP3:XM_024452862.1:synonymous_variant:LOW:exon4/8:c.786A>G:p.Arg262=:,NLRP3:XM_024452874.1:synonymous_variant:LOW:exon4/7:c.786A>G:p.Arg262=:		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	403243 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Keratitis fugax hereditaria,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome,not specified,not provided];			rs4925543	0.9463	0.8482,0.9714,0.9988,0.9579,0.8828	65724,.	9700	10868	-0.0360			6.58				0	24033266,28847925	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434047	247434047	-	GAGCTCTCTGGTCAGATGTGTTCTGAGGCCTTCTCTATTCCA	wt	het	hom	off-target;low_conf_region	QUAL=1161;DP=104,12,44;AF=0.00,0.75,1.00;MQM=51;SAP=118;ABP=10	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron5/8:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-101_2322-100insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron6/10:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron5/8:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron4/8:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron5/9:c.2322-41_2322-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron5/9:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron4/7:c.2151-41_2151-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron5/9:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron6/10:c.2328-41_2328-40insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+4307_2327+4308insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2156+8463_2156+8464insATGTGTTCTGAGGCCTTCTCTATTCCAGAGCTCTCTGGTCAG::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs566064212	0.0001		0,.	1	44853				0.35				0.03		5523	2559	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434063	247434063	G	A	hom	hom	hom	off-target	QUAL=9015;DP=131,70,114;AF=1.00,1.00,1.00;MQM=57;SAP=579;ABP=0	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-40G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-40G>A::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron5/8:c.2328-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-100G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron5/9:c.2328-40G>A::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron4/7:c.2151-40G>A::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron5/9:c.2328-40G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron6/10:c.2328-40G>A::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+4308G>A::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2156+8464G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs10925022	0.3091		10045,.	21862	93756	-1.8440			0.36				0.03		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435930	247435930	G	A	het	het	het	off-target	QUAL=1373;DP=46,38,62;AF=0.50,0.39,0.50;MQM=60;SAP=29;ABP=4	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1657G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1657G>A::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron6/8:c.2498+1657G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-40G>A::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron6/8:c.2492+1657G>A::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron6/9:c.2499-40G>A::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron5/7:c.2321+1657G>A::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron6/9:c.2499-40G>A::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron7/10:c.2499-40G>A::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron5/7:c.2327+6175G>A::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron4/6:c.2157-8042G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1259697 [benign DISEASE=not provided];			rs10754557	0.5915	0.2406,0.4940,0.6688,0.6219,0.6035	22556,.	33186	73424	-0.6010			1.37				0.09	29850521,32104685,22318840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247448358	247448359	AG	-	het	het	wt	off-target	QUAL=2097;DP=181,39,76;AF=0.44,0.54,0.00;MQM=60;SAP=197;ABP=6	NLRP3	intron	NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron6/6:c.2664-45_2664-44del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron7/7:c.2835-45_2835-44del::,NLRP3:ENST00000366497.6:intron_variant:MODIFIER:intron8/8:c.2841-45_2841-44del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron8/8:c.2946-45_2946-44del::	NLRP3:NM_001079821.3:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:NM_001127461.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:NM_001127462.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:NM_001243133.2:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:NM_004895.5:intron_variant:MODIFIER:intron9/9:c.3012-45_3012-44del::,NLRP3:NM_183395.3:intron_variant:MODIFIER:intron7/7:c.2664-45_2664-44del::,NLRP3:XM_011544048.2:intron_variant:MODIFIER:intron9/9:c.3012-45_3012-44del::,NLRP3:XM_017000181.1:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::,NLRP3:XM_017000182.1:intron_variant:MODIFIER:intron10/10:c.3012-45_3012-44del::,NLRP3:XM_024452862.1:intron_variant:MODIFIER:intron7/7:c.2670-45_2670-44del::,NLRP3:XM_024452874.1:intron_variant:MODIFIER:intron6/6:c.2499-45_2499-44del::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs201053423	0.0494	0.0102,0.0263,0.0341,0.0561,0.0969	185,.	5688	142412	-0.3360			1.81				0.01		44	1459	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247448734	247448734	G	C	hom	hom	hom		QUAL=50334;DP=702,384,501;AF=1.00,1.00,1.00;MQM=60;SAP=991;ABP=0	NLRP3	3'UTR	NLRP3:ENST00000336119.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000348069.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000366497.6:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391827.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000391828.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::	NLRP3:NM_001079821.3:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:NM_001127461.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_001127462.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:NM_001243133.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:NM_004895.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:NM_183395.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:XM_011544048.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:XM_017000181.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:XM_017000182.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:XM_024452862.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:XM_024452874.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296956 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Cryopyrin associated periodic syndrome];			rs10754558	0.6356		31418,.	33787	55393	0.2860			7.16			COSV59510002	0	27810495,22110538,22112657,23110140,24901306,27446957,29214547,30728751,24144834,26833430,28503575,29385859,26698117,30208882,18576390,21258359,29102545,29430721,28116820,31405022,19767079,23973727,26444566,27455015,29850543,29888470,25297810,26440629,28139755,16642435,20370570,20502346,21245836,22227487,23031505,26236392,26689701,26945813,27060062,27110561,27942564,28456882,28764843,29230505,29732382,31448710,32020248,26273672,26462562,30783474,29507526,30447690,26722603,25788762,29171506,28337127,29026154,23658628,30182779,28740569,27021275,31276515,21163704,30873162,30214462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247449133	247449133	A	T	hom	hom	n/a	off-target	QUAL=1339;DP=38,3,1;AF=1.00,1.00,1.00;MQM=60;SAP=78;ABP=0	OR2B11	3'UTR	OR2B11:ENST00000641149.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1896T>A::,OR2B11:ENST00000641527.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1896T>A::	OR2B11:NR_169840.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.3504T>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs4925547	0.3635		10790,.	33662	96736	0.5200			7.58						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	hom	wt		QUAL=255790;DP=4341,4379,4604;AF=0.99,0.99,0.00;MQM=55;SAP=1233;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879158303	0.0250					-0.0730									559	27	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	wt	hom		QUAL=124489;DP=4274,4418,4697;AF=0.01,0.00,1.00;MQM=51;SAP=319;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs869183622	0.7157					-1.2370									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	wt	hom		QUAL=128428;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs62581312	0.1663					-3.9110									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	wt	hom		QUAL=128428;DP=4145,3297,4003;AF=0.00,0.00,0.99;MQM=60;SAP=901;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs117135796	0.3173					-1.7640									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	wt	hom		QUAL=108106;DP=3712,2438,3379;AF=0.00,0.00,1.00;MQM=60;SAP=968;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs2857291	0.2761					0.2630								22723804,27217714,26550561	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	wt	hom		QUAL=100254;DP=3334,2041,3148;AF=0.00,0.00,0.99;MQM=60;SAP=1009;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879219259	0.0082					0.8940									204	20	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=195056;DP=2667,1158,2350;AF=1.00,1.00,1.00;MQM=60;SAP=2871;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::			441147 [not provided DISEASE=not provided];			rs2853515	0.9907					0.1780								22723804	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	wt	hom		QUAL=56806;DP=2186,774,1909;AF=0.00,0.00,0.99;MQM=60;SAP=792;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41528348	0.0560					-2.8920									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	het	wt		QUAL=47818;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=1768;ABP=175	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::							0.0000														560	2347	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	het	wt		QUAL=47818;DP=771,308,1292;AF=0.75,0.75,0.00;MQM=58;SAP=162;ABP=396	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::							0.0000														37	500	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	hom	wt		QUAL=47818;DP=771,308,1292;AF=0.04,0.01,0.00;MQM=59;SAP=42;ABP=638	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs369786048	0.6255														n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	wt	hom		QUAL=47818;DP=771,308,1292;AF=0.06,0.06,0.00;MQM=60;SAP=452;ABP=655	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs1556422422	0.0043														142	11	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	wt	hom		QUAL=49710;DP=1969,475,1656;AF=0.00,0.00,0.99;MQM=60;SAP=365;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879055956	0.0067					-0.2030									198	5	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	wt	hom		QUAL=54755;DP=2897,1254,1857;AF=0.00,0.00,0.99;MQM=60;SAP=547;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs1603218409	0.0002					-1.1600									9	1	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	wt	hom		QUAL=66241;DP=3034,1850,2270;AF=0.00,0.00,0.99;MQM=60;SAP=361;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs28625645	0.1094					-1.4590								26116242	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	wt	hom		QUAL=66411;DP=3168,1837,2288;AF=0.00,0.00,0.99;MQM=60;SAP=69;ABP=0	MT-ND1,MT-ND2,MT-TL1,MT-TF,MT-TV,MT-RNR2,MT-TI,MT-TQ,MT-TM,MT-TW,MT-RNR1	upstream_gene,downstream_gene	MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs879162984	0.0112					-2.2930									246	17	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=291960;DP=3350,2666,3125;AF=1.00,1.00,1.00;MQM=59;SAP=176;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::	::intergenic_variant:MODIFIER::::			441148 [not provided DISEASE=not provided];			rs2853518	0.9834					6.9050									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=710808;DP=8518,6306,7279;AF=1.00,1.00,1.00;MQM=56;SAP=599;ABP=0	MT-RNR1	non_coding_transcript_exon	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::	::intergenic_variant:MODIFIER::::			42220 [benign DISEASE=not specified,not provided];			rs2001030	0.9561					0.2380								24033266,9519725,18830133	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	wt	hom		QUAL=121522;DP=5784,3332,3825;AF=0.00,0.00,0.99;MQM=60;SAP=11;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::	::intergenic_variant:MODIFIER::::						rs878878913	0.0044					2.0490									139	15	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=181791;DP=3107,1273,1453;AF=1.00,1.00,1.00;MQM=60;SAP=239;ABP=0	MT-RNR2	non_coding_transcript_exon	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::	::intergenic_variant:MODIFIER::::					LSU-rRNA_Hsa (rRNA)	rs2854128	0.7395					-0.0780								30242290	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	wt	hom		QUAL=105469;DP=3787,3101,3517;AF=0.00,0.00,0.99;MQM=45;SAP=243;ABP=0	MT-ND1	missense	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase]	::intergenic_variant:MODIFIER::::			9724 [benign DISEASE=Leber optic atrophy,Leigh syndrome,not provided];			rs1599988	0.1176					0.2170	T(1.00)	B(0.01)				COSV62293824		1732158,1900003,7635294,20301353,22723804,29370225,1417830,30684245,27594409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	hom	wt		QUAL=102690;DP=2456,1672,1946;AF=0.99,0.99,0.00;MQM=31;SAP=14;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs28357975	0.0242					-3.5290									349	10	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=170622;DP=2340,2039,2312;AF=1.00,1.00,1.00;MQM=33;SAP=1560;ABP=0	MT-ND2	synonymous	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::			441150 [not provided DISEASE=not provided];			rs3021086	0.9839					-20.0000									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT; NGSD: >13000 other homo samples; gnomAD 3.1: >98% are also homo"			MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=309502;DP=3122,3481,4000;AF=0.99,1.00,1.00;MQM=43;SAP=343;ABP=0	MT-CO1	synonymous	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I]	::intergenic_variant:MODIFIER::::						rs2015062	0.7494					-9.1980									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	wt	hom		QUAL=45025;DP=4058,1392,1603;AF=0.00,0.00,0.99;MQM=43;SAP=195;ABP=0	MT-TS1	non_coding_transcript_exon	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::	::intergenic_variant:MODIFIER::::			42228 [benign/likely benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke,not specified];		tRNA-Ser-TCA(m) (tRNA)	rs201950015	0.0110					-0.8360								24033266,15286157,18790089,8155739,8728705,9384601,19371214,21621438	266	16	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	wt	hom		QUAL=142185;DP=7840,5642,4982;AF=0.00,0.00,0.99;MQM=58;SAP=4418;ABP=0	MT-CO2	synonymous	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain]	::intergenic_variant:MODIFIER::::			376897 [benign DISEASE=not provided];			rs386829014	0.0110					-9.8780								25741868	262	45	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=172704;DP=1893,2140,2331;AF=1.00,1.00,1.00;MQM=34;SAP=12;ABP=0	MT-ATP6	missense	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain]	::intergenic_variant:MODIFIER::::			693004 [benign DISEASE=Leigh syndrome];			rs2001031	0.9938					0.2660	T(0.10)	B(0.00)							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT variant; MitoMap: in >99% of gnomAD 3.1 sequences homo; NGSD: almost existing in each sample homo"			MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	wt	hom		QUAL=119866;DP=4708,3107,3733;AF=0.00,0.00,0.99;MQM=60;SAP=202;ABP=0	MT-ND3	missense	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:	::intergenic_variant:MODIFIER::::			9713 [benign DISEASE=Leigh syndrome,Parkinson disease, resistance to];			rs2853826	0.4185					-0.3380	T(1.00)	B(0.00)						24437375,23133645,6343397,17066297,26116242,26336829,23944767,25580814,30275759	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	wt	hom		QUAL=122661;DP=4622,3081,3752;AF=0.00,0.00,0.99;MQM=60;SAP=6;ABP=0	MT-ND4L	synonymous	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L]	::intergenic_variant:MODIFIER::::			376866 [benign DISEASE=not provided];			rs1057520074	0.0074					-1.0050								25741868	192	21	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	wt	hom		QUAL=178485;DP=6509,4782,5630;AF=0.00,0.00,0.99;MQM=60;SAP=79;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs869096886	0.1101					-6.9950						COSV62293827		29370225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	wt	hom		QUAL=145312;DP=6159,4070,4560;AF=0.00,0.00,0.99;MQM=60;SAP=410;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs193302938	0.0136					1.9500									307	71	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	wt	hom		QUAL=166017;DP=6942,4183,5325;AF=0.00,0.01,1.00;MQM=57;SAP=15;ABP=0	MT-ND4	synonymous	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter]	::intergenic_variant:MODIFIER::::						rs2853495	0.7110					-12.2800						COSV104668829		27716073,27877219	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	wt	hom		QUAL=164517;DP=7635,4367,5142;AF=0.00,0.00,0.99;MQM=60;SAP=167;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus]	::intergenic_variant:MODIFIER::::						rs28359172	0.0578					-3.2010									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	wt	hom		QUAL=51211;DP=4575,1555,1715;AF=0.00,0.00,0.99;MQM=60;SAP=5;ABP=0	MT-ND5	missense	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			9696 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs28359178	0.0756					0.6330	T(0.19)	B(0.00)						19387457,29594131,1732158,1900003,7635294,20301353,1417830,1764087,25925750	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	wt	hom		QUAL=53889;DP=4657,1669,1807;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377244 [benign DISEASE=not provided];			rs386829190	0.0076					-7.6180								25741868	197	19	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	wt	hom		QUAL=97116;DP=3887,2752,3083;AF=0.00,0.00,0.99;MQM=60;SAP=27;ABP=0	MT-ND5	synonymous	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus]	::intergenic_variant:MODIFIER::::			377029 [benign DISEASE=not provided];			rs879100848	0.0079					-7.4090								25741868	188	29	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	hom	wt		QUAL=192537;DP=3958,2175,2360;AF=0.99,0.99,0.00;MQM=60;SAP=48;ABP=0	MT-ND6	synonymous	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6]	::intergenic_variant:MODIFIER::::						rs1603224697	0.0007					-11.2190									19	1	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	wt	hom		QUAL=71339;DP=3291,2101,2288;AF=0.00,0.01,1.00;MQM=60;SAP=263;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:	::intergenic_variant:MODIFIER::::			140587 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs193302980	0.7068					0.1160	D(0.04)	B(0.00)							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	wt	hom		QUAL=122515;DP=4505,3615,3830;AF=0.00,0.00,0.99;MQM=60;SAP=23;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF00033 [Cytochrome b/b6/petB]	::intergenic_variant:MODIFIER::::			9674 [benign DISEASE=Leber optic atrophy,Leigh syndrome];			rs41518645	0.0127					6.1030	D(0.01)	B(0.01)				COSV62378578		1732158,7635294,20301353,1764087,7901141,8240104,8321540,8755941	316	63	0 / 0					MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=370563;DP=4451,3485,3653;AF=1.00,1.00,1.00;MQM=60;SAP=208;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF00033 [Cytochrome b/b6/petB]	::intergenic_variant:MODIFIER::::			140592 [benign DISEASE=Leigh syndrome,Familial cancer of breast];			rs2853508	0.9934					-5.3890	T(0.28)	B(0.01)						31267007	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	wt	hom		QUAL=107039;DP=6681,3238,3396;AF=0.00,0.00,0.99;MQM=60;SAP=15;ABP=0	MT-CYB	missense	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:	::intergenic_variant:MODIFIER::::			143925 [benign DISEASE=Neoplasm of ovary,Leigh syndrome];			rs193302994	0.1103					-2.5920	T(0.51)	B(0.24)						29594131,29370225,30684245	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	hom	wt		QUAL=301744;DP=5974,3321,3771;AF=0.99,0.99,0.00;MQM=60;SAP=21;ABP=0	MT-TT	non_coding_transcript_exon	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::	::intergenic_variant:MODIFIER::::			690224 [benign DISEASE=Juvenile myopathy, encephalopathy, lactic acidosis AND stroke];			rs35788393	0.0224					-0.9230									433	17	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	wt	hom		QUAL=119059;DP=5768,3606,3741;AF=0.00,0.00,0.99;MQM=60;SAP=21;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147903261	0.0562					-2.0290								28813576	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	wt	hom		QUAL=123839;DP=5728,4018,3919;AF=0.00,0.00,0.99;MQM=60;SAP=165;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs147029798	0.1432					-0.6180									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	wt	hom		QUAL=124342;DP=5664,4053,3945;AF=0.00,0.00,0.99;MQM=60;SAP=148;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs41419246	0.0284					-1.2640									556	89	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	wt	hom		QUAL=149870;DP=6609,4462,4804;AF=0.00,0.00,0.99;MQM=60;SAP=112;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					(CAACTAT)n (Simple_repeat)	rs386829286	0.0078					-0.3440									183	28	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	wt	hom		QUAL=149995;DP=7144,4286,4789;AF=0.00,0.00,0.99;MQM=60;SAP=28;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs138126107	0.0365					-1.3990									659	121	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	hom	wt		QUAL=332631;DP=6107,4219,4816;AF=0.99,0.99,0.00;MQM=60;SAP=110;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs148377232	0.0498					-0.9170									766	132	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	hom	wt		QUAL=378419;DP=6991,5418,5370;AF=1.00,1.00,0.02;MQM=55;SAP=15;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs3937033	0.6573					-0.2250								22723804,26550561	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)		"hohe Frequenz [1] ahbecks1 15.09.2021 [n/a] ahbecks1 15.09.2021"			MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
